class;term;comment
process;intralymphatic administration;An administration of a substance into the lymphatic system of an organism.
process;intraepidermal administration;An administration of a substance into the epidermis of an organism.
process;urethral administration;An administration of a substance into the urethra of an organism.
process;lymph node administration;An intralymphatic administration in which the substance is administered into a lymph node.
process;intrauteral administration;An adminstration of a substance into the uterus of an organism.
process;skin scarification administration;An intraepidermal administration in which the skin is scratched before the substance is administered to the skin.
process;intra-arterial administration;An administration of a substance into the artery of an organism.
process;intra-amniotic administration;An administration of a substance into the amnion of an organism.
process;intracranial administration;An administration of a substance into the cranium of an organism.
generically dependent continuant;pathologic primary tumor stage for lung according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of lung cancer following the rules of the TNM American Joint Committee on Cancer (AJCC) version 7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;intracerebral administration;An administration of a substance into the cerebrum of an organism.
process;skin of body microbiology assay;An organism detection assay that detects microorganisms in a skin of body specimen.
process;scratching;A process in which the target material entity is scraped by another material entity.
process;bone marrow microbiology assay;An organism detection assay that detects microorganisms in a bone marrow specimen.
generically dependent continuant;skin of body microbiology datum;An organism detection datum that is the specified output of a skin of body microbiology assay.
generically dependent continuant;bone marrow microbiology datum;An organism detection datum that is the specified output of a bone marrow microbiology assay.
process;intracarotid administration;An intra-arterial administration in which the substance is administered into the carotid artery.
process;intraplacental administration;An administration of a substance into the placenta of an organism.
process;intraocular administration;An administration of a substance to the eye of an organism.
process;intrasplenic administration;An administration of a substance into the spleen of an organism.
generically dependent continuant;pathologic primary tumor stage for kidney according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of renal cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;intrarectal administration;An administration of a substance into the rectum of an organism.
process;cell culture assay;An assay that has cell culture as an input.
generically dependent continuant;pathologic primary tumor stage for ovary according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;Annexin V staining;Staining using Annexin V to detect apoptotic cells.
process;serum anti-Epstein-Barr virus antibody level assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to Epstein-Barr virus (EBV) antigens in a serum sample.
generically dependent continuant;nasal aspirate microbiology datum;An organism detection datum that is the specified output of a nasal aspirate microbiology assay.
process;nasal aspirate microbiology assay;An organism detection assay that detects microorganisms in a nasal aspirate specimen.
process;cell viability assay;A cytometry assay which measures the number of living cells in a population.
process;cell proliferation assay using carboxyfluorescein succinimidyl ester staining;A cell proliferation assay that uses carboxyfluorescein succinimidyl ester staining to detect cell division.
process;carboxyfluorescein succinimidyl ester staining;Staining using carboxyfluorescein succinimidyl ester.
process;cell viability assay using Annexin V staining;A cell viability assay that uses Annexin V staining to detect apoptotic cells.
process;single cell B cell receptor repertoire sequencing assay;A B cell receptor repertoire sequencing assay that determines the sequence of DNA or RNA molecules that encode the repertoire of B cell receptors that can be traced to a single cell of origin.
process;single cell T cell receptor repertoire sequencing assay;A T cell receptor repertoire sequencing assay that determines the sequence of DNA or RNA molecules that encode the repertoire of T cell receptors that can be traced to a single cell of origin.
process;serum anti-cytomegalovirus antibody level assay;A CMV antibody assay that has serum as an input.
generically dependent continuant;sequential organ failure assessment score;A clinical data item that quantifies the degree of function of a critically ill patient's organs.
generically dependent continuant;chronic allograft damage index score;A clinical data item that quantifies the degree of tissue damage in biopsies taken from transplanted kidneys.
generically dependent continuant;human leukocyte antigen mismatch count;A genetic characteristics information that is about the number of dissimilarities in the human leukocyte antigen gene complexes of two humans.
generically dependent continuant;physician's global assessment of disease activity;A clinical data item that quantifies a physician's judgement of the overall activity of some specific disease in a patient.
material entity;nasal lavage fluid;A specimen collected through nasal cavity lavage that contains the reagents used to for the lavage process, organisms, cells, cellular secretions, and other biomaterials present in the nasal cavity space.
material entity;liquid chromatography autosampler;Designed to perform capillary LC with injection of sample volumes ranging from nL to L.
process;stance feet apart assessment, with eyes closed;A limits of stability assessment designed to assess an individual's ability to maintain a stable stance with their eyes closed.
material entity;rapid resolution column;A rapid resolution column is a chromatography column as marketed by Agilent, which is used with a rapid resolution cartridge to ensure a fast chromatography process with good separation resolution.
process;stance feet apart assessment;A limits of stability assessment designed to assess an individual's ability to maintain a stable stance with feet 20 cm apart.
generically dependent continuant;sequential design;Any design in which the decision as to whether to enroll the next patient, pair of patients, or block of patients is determined by whether the cumulative treatment difference for all previous patients is within specified limits. Enrollment is continued if the difference does not exceed the limits. It is terminated if it does
material entity;Bruker B-ACS system;The Bruker Automatic Sample Changer (B-ACS 60/120), used in conjunction with Bruker DISNMR, UXNMR or XWIN-NMR software, provides dialog-guided facilities which allow the user to easily and effectively perform automatic (continuous) experiments. Features include a 60 or 120 sample capacity, random accessing of samples, positive sample identification with the optional bar code reader, and temperature control of individual samples with the optional sample heater unit.
process;stance feet together assessment, with eyes closed;A limits of stability assessment designed to assess an individual's ability to maintain a stable stance with feet together and eyes closed.
material entity;direct detection NMR probe;An NMR probe designed to allow the direct detection of acquisition nuclei.
process;stance feet together assessment;A limits of stability assessment designed to assess an individual's ability to maintain a stable stance with feet together.
material entity;cation exchange column;A cation exchange column is a chromatography column that is used in cation exchange chromatography.
process;stance on one foot assessment;A limits of stability assessment designed to assess an individual's ability to maintain a stable stance on one foot.
process;tandem stance assessment;A limits of stability assessment designed to assess an individual's ability to maintain a stable stance with feet in tandem placement.
process;gait assessment;A limits of stability assessment designed to assess an individual's manner or pattern of walking.
process;tandem walk assessment;A limits of stability assessment designed to assess an individual's ability to maintain balance while walking in a straight line placing steps in tandem.
material entity;NMR console;A component of an NMR instrument that controls the activities of the other components.
material entity;NMR tube washing system;An automatic cleaning system for NMR tubes that removes previous probe and sample residues in order to allow for tube recycling.
material entity;sample inlet;The column inlet (or injector) provides the means to introduce a sample into a continuous flow of carrier gas. The inlet is a piece of hardware attached to the column head.
material entity;capillary column;A capillary column is a thin tube with a small inner diameter, usually around 0.5 mm.
generically dependent continuant;observation design;observation design is a study design in which subjects are monitored in the absence of any active intervention by experimentalists.
material entity;vacuum degasser;A degassing system used for degassing solvents in liquid chromatography. Dissolved gasses, usually nitrogen and oxygen from the air, tend to be evolved in the mobile phase as the pressure is reduced when the mobile phase leaves the liquid chromatography column and enters the detector. Gasses in the mobile phase in the detector can produce completely unacceptable noise and, thus, must be removed. The dissolved gasses were originally removed under vacuum but, unfortunately, are soon replaced if the solvent is left in contact with air at atmospheric pressure. For this reason degassing is now usually carried out by bubbling helium through the mobile phase reservoirs. Secondly, vacuum is used in the thermionic detector. This consists of a device, very similar in design to the thermionic valve which is attached to a vacuum and a small quantity of the eluent from a gas chromatography column allowed to bleed through it. Helium is used as the carrier gas. The presence of solute vapor causes the thermionic current to fall. This type of detector tends to become contaminated rather readily.
process;spontaneous speech assessment;A functional assessment of an individual's ability to articulate spoken words.
process;bulbar assessment;A functional assessment of an individual's lower cranial nerve function via proxy of facial muscle performance.
generically dependent continuant;cannot be assessed determination;A reason for lack of data item that is the negative output of a determination if assay will provide reliable results.
process;lower limb coordination assessment;A limb coordination assessment designed to assess an individual's ability to coordinate lower limb movement.
process;determination if assay will provide reliable results;A planned process that is used to assess whether an assay will provide reliable results based on the conditions or qualities of the inputs, devices, and other participants of the assay.
process;upper limb coordination assessment;A limb coordination assessment designed to assess an individual's ability to coordinate upper limb movement.
generically dependent continuant;GX;A cannot be assessed determination for histologic tumor grade.
process;upright stability assessment;A functional assessment of an individual's ability to maintain upright body posture.
generically dependent continuant;pTX;A cannot be assessed determination for pathologic primary tumor staging.
process;nervous system functionality assessment;A functional assesment of an individual's nerve performance. Specifically the nerves connecting the sensory and motor structures with the central nervous system.
generically dependent continuant;pNX;A cannot be assessed determination of pathologic staging of lymph nodes.
process;observational assessment of individual;A physical examination of an organism through visual assesment.
generically dependent continuant;histologic grade according to AJCC 7th edition;A categorical value specification that is a histologic grade assigned to a tumor slide specimen according to the American Joint Committee on Cancer (AJCC) 7th Edition grading system.
process;deep tendon reflex assessment of the knee joint;A deep tendon reflex assessment of an individual's reaction to stimulus applied to a knee joint.
process;deep tendon reflex assessment of the tendon of biceps brachii;A deep tendon reflex assessment of an individual's reaction to stimulus applied to a tendon of biceps brachii.
process;deep tendon reflex assessment of the ankle joint;A deep tendon reflex assessment of an individual's reaction to stimulus applied to an ankle joint.
process;limb coordination assessment;A functional assessment of an individual's ability to coordinate limb movement.
process;deep tendon reflex assessment of the brachioradialis;A deep tendon reflex assessment of an individual's reaction to stimulus applied to a brachioradialis.
process;microarray assay measuring NS1;A microarray assay that detects NS1.
process;microarray assay measuring Dengue IgM antibody;A microarray assay that detects the IgM antibody that binds Dengue.
process;ELISA measuring Chikungunya IgM antibody;An enzyme-linked immunosorbent assay that detects the IgM antibody that binds Chikungunya.
process;analytical chromatography measuring Chikungunya IgM antibody;Analytical chromatography that detects the IgM antibody that binds Chikungunya.
generically dependent continuant;histologic grade for ovarian tumor;A categorical value specification that is a histologic grade assigned to a ovarian tumor.
process;liquid chromatography;A preparative chromatography in which material components are separated in a liquid solution.
generically dependent continuant;histologic grade for ovarian tumor according to a two-tier grading system;A histologic grade for ovarian tumor that is from a two-tier histological classification of tumors.
process;microarray ELISA measuring Chikungunya IgM antibody;An enzyme-linked immunosorbent assay that uses a microarray as the solid support and detects the IgM antibody that binds Chikungunya.
generically dependent continuant;lower limit of detection;A value specification that specifies the smallest concentration/amount of a substance that can be detected in an analyte assay.
generically dependent continuant;upper limit of detection;A value specification that specifies the largest concentration/amount of a substance that can be quantified in an analyte assay.
process;ELISA measuring Orientia tsutsugamushi IgM antibody;An enzyme-linked immunosorbent assay that detects the IgM antibody that binds Orientia tsutsugamushi.
generically dependent continuant;histologic grade according to the Fuhrman Nuclear Grading System;A categorical value specification that is a histologic grade assigned to a tumor slide specimen according to the Fuhrman Nuclear Grading System.
process;tandem mass spectrometry assay;A mass spectrometry assay that uses two or more analyzers separated by a region in which ions can be induced to fragment by transfer of energy (frequently by collision with other molecules).
generically dependent continuant;histologic grade for ovarian tumor according to the World Health Organization;A histologic grade for ovarian tumor that is from a histological classification by the World Health Organization (WHO).
process;intracolonic administration;An administration of a substance into the colon of an organism.
process;intragastric administration;An administration of a substance into the stomach of an organism.
generically dependent continuant;pathologic primary tumor stage for colon and rectum according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of colorectal cancer following the rules of the TNM American Joint Committee on Cancer (AJCC) version 7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;topical administration;An administration of a substance onto the surface of the skin of an organism.
process;vaginal administration;An administration of a substance into the vagina of an organism.
process;conjunctival administration;An administration of a substance to the conjunctiva of an organism.
process;cervical administration;An administration of a substance to the cervix of an organism.
process;intratracheal administration;An administration of a substance into the trachea of an organism.
material entity;odor baited CDC light trap;A CDC light trap that uses odorous gas from a human being as an attractant, by pumping it from the room where the human being sleeps into the trap.
process;proximity ligation-assisted ChIP-seq;A chromosome conformation capture assay in which proximity ligation is conducted in nuclei prior to chromatin shearing and immunoprecipitation. Immunopreciptation with an antibody that targets a transcription factor or histone modification allows for selection and enrichment of specific genomic regions for investigation of long-range chromosomal interactions.
material entity;resting clay pot trap;A resting arthropod trap that consists of a container composed primarily of clay.
material entity;regulatory agency;A regulatory agency is a organization that has responsibility over or for the legislation (acts and regulations) for a given sector of the government.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific macrophage inflammatory protein-1 gamma production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects macrophage inflammatory protein-1 gamma production by T cells.
process;CBC with manual differential venous blood neutrophil count assay;A cytometry assay that measures the count of neutrophils in venous blood as part of a CBC with manual differential order
process;intracellular cytokine staining assay measuring epitope specific monocyte chemotactic protein-1 production by T cells;A flow cytometry assay that detects monocyte chemotactic protein-1 production by T cells.
process;b transformation;A b transformation is a data transformation obtained by applying the function B described in what follows to a (one dimensional) real number input. B(x)= a*exp(b*x)-c*exp(-d*x)+f, where exp denotes an exponential transformation and a, b, c, d, f are real constants with a, b, c, d positive with the objective of normalization.
process;creatinine clearance urine creatinine assay;An analyte assay that measures the abundance of creatinine in urine as part of a creatinine clearance order
process;ELISPOT assay measuring epitope specific monocyte chemotactic protein-1 production by T cells;An enzyme-linked immunospot assay that detects monocyte chemotactic protein-1 production by T cells.
process;venous blood beta hydroxybutryic acid assay;An analyte assay that measures the abundance of beta hydroxybutryic acid in venous blood
process;intracellular cytokine staining assay measuring epitope specific macrophage inflammatory protein-1 gamma production by T cells;A flow cytometry assay that detects macrophage inflammatory protein-1 gamma production by T cells.
process;venous blood megakaryocyte count assay;A cytometry assay that measures the count of megakaryocytes in venous blood
process;ELISPOT assay measuring epitope specific macrophage inflammatory protein-1 gamma production by T cells;An enzyme-linked immunospot assay that detects inflammatory protein-1 gamma production by T cells.
process;venous blood nucleated RBC count assay;A cytometry assay that measures the count of nucleated RBCs in venous blood
process;cytometric bead array assay measuring epitope specific vascular endothelial growth factor production by T cells;A cytometric bead array assay that detects vascular endothelial growth factor production by T cells.
process;venous blood WBC count assay;A cytometry assay that measures the count of WBCs in venous blood
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects tumor necrosis factor superfamily cytokine production by T cells.
process;automated count venous blood reticulocyte count assay;A cytometry assay that measures the count of reticulocytes in venous blood as part of a automated count order
process;intracellular cytokine staining assay measuring epitope specific RANTES production by T cells;A flow cytometry assay that detects RANTES production by T cells.
process;total venous blood homocysteine assay;An analyte assay that measures the abundance of homocysteine in venous blood as part of a total order
generically dependent continuant;manufacturing objective;is the objective to manufacture a material of a certain function (device)
process;manufacturing;A planned process with the objective to produce a processed material which will have a function for future use.
generically dependent continuant;material transformation objective;an objective specifiction that creates an specific output object from input materials.
function;consume data function;Process data function is a function that is borne by in a material entity by virtue of its structure. When realized the material entity consumes data.
process;extracellular electrophysiology recording assay;An electrophysiology assay where the recording location of the electrode is extracellular.
function;measure function;Measure function is a function that is borne by a processed material and realized in a process in which information about some entity is expressed relative to some reference.
process;ELISPOT assay measuring epitope specific macrophage inflammatory protein-1 alpha production by T cells;An enzyme-linked immunospot assay that detects macrophage inflammatory protein-1 alpha production by T cells.
process;liver fibrosis (chronic viral hepatitis) venous blood platelet count assay;A cytometry assay that measures the count of platelets in venous blood as part of a liver fibrosis (chronic viral hepatitis) order
generically dependent continuant;normalized data set;A data set that is produced as the output of a normalization data transformation.
process;cytometric bead array assay measuring epitope specific macrophage inflammatory protein-1 gamma production by T cells;A cytometric bead array assay that detects macrophage inflammatory protein-1 gamma production by T cells.
process;venous blood T3 assay;An analyte assay that measures the abundance of T3 in venous blood
process;canonical variate analysis;canonical variate analysis is a form of discriminant analysis that takes several continuous predictor variables and uses the entire set to predict several criterion variables, each of which is also continuous. CVA simultaneously calculates a linear composite of all x variables and a linear composite of all y variables. Unlike other multivariate techniques, these weighted composites are derived in pairs. Each linear combination is called a canonical variate and takes the general linear form.
process;regression analysis method;Regression analysis is a descriptive statistics technique that examines the relation of a dependent variable (response variable) to specified independent variables (explanatory variables). Regression analysis can be used as a descriptive method of data analysis (such as curve fitting) without relying on any assumptions about underlying processes generating the data.
process;linear discriminant functional analysis;Linear discriminant functional analysis (LDFA) is a multivariate technique used in special applications where there are several intact groups (random assignment may be impossible) and they have been measured on several independent measures. Thus, you will want to describe how these groups differ on the basis of these measures. In this case, classification and prediction is the main objective.
process;principal component regression;The Principal Component Regression method is a regression analysis method that combines the Principal Component Analysis (PCA)spectral decomposition with an Inverse Least Squares (ILS) regression method to create a quantitative model for complex samples. Unlike quantitation methods based directly on Beer's Law which attempt to calculate the absorbtivity coefficients for the constituents of interest from a direct regression of the constituent concentrations onto the spectroscopic responses, the PCR method regresses the concentrations on the PCA scores.
process;multiple linear regression analysis;multiple linear regression is a regression method that models the relationship between a dependent variable Y, independent variables Xi, i = 1, ..., p, and a random term epsilon. The model can be written as Y = \beta 0 + \beta 1 X 1 + \beta 2 X 2 + \cdots +\beta p X p + \varepsilon where \beta 0 = 0 is the intercept ("constant" term), the \beta i s are the respective parameters of independent variables, and p is the number of parameters to be estimated in the linear regression.
process;discriminant analysis;Discriminant function analysis is used to determine which variables discriminate between two or more naturally occurring groups. Analysis is used to determine which variable(s) are the best predictors of a particular outcome.
process;partial least square regression analysis;Partial least squares regression is an extension of the multiple linear regression model (see, e.g., Multiple Regression or General Stepwise Regression). In its simplest form, a linear model specifies the (linear) relationship between a dependent (response) variable Y, and a set of predictor variables, the X's, so that Y = b0 + b1X1 + b2X2 + ... + bpXp In this equation b0 is the regression coefficient for the intercept and the bi values are the regression coefficients (for variables 1 through p) computed from the data.
process;eh transformation;An eh transformation is a data transformation obtained by applying the function EH described in what follows to a (one dimensional) real number input. EH(x)=exp(x*d/r)+b*(d/r)*x-1, if x>=0, and EH(x)=-exp(-x*d/r)+b*(d/r)*x+1, otherwise. Here exp denotes an exponential transformation and b, d, r are positive real constants with the objective of normalization.
process;partial least square discriminant analysis;PLS Discriminant Analysis (PLS-DA) is a discriminant analysis performed in order to sharpen the separation between groups of observations, by hopefully rotating PCA (Principal Components Analysis) components such that a maximum separation among classes is obtained, and to understand which variables carry the class separating information.
process;cytometric bead array assay measuring epitope specific lymphotoxin A production by T cells;A cytometric bead array assay that detects lymphotoxin A production by T cells.
process;GEM4 arterial blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in arterial blood as part of a GEM4 order
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific lymphotoxin A production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects lymphotoxin A production by T cells.
process;GEM4 arterial blood sodium assay;An analyte assay that measures the abundance of sodium in arterial blood as part of a GEM4 order
process;ELISPOT assay measuring epitope specific IP-10 production by T cells;An enzyme-linked immunospot assay that detects IP-10 production by T cells.
process;GEM4 arterial blood potassium assay;An analyte assay that measures the abundance of potassium in arterial blood as part of a GEM4 order
process;intracellular cytokine staining assay measuring epitope specific IP-10 production by T cells;A flow cytometry assay that detects IP-10 production by T cells.
process;GEM4 arterial blood temperature assay;An assay that measures temperature in arterial blood as part of a GEM4 order
process;ELISPOT assay measuring epitope specific interleukin-9 production by T cells;An enzyme-linked immunospot assay that detects interleukin-9 production by T cells.
process;GEM4 arterial blood glucose assay;An analyte assay that measures the abundance of glucose in arterial blood as part of a GEM4 order
process;intracellular cytokine staining assay measuring epitope specific interleukin-9 production by T cells;A flow cytometry assay that detects interleukin-9 production by T cells.
process;GEM4 arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a GEM4 order
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-9 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-9 production by T cells.
process;GEM4 arterial blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in arterial blood as part of a GEM4 order
material entity;solvent mixer;A liquid chromatography device that mixes different solvents, e.g. under high pressure and in differrent volumes ranging from 5 ml to 5 L capacity. Powerful magnetic mixers provide vigorous agitation required for high pressure reaction chemistry.
material entity;protein column;A protein column is a chromatography column used for the separation of complex protein mixtures. Protein columns enable sample desalting, followed by chromatographic separation or fractionation of complex protein samples, e.g. immunodepleted serum or plasma proteins.
material entity;Bruker US 2 NMR magnet;An actively-shielded superconducting magnet from Bruker that combines Bruker BioSpin's advanced, proprietary UltraShield active shielding and UltraStabilized sub-cooling technologies. This shielded and stabilized (US2) magnet system delivers high sensitivity and spectral dispersion.
material entity;thermal conductivity detector;The most commonly used detector in preparative GC is the thermal conductivity detector (hot wire detector). Even this detector, however, is often too sensitive and has too high a flow impedance. Under such circumstances, the procedure mentioned above must be employed. The eluent from the preparative column is split and a small portion diverted through the detector (sometimes with further dilution with carrier gas to reduce sensitivity).
material entity;organic acid column;An organic acid column is a chromatography column which enables (reversed-phase) separation of hydrophilic aliphatic and aromatic organic acids with UV detection. Organic acid columns allow retention of polar and apolar organic acids and are hydrolysis resistant.
material entity;Bruker autosampler;A Bruker autosampler is an autosampler made by Bruker.
process;ELISPOT assay measuring epitope specific RANTES production by T cells;An enzyme-linked immunospot assay that detects RANTES production by T cells.
process;venous blood Ceruloplasmin assay;An analyte assay that measures the abundance of Ceruloplasmin in venous blood
material entity;column chromatography detector;There is a wide range of detectors available for both GC and LC each having their own particular areas of application. In general the more catholic the response, the less sensitive the detector and the most sensitive detectors are those that have a specific response. The performance of all detectors should be properly specified so that the user can determine which is most suitable for a specific application. Such specifications are also essential to compare the performance of different detectors supplied by alternative instrument manufactures. Detector specifications should be presented in a standard form and in standard units, so that detectors can be compared that function on widely different principles.
process;ELISPOT assay measuring epitope specific lymphotoxin A production by T cells;An enzyme-linked immunospot assay that detects lymphotoxin A production by T cells.
process;GEM4 arterial blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in arterial blood as part of a GEM4 order
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific macrophage inflammatory protein-1 alpha production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects macrophage inflammatory protein-1 alpha production by T cells.
process;GEM4 arterial blood lactic acid assay;An assay that measures lactic acid in arterial blood as part of a GEM4 order
process;CBC with manual differential venous blood plasma cell count assay;A cytometry assay that measures the count of plasma cells in venous blood as part of a CBC with manual differential order
process;study design execution;a planned process that carries out a study design
process;venous blood erythropoietin assay;An analyte assay that measures the abundance of erythropoietin in venous blood
process;mass spectrometry assay;An assay that identifies the amount and type of material entities present in a sample by fragmenting the sample and measuring the mass-to-charge ratio of the resulting particles.
process;functional assessment of individual;A physical examination of an organism's ability to perform functional activities.
process;blood gas arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a blood gas order
process;blood gas arterial blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in arterial blood as part of a blood gas order
process;tongue atrophy assessment;An observational assessment of the loss of muscle tissue related to tongue movement due to inactivity or disease.
process;blood gas arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a blood gas order
process;facial atrophy assessment;An observational assessment of the loss of facial muscle tissue due to inactivity or disease.
process;free/total venous blood PSA assay;An analyte assay that measures the abundance of PSA in venous blood as part of a free/total order
process;speech test assessment;A functional assessment of an individual's ability to understandably repeat spoken sentences.
process;forced cough assessment;A functional assessment of an individual's ability to cough forcefully.
material entity;solid NMR probe;An NMR probe that is designed to hold a solid sample.
material entity;column connector;A device that connects two or more columns together in a functional way with leak-tight connection, low dead volume, low thermal mass and high inertness.
material entity;Varian GEMINI spectrometer;An older Varian Broadband NMR spectrometer.
material entity;manual injection system;The traditional hardware system that allows a human to inject a sample into an inlet by hand, using a syringe.
process;GEM4 arterial blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in arterial blood as part of a GEM4 order
material entity;Bruker AutoClean system;NMR tubes are often used once and discarded, creating needless waste. With the Bruker BioSpin Autoclean system you can now recycle 5mm, 3mm, or 5mm/3mm step-down (Wilmad 520-1B) NMR tubes. AutoClean NMR Tube Washing System is a simple way to recoup the substantial investment your organization makes in quality NMR tubes, and cut back on needless waste material.
process;GEM4 arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a GEM4 order
material entity;nano pump system;A pump system optimized for nano flow chromatography.
process;liver fibrosis (NAFLD) venous blood platelet count assay;A cytometry assay that measures the count of platelets in venous blood as part of a liver fibrosis (NAFLD) order
material entity;Bruker NMR Case sample changer;The NMR Case is an economical NMR sample changer for laboratories with modest automation needs. It expands the maximum number of samples your spectrometer can process during unattended operation to 24. The NMR Case consists of multiple components. The NMR Case exchange module installed atop your cryostat. The two front legs are adjustable, making the NMR Case compatible with many different cryostats.
process;venous blood beta hydroxybutric acid assay;An analyte assay that measures the abundance of beta hydroxybutric acid in venous blood
process;nose to finger assessment;A functional assessment of an individual's ability to touch their own nose and then touch an examiners finger in front of them and then touch their own nose once more.
process;finger to finger assessment;A functional assessment of an individual's ability to touch index fingers together in front of the sternum without oscillation for a specified duration of time
process;rapid alternating hands assessment;A functional assessment of an individual's ability to alternate the forearm between pronation and suppination as quickly as possible during a specified duration of time
process;dysmetria assessment;A functional assessment of an individual's ability to accurately touch a moving target with their finger and then touch their own chin a number of times in a row.
material entity;APOLLO console;The APOLLO is a compact, modular, multiple-DSP, Windows XP Professional-based console that can be equipped with up to 8 DDS-based RF transmitter channels configurable from 2 kHz to 3.5 GHz. Each transmitter channel produces a nominal 1V output and has the most agile frequency, phase and amplitude control of any system on the market. An array of additional options are available including multiple RF transmitters, linear high-power RF amplifiers, digital receiver arrays, low noise figure preamplifiers, a gradient control system, shim unit, MAS spin-speed controller, variable temperature unit, digital lock system and probe/coil interface. With its numerous options, the Apollo can be configured for any NMR, NQR or MRI application.
process;finger taps assessment;A functional assessment of an individual's ability to touch their finger-tip to thumb as many times as possible during a specified duration of time.
process;cerebrospinal fluid monocyte count assay;A cytometry assay that measures the count of monocytes in cerebrospinal fluid
material entity;normal phase column;A normal phase column is a chromatography column in which the stationary phase is more polar than the mobile phase. Its counterpart is the reversed phase column.
process;cerebrospinal fluid eosinophil count assay;A cytometry assay that measures the count of eosinophils in cerebrospinal fluid
material entity;chromatography detector;A chromatography detector is a device that locates in the dimensions of space and time, the positions of the components of a mixture that has been subjected to a chromatographic process and thus permits the senses to appreciate the nature of the separation. Defining characteristics are Dynamic Range, Response Index or Linearity, Linear Dynamic range, Detector Response, Detector Noise Level, Detector Sensitivity or Minimum Detectable Concentration, Total System Dispersion, Sensor Dimensions, Detector Time Constant, Pressure Sensitivity, Flow Sensitivity, Operating Temperature Range.
process;heel to shin assessment;A functional assessment of an individual's ability to tap their heel to the midpoint of the contralateral shin a number of times.
process;venous blood beta-2-microglobulin assay;An analyte assay that measures the abundance of beta-2-microglobulin in venous blood
material entity;Bruker high resolution probe;BRUKER BIOSPIN's experienced Research & Development group not only delivers top-performance probes for the more common experiments, but also a wealth of special probes for almost any application. For high resolution (HR) NMR we offer probes with a variety of important characteristics and features.
process;heel along shin assessment;A functional assessment of an individual's ability to slide their heel back and forth along their contralateral tibia from the patella to the ankle with the contralateral leg extended.
process;lipid panel reflex direct venous blood low density lipoprotein assay;An analyte assay that measures the abundance of low density lipoprotein in venous blood as part of a Lipid panel reflex direct order
process;muscle weakness assessment;A functional assessment of an individual's ability to perform muscle movement to overcome gravity or physical resistence.
process;lipid panel reflex direct venous blood triglyceride assay;An analyte assay that measures the abundance of triglyceride in venous blood as part of a Lipid panel reflex direct order
process;muscle atrophy assessment;An observational assesment of an individual's muscle tissue loss due to inactivity or disease.
process;position sense assessment;A functional assessment of an individual's ability to sense the position of a finger or toe that has been manipulated by minimal random movements.
process;vibratory sense assessment;A functional assessment of an individual's ability to sense vibration.
material entity;nitrogen phosphorous detector;The nitrogen phosphorus detector (NPD) (sometimes called the thermionic detector) is a very sensitive, specific detector the design of which, is based on the FID. Physically the sensor appears to be very similar to the FID but, in fact, operates on an entirely different principle. The nitrogen phosphorous detector (sometimes called the thermionic detector) is a very sensitive but specific detector that responds almost exclusively to nitrogen and phosphorous compounds. It is based on the flame ionization detector but differs in that it contains a rubidium or cesium silicate (glass) bead situated in a heater coil, a little distance from the hydrogen flame. If the detector is to respond to both nitrogen and phosphorous then the hydrogen flow should be minimal so that the gas does not ignite at the jet. If the detector is to respond to phosphorous only, a large flow of hydrogen is used which is burnt at the jet. The heated bead emits electrons by thermionic emission. These electrons are collected under a potential of a few volts by an appropriately placed anode, and provides a background current. When a solute containing nitrogen or phosphorous is eluted from the column, the partially combusted nitrogen and phosphorous materials are adsorbed on the surface of the bead. The adsorbed material reduces the work function of the surface and, as consequence, the emission of electrons is increased which raises the current collected at the electrode. The sensitivity of the detector to phosphorous is about 10-12 gram per ml and for nitrogen about 10-11 gram per ml at a signal to nose ratio of 2. The alkali bead as a finite life and needs regular replacement.
process;cerebrospinal fluid lymphocyte count assay;A cytometry assay that measures the count of lymphocytes in cerebrospinal fluid
material entity;fourier transformation NMR instrument;In fourier transformation NMR, all frequencies in a spectrum are irradiated simultaneously with a radio frequency pulse. Following the pulse, the nuclei return to thermal equilibrium. A time domain emission signal is recorded by the instrument as the nuclei relax. A frequency domain spectrum is obtained by Fourier transformation.
process;cerebrospinal fluid segmented neutrophil count assay;A cytometry assay that measures the count of segmented neutrophils in cerebrospinal fluid
material entity;continuous wave NMR instrument;Continuous wave NMR spectrometers are similar to optical spectrometers, but the sample is held in a strong magnetic field, where the frequency of the source is slowly scanned (in some instruments, the source frequency is held constant, and the field is scanned).
process;cerebrospinal fluid mesothelial cell count assay;A cytometry assay that measures the count of mesothelial cells in cerebrospinal fluid
material entity;chromatography instrument;Any instrument that is used to carry out a chromatography experiment.
process;cerebrospinal fluid macrophage count assay;A cytometry assay that measures the count of macrophages in cerebrospinal fluid
material entity;NMR sample holder;An NMR sample holder is the part of an NMR instrument, which carries the NMR probe,sample tube and the nmr sample.
process;cerebrospinal fluid basophil count assay;A cytometry assay that measures the count of basophils in cerebrospinal fluid
process;limits of stability assessment;The functional assessment of an individual's ability to maintain balance, posture or upright stability.
process;deep tendon reflex assessment;A functional assessment of an individual's muscle contraction when a muscle is triggered by a signal from a muscle spindle in response to a stimulus applied to a specific trigger point on the body.
process;sitting posture assessment;A limits of stability assessment designed to assess an individual's ability to maintain unsupported posture while sitting over a given time period.
process;quenching assay measuring the off rate [koff] of a B cell epitope:antibody complex;A fluorescence quenching assay that measures the off rate [koff] of an antigen binding with an antibody.
process;surface plasmon resonance assay measuring the on rate [kon] of a B cell epitope:antibody complex;A surface plasmon resonance binding assay that measures the on rate [kon] of an antigen binding with an antibody.
process;quenching assay measuring the on rate [kon] of a B cell epitope:antibody complex;A fluorescence quenching assay that measures the on rate [kon] of an antigen binding with an antibody.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-1 beta production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-1 beta production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-1 alpha production by T cells;A flow cytometry assay that detects interleukin-1 alpha production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-1 alpha production by T cells;An enzyme-linked immunospot assay that detects interleukin-1 alpha production by T cells.
process;cell cycle synchronization;a process with the objective to obtain a cell culture in which all cells are in the same stage of the cell cycle
role;cloning vector role;A material to be added role played by a small, self-replicating DNA or RNA molecule - usually a plasmid or chromosome - and realized in a process whereby foreign DNA or RNA is inserted into the vector during the process of cloning.
material entity;recombinant plasmid;a plasmid in which extraneous DNA has been inserted.
material entity;reverse transcriptase;enzyme and has function some GO:0003964 (RNA-directed DNA polymerase activity)
process;measuring glucose concentration in blood serum assay;An assay that determines the concentration of glucose molecules in a blood serum sample
role;cloning insert role;cloning insert role is a role which inheres in DNA or RNA and is realized by the process of being inserted into a cloning vector in a cloning process.
process;polymerase chain reaction;PCR is the process in which a DNA polymerase is used to amplify a piece of DNA by in vitro enzymatic replication. As PCR progresses, the DNA thus generated is itself used as a template for replication. This sets in motion a chain reaction in which the DNA template is exponentially amplified.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-1 alpha production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-1 alpha production by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-1 alpha production by T cells;A cytometric bead array assay that detects interleukin-1 alpha production by T cells.
process;ELISPOT assay measuring epitope specific interferon-beta production by T cells;An enzyme-linked immunospot assay that detects interferon-beta production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interferon-beta production by T cells;A flow cytometry assay that detects interferon-beta production by T cells.
process;intracellular cytokine staining assay measuring epitope specific granulocyte colony stimulating factor production by T cells;A flow cytometry assay that detects granulocyte colony stimulating factor production by T cells.
process;ELISA measuring epitope specific interferon-beta production by T cells;An enzyme-linked immunosorbent assay that detects interferon-beta production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific granulocyte colony stimulating factor production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects granulocyte colony stimulating factor production by T cells.
process;ELISPOT assay measuring epitope specific granulocyte colony stimulating factor production by T cells;An enzyme-linked immunospot assay that detects granulocyte colony stimulating factor production by T cells.
process;cytometric bead array assay measuring epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;A cytometric bead array assay that detects chemokine (C-X-C motif) ligand 9 production by T cells.
generically dependent continuant;selection criterion;A directive information entity which defines and states a principle of standard by which selection process may take place.
process;ELISPOT assay measuring epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;An enzyme-linked immunospot assay that detects chemokine (C-X-C motif) ligand 9 production by T cells.
generically dependent continuant;averaging objective;An averaging objective is a data transformation objective where the aim is to perform mean calculations on the input of the data transformation.
process;transcription profiling assay;An assay that determines gene expression and transcription activity using ribonucleic acids collected from a material entity.
material entity;extract;an extract is a material entity which results from an extraction process
material entity;syringe;A processed material which is used to introduce or draw fluids from a material entity. A syringe is made of a piston and body. the movement of the piston in the body determines the amount/volume of fluid to inject or draw
process;intraperitoneal administration;The administration of a substance into the peritoneum of an organism
material entity;enzyme;(protein or rna) or has part (protein or rna) and has function some GO:0003824 (catalytic activity)
process;injection;injection is process which aims at introducing a compound or a mixture into a material entity (either biological entity or instrument) by relying on devices such as syringe or injector connection, attached or forced into a vascular system (veins of an organism or tubes of a machine) or in a tissue.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-X-C motif) ligand 9 production by T cells.
process;ELISPOT assay measuring epitope specific chemokine (C-C motif) ligand 4 production by T cells;An enzyme-linked immunospot assay that detects chemokine (C-C motif) ligand 4 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-X-C motif) ligand 12 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-X-C motif) ligand 12 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-X-C motif) ligand 13 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-X-C motif) ligand 13 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-X-C motif) ligand 16 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-X-C motif) ligand 16 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-C motif) ligand 21 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-C motif) ligand 21 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-C motif) ligand 22 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-C motif) ligand 22 production by T cells.
process;cytometric bead array assay measuring epitope specific chemokine (C-C motif) ligand 4 production by T cells;A cytometric bead array assay that detects chemokine (C-C motif) ligand 4 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-C motif) ligand 4 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-C motif) ligand 4 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific vascular endothelial growth factor production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects vascular endothelial growth factor production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-C motif) ligand 19 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-C motif) ligand 19 production by T cells.
material entity;needle;A needle is a sharp, hollow device used to penetrate tissue or soft material. When attached to a syringe. it allows delivery of a specific volume of liquid or gaseous mixture.
process;genotyping assay;An assay which generates data about a genotype from a specimen of genomic DNA. A variety of techniques and instruments can be used to produce information about sequence variation at particular genomic positions.
generically dependent continuant;adding material objective;is the specification of an objective to add a material into a target material. The adding is asymmetric in the sense that the target material largely retains its identity
process;DNA sequence feature detection assay;An assay with the objective to determine a sequence feature of DNA
material entity;polyacrylamide gel;a material entity resulting from the polymerization of acrylamide with TEMED in some buffer solution
process;injection into organ section;A process in which an input substance is injected into a organ section.
material entity;plasmid;plasmid = DNA and has quality circular and has function (is realized as some gene expression) GO:0010467
material entity;agarose gel;a material entity resulting from the polymerization of agarose after heating agarose suspended in some buffer solution
process;DNA sequence variation detection assay;An assay that measures changes (expansion, amplification, deletion, mutation) in the sequence of a DNA molecule.
generically dependent continuant;analyte measurement objective;an assay objective to determine the presence or concentration of an analyte in the evaluant
process;intracellular cytokine staining assay measuring epitope specific chemokine (C-C motif) ligand 1 production by T cells;A flow cytometry assay that detects chemokine (C-C motif) ligand 1 production by T cells.
role;specimen collector role;An Investigation agent role borne by a person or organization which is realized in a specimen collection process.
process;ELISPOT assay measuring epitope specific vascular endothelial growth factor production by T cells;An enzyme-linked immunospot assay that detects vascular endothelial growth factor production by T cells.
process;assay measuring epitope specific interleukin-17F production by T cells;An assay of epitope specific interleukin-17 production by T cells that detects interleukin-17F production.
process;assay measuring epitope specific interleukin-17A production by T cells;An assay of epitope specific interleukin-17 production by T cells that detects interleukin-17A production.
process;assay measuring epitope specific chemokine (C-C motif) ligand 21 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-C motif) ligand 21 production by T cells.
process;assay measuring epitope specific chemokine (C-C motif) ligand 19 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-C motif) ligand 19 production by T cells.
process;assay measuring epitope specific chemokine (C-X-C motif) ligand 12 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-X-C motif) ligand 12 production by T cells.
process;assay measuring epitope specific chemokine (C-C motif) ligand 22 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-C motif) ligand 22 production by T cells.
process;assay measuring epitope specific chemokine (C-X-C motif) ligand 16 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-X-C motif) ligand 16 production by T cells.
process;intracellular electrophysiology recording assay;An electrophysiology assay where the recording location of the electrode is intracellular.
process;mass measurement assay;An assay that determines the mass of an evaluant
role;target of material addition role;A role of a material entity that is realized in an "adding a material entity into a target" process where the bearer of the role (the target) receives the addition of another material entity.
process;analyte assay;An assay with the objective to capture information about the presence, concentration, or amount of an analyte in an evaluant.
generically dependent continuant;assay objective;an objective specification to determine a specified type of information about an evaluated entity (the material entity bearing evaluant role)
process;intracellular cytokine staining assay measuring epitope specific vascular endothelial growth factor production by T cells;A flow cytometry assay that detects vascular endothelial growth factor production by T cells.
material entity;packed column;A packed column is a chromatography column where the particles of the solid stationary phase or the support coated with a liquid stationary phase may fill the whole inside volume of the tube.
process;assay measuring epitope specific chemokine (C-X-C motif) ligand 13 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-X-C motif) ligand 13 production by T cells.
process;epitope specific chemokine (C-X-C motif) ligand 16 production by T cells;A process of chemokine (C-X-C motif) ligand 16 production by T cells resulting from the recognition of a T cell epitope.
process;lipid panel reflex direct venous blood cholesterol assay;An analyte assay that measures the abundance of cholesterol in venous blood as part of a Lipid panel reflex direct order
process;ELISPOT assay measuring epitope specific interleukin-22 production by T cells;An enzyme-linked immunospot assay that detects interleukin-22 production by T cells.
process;lipid panel reflex direct venous blood high density lipoprotein assay;An analyte assay that measures the abundance of high density lipoprotein in venous blood as part of a Lipid panel reflex direct order
process;ELISPOT assay measuring epitope specific interleukin-23 production by T cells;An enzyme-linked immunospot assay that detects interleukin-23 production by T cells.
process;pooled clone sequencing assay;A DNA sequencing assay in which the DNA input is derived from pooled clones (for example BACs and Fosmids) is sequenced.
process;gene list visualization;Adata visualization which has input of a gene list and produces an output of a report graph which is capable of rendering data of this type.
process;clustered data visualization;A data visualization which has input of a clustered data set and produces an output of a report graph which is capable of rendering data of this type.
process;data vector reduction data transformation;A data vector reduction is a data transformation that has objective data vector reduction and that consists of reducing the input vectors k to a smaller number of output vectors j, where j<k.
process;center calculation data transformation;A center calculation data transformation is a data transformation that has objective of center calculation.
process;descriptive statistical calculation data transformation;A descriptive statistical calculation data transformation is a data transformation that has objective descriptive statistical calculation and which concerns any calculation intended to describe a feature of a data set, for example, its center or its variability.
generically dependent continuant;scaling objective;is a data transformation objective where all, or some of a data set is adjusted by some data transformation according to some scale, for example a user defined minimum or maximum
generically dependent continuant;error correction objective;An error correction objective is a data transformation objective where the aim is to remove (correct for) erroneous contributions arising from the input data, or the transformation itself.
process;scaling data transformation;A scaling data transformation is a data transformation that has objective scaling.
generically dependent continuant;cross validation objective;A cross validation objective is a data transformation objective in which the aim is to partition a sample of data into subsets such that the analysis is initially performed on a single subset, while the other subset(s) are retained for subsequent use in confirming and validating the initial analysis.
process;sequence analysis data transformation;A sequence analysis data transformation is a data transformation that has objective sequence analysis and has the aim of analysing ordered biological data for sequential patterns.
process;epitope specific chemokine (C-C motif) ligand 21 production by T cells;A process of chemokine (C-C motif) ligand 21 production by T cells resulting from the recognition of a T cell epitope.
process;intracellular cytokine staining assay measuring epitope specific interleukin-18 production by T cells;A flow cytometry assay that detects interleukin-18 production by T cells.
generically dependent continuant;merging objective;A merging objective is a data transformation objective in which the data transformation has the aim of performing a union of two or more sets.
process;epitope specific chemokine (C-C motif) ligand 19 production by T cells;A process of chemokine (C-C motif) ligand 19 production by T cells resulting from the recognition of a T cell epitope.
process;ELISPOT assay measuring epitope specific interleukin-21 production by T cells;An enzyme-linked immunospot assay that detects interleukin-21 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-C motif) ligand 1 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-C motif) ligand 1 production by T cells.
process;cytometric bead array assay measuring epitope specific chemokine (C-C motif) ligand 1 production by T cells;A cytometric bead array assay that detects chemokine (C-C motif) ligand 1 production by T cells.
process;ELISPOT assay measuring epitope specific chemokine (C-C motif) ligand 1 production by T cells;An enzyme-linked immunospot assay that detects chemokine (C-C motif) ligand 1 production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-17F production by T cells;An enzyme-linked immunospot assay that detects interleukin-17F production by T cells.
process;ELISA measuring epitope specific interleukin-17F production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-17F production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-17F production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-17F production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-17A production by T cells;An enzyme-linked immunospot assay that detects interleukin-17A production by T cells.
material entity;variable wavelength detector;A chromatography detector, that can detect signals within a certain range at user-defined wavelengths.
material entity;dual loop autosampler;A dual loop autosampler is an autosampler that is designed for handling both analytical (10 mL/min flow rate) to preparative scale sample purification (100 mL/min flow rate).
generically dependent continuant;spread calculation objective;is a data transformation objective whereby the aim is to the calculate the spread of a dataset, spread is a descriptive statistic which describes the variability of values in a data set.
process;partitioning data transformation;A partitioning data transformation is a data transformation that has objective partitioning.
material entity;electron capture detector;The electron capture detector is a GC detector that uses a radioactive Beta emitter (electrons) to ionize some of the carrier gas and produce a current between a biased pair of electrodes. When organic molecules that contain electronegative functional groups, such as halogens, phosphorous, and nitro groups pass by the detector, they capture some of the electrons and reduce the current measured between the electrodes.
process;averaging data transformation;An averaging data transformation is a data transformation that has objective averaging.
material entity;column jacket;A column jacket is a piece of column chromatography equipment that covers a column in order to ensure thermoisolation and create a controllable thermostatic microenvironment.
generically dependent continuant;background correction objective;A background correction objective is a data transformation objective where the aim is to remove irrelevant contributions from the measured signal, e.g. those due to instrument noise or sample preparation.
material entity;gas generator;An instrument that generates gases for use with the gas chromatograph. Previously gas was obtained from gas tanks or gas cylinders. However, over the past decade the use of gas generators have become more popular as it avoids having gases at high pressure in the laboratory which is perceived by some as potentially dangerous. In addition, the use of a hydrogen generator avoids the use of a cylinder of hydrogen at high pressure which is also perceived by some as a serious fire hazard despite the fact that they have been used in laboratories, quite safely for nearly a century.
generically dependent continuant;partitioning objective;A partitioning objective is a data transformation objective where the aim is to generate a collection of disjoint non-empty subsets whose union equals a non-empty input set.
material entity;photoionization detector;The selective determination of aromatic hydrocarbons or organo-heteroatom species is the job of the photoionization detector (PID). This device uses ultraviolet light as a means of ionizing an analyte exiting from a GC column. The ions produced by this process are collected by electrodes. The current generated is therefore a measure of the analyte concentration. f the amount of ionization is reproducible for a given compound, pressure, and light source then the current collected at the PID's reaction cell electrodes is reproducibly proportional to the amount of that compound entering the cell. The reason why the compounds that are routinely analyzed are either aromatic hydrocarbons or heteroatom containing compounds (like organosulfur or organophosphorus species) is because these species have ionization potentials (IP) that are within reach of commercially available UV lamps. The available lamp energies range from 8.3 to 11.7 ev, that is, lambda max ranging from 150 nm to 106 nm. Although most PIDs have only one lamp, lamps in the PID are exchanged depending on the compound selectivity required in the analysis.
process;class discovery data transformation;A class discovery data transformation (sometimes called unsupervised classification) is a data transformation that has objective class discovery.
material entity;multiple wavelength detector;A chromatography detector, that can detect many discrete wavelengths in parallel and produces a multiple wavelength chromatographic profile.
generically dependent continuant;curve fitting objective;A curve fitting objective is a data transformation objective in which the aim is to find a curve which matches a series of data points and possibly other constraints.
material entity;sample injection system;An automated chromatography system that injects the sample into the chromatography columns in order to increase speed and minimize human involvement in the purification process for better reproducibility.
generically dependent continuant;center calculation objective;A center calculation objective is a data transformation objective where the aim is to calculate the center of an input data set.
material entity;Bruker LC-NMR platform;The LC-NMR/MS setup was first introduced by Bruker BioSpin in 1999. An LC-NMR system including a Bruker Peak Sampling Unit (BPSU-36) was coupled with a Bruker Daltonics esquire series ion trap mass spectrometer via a Bruker NMR-MS interface (BNMI). Since October 2004 the Bruker Daltonics microTOF-LC time-of-flight mass spectrometer can also be integrated in an LC-NMR setup.
process;Fisher's exact test;Fisher's exact test is a data transformation used to determine if there are nonrandom associations between two Fisher's exact test is a statistical significance test used in the analysis of contingency tables where sample sizes are small where the significance of the deviation from a null hypothesis can be calculated exactly, rather than relying on an approximation that becomes exact in the limit as the sample size grows to infinity, as with many statistical tests.
process;drawing a conclusion;A planned process in which new information is inferred from existing information.
generically dependent continuant;class prediction objective;A class prediction objective (sometimes called supervised classification) is a data transformation objective where the aim is to create a predictor from training data through a machine learning technique. The training data consist of pairs of objects (typically vectors of attributes) and class labels for these objects. The resulting predictor can be used to attach class labels to any valid novel input object. Depending on usage, the prediction can be definite or probabilistic. A classification is learned from the training data and can then be tested on test data.
process;cytometric bead array assay measuring epitope specific interleukin-18 production by T cells;A cytometric bead array assay that detects interleukin-18 production by T cells.
generically dependent continuant;class discovery objective;A class discovery objective (sometimes called unsupervised classification) is a data transformation objective where the aim is to organize input data (typically vectors of attributes) into classes, where the number of classes and their specifications are not known a priori. Depending on usage, the class assignment can be definite or probabilistic.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-16 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-16 production by T cells.
process;ELISA measuring epitope specific interleukin-16 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-16 production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-16 production by T cells;An enzyme-linked immunospot assay that detects interleukin-16 production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-16 production by T cells;A flow cytometry assay that detects interleukin-16 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-17A production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-17A production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-1 beta production by T cells;A flow cytometry assay that detects interleukin-1 beta production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-1 beta production by T cells;An enzyme-linked immunospot assay that detects interleukin-1 beta production by T cells.
process;detection of specific nucleic acids with complementary probes measuring epitope specific interleukin-15 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-15 production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-12 production by T cells;An enzyme-linked immunospot assay that detects interleukin-12 production by T cells.
material entity;DISCOVERY console;The Discovery console is a Windows XP Professional-based, integrated console designed especially for Solid-State NMR. The console includes everything needed to interface to any magnet and solids probe - from computer to cables to duplexing network.
process;isolation of cell population;a process in which a population of cells with certain characteristics is isolated from a larger population
material entity;injector lubricant;A lubricant used in liquid chromatography that eases sample injector penetration.
material entity;reversed phase column;A reversed phase column is a chromatography column in which the mobile phase is more polar than the stationary phase. Its counterpart is the normal phase column.
process;generalized family wise error rate correction method;A generalized FWER correction method is a multiple testing procedure that controls the probability of at least k+1 false positives, where k is a user-supplied integer.
material entity;flow probe;An NMR probe that allows the automatized flow-through of a sample. The sample is aspirated via a syringe pump into the Flow probe, the NMR spectrum is acquired and when the experiment is complete, the sample is returned to back to an external source (well plate) or flushed to waste. Sometimes pulsed field gradients (PFG) can be established in flow probes.
process;tail probability for the proportion of false positives correction method;A TPPFP correction method is a MTP that controls the probability that the proportion of false positives among all rejected hypotheses is no greater than a constant q, where q is between 0 and 1.
material entity;trap column;A trap column is a chromatography column which is used prior to a, e.g. mass spectrometry, separation to clean up or concentrate controlled amounts of samples prior to elution to a detector.
process;quantile number of false positives correction method;A quantile number of false positives correction method is a MTP that controls for the pth quantile of the distribution of the number of false positives out of the total number of tests performed'
material entity;NMR magnet;A magnet which induces a certain frequency (MHz) and which has a certain bore diameter.n alt The NMR signal is a natural physical property of the certain atomic nuclei but it can only be detected with an external magnetic field. A magnet is a fundamental part of an NMR instrument which induces an electromagnetic force field (RF pulse) and by this excites and aligns the spins of the electrons of the NMR acquisition nucleus. It is usually a big (superconducting) electromagnet which is cooled by liquid helium and can be adjusted to a frequency between 200 and 950 MHz. The magnetic field strength is measured in Tesla or Gauss.
process;proportion of expected false positives correction method;A proportion of expected false positives correction method is a multiple testing procedure that controls the ratio of the expected value of the numbers of false positives to the expected value of the numbers of rejected hypotheses.
material entity;NMR probe;Part of an NMR instrument that detects the signals emitted from a sample. No single probe can perform the full range of experiments, and probes that are designed to perform more than one type of measurement usually suffer from performance compromises. The probe represents a rather fragile single point of failure that can render an NMR system completely unusable if the probe is dropped or otherwise damaged. Probes are usually characterised by Sample diameter and Frequency.n alt The instrument that transmits and receives radiofrequency to and from the NMR sample.
process;false discovery rate correction method;The false discovery rate is a data transformation used in multiple hypothesis testing to correct for multiple comparisons. It controls the expected proportion of incorrectly rejected null hypotheses (type I errors) in a list of rejected hypotheses. It is a less conservative comparison procedure with greater power than familywise error rate (FWER) control, at a cost of increasing the likelihood of obtaining type I errors. .
material entity;chromatofocusing column;A chromatofocusing column is a chromatography column in which a resin is equilibrated at one pH and eluted at a second pH. The use of a weak ion-exchange resin causes a pH gradient to be formed at the solvent front owing to the buffering action of the resin. This pH gradient in turn leads to an ordering of proteins by isoelectric point. Molecules of charge sign opposite the resin bind. those of charge sign like the resin do not bind.
generically dependent continuant;data transformation objective;An objective specification to transformation input data into output data
material entity;Bruker AMX series NMR instrument;A series of older Bruker NMR magnets, now out of production. The Bruker AMX500 has proven an extremely reliable workhorse, with excellent lineshape yielding superior water suppression even without gradients. The Oxford 11.7 Tesla 5.2 cm bore magnet rests on a TMC vibration damping table. Homogeneity is controlled by a BSN-18 and BSN-2 with 19 shim controls. In addition to the 5 mm triple resonance probe, the AMX is equipped with a 10mm broadband observe probe.
process;quantile proportion of false positives correction method;A quantile proportion of false positives correction method is a multiple testing procedure that controls the pth quantile of the distribution of the proportion of false positives among the rejected hypothesis (false discovery rate).
process;intracellular cytokine staining assay measuring epitope specific interleukin-15 production by T cells;A flow cytometry assay that detects interleukin-15 production by T cells.
generically dependent continuant;correction objective;A correction objective is a data transformation objective where the aim is to correct for error, noise or other impairments to the input of the data transformation or derived from the data transformation itself
process;ELISPOT assay measuring epitope specific interleukin-15 production by T cells;An enzyme-linked immunospot assay that detects interleukin-15 production by T cells.
generically dependent continuant;data normalization objective;A normalization objective is a data transformation objective where the aim is to remove systematic sources of variation to put the data on equal footing in order to create a common base for comparisons.
process;chromatin interaction analysis by paired-end tag sequencing assay;An assay that incorporates chromatin immunoprecipitation (ChIP)-based enrichment, chromatin proximity ligation, Paired-End Tags, and high-throughput sequencing to determine de novo long-range chromatin interactions genome-wide.
process;normalization data transformation;A normalization data transformation is a data transformation that has objective normalization.
process;structural analysis by paired-end tag sequencing assay;An assay that incorporates Paired-End Tags and sequencing technology to determine structural variants.
process;transcript analysis by paired-end tag sequencing assay;A transcription profiling assay that determines transcripts, gene structures, and gene expressions using Paired-End Tags and sequencing technology.
generically dependent continuant;transcription start site identification objective;A transcription profiling identification objective that aims to characterize the transcription start sites of genes.
process;paired-end library preparation;A library preparation that results in the creation of a library of the 5' and 3' ends of DNA or cDNA fragments using adaptors and endonucleases. The preparation may or may not include cloning process.
process;DNase I hypersensitive sites sequencing assay;An assay that identifies the location of regulatory regions, based on the genome-wide sequencing of regions super sensitive to cleavage by DNase I.
generically dependent continuant;protein and RNA interaction identification objective;A sequence feature identification objective that aims to characterize the interactions between protein and RNA.
material entity;Varian VXR spectrometer;A Varian NMR spectrometer.
material entity;magic angle spinning rotor;A rotor device that holds the NMR sample and enables the adjustment of the orientation of the rotation axis for a sample in a NMR instrument in the magic angle.
material entity;vial;A container made from solid material and primarily used for holding liquid.
material entity;flame ionization detector;A flame ionization detector is a GC detector that consist of a hydrogen/air flame and a collector plate which are normally heated independently of the chromatographic oven. Heating is necessary in order to prevent condensation of water generated by the flame and also to prevent any hold-up of solutes as they pass from the column to the flame. There is an electrode above the flame to collect the ions formed at a hydrogen/air flame. The number of ions hitting the collector is measured and a signal is generated. Flame ionization detectors are most widely used and generally applicable for gas chromatography and hence is used for routine and general purpose analysis. It is easy to use but destructive of the sample.
process;clinical chemistry assay;An analyte assay which uses analytical methods to produce measurements and data on the concentration of chemical parameters (analytes) present in a bodily fluid collected from an organism.
process;exponential base;The exponential base is a feature of an exponential function which is defined in http://en.wikipedia.org/wiki/Exponential function. Its value can be any positive real number (typically different from 1).
material entity;JEOL NMR probe;An NMR probe that is manufactured by JEOL.
process;MA transformation;An MA transformation is a data transformation which takes as input a collection of data points (g 1, r 1), (g 2, r 2), ..., (g n, r n) with the r i and g i positive real numbers, and whose output is the collection of data points (A 1, M 1), (A 2, M 2), ..., (A n, M n) where, for each i, A i=(log(g i)+log(r i))/2 and M i=log(r i)-log(g i). Here log denotes a logarithmic transformation.
material entity;liquid chromatography valve;A sample valve that must be able to sustain pressures up to 10,000 p.s.i., although it is most likely to operate on a continuous basis, at pressures of 3,000 p.s.i. or less. The higher the operating pressure the tighter the valve seating surfaces must be forced together to eliminate any leak. It follows that any abrasive material, however fine, that passes into the valve can cause the valve seating to become scored each time it is rotated which will ultimately lead to leaks. This will cause the sample size to vary between samples and eventually affect the accuracy of the analysis. It follows that any solid material must be carefully removed from any sample before filling the valve. The sample volume of an internal loop valve is situated in the connecting slot of the valve rotor and can be used only for relatively small sample volumes. Internal sample loop valves provide samples with volumes ranging from 0.1 ml to about 0.5 ml. Valve operation is shown in figure 6. The left-hand side diagram shows the load position. The sample occupies the rotor slot and has been filled by passing the sample from an appropriate syringe through the rotor slot to waste. While loading the sample, the mobile phase supply is passed through the valve directly to the column. To place the sample onto the column, the valve is then rotated and the valve slot containing the sample is now placed between the solvent supply and the column. As a result, the sample is passed into the column by the flow of solvent.
process;number of variables;The number of variables is a feature of any function (including polynomial functions) with domain contained in an n-dimensional vector space and is defined as n, the dimension of such space.
material entity;flow high resolution probe;Hyphenated analytical techniques combining mass spectrometry and chromatography are well-established laboratory tools. The combination of chromatography and NMR has also made its way into the analytical laboratory. Further developments even combine all three techniques into an LC-NMR/NMR-MS system. The use of solid phase extraction provides an efficient interface between chromatography and NMR with demands for special type of flow probes.
process;polynomial degree;The polynomial degree is a feature of a polynomial function defined as the highest power of the polynomial's terms, where the terms of a polynomial are the individual summands with the coefficients omitted.
material entity;preparative autosampler;For preparative LC with injection of sample volumes ranging from L to mL ranges.
process;divisive hierarchical clustering;A divisive hierarchical clustering is a hierarchical clustering which starts with a single cluster and then successively splits resulting clusters until only clusters of individual objects remain.
material entity;splitless GC injector;Injected sample enters column immediately (while split valve to split vent is closed). Here a sample is introduced into a heated small chamber via a syringe through a septum - the heat facilitates volatilization of the sample and sample matrix. The carrier gas then either sweeps the entirety (splitless mode) or a portion (split mode) of the sample into the column. In split mode, a part of the sample/carrier gas mixture in the injection chamber is exhausted through the split vent.
process;agglomerative hierarchical clustering;An agglomerative hierarchical clustering is a hierarchical clustering which starts with separate clusters and then successively combines these clusters until there is only one cluster remaining.
generically dependent continuant;data vector reduction objective;Data vector reduction is a data transformation objective in which k m-dimensional input vectors are reduced to j m-dimensional output vectors, where j is smaller than k.
process;RNP (ribonuclear particle) immunoprecipitation high- throughput sequencing assay;An analyte assay that combines immunoprecipitation of an RNA-binding protein and RNA-seq to identify mRNAs associated with selected RNA binding proteins (RBPs).
process;data partitioning;Data partitioning is a data transformation with the objective of partitioning or separating input data into output subsets.
process;cross-linking immunoprecipitation high-throughput sequencing assay;An analyte assay that employs UV-crosslinking between RNA and a protein, followed by immunoprecipitation with antibodies for the protein, fragmentation, and high-throughput screening for RNA sequences that interact with a particular RNA-binding protein.
process;formaldehyde-assisted isolation of regulatory elements assay;An assay to determine the sequences of those DNA regions in the genome associated with regulatory activity.
process;mathematical feature;feature is a (parent class) that describes a characteristic, trait or quality of a data transformation
process;log base;The log base is a feature of a logarithmic function which is defined in http://en.wikipedia.org/wiki/Logarithm. Its value can be any positive real number different from 1.
process;subgraph out-degree calculation;A network subgraph quality calculation in which an input data set describing subgraphs and relationship edges between subgraphs and other network objects is used to enumerate the number of unique relationships pointing out of an individual subgraph.
process;subgraph in-degree calculation;A network subgraph quality calculation in which an input data set describing subgraphs and directional relationship edges between subgraphs and other network objects is used to enumerate the number of unique relationships pointing into an individual subgraph.
process;subgraph modularity calculation;A network subgraph quality calculation in which an input data set of subgraph in-degree and out-degree qualities is used to calculate the ratio of indegree to outdegree as a measure of modularity.
process;intra subgraph connectivity calculation;A network subgraph quality calculation in which an input data set describing internal nodes, edges and node degrees is used to determine the average node degree within the subgraph.
process;network graph quality calculation;A network analysis in which an input data set describing node objects and edge relationships between node objects is used to determine the output quality of the network as a whole.
process;unit-variance scaling;A unit-variance scaling is a data transformation that divides all measurements of a variable by the standard deviation of that variable.
process;quantitative node degree calculation;A node quality calculation in which an input data set describing object nodes and quantitative relationship edges between object nodes is used to sum all of the quantitative relationships of an individual object node.
process;node degree calculation;A node quality calculation in which an input data set describing object nodes and relationship edges between object nodes is used to enumerate the number of unique relationships of an individual object node.
process;node out-degree calculation;A node quality calculation in which an input data set describing object nodes and directional relationship edges between object nodes is used to enumerate the number of unique relationships pointing out of an individual object node.
process;node in-degree calculation;A node quality calculation in which an input data set describing object nodes and directional relationship edges between object nodes is used to enumerate the number of unique relationships pointing into an individual object node.
process;edge quality calculation;A network analysis in which an input data set describing node objects and edge relationships between node objects is used to determine the output quality of one of the edge relationships in the network.
process;node shortest path identification;A node quality calculation in which a path describing the shortest path needed to transverse through connected nodes and edges to arrive at a specific target node in the network.
process;network subgraph quality calculation;A network analysis in which an input data set describing node objects and edge relationships between node objects is used to determine the output quality of a subgraph partition of the network.
process;edge betweenness calculation;An edge quality calculation in which the input is a data sets of shortest paths between all pairs of node in the network and the output is the sum of all shortest paths that traverse the specific edge.
process;quantitative subgraph degree calculation;A network subgraph quality calculation in which an input data set describing subgraphs and quantitative relationship edges between subgraphs and other network objects is used to sum the quantitative relationships of an individual subgraph.
process;subgraph degree calculation;A network subgraph quality calculation in which an input data set describing subgraphs and relationship edges between subgraphs and other network objects is used to enumerate the number of unique relationships of an individual subgraph.
process;ELISPOT assay measuring epitope specific interleukin-8 production by T cells;An enzyme-linked immunospot assay that detects interleukin-8 production by T cells.
process;assay measuring epitope specific granzyme A release by T cells;A T cell epitope specific cytotoxic T cell degranulation assay that detects granzyme A release by T cells.
process;variance calculation;A variance calculation is a descriptive statistics calculation in which the variance is defined as the average squared distance of each observation in the data set to the mean of the data set. It is also known as the second central moment.
process;interquartile-range calculation;The interquartile range is a descriptive statistics calculation defined as the difference between the 0.75 quantile and the 0.25 quantile for a set of data.
process;standard deviation calculation;A standard deviation calculation is a descriptive statistics calculation defined as the square root of the variance. Also thought of as the average distance of each value to the mean.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-8 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-8 production by T cells.
process;kurtosis calculation;A kurtosis calculation is a descriptive statistics calculation defined as a parameter that measures how large or small the tails of a distribution are relative to the mean. For details, see http://davidmlane.com/hyperstat/A53638.html
process;ELISPOT assay measuring epitope specific interleukin-3 production by T cells;An enzyme-linked immunospot assay that detects interleukin-3 production by T cells.
process;skewness calculation;A skewness calculation is a descriptive statistics calculation defined as a parameter that describes how much a distribution (or a data set) varies from a bell-shaped curve. See http://www.riskglossary.com/link/skewness.htm for details. It is also known as the third central moment
process;ELISA measuring epitope specific interleukin-7 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-7 production by T cells.
process;network graph construction;A network analysis in which an input data set describing objects and relationships between objects is transformed into an output representation of these objects as nodes and the relationships as edges of a network graph.
process;ELISPOT assay measuring epitope specific interleukin-7 production by T cells;An enzyme-linked immunospot assay that detects interleukin-7 production by T cells.
process;data combination;A data transformation in which individual input data elements and values are merged together into a output set of data elements and values.
process;intracellular cytokine staining assay measuring epitope specific interleukin-7 production by T cells;A flow cytometry assay that detects interleukin-7 production by T cells.
process;directed network graph construction;A network graph construction in which an input data set describing objects and directional relationships between objects is transformed into and output representation of these objects as nodes and the directional relationships as directed edges of a network graph.
process;intracellular cytokine staining assay measuring epitope specific interleukin-27 production by T cells;A flow cytometry assay that detects interleukin-27 production by T cells.
process;weighted network graph construction;A network graph construction in which an input data set describing objects and quantitative relationships between objects is transformed into and output representation of these objects as nodes and the quantitative relationships as weighted edges of a network graph.
process;cytometric bead array assay measuring epitope specific interleukin-3 production by T cells;A cytometric bead array assay that detects interleukin-3 production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-3 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-3 production by T cells.
process;node quality calculation;A network analysis in which an input data set describing node objects and edge relationships between node objects is used to determine the output quality of one of the node objects in the network.
process;assay measuring epitope specific granulysin release by T cells;A T cell epitope specific cytotoxic T cell degranulation assay that detects granulysin release by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-27 production by T cells;A cytometric bead array assay that detects interleukin-27 production by T cells.
process;data visualization;A planned process with the objective to graphically represent some data by inputing the data and outputting images, diagrams or animations.
process;s transformation;An s transformation is a data transformation obtained by applying the function S described in what follows to a (one dimensional) real number input. S(x)=T*exp(w-m)*(exp(x-w)-(p^2)*exp((w-x)/p)+p^2-1) if x>=w, S(x)=-S(w-x) otherwise. where exp denotes an exponential transformations, 'p^' denotes the exponential transformation with base p. T, w, m, p are real constants with T, m, and p positive and w non-negative, and where w and p are related by w=2p*ln(p)(p+1) with the objective of normalization.
process;intracellular cytokine staining assay measuring epitope specific interleukin-23 production by T cells;A flow cytometry assay that detects interleukin-23 production by T cells.
process;similarity calculation;A similarity calculation is a data transformation that attaches to each pair of objects in the input a number that is meant to reflect how 'close' or 'similar' those objects are.
process;ELISPOT assay measuring epitope specific interleukin-27 production by T cells;An enzyme-linked immunospot assay that detects interleukin-27 production by T cells.
process;ELISA measuring epitope specific interleukin-27 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-27 production by T cells.
process;pearson correlation coefficient calculation;A pearson correlation coefficient calculation is a similarity calculation which attaches to each pair of random variables X and Y the ratio of their covariance by the product of their standard deviations. Given a series of n measurements of X and Y written as x i and y i where i = 1, 2, ..., n, then their Pearson correlation coefficient refers to the "sample correlation coefficient" and is written as the sum over i of the ratios (x i-xbar)*(y i-ybar)/((n-1)*s x*s y) where xbar and ybar are the sample means of X and Y , s x and s y are the sample standard deviations of X and Y. The closer the pearson correlation coefficient is to 1, the more similar the inputs are considered.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-18 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-18 production by T cells.
process;euclidean distance calculation;An euclidean distance calculation is a similarity calculation that attaches to each pair of real number vectors of the same dimension n the square root of the sum of the square differences between corresponding components. The smaller this number, the more similar the two vectors are considered.
process;epitope specific chemokine (C-X-C motif) ligand 13 production by T cells;A process of chemokine (C-X-C motif) ligand 13 production by T cells resulting from the recognition of a T cell epitope.
process;mode calculation;A mode calculation is a descriptive statistics calculation in which the mode is calculated which is the most common value in a data set. It is most often used as a measure of center for discrete data.
process;ELISPOT assay measuring epitope specific interleukin-18 production by T cells;An enzyme-linked immunospot assay that detects interleukin-18 production by T cells.
process;loess fitting;A loess fitting is a curve fitting obtained by localized regression. The latter refers to fitting a polynomial (straight line, quadratic, cubic, etc) to data values within a window covering a fraction of the total number of observations. As the window slides along the axis, a new polynomial is fit to the observations falling within the window. This continues until all points are fit with a local polynomial. The results are then smoothed together to form a curve. The smoothness of loess fits is controlled by a smoothing parameter (often denoted as alpha, usually between 1/4 and 1) and the degree of the polynomial that is fitted by the method (usually denoted by lambda).
process;epitope specific chemokine (C-X-C motif) ligand 12 production by T cells;A process of chemokine (C-X-C motif) ligand 12 production by T cells resulting from the recognition of a T cell epitope.
process;median calculation;A median calculation is a descriptive statistics calculation in which the midpoint of the data set (the 0.5 quantile) is calculated. First, the observations are sorted in increasing order. For an odd number of observations, the median is the middle value of the sorted data. For an even number of observations, the median is the average of the two middle values.
process;epitope specific chemokine (C-C motif) ligand 22 production by T cells;A process of chemokine (C-C motif) ligand 22 production by T cells resulting from the recognition of a T cell epitope.
process;quantile calculation;A quantile calculation is a descriptive statistics calculation in which the kth quantile is the data value for which an approximate k fraction of the data is less than or equal to that value. See http://www.stat.wvu.edu/SRS/Modules/Quantiles/quantiles.html for details.
generically dependent continuant;pathologic lymph node stage for lung according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of lung cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.
generically dependent continuant;pathologic lymph node stage for colon and rectum according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of colorectal cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.
generically dependent continuant;pathologic lymph node stage for kidney according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of renal cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.
generically dependent continuant;pathologic lymph node stage for ovary according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.
generically dependent continuant;pathologic distant metastases stage for colon according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of colon cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;digital curation;Digital curation is the process of establishing and developing long term repositories of digital assets for current and future reference by researchers, scientists, and historians, and scholars generally.
process;electroporation;a process in which a significant increase in the electrical conductivity and permeability of the cell plasma membrane caused by an externally applied electrical field. It is usually used in molecular biology as a way of introducing some substance into a cell, such as loading it with a molecular probe, a drug that can change the cell's function, or a piece of coding DNA
process;validation;a planned process with objective to check that the accuracy or the quality of a claim or prediction satisfies some criteria and which is assessed by comparing with independent results
process;prediction;a process by which an event or an entity is described before it actually happens or is being discovered and identified.
generically dependent continuant;pathologic distant metastases stage for lung according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of lung cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;nucleic acid hybridization;a planned process by which totally or partially complementary, single-stranded nucleic acids are combined into a single molecule called heteroduplex or homoduplex to an extent depending on the amount of complementarity.
process;immobilization;immbolization is a process by which material entity become (possibly covalently but not necessarily) attached to the surface of another material entity used a substratum.
process;group randomization;A group assignment which relies on chance to assign materials to a group of materials in order to avoid bias in experimental set up.
process;background corrected data visualization;A data visualization which has input of a background corrected data set and produces an output of a report graph which is capable of rendering data of this type.
process;classified data visualization;A data visualization which has input of a classified data set and produces an output of a report graph which is capable of rendering data of this type.
process;proportional hazards model estimation;Proportional hazards model is a data transformation model to estimate the effects of different covariates influencing the times-to-failure of a system.
process;survival analysis data transformation;A data transformation which has the objective of performing survival analysis.
process;document editing;is a planned process with specified input original document and specified output edited document
generically dependent continuant;spectrum analysis objective;is a data transformation objective where the aim is to analyse some aspect of spectral data by some data transformation process.
generically dependent continuant;correlation study objective;A data transformation objective in which correlation is obtained (often measured as a correlation coefficient, ) which indicates the strength and direction of a relationship between two random variables.
process;DNA Subtraction;a material separation process by which repetitive genomic DNA is removed during the construction of cDNA library.
process;gas chromatography mass spectrometry;Gas chromatography mass spectrometry is a data transformation combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.
process;elution;the process of extracting one material from another by washing with a solvent to remove adsorbed material from an adsorbent (as in washing of loaded ion-exchange resins to remove captured ions)
process;Fe-BABE RNA structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic secondary structure at a nucleotide resolution scale using Fe-BABE as reagent and chemical probe.
process;electrocution;electrocution is process by which electric current is applied to a material with quality alive and result the termination of life process.
process;RNASE U2 structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using RNAase U2 as reagent and enzymatic probe
material entity;Illumina NovaSeq Series Instrument;A DNA Sequencer manufactured and/or marketed by Illumina and branded with the word NovaSeq.
process;cell lysis;cell lysis is a process by which cell membrane integrity of live cells is compromised and leads to cell death. Cell lysis may be achieved by means of viral action or osmotic shock.
process;binding constant determination assay;A binding assay where the specified output is a binding constant
generically dependent continuant;performance status value specification;A categorical value specification that is an assessment of a participant's performance status (general well-being and activities of daily life).
process;storage;A planned process with the objective to preserve and protect material entities by placing them in an identified location which may have a controlled environment.
process;NMIA RNA structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at the nucleotide resolution scale using NMIA as reagent and chemical probe
generically dependent continuant;Eastern Cooperative Oncology Group score value specification;A performance status value specification designed by the Eastern Cooperative Oncology Group to assess disease progression and its affect on the daily living abilities of the patient.
process;enzymatic ligation;An enzymatic ligation is a planned process in which molecules are joined by covalent bonds through the action of an material entity with a ligase activity
process;Terbium RNA structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using Terbium as reagent and chemical probe
process;trypsination;trypsination is a protease cleavage which uses enzyme trypsin to act on proteins present in an input material entity
process;feature extraction;A planed process with objective of obtaining quantified values from an image.
process;polymerization;polymerization is process by which molecular entity of small mass are aggregated in motifs over the course of a chemical reaction catalyzed by enzymes or other molecular entities acting as catalyst. polymerization results in molecular entity of high molecular weight
process;OH-radical structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay hat determines nucleic acid secondary structure at a nucleotide resolution scale using hydroxyl radical as reagent and chemical probe
process;decapitation;decapitation is a process by which the head of a living organism is physically removed from the body, usually resulting in rapid death (in the case of Rhodnius prolixus, it might take a bit longer..)
process;Lead structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay that determines nucleic acid secondary structure at nucleotide resolution scale using lead as reagent and chemical probe
process;intentional overdosing;intentional overdosing is a process by which an excess dose of a chemical compound is given with the intent of causing death
process;RNASE T2 structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using RNAse T2 as reagent and enzymatic probe
material entity;Illumina NextSeq Series Instrument;A DNA Sequencer manufactured and/or marketed by Illumina and branded with the word NextSeq.
process;asphyxiation;asphyxiation is a process by which oxygen supplies are restricted (by mechanical, e.g obstructing airways or chemical means, e.g. increasing CO2 partial pressure) resulting in termination of life in oxygen reliant organisms.
process;gene dosage assay;An assay that measures changes in phenotype due to increased or decreased dosage of a single allele of a gene.
material entity;Illumina HiSeq Series Instrument;A DNA Sequencer manufactured and/or marketed by Illumina and branded with the word HiSeq.
process;cervical dislocation;cervical dislocation is a process by which a Vertebrate organism has its life terminated by rupturing spinal cord between cervical vertebrae induced by excessive mechanical torsion
material entity;environmental control device;An environmental control device is a device which has the function to control some aspect of the environment such as temperature, or humidity.
process;extraction;A material separation in which a desired component of an input material is separated from the remainder
process;Nuclease S1 structure mapping assay;A single-nucleotide-resolution deoxyribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using DNAse 1 as reagent and enzymatic probe.
function;specimen fixation function;a function that allows specific identification of individual speciment from one another.
generically dependent continuant;clinical history of cancer;A clinical history in which there is a diagnosis of cancer.
process;Ruthenium structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using Rhutenium as reagent and chemical probe
generically dependent continuant;clinical history devoid of cancer;A clinical history in which there was no diagnosis of cancer.
process;inline probing RNA structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at nucleotide resolution scale using intromolecular reactivity
process;planned irradiation;A planned process by which a material entity is exposed to radiative energy, which could be ionizing radiation (such as gamma rays, X-rays, charged particles or neutrons) or non-ionizing radiation (such as UV light or microwaves)
process;RNASE T1 structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale uses RNAse T1 as reagent and enzymatic probe.
process;washing;washing is a process by which a material entity acting as contaminant (e.g. excess staining reagent) is removed by application of one or more cycles of solution in flow.
process;array image creation;An image creation process that generate an image from the array.
process;staining;Staining is a process which results in the addition a class-specific (DNA, proteins, lipids, carbohydrates) dye to a substrate to qualify or quantify the presence of a specific compound.
material entity;light emission device;A device which has a function to emit light.
generically dependent continuant;Karnofsky score vaue specification;A performance status value specification designed for classifying patients 16 years of age or older by their functional impairment.
process;centrifugation;centrifugation is a process separating molecules by size or density using centrifugal forces generated by a spinning rotor. G-forces of several hundred thousand times gravity are generated in ultracentrifugation
material entity;perturbation device;A perturbation device is a device which is designed to perform a perturb function
process;filtration;filtration is a process which separates components suspended in a fluid based on granularity properties relying on a filter device
material entity;capillary blotter;A device that is used to transfer nucleic acids from agarose gels onto a membrane, based on the movement of buffer from a reservoir through the gel and the blotting membrane to a stack of dry blotting paper by capillary force. The molecules are carried to the blotting membrane on which they are adsorbed.
generically dependent continuant;father clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a male parent.
process;living in endemic area;a process in which a potential host organism lives in a geographic area in which an infectious agent is present to such a degree of frequency that contact is likely
material entity;bioreactor;A device or system that supports a biologically active environment.
generically dependent continuant;mother clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a female parent.
process;pathogen release in laboratory accident;a process in which a an infectious agent maintained in a laboratory setting is not contained as planned, leading to potential exposure of human beings to the agent
material entity;pH meter;A device that is used to measure the pH (acidity or alkalinity) of a liquid.
generically dependent continuant;sister clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a female sibling.
material entity;digital camera;An image acquisition device that takes video or still photographs, or both, digitally by recording images via an electronic image sensor.
generically dependent continuant;son clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a person's male child.
material entity;chip spotting device;A device for dropping and immobilizing a solution of biomolecules, for example, nucleic acids such as probe DNA, mRNA, and peptide nucleic acid (PNA), and proteins on a DNA microarray surface to manufacture a DNA microarray.
generically dependent continuant;unknown clinical history of cancer;A clinical history in which it is not known whether there was a diagnosis of cancer.
function;current amplification function;A current amplification function is an amplification function that increases the amplitude of a current.
generically dependent continuant;diagnosis of cancer;A diagnosis that is an assertion that a patient who is the subject of a diagnostic process has cancer.
function;stabilization function;A stabilization function is a function that holds or isolates an entity such as an instrument or specimen steadfast or at an unfluctuating level or quantity.
generically dependent continuant;family clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a blood relative.
function;pump function;a transfer unction where the transfer requires work to move the entity, often against a gradient.
generically dependent continuant;aunt clinical history of cancer;A clinical history in which there is a diagnosis of cancer in the female sibling of a parent.
function;cell transfer function;is a transfer function that displaces cells from one place to another
generically dependent continuant;brother clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a male sibling.
material entity;angiograph;A device that records the patterns of pulse waves inside blood vessels.
generically dependent continuant;daughter clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a person's female child.
disposition;disposition to cause an allergic reaction;The role borne by a material entity that is realized when it is recognized by the immune system and results in the occurrence of an allergic disease.
process;allergic reaction;an allergic reaction is an pathologic immune response by an organism to a non-self entity that is normally harmless(the allergen)
process;occurrence of allergy;The process of an allergic disease occurring in an organism.
process;ELISPOT assay measuring epitope specific interleukin-2 production by T cells;An enzyme-linked immunospot assay that detects interleukin-2 production by T cells.
process;epitope binding by adaptive immune receptor;is the process in which an adaptive immune receptor binds to a material entity (realizing its disposition). The binding affinity is significant enough to trigger an immune response. Specifically, transient non-specific binding of adaptive immune receptors occurring during immune surveillance is not considered significant binding.
process;Immunization in vivo;Process of administering an object playing the role of immunogen to a living organism
function;adaptive immune effector function;A function realized as an immune response, which inheres in a T cell, B cell or antibody which derives from or is produced by a cell with prior antigen experience.
process;living with infected household contact;a process in which a a human being lives in the same household as another human being that is known to be infected with an infectious agent
material entity;DNA synthesizer;An oligonucleotide synthesizer that is used to custom-build DNA molecules to contain a particular sequence of nucleotides.
generically dependent continuant;diagnosis of hepatitis C;A diagnosis of infectious disease caused by the hepatitis C virus.
process;administration in vivo with infectious agent;is an administration of an infectious agent to a host organism
material entity;high performance liquid chromatography instrument;A liquid chromatography instrument that consists of a reservoir of mobile phase, a pump, an injector, a separation column, and a detector. The pump (rather than gravity) provides the higher pressure required to propel the mobile phase and analyte through the densely packed column.
generically dependent continuant;diagnosis of HIV;A diagnosis of infectious disease caused by the human immunodeficiency virus (1 or 2).
process;occurrence of infectious disease;Is an occurrence of a disease caused by an infection
material entity;microplate reader;A measurement device that detects biological, chemical or physical events of samples in microtiter plates.
generically dependent continuant;clinical history of repeated HIV assays;A clinical history in which there is repeated reactive screening assays for human immunodeficiency virus (1 or 2) antibodies regardless of the results of supplemental assays.
material entity;ELISA microplate reader;A microplate reader that is used for enzyme-linked immunosorbent assays (ELISA).
generically dependent continuant;uncle clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a male sibling of a parent.
material entity;RNA extraction/purification instrument;A device that is used to isolate and collect RNA for subsequent molecular analysis.
generically dependent continuant;grandmother clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a female parent of a parent.
material entity;DNA extract;The output of an extraction process in which DNA molecules are purified in order to exclude DNA from organellas.
generically dependent continuant;grandfather clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a male parent of a parent.
material entity;two-photon laser/detector;A light source used in fluorescence imaging that allows the imaging of living tissue up to a depth of 1 mm, based on the concept that two photons of low energy can excite a fluorophore in a quantum event, resulting in the emission of a fluorescence photon, typically at a higher energy than either of the two excitatory photons.
generically dependent continuant;nephew clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a male child of a sibling.
material entity;electrophoresis system;A device that moves charged particles through a medium by using an electric field induced by electrodes.
generically dependent continuant;niece clinical history of cancer;A clinical history in which there is a diagnosis of cancer in a female child of a sibling.
material entity;PET synthesizer;A device that is used to produce targeted molecular pharmaceuticals for use in positron emission tomography.
generically dependent continuant;diagnosis of infectious disease;A diagnosis that is an assertion that a patient who is the subject of a diagnostic process has an infectious disease.
material entity;spinning-disk confocal microscope;A confocal microscope that uses a Nipkow disk, a mechanical, geometrically operating image scanning device.
generically dependent continuant;diagnosis of hepatitis B;A diagnosis of infectious disease caused by the hepatitis B virus.
material entity;epitope;A material entity with the disposition to be bound by an adaptive immune receptor.
process;host exposure to infectious agent;a process in which an infectious agent comes into physical contact with a host organism.
generically dependent continuant;pathologic distant metastases stage for ovary according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;antibody purification of mouse MHC class II protein complex;An antibody purification of MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of mouse MHC class II protein complex, while others contain impurities and are not of interest.
process;antibody purification of HLA protein complex with DQ3 serotype;An antibody purification of human MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA protein complex with DQ3 serotype, while others contain impurities and are not of interest.
process;antibody purification of H2-IAg7 protein complex;An antibody purification of mouse MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-IAg7 protein complex, while others contain impurities and are not of interest.
process;antibody purification of H2-IA protein complex;An antibody purification of mouse MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-IA protein complex, while others contain impurities and are not of interest.
generically dependent continuant;clinical tumor stage group according to AJCC 7th edition;A categorical value specification that is an assessment of the stage of a cancer according to the American Joint Committee on Cancer (AJCC) v7 staging systems.
process;antibody purification of mouse MHC class II protein complex and/or rat MHC class II protein complex with RT1-A haplotype;An antibody purification of MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of mouse MHC class II protein complex and/or rat MHC class II protein complex with RT1-A haplotype, while others contain impurities and are not of interest.
process;antibody purification of H2-IAd protein complex;An antibody purification of mouse MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-IAd protein complex, while others contain impurities and are not of interest.
process;liquid chromatrography mass spectrometry analysis;
process;tandem mass spectrometry analysis;
material entity;genetically modified organism;an organism that is the output of a genetic transformation process
process;antibody purification of HLA-DR protein complex;An antibody purification of human MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA-DR protein complex, while others contain impurities and are not of interest.
process;experimental infection of cell culture;is the administration of an infectious agent to a cell culture with the objective to have the agent colonize and replicate in culture
material entity;EL-4 cell line;A cell line derived from mouse (C57BL/6N) lymphoma cells.
material entity;HeLa cell line;A cell line derived from human cervical cancer cells.
process;liquid chromatography-tandem mass spectrometry analysis;
material entity;JAWS II cell line;A cell line derived from mouse dendritic cells.
material entity;antigen;A material entity that has the antigen role.
material entity;Jurkat cell line;A cell line derived from human T cells.
material entity;JY cell line;The JY cell line is an Epstein-Barr virus (EBV)-immortalised b cell lymphoblastoid line.(wikipedia)
process;assay measuring binding of a T cell epitope:MHC:TCR complex;A T cell epitope assay that measures the binding of T cell receptor to an epitope.
material entity;RMA cell line;A cell line derived from a mouse lymphoma, specifically a Rauscher virus-induced tumor.This cell ine is antigen processing-defective and expresses a very low level of MHC molecules on its surface.
material entity;T2 cell line;A human T-B lymphoblastoid hybrid cell line
process;fasting;A planned process in which an organism drinks only water and does not eat for a specified period of time.
generically dependent continuant;curated information;An information content entity that has undergone a digital curation performed by a curator for accuracy checks and compliance with curation requirements. Information which has been assessed for accuracy by domain experts.
material entity;C1R cell line;A cell line derived from human B cells. This cell line was created by EBV transformation (B-lymphoblastoid cell-line (BLCL)).
material entity;albumin-free serum;A blood serum specimen that contains no albumin.
quality;fasted;An organismal quality that inheres in an organism that has completed a fasting process, and which ceases to inhere in that organism once that organism drinks a liquid other than water or eats.
process;overnight fasting;A fasting with a duration of 812 hours, typically occurring overnight.
generically dependent continuant;minimum resolved unit of measurement;An information content entity that indicates the smallest increment that can be resolved on the scale of a measurement instrument.
generically dependent continuant;International Federation of Gynecology and Obstetrics cervical cancer stage value specification;A categorical value specification that is an assessment of the stage of a gynecologic cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging systems.
process;water filtration;A filtration process of water intended to remove or reduce the concentration of particulate matter, such as suspended particles, parasites, bacteria, algae, viruses, and fungi, as well as other undesirable chemical and biological contaminants.
process;in vitro CRISPR screen assay;An assay in which cells expressing a Cas system are infected with a library of guide RNAs with the intent of causing a perturbation at the target of the guide RNAs.
generically dependent continuant;ring trial design;A study design with the objective of establishing the reproducibility of an experimental approach by performing experiments in different laboratories under the same conditions and comparing the experimental outcomes.
material entity;methylated polymer;A methylated polymer which has artificially acquired one or more methyl groups
role;randomized group participant role;a role that borne by an organism and realized by some group randomization process
generically dependent continuant;multidimensional fatigue inventory score;A clinical data item that quantifies the severity of a person's fatigue as measured by a 20-item self-report instrument.
material entity;Illumina Infinium MethylationEPIC v2.0 BeadChip;An Illumina methylation BeadChip that targets 935,000 methylation sites per sample at single-nucleotide resolution.
material entity;FFPE specimen;A specimen that has been fixed in formalin and embedded in paraffin.
process;Immunization in vitro;A planned process with the objective to administer an object playing the role of immunogen to a cell culture.
process;infection process;the detrimental process in which an infectious agent colonizes or replicates in a host environment
material entity;adaptive immune receptor;is a receptor produced by cells of the adaptive immune system with the purpose of binding epitopes.
material entity;immunogen;a material entity bearing the immunogen role
process;environmental exposure to infectious agent;Is a process in which an infectious agent is in direct contact with a potential host organism in its habitat. This is preceded by proximity to the infectious agent
material entity;host of immune response;An organism in which an immune response process occurs.
material entity;293-T cell line;A cell line derived from human embryonic kidney cells. This cell line contains the SV40 Large T-antigen, allowing episomal replication of transfected plasmids containing the SV40 origin of replication.
process;Edinburgh handedness assay;An assay that uses a set of questions (the Edinburgh Handedness inventory) to generate a score that can be used to assess the dominance of a person's right or left hand in everyday activities. The inventory can be used by an observer assessing the person, or by a person self-reporting hand use. The latter method tends to be less reliable due to a person over-attributing tasks to the dominant hand.
material entity;Illumina NovaSeq X Plus;A DNA sequencer with three flow cell types manufactured by Illumina. It features a dual-flow cell configuration, allowing to reach an output of up to 16 Tb (52-104 billion reads per run). The sequencer utilizes XLEAP-SBS chemistry, an advanced version of Illumina's sequencing by synthesis (SBS) technology, which enables faster and more accurate sequencing.
material entity;Faraday cage;A device formed by conducting material or by a mesh of such material, that blocks out external static electric fields.
material entity;Illumina NovaSeq X;A DNA sequencer with three flow cell types manufactured by Illumina. The NovaSeq X provides an output of up to 8 Tb (26-52 billion reads per run). The sequencer utilizes XLEAP-SBS chemistry, an advanced version of Illumina's sequencing by synthesis (SBS) technology, which enables faster and more accurate sequencing.
process;agar stab storage;a storage process with input cell culture and agar and output agar stab for long time storage
material entity;lavage fluid specimen;A specimen obtained through a lavage process which includes fluid in addition to cells and/or cellular secretions.
process;RNASE CL3 structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using RNAse CL3 as reagent and enzymatic probe.
process;CMCT structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay which uses CMCT as reagent and chemical probe to generate data and information at nucleotide resolution scale contributing to the determination of nucleic acid secondary structure
material entity;oral lavage fluid;A specimen collected through oral cavity lavage that contains the reagents used to for the lavage process, organisms, cells, cellular secretions, and other biomaterials present in the oral cavity space.
process;image creation;A planned process that captures an image of an object.
process;MPE-Fe(II) structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at the nucleotide resolution scale using Fe-MP as reagent and chemical probe.
process;in vitro CRISPR screen using single-cell RNA-seq;An in vitro CRISPR screen assay that uses single-cell RNA-Seq to detect induced changes in gene expression.
material entity;dissolved material entity;A material entity that has been going through a process of being put into solution
process;single-nucleus methylcytosine and transcriptome sequencing assay;A DNA methylation profiling by high throughput sequencing assay that measures the cytosine DNA methylation and gene expression signature of single nuclei.
generically dependent continuant;questionnaire;A document with a set of printed or written questions with a choice of answers, devised for the purposes of a survey or statistical study.
process;in vitro CRISPR screen using flow cytometry;An in vitro CRISPR screen assay that uses flow cytometry to detect induced changes in gene expression of the targeted genes.
generically dependent continuant;edited document;A document which is the output of a document editing process
material entity;cultured CD4- T cell population;A T cell population characterized by not expressing the CD4 molecule on its surface.
material entity;cultured CD8- T cell population;A T cell population characterized by not expressing the CD8 molecule on its surface.
material entity;cultured CD4-/CD8- T cell population;A T cell population characterized by not expressing the CD4 nor the CD8 molecule on its surface.
disposition;cancer;A disease characterized by abnormal and uncontrolled cell division
disposition;autoimmune disease;Is a disease characterized by an immune response of an organism against parts of itself
process;epitope specific IL-2 release by T cells;A biological process where T cells produce IL-2 resulting from the recognition of a T cell epitope.
process;MHC:epitope complex binding to TCR;a process of an MHC molecule binding to an entity playing the role of epitope to create an MHC:epitope complex which is then bound by a TCR molecule.
process;ELISPOT assay measuring epitope specific interferon-gamma production by T cells;An enzyme-linked immunospot assay that detects interferon-gamma production by T cells.
process;RNASE V1 structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using RNAse V1 as reagent and enzymatic probe
process;kethoxal structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay that determines nucleic acid secondary structure at nucleotide resolution scale using kethoxal as reagent and chemical probe
process;single-nucleotide-resolution nucleic acid structure mapping assay using enzymatic probing;A single-nucleotide-resolution nucleic acid structure mapping assay that determines structural information about the RNA species under study using proteins acting as enzymatic probes.
process;DMS structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay which determins nucleic acid secondary structure at a nucleotide resolution scale using DMS as reagent and chemical probe
process;DNASE 1 structure mapping assay;A single-nucleotide-resolution deoxyribonucleic acid structure mapping assay which uses DNAse 1 as reagent and enzymatic probe to generate data and information at nucleotide resolution scale contributing to the determination of nucleic acid secondary structure
process;single-nucleotide-resolution nucleic acid structure mapping assay using chemical probing;A single-nucleotide-resolution nucleic acid structure mapping assay that determines structural information about the RNA species under study using small chemical compounds acting as chemical probes.
process;Rhodium DNA structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using Rhodium as reagent and chemical probe.
process;RNA ADA I RNA structure mapping assay;A single-nucleotide-resolution ribonucleic acid structure mapping assay that determines nucleic acid secondary structure at a nucleotide resolution scale using RNA adenosine deaminase I as reagent and enzymatic probe.
generically dependent continuant;mean-centered data;a data item which has been processed by a mean centering data transformation where each output value is produced by subtracting the mean from the inout value
generically dependent continuant;predicted data item;A data item that was generated on the basis of a calculation or logical reasoning
material entity;nucleic acid extract;An extract that is the output of an extraction process in which nucleic acid molecules are isolated from a specimen.
generically dependent continuant;International Federation of Gynecology and Obstetrics ovarian cancer stage value specification;A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the FIGO classification system.
process;ENU structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay that determines the secondary structure of a nucleic acid at the nucleotide resolution scale which uses ENU as reagent and chemical probe
disposition;infectious disease;is a disease caused by an infectious agent
material entity;lymph node cell specimen;A cell specimen comprised of a mixed population of cells obtained by processing whole lymph node into individual cells, typically performed using a sieve. This population includes T cells, B cells, macrophages, and other cell types.
material entity;cultured adherent cell population;A mixed cell population that is characterized by its ability to bind to tissue culture flasks or plates. This population typically contains macrophages and other cells capable of playing the antigen presenting cell role.
material entity;cultured PBMC cell population;A mixed cell population obtained by processing whole blood. The cells are characterized by having a similar density and are largely mononuclear cells (includes T cells, B cells, and other cell types).
disposition;disposition to be bound by an adaptive immune receptor;Is the disposition borne by a material entity that is realized in a process of being bound by a adaptive immune receptor.
process;organ harvesting;The process of removing an organ from its source organism
material entity;cultured CD3+ T cell population;A T cell population characterized by expressing the CD3 molecule on its surface.
material entity;cultured CD3- T cell population;A T cell population characterized by not expressing the CD3 molecule on its surface.
disposition;allergy;is a disease in which an abnormally strong inflammatory immune response is triggered against non-self entities, and the immune response has no protective effect
role;manufacturer role;Manufacturer role is a role which inheres in a person or organization and which is realized by a manufacturing process.
process;chem16 venous blood triglyceride assay;An analyte assay that measures the abundance of triglyceride in venous blood as part of a chem16 order
material entity;spin column;A spin column is a chromatography column which is suitable for putting it into a centrifuge. A spin column enforces separation through increased G-forces while spinning the column in a centrifuge. It is often used in DNA gel extraction kits.
process;chem16 venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a chem16 order
generically dependent continuant;hypertension grade;A categorical value specification that indicates the severity of hypertension.
process;chem16 venous blood phosphate assay;An analyte assay that measures the abundance of phosphate in venous blood as part of a chem16 order
process;chem16 venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a chem16 order
process;quartz crystal microbalance assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A quartz crystal microbalance assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
process;chem16 venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a chem16 order
process;quartz crystal microbalance assay;An assay that measures the change in frequency of a quartz crystal resonator resulting from the addition or removal of a small mass of a ligand specifically binding at the surface of the resonator.
process;chem16 venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a chem16 order
process;multiplexed error-robust fluorescence in situ hybridization assay;A fluorescence in-situ hybridization assay that uses combinatorial FISH labeling with error resistant encoding schemes for highly multiplexed single-molecule imaging.
process;chem16 venous blood chloride assay;An analyte assay that measures the abundance of chloride in venous blood as part of a chem16 order
process;intratumoral administration;An administration of a substance into a tumor of an organism.
process;chem16 venous blood alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase in venous blood as part of a chem16 order
material entity;Varian UNITY spectrometer;The predecessor series of the Varian UNITY INOVA spectrometer.
material entity;NMR sample tube;The sample-tube holds the NMR sample and sits in the nmr probe. It is usually a glass tube of 5-20mm diameter.
material entity;scattered molecular aggregate;a material entity that consists of all the molecules of a specific type that are located in some bounded region and which is part of a more massive material entity that has parts that are other such aggregates
material entity;Bruker Ultrastabilized NMR magnet;An NMR magnet manufactured by Bruker for Ultra-High Field NMR, available from 750 MHz to 900 MHz, which provides reliable operation at reduced temperature and ambient pressure via being rigidly mounted and stabilized.
material entity;high temperature column;A high temperature column is a chromatography column which is suitable for and withstands very high temperatures in chromatography ovens.
material entity;gradient pump system;A pump system optimized for gradient chromatography.
material entity;transfer line;A combination of devices that are used in connection with a sampling head for transferring components of an applied sample to the analyzing part of a chromatography system.
process;chem16 venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a chem16 order
material entity;Illumina NextSeq 1000;A DNA sequencer which is manufactured by the Illumina corporation using sequence-by-synthesis chemistry that fits on a benchtop and uses P1 and P2 flow cells.
process;chem16 venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a chem16 order
process;single molecule fluorescence in situ hybridization;A fluorescence in-situ hybridization assay that detects single RNA molecules in fixed cells, allowing for both the quantification and localization at the single-cell level and single-molecule resolution.
generically dependent continuant;disease severity reduction objective;An objective specification that is fulfilled by reducing the severity of a disease in a particular organism.
generically dependent continuant;disease causation objective;An objective specification that is fulfilled by causing a disease in a particular organism.
generically dependent continuant;disease prevention objective;An objective specification that is fulfilled by preventing the development of a disease in a particular organism.
material entity;Bruker LC-NMR/MS platform;Includes the connection to a high-resolution TOF-LC-MS system.
process;POC chem8 arterial blood potassium assay;An analyte assay that measures the abundance of potassium in arterial blood as part of a POC chem8 order
material entity;y-column connector;A column connector that connects one column on one side with two columns at the other side, hence building a Y shaped structure.
process;POC chem8 arterial blood sodium assay;An analyte assay that measures the abundance of sodium in arterial blood as part of a POC chem8 order
material entity;AVANCE II spectrometer;A spectrometer suitable for metabolomics and in vivo NMR studies but structural analysis of small molecules and low molecular weight proteins can also be performed. To accomplish these studies there are six probe-heads available. A successor, the AVANCE III came out recently.
role;precursor role;A role borne by a biological or chemical entity which serves as the core component of a chemical reaction process, upon which other reactants, like reagents or solvents, act.
process;POC chem8 arterial blood creatinine assay;An analyte assay that measures the abundance of creatinine in arterial blood as part of a POC chem8 order
role;reactant role;A role borne by a biological or chemical entity that participates or has molecular components that participate in a chemical reaction.
process;POC chem8 arterial blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in arterial blood as part of a POC chem8 order
process;electron microscopy assay determining the 3D structure of a MHC:ligand complex;An electron-microscopy 3D molecular structure determination assay that characterizes the 3-dimensional molecular structrue of a MHC:ligand complex.
process;POC chem8 arterial blood chloride assay;An analyte assay that measures the abundance of chloride in arterial blood as part of a POC chem8 order
process;electron microscopy assay determining the 3D structure of a T cell epitope:MHC:TCR complex;An electron-microscopy 3D molecular structure determination assay that characterizes the 3-dimensional molecular structrue of a T cell epitope:MHC:TCR complex.
process;peak venous blood tobramycin assay;An analyte assay that measures the abundance of tobramycin in venous blood as part of a peak order
process;antibody purification of MHC protein complex;A purification to separate a material entity into different compositions of which one fraction contains a higher concentration of MHC protein complex, while others contain impurities and are not of interest.
process;24 hour urine creatinine assay;An analyte assay that measures the abundance of creatinine in urine as part of a 24 hour order
generically dependent continuant;disease prevalence reduction objective;An objective specification that is fulfilled by reducing the prevalence of a disease in a population of organisms.
process;intact venous blood PTH assay;An analyte assay that measures the abundance of PTH in venous blood as part of a intact order
material entity;chromatography pump system;Better flow rates can be achieved by using a pump or by using compressed gas (e.g. air, nitrogen, or argon) to push the solvent through the column (flash column chromatography).
material entity;flame photometric detector;The determination of sulfur or phosphorus containing compounds is the job of the flame photometric detector (FPD). This device uses the chemiluminescent reactions of these compounds in a hydrogen/air flame as a source of analytical information that is relatively specific for substances containing these two kinds of atoms. The emitting species for sulfur compounds is excited S2. The lambda max for emission of excited S2 is approximately 394 nm. The emitter for phosphorus compounds in the flame is excited HPO (lambda max = doublet 510-526 nm). In order to selectively detect one or the other family of compounds as it elutes from the GC column, an interference filter is used between the flame and the photomultiplier tube (PMT) to isolate the appropriate emission band. The drawback here being that the filter must be exchanged between chromatographic runs if the other family of compounds is to be detected.
material entity;plunger column;A plunger column is a chromatography column with adjustable heigth control. By means of an adjustable endpiece (plunger) the user can adjust the column length without disturbing the packed bed. Plunger columns can equalize volume changes and thus avoids dead volumes within the column.
material entity;anion exchange column;An anion exchange column is a chromatography column that is used in anion exchange chromatography and which enables the separation of anion mixtures.
process;POC chem8 arterial blood glucose assay;An analyte assay that measures the abundance of glucose in arterial blood as part of a POC chem8 order
material entity;refractive index detector;For analyzing non-UV absorbing substances, such as carbohydrates, lipids and polymers. This is also the detector of choice for gel permeation chromatography. The refractive index detector is one of the least sensitive LC detectors. It is very sensitive to changes in ambient temperature, pressure changes, flow-rate changes and can not be used for gradient elution. Despite these many disadvantages, this detector is extremely useful for detecting those compounds that are nonionic, do not adsorb in the UV, and do not fluoresce. There are many optical systems used in refractive index detectors but one of the most common is the differential refractive index detector.
process;POC chem8 arterial blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in arterial blood as part of a POC chem8 order
process;exposure resulting in immune reactivity;a process in which an organism (host) is exposed to some material entity, which results in an immune reactivity
process;antibody purification of human MHC class I protein complex;An antibody purification of MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of human MHC class I protein complex, while others contain impurities and are not of interest.
process;antibody purification of MHC class I protein complex;An antibody purification of MHC protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of MHC class I protein complex, while others contain impurities and are not of interest.
process;antibody purification of HLA protein complex with A24 serotype;An antibody purification of human MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA protein complex with A24 serotype, while others contain impurities and are not of interest.
process;antibody purification of HLA protein complex with A2 serotype;An antibody purification of human MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA protein complex with A2 serotype, while others contain impurities and are not of interest.
material entity;cation trap column;A cation trap column is a trap column and ion-exchange column which contains anionic cation-exchange resins.
process;antibody purification of HLA protein complex with A2 serotype and/or HLA protein complex with A28 serotype;An antibody purification of human MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA protein complex with A2 serotype and/or HLA protein complex with A28 serotype, while others contain impurities and are not of interest.
process;total venous blood cholesterol assay;An analyte assay that measures the abundance of cholesterol in venous blood as part of a total order
material entity;chromatography detector filter;An optical filter that is used to obtain monochromatic light of a defined wavelength from detector lamps.
process;venous blood triglyceride assay;An analyte assay that measures the abundance of triglyceride in venous blood
material entity;Bruker BEST NMR system;The introduction of biological screening and combinatorial chemistry for chemical synthesis has also introduced new requirements for NMR automation, e.g., the use of well plates for sample input, increased demands on throughput, and the need for quick and simple interpretation of the acquired NMR data.
process;antibody purification of HLA protein complex with B27 serotype;An antibody purification of human MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA protein complex with B27 serotype, while others contain impurities and are not of interest.
process;tube 4 count cerebrospinal fluid cell count assay;A cytometry assay that measures the count of cells in cerebrospinal fluid as part of a tube 4 count order
material entity;Bruker 1mm MicroProbe;Over the past few years there has been a significantly growing demand for miniaturization in all areas ofmodern research and development. Evoked by many exciting applications, there is a need for analytical methods which require less amounts of sample. Bruker BioSpin meets this challenge with a revolutionary NMR probe design: The 1mm MicroProbe. It operates with disposable 1mm capillary sample tubes and the sample volume of 5 microliters enables the use of lowest amounts of sample to run all high resolution NMR experiments with outstanding sensitivity and up to 16 times faster measurements. Due to the TXI-type probe design, the z-gradient coil and the automatic matching and tuning accessory, the 1mm MicroProbe can be used for a wide variety of NMR experiments. The key advantages of this probe include:n up to 4 times higher mass sensitivity than 5mm conventional probes (with respect to the same sample amount)n excellent solvent suppression propertiesn virtually no salt effectn discrete samples in tubes that can be sealed and storedn automation accessory for sample preparation and handling available.
process;antibody purification of HLA protein complex with A29 serotype;An antibody purification of human MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA protein complex with A29 serotype, while others contain impurities and are not of interest.
process;cerebrospinal fluid protein assay;An analyte assay that measures the abundance of protein in cerebrospinal fluid
process;antibody purification of pig MHC class I protein complex;An antibody purification of MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of pig MHC class I protein complex, while others contain impurities and are not of interest.
process;cerebrospinal fluid glucose assay;An analyte assay that measures the abundance of glucose in cerebrospinal fluid
process;antibody purification of HLA-C protein complex;An antibody purification of human MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA-C protein complex, while others contain impurities and are not of interest.
process;tube 1 count cerebrospinal fluid cell count assay;A cytometry assay that measures the count of cells in cerebrospinal fluid as part of a tube 1 count order
process;antibody purification of rat MHC class I protein complex;An antibody purification of MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of rat MHC class I protein complex, while others contain impurities and are not of interest.
process;venous blood dehydroepiandrosterone assay;An analyte assay that measures the abundance of dehydroepiandrosterone in venous blood
process;antibody purification of cattle MHC class I protein complex;An antibody purification of MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of cattle MHC class I protein complex, while others contain impurities and are not of interest.
material entity;tecmag NMR console;An NMR console manufactured by tecmac.
material entity;ozone-induced chemiluminescence detector;Although there are many direct ozone chemiluminescent reactions with various gaseous molecules, the incorporation of a conversion step to convert various non-chemiluminescent analytes to a species capable of reacting with ozone to produce chemiluminescence broadens the horizon of this technique tremendously. The conversion of nearly all nitrogen- and sulfur-containing compounds to their respective chemiluminescent species for universal nitrogen and sulfur detection has made nitrogen/sulfur chemiluminescence detection the most widely used analytical methods based upon ozone-induced chemiluminescence. In addition to non-chromatographic applications, nitrogen/sulfur chemiluminescence detection has been adapted to various chromatographic techniques from gas chromatography to liquid and supercritical fluid chromatography as specialized element-specific detectors. The characteristics of these detectors are evaluated and compared to other element-selective detection techniques. The unique features of the chemiluminescence detectors have made them powerful tools in many diverse fields of analytical chemistry.
material entity;Bruker NMR magnet;An NMR magnet that is manufactured by Bruker.
material entity;Bruker NMR instrument;An NMR instrument that is manufactured by Bruker.
process;total venous blood PSA assay;An analyte assay that measures the abundance of PSA in venous blood as part of a total order
material entity;pulsed amperometric detector;A chromatography detector as used by high-performance anion exchange chromatography that provides sensitive and specific detection of carbohydrates. Pulsed Electrochemical Detection (PED) allows simple, sensitive, and direct detection of numerous polar aliphatic compounds, especially carbohydrates. This technique exploits the electrocatalytic activity of noble metal electrode surfaces to oxidize various polar functional groups. In PED, multi-step potential-time waveforms at Au and Pt electrodes realize amperometric/coulometric detection while maintaining uniform and reproducible electrode activity. The response mechanisms in PED are dominated by the surface properties of the electrode, and, as a consequence, members of each chemical class of compounds produce virtually identical voltammetric responses. Thus, the full potential is realized when combined with high performance liquid chromatography (HPLC).
process;total venous blood T3 assay;An analyte assay that measures the abundance of T3 in venous blood as part of a total order
material entity;column adapter;An Adapter that enabled the connection of a column to additional devices.
process;24 hour urine protein assay;An analyte assay that measures the abundance of protein in urine as part of a 24 hour order
role;immune epitope carrier role;A role inhering in a material entity that is covalently bound to an epitope in order to increase the epitopes immunogenicity.
role;adjuvant role;Adjuvant role is a role that inheres in a material entity and which is realized through a process of modifying a biological response.
disposition;disposition to infect an organism;Is a role borne by an agent, and realized when in contact with or inside another organism in which it is capable of replicating and causing disease
process;immunization;The process of an epitope that is part of or derived from an immunogen coming into contact with adaptive immune cells resulting in these cells acquiring immune effector functions specific for the epitope.
process;blood harvesting;A material separation where blood is taken from an organism.
process;antibody purification of H2-Dd protein complex;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-Dd protein complex, while others contain impurities and are not of interest.
process;antibody purification of mouse MHC class I protein complex;An antibody purification of MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of mouse MHC class I protein complex, while others contain impurities and are not of interest.
material entity;L cell line;A cell line derived from mouse fibroblasts.
process;antibody purification of H2-Db protein complex;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-Db protein complex, while others contain impurities and are not of interest.
process;antibody purification of H2-Ld protein complex, H2-Db protein complex, and/or H2-Dq protein complex;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-Ld protein complex, H2-Db protein complex, and/or H2-Dq protein complex while others contain impurities and are not of interest.
process;ABL90 panel arterial blood lactic acid assay;An assay that measures lactic acid in arterial blood as part of a ABL90 panel order
process;antibody purification of H2-Kd protein complex;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-Kd protein complex, while others contain impurities and are not of interest.
process;ABL90 panel arterial blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in arterial blood as part of a ABL90 panel order
process;antibody purification of mouse MHC class I protein complex with H2-b haplotype and/or mouse MHC protein complex with H2-p haplotype;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of mouse MHC class I protein complex with H2-b haplotype and/or mouse MHC protein complex with H2-p haplotype while others contain impurities and are not of interest.
process;ABL90 panel arterial blood chloride assay;An analyte assay that measures the abundance of chloride in arterial blood as part of a ABL90 panel order
process;antibody purification of H2-Dd protein complex and/or H2-Kd protein complex;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of H2-Dd protein complex and/or H2-Kd protein complex while others contain impurities and are not of interest.
process;ABL90 panel arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a ABL90 panel order
process;antibody purification of pig MHC class I protein complex, cattle MHC class I protein complex, and/or human MHC class I protein complex;An antibody purification of MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of pig MHC class I protein complex, cattle MHC class I protein complex, and/or human MHC class I protein complex, while others contain impurities and are not of interest.
process;ABL90 panel arterial blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in arterial blood as part of a ABL90 panel order
process;antibody purification of H2-Kb protein complex, H2-Ks protein complex, and/or H2-Kq protein complex;An antibody purification of mouse MHC class I protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of mouse H2-Kb protein complex, H2-Ks protein complex, and/or H2-Kq protein complex while others contain impurities and are not of interest.
process;ABL90 panel arterial blood calcium assay;An analyte assay that measures the abundance of calcium in arterial blood as part of a ABL90 panel order
process;antibody purification of cattle MHC class II protein complex;An antibody purification of MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of cattle MHC class II protein complex, while others contain impurities and are not of interest.
generically dependent continuant;pathologic distant metastases stage for kidney according to AJCC 7th edition;A categorical value specification that is a pathologic finding about one or more characteristics of renal cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.
process;antibody purification of MHC class II protein complex;An antibody purification of MHC protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of MHC class II protein complex, while others contain impurities and are not of interest.
process;venous blood cortisol assay;An analyte assay that measures the abundance of cortisol in venous blood
process;ABL90 panel arterial blood sodium assay;An analyte assay that measures the abundance of sodium in arterial blood as part of a ABL90 panel order
process;ABL90 panel arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a ABL90 panel order
process;ABL90 panel arterial blood glucose assay;An analyte assay that measures the abundance of glucose in arterial blood as part of a ABL90 panel order
role;immunogen role;A role of a material entity that is realized when the material elicits an immune response targeting itself in whole or in part.
role;host of immune response role;is a role borne by an organism. It is realized by the organism during an immunization or an immune response taking place inside or on the surface of the organism, and in which the responding or stimulated immune system is part of the host.
function;effector T cell function;The function inhering in a T cell that is realized in an immune response that results from the T cell receptor binding to the MHC:epitope complex.
function;antigen presentation function;a function inhering in a cell that expresses MHC molecules which is realized in the process of antigen processing and presentation of antigen derived parts by MHC molecules on the cell surface.
role;restricting MHC role;The role played by an MHC molecule by binding a material entity playing the role of epitope when that epitope/MHC molecule pair are recognized (bound) by a TCR molecule on the surface of a cell playing the role of effector cell.
process;antibody purification of HLA-DP protein complex;An antibody purification of human MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of HLA-DP protein complex, while others contain impurities and are not of interest.
role;donor role;A role which inheres in an organism or part thereof from which any part including cell, organ or tissue is removed with the intention that the donated part will be placed into another organism and/or cultured in vitro.
process;antibody purification of human MHC class II protein complex;An antibody purification of MHC class II protein complex to separate a material entity into different compositions of which one fraction contains a higher concentration of human MHC class II protein complex, while others contain impurities and are not of interest.
process;ABL90 panel venous blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in venous blood as part of a ABL90 panel order
process;ABL90 panel venous blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in venous blood as part of a ABL90 panel order
process;methylation-sensitive restriction enzyme sequencing assay;An assay that identifies unmethylated CpGs using methylation sensitive restriction enzymes to fragment DNA.
process;ABL90 panel venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a ABL90 panel order
process;reduced representation bisulfite sequencing assay;A bisulfite sequencing assay that identifies genomic methylation patterns using a bisulfite based protocol that enriches CG-rich parts of the genome.
process;ABL90 panel venous blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in venous blood as part of a ABL90 panel order
process;shotgun bisulfite-seq assay;A bisulfite sequencing assay that identifies methylated cytosines across the genome using high throughput sequencing.
process;ABL90 panel venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a ABL90 panel order
process;RNA Annotation and Mapping of Promoters for the Analysis of Gene Expression assay;An transcription profiling assay that identifies transcription start sites (TSS), the quantification of their expression and the characterization of their transcripts using high throughput sequencing.
material entity;assay array;A device made to be used in an analyte assay for immobilization of substances that bind the analyte at regular spatial positions on a surface.
material entity;secondary cultured cell;A cultured cell that has been passaged or derives from a cell that has been passaged in culture.
material entity;gel filtration column;A Gel filtration column is a chromatography column for size-exclusion chromatography, in which the stationary phase is a gel. The main application of gel filtration chromatography is the fractionation of proteins and other water-soluble polymers.
material entity;tecmag NMR instrument;An NMR instrument that is manufactured by tecmag.
material entity;affinity column;An affinity column is a chromatography column that is used in affinity chromatography. Differences in the affinity of molecules to be separated to a stationary phase are used for discriminate retention.
material entity;column cartridge;A device that binds the chromatography column and additional connector elements and / or valves or syringes into one physical unity for further processing.
process;ABL90 panel arterial blood temperature assay;An assay that measures temperature in arterial blood as part of a ABL90 panel order
material entity;Bruker CryoProbe;The Bruker BioSpin CryoProbe is a high-performance cryogenically cooled probe developed for high-resolution applications. It has improved signal/noise (S/N) ratios obtained by reducing the operating temperature of the coil and the pre-amplifier. As a result, the efficiency of the coil is improved and the noise of the coil and the pre-amplifier are reduced.The dramatic increase in the S/N ratio by a factor of 3-4, as compared to conventional probes, leads to a possible reduction in experiment time of up to 16 or a reduction in required sample concentration by a factor of up to 4. The CryoProbes possess key characteristics for NMR analysis:n Significant S/N gains (with moderately salty samples also)n Short pulse widthsn Short ring down timesn Linear behavior in power responsen Gradient capabilityn CryoProbes are available as Triple Resonance, Dual, Selective X Detection, MicroImaging, and Quad Nucleus Probes configurations at 400 MHz and highern All high resolution probes have a lock circuitn All high resolution probes have Z-gradient.
process;ABL90 panel arterial blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in arterial blood as part of a ABL90 panel order
material entity;Bruker UltraShield Plus NMR magnet;An NMR magnet of which Brukers claims it is the latest and most advanced self-shielding NMR magnet technology ever developed. These magnets are the ultimate advancement in high performance, actively-shielded NMR solutions. They offer unprecedented shielding performance whilst ensuring no compromise in system homogeneity, stability or cryogenic specifications.
process;ABL90 panel arterial blood potassium assay;An analyte assay that measures the abundance of potassium in arterial blood as part of a ABL90 panel order
process;CBC with manual differential venous blood promyelocyte count assay;A cytometry assay that measures the count of promyelocytes in venous blood as part of a CBC with manual differential order
process;ABL90 panel venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a ABL90 panel order
material entity;imaging NMR probe;An NMR probe that is designed for generating pictures from sample states via NMR imaging.
material entity;in-line filter;A solvent filter that sits between the pump and the injection valve that prevents dust particles, general debris and, to some extent, bacteria from entering the chromatography system. Contaminants can interfere with the low-pressure gradient former or the pump and particles entering valves may interfere with the proper function. The result could cause an increased baseline noise, non-repeatable gradient forming, unreliable flow rate or other interferences. Solvent in-line filters are low-pressure filters and will allow a high flow rate due to a large surface area and large porosity.
process;copy number variation profiling assay;An assay that determines lost or amplified genomic regions of DNA by comparing genomic DNA originating from tissues from the same or different individuals using specific techniques such as CGH, array CGH, SNP genotyping
material entity;fraction collector;A fraction detector is a device that allows regular or specified samples to be taken from a column eluate and stored in a retrievable form. The storage vessels are usually small sample tubes or vials that are oriented in a rotating disk or in a moving belt, there movement usually being controlled by a microprocessor. On receiving a signal from the microprocessor, the next vial is placed under the column outlet and the eluate collected until receiving another signal from the computer. Once the properties of the chromatogram that describes the separation has been ascertained, then the collection program can be defined. The fractions can be collected on a basis of time either at regular intervals or a specific times to collect specific peaks. Alternatively the fractions can be collected by monitoring the detector output and when a peak starts to elute the fraction collector is activated and the peak collected in a specific vial. When the peak returns to base line the column eluate is then directed to waste until the next peak starts eluting. Fraction collectors are in common use with most liquid chromatographs. They are used to collect samples for further purification, subsequent examination by spectroscopic techniques or for biological or organoleptic testing.
process;establishing cell line;a process whereby a new type of cell line is created, either through passaging of a primary cell culture to relative genetic stability and compositional homogeneity, or through some experimental modification of an existing cell line to produce a new line with novel characteristics (e.g. immortalization or some other stable genetic modification, or selection of some defined subset).
material entity;genetic material;A nucleic acid macromolecule that is part of a cell or virion and is inherited from an immediate ancestor, or incorporated in a manner that it has the disposition to be replicated and inherited by descendants.
material entity;Illumina BeadChip;An array that consists of 3-micron silica beads that self assemble in microwells on either of two materials: fiber optic bundles or planar silica slides.
material entity;Illumina methylation BeadChip;A BeadChip made for an analyte assay that generates information about DNA methylation.
process;ABL90 panel venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a ABL90 panel order
material entity;LSRFortessa X-20;A flow cytometer analyzer manifactured by Becton ans Dickinson. Can be configured with up to 5 lasers, 488nm, 532 or 561 nm, 640 nm, 405 nm, 355 nm for measuring up to 20 parameters simultaneously.
process;urine sodium assay;An analyte assay that measures the abundance of sodium in urine
process;sequence assembly process;A data transformation that assembles two or more individual sequence reads into contiguous sequences (i.e., contigs).
process;bone profile venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a bone profile order
generically dependent continuant;number of errors;a data item that is the number of times that a given process failed, as an integer
process;bone profile venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a bone profile order
generically dependent continuant;random access memory size;random access memory size is a scalar measurement datum which denotes the amount of physical memory know as random access memory present of a computer or required by a computational process or data transformation
material entity;cultured immune cell population;a cultured cell population comprised of a single type of immune system cell
material entity;cell culture;A material entity comprised of cultured cells and the media in which they are being propagated or stored.
material entity;random access memory;Random-access memory (RAM) is a form of computer data storage. A random-access device allows stored data to be accessed directly in any random order. In contrast, other data storage media such as hard disks, CDs, DVDs and magnetic tape, as well as early primary memory types such as drum memory, read and write data only in a predetermined order, consecutively, because of mechanical design limitations. Therefore, the time to access a given data location varies significantly depending on its physical location
material entity;capillary pump system;A pump system optimized for capillary chromatography.
material entity;column compartment;For chromatography analyses, the ability to maintain a stable column environment regardless of ambient temperature fluctuations is critical for maintaining retention time precision. In order to ensure such stable conditions at different chromatography steps a column compartment can be installed that ensures e.g. stable temperature of the column in a given step.
material entity;Bruker SampleRail system;This Instrument system automatically prepares an NMR sample, inserts it into an NMR magnet, performs NMR experiments on the sample, and transports it back to the preparation system. The SampleRail fulfills the transporting tasks from the preparation system into the NMR magnet and back.
process;ABL90 panel venous blood oxygen assay;An analyte assay that measures the abundance of oxygen in venous blood as part of a ABL90 panel order
material entity;syringe filter;A small membrane filter of defined pore size, that filters samples from a syringe.
process;ABL90 panel venous blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in venous blood as part of a ABL90 panel order
material entity;gas chromatography equipment;Any device used in a gas chromatography experiment.
process;ABL90 panel venous blood lactic acid assay;An assay that measures lactic acid in venous blood as part of a ABL90 panel order
material entity;Bruker AC series NMR instrument;A series of older Bruker NMR magnets, now out of production.
process;ABL90 panel venous blood chloride assay;An analyte assay that measures the abundance of chloride in venous blood as part of a ABL90 panel order
process;isolation of adherent cells;a material separation process in which cells that stick to the container in which they are grown as a cell culture are separated from those in the liquid component of the culture. The output of this process are adherent cells.
process;venous blood T4 assay;An analyte assay that measures the abundance of T4 in venous blood
process;free venous blood T4 assay;An analyte assay that measures the abundance of T4 in venous blood as part of a free order
material entity;column cartridger;A chromatography device where the column cartridge is inserted into and stabilised.
process;isolation of PBMCs;a process in which cells with a single nucleus are isolated from a blood sample
material entity;evaporative light scattering detector;The evaporative light scattering detector, as its name implies, utilizes a spray that continuously atomizes the column eluent into small droplets. These droplets are allowed to evaporate, leaving the solutes as fine particulate matter suspended in the atomizing gas.
process;establishing primary cell culture;an establishing cell culture process whereby cells explanted directly from an organismal source or specimen, and placed in culture for maintenance or propagation as a primary cell culture
material entity;reagent;A biological or chemical entity that bears a reagent role in virtue of it being intended for application in a scientific technique to participate in (or have molecular parts that participate in) a chemical reaction that facilitates the generation of data about some distinct entity, or the generation of some distinct material specified output.
material entity;organization of Bioinformatics Resource Center contact person;An organization that is the affiliation of the person who is contact representative of a Bioinformatics Resource Center
generically dependent continuant;target material in specimen specification;A plan specification which specifies the type of material that will be assayed in an investigation.
material entity;Bioinformatics Resource Center contact person;A person who is the contact representative of a Bioinformatics Resource Center
generically dependent continuant;specimen-based scope of investigation specification;A plan specification which specifies the scope of an investigation based on the heterogeneity of organisms or type of material that are the specified input of specimen collection.
material entity;specimen repository organization;An organization that provides a service to store and distribute specimens
generically dependent continuant;email address of Bioinformatics Resource Center contact person;An email address of the person who is contact representative of a Bioinformatics Resource Center
material entity;sequencing facility contact person;A person who is the contact representative at the sequencing facility
material entity;flash pump system;Any pump system used in flash column chromatography to push the solvent through the column. Better flow rates can be achieved by using a pump or by using compressed gas (e.g. air, nitrogen, or argon) to push the solvent through the column (flash column chromatography).
material entity;isocratic pump system;A pump system optimized for isocratic chromatography.
material entity;autosampler;An optional part of an NMR instrument used to hold samples prior to NMR analysis and that sequentially loads these samples into the analytical part of the NMR instrument. n alt The autosampler is an automatic sample changer device.
material entity;gas chromatography oven;A gas chromatography oven is an oven with a heated connection between the GC and the MS instrument in a GCMS-analysis, that keeps compounds in the gas phase as they leave the GC oven.
material entity;Bruker Capillary LC-NMR platform;Capillary LC-NMR is a hyphenated technique coupling capillary liquid chromatography and NMR, which increases sensitivity dramatically through the use of miniaturization of the chromatographic techniques and NMR detection volume. LC-NMR hyphenated systems separate a mixture into its pure components and couple the output to NMR for automatic sample analysis. The ever increasing need to measure lower sample amounts and lower level impurities demands the highest NMR sensitivity. Traditional LC-NMR systems with relatively large peak volumes are not optimized for such low levels of detection. Bruker BioSpin, together with Waters and Protasis has developed a Capillary LC-NMR system. The latest capillary LC attributes and highest capillary flow probe sensitivity combine with state of the art NMR systems technology. Greater mass sensitivity and faster spectral analysis with smaller sample volumes is possible. This system is ideal for analysis of metabolites and impurities associated with the drug development process.
process;reverse transcribed polymerase chain reaction;reverse transcribe pcr is a process which allow amplification of cDNA during a pcr reaction while the cDNA results from a retrotranscription of messenger RNA isolated from a material entity.
material entity;needle assembly;The needle assembly attached to the autosampler, comprises the injector needle that feeds a sample or carrier gas into the inlet
material entity;nitrogen generator;A gas generator that generates nitrogen gas.
material entity;organization of specimen provider principal investigator;An organization that is the affiliation of the principal investigator providing the specimens for the investigation
material entity;liquid NMR probe;An NMR probe that is designed to hold a liquid sample.
material entity;Varian UNITY INOVA spectrometer;The UNITY INOVA is also the easiest spectrometer to use and is also the choice of those interested in using advanced NMR techniques in their own research, but without becoming, or hiring, an NMR expert. A complete set of turnkey operating environments is available for the UNITY INOVA covering the structure and dynamics of biological macromolecules, small molecules, solids, and imaging. These packages put the combined NMR expertise of the entire Varian NMR community at your fingertips.
material entity;specimen provider principal investigator;A person who is a principal investigator and provides the specimen
material entity;assay bead;A globular or round particle of defined physicochemical properties and size which can be exploited as either the primary substance for detection or as a secondary solid platform for the attachment of bioactive molecules.
material entity;ion exchange column;An ion exchange column is a chromatography column that is used in ion exchange chromatography and anion or cation exchange resins to enable separation.
generically dependent continuant;specification of data to be generated in an investigation;An objective specification which indicates the type of data that will be generated and submitted to a database.
material entity;organization of specimen collector;An organization that is the affiliation of the person collecting the specimen
generically dependent continuant;email address of sequencing facility contact person;An email address of the contact representative at the sequencing facility
material entity;specimen collector;A person who collects the specimen
generically dependent continuant;investigation assay specification;A plan specification which indicates the assay type used to obtain data.
material entity;organization of sequencing facility contact person;An organization that is the affiliation of the contact representative at the sequencing facility
generically dependent continuant;comment on investigation;A textual entity that is about any of the aspects of an investigation worth noting
generically dependent continuant;target capture specification;A plan specification which specifies how the material enrichment procedure will influence the scale, or type of material that will be assayed in the specimen.
material entity;piston-seal;The seal made by a piston in a diaphragm pump. The unique property of the reciprocating diaphragm pump is that the actuating piston does not come into direct contact with the mobile phase and thus, the demands on the piston-cylinder seal are not so great. The diaphragm has a relatively high surface area and thus, the movement of the diaphragm is relatively small and consequently the pump can be operated at a fairly high frequency. High frequency pumping results in a very significant reduction in pulse amplitude and, in addition, high frequency pulses are more readily damped by the column system. Nevertheless, it must be emphasized that diaphragm pumps are not pulseless.
material entity;Bruker UltraShield NMR magnet;An NMR magnet manufactured by Bruker that ensures field homogeneity without amplified effects from vibrations or thermal changes. This magnet technology uses active shielding and optimizes coil design.
material entity;NMR instrument;An Instrument which is used to carry out a NMR analysis of some sample.
material entity;electrical conductivity detector;The electrical conductivity detector measures the conductivity of the mobile phase. There is usually background conductivity which must be backed-off by suitable electronic adjustments. If the mobile phase contains buffers, the detector gives a base signal that completely overwhelms that from any solute usually making detection impossible. Thus, the electrical conductivity detector a bulk property detector. and senses all ions whether they are from a solute or from the mobile phase. In order to prevent polarization of the sensing electrodes, AC voltages must be used and so it is the impedance not the resistance of the electrode system that is actually measured. From a physical chemistry stand point the conductivity of a solution is more important than its resistance. However, it is the resistance (impedance) of the electrode system that determines the current across it. The resistance of any conductor varies directly as its length and inversely as its cross sectional area.
material entity;tecmag EAGLE probe;The Eagle is a 4 mm 1H/X solid-state MAS probe with a top spinning speed of 18 kHz. Its simple design is robust, reliable and easy to spin. Configurations are available for 200 to 600 MHz wide bore magnets on Tecmag, Bruker, Chemagnetics, JEOL and Varian spectrometers.
material entity;fluorescene detector;A single wavelength detector, where the excitation light wavelength is normally a mercury lamp generated high intensity UV light at 253.7 nm. Many substances that fluoresce will be excited by light of this wavelength and hence be detected.
material entity;anion trap column;An anion trap column is a trap column and ion-exchange column which contains cationic anion-exchange resins.
generically dependent continuant;email address of specimen collector;An email address of the person collecting the specimen
material entity;Bruker NMR probe;An NMR probe that is manufactured by Bruker.
material entity;sequencing facility organization;An organization that provides sequence determination service
material entity;mass selective detector;A mass selective detector is a GC detector that uses mass spectrometry. It is based upon the ionization of solute molecules in the ion source and the separation of the ions generated on the basis of their mass/charge ratio by an analyzer unit. This may be a magnetic sector analyzer, a quadruple mass filter, or an ion trap. Ions are detected by a dynode electron multiplier.
generically dependent continuant;loop design;A loop experiment design is where labeled extracts are compared in consecutive pairs. synonym: circular design
generically dependent continuant;N50;the weighted median item size or N50 is a weighted median of the lengths of items, equal to the length of the longest item i such that the sum of the lengths of items greater than or equal in length to i is greater than or equal to half the length of all of the items. With regard to assemblies the items are typically contigs or scaffolds. It therefore denotes the ability of the software to create contigs and provides information about the resulting sequence assembly
generically dependent continuant;balanced incomplete block design;balanced incomplete block design is a kind of factorial design where all treatment pairs occur together within a block an equal number ?? times. ??ii' is the number of times treatment i occurs with i'
generically dependent continuant;contig N50;N50 statistic computed for the contigs produced by the assembly process. A contig N50 is calculated by first ordering every contig by length from longest to shortest. Next, starting from the longest contig, the lengths of each contig are summed, until this running sum equals one-half of the total length of all contigs in the assembly. The contig N50 of the assembly is the length of the shortest contig in this list.
generically dependent continuant;randomized complete block design;A randomized complete block design is a study design which assigns randomly treatments to block. The number of units per block equals the number of treatment so each block receives each treatment exactly once (hence the qualifier 'complete'). The design was originally devised from field trials used in agronomy and agriculture. The analysis assumes that there is no interaction between block and treatment. The method was then used in other settings So The randomised complete block design is a design in which the subjects are matched according to a variable which the experimenter wishes to control. The subjects are put into groups (blocks) of the same size as the number of treatments. The members of each block are then randomly assigned to different treatment groups.
material entity;grant agency;An organization that provides funding support for projects such as investigations.
generically dependent continuant;parallel group design;A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment
generically dependent continuant;software pipeline;A plan specification that specifies a chain encoded in software of processing elements (processes, threads, coroutines, etc.), arranged so that the output of each element is the input of the next. Usually some amount of buffering is provided between consecutive elements.
generically dependent continuant;matched pairs design;A matched pair design is a study design which use groups of individuals associated (hence matched) to each other based on a set of criteria, one member going to one treatment, the other member receiving the other treatment.
material entity;Bruker MATCH tube holder system;The Bruker Multiple Adjustable Tube Clamp Holder MATCH system is a holder for 100 mm long NMR sample tubes with diameters ranging from micro tubes up to 5 mm NMR tubes. The MATCH insert fits into a standard 10 mm Bruker spinner and is suitable for all non-spinning applications.n The MATCH system provides an easy and cost efficient means of optimizing the signal-to-noise ratio of each sample. By matching the NMR tube diameter to the size of the sample, most of the sample can be placed in the active column of the NMR coil. This leads to an enhanced signal detection compared to diluting the same sample quantity in a larger tube.
generically dependent continuant;n-to-1 design;N-of-1 design is a cross-over design in which the same patient is repeatedly randomised to receive either the experimental treatment or its control (Senn, 1993).
material entity;Varian NMR instrument;An NMR instrument that is manufactured by Varian.
generically dependent continuant;cross over design;a repeated measure design which ensures that experimental units receive, in sequence, the treatment (or the control), and then, after a specified time interval (aka *wash-out periods*), switch to the control (or treatment). In this design, subjects (patients in human context) serve as their own controls, and randomization may be used to determine the ordering which a subject receives the treatment and control
material entity;auto injector;A gas chromatography device that can auto-inject a small number of samples an inlet.
generically dependent continuant;repeated measure design;a study design which use the same individuals and exposure them to a set of conditions. The effect of order and practice can be confounding factor in such designs
generically dependent continuant;clinical study design;Plan for the precise procedure to be followed in a clinical trial, including planned and actual timing of events, choice of control group, method of allocating treatments, blinding methods. assigns a subject to pass through one or more epochs in the course of a trial. Specific design elements, e.g., crossover, parallel. dose-escalation [Modified from Pocock, Clinical Trials: A Practical Approach]
generically dependent continuant;study design;A plan specification comprised of protocols (which may specify how and what kinds of data will be gathered) that are executed as part of an investigation and is realized during a study design execution.
process;edge weighting;Edge weighting is the substitution or transformation of edge length using numerical data. Data input include a symmetric adjacency matrix for a network and a second data set, for example a list of interactor pairs and a confidence score associated with the experimental detection of each pair's interaction. Each element in the adjacency matrix is transformed or replaced with the corresponding number in the second data set. Output data are a modified adjacency matrix reflecting the transformed state of the network.
process;data imputation;Imputation is a means of filling in missing data values from a predictive distribution of the missing values. The predictive distribution can be created either based on a formal statistical model (i,e, a multivariate normal distribution) or an algorithm.
material entity;chromatography splitter;An adjustable restriction that is placed in the waste outlet to allow the necessary pressure to develop at the column inlet to force a flow (q ml/min) through the column. If the flow of mobile phase is Q ml/min then the waste flow will be (Q-q) ml/min. by adjusting the waste flow, the proportion of the sample entering the capillary column can be varied over a wide range of values and the necessary minimum permissible volume for the particular column in use can be selected for analysis. Unfortunately, the fraction taken in this way may not be representative of the original sample. This is due to the individual solutes in the mixture having different diffusivities and, thus, they distribute themselves across the sampling tube in an irregular manner. In general, the components with higher diffusivities (e.g., those solutes of lower molecular weight) will diffuse away from the bulk sample more quickly than those having lower diffusivities.
process;t cell epitope prediction;A T cell epitope prediction takes as input an antigen sequence, and through an analysis of this sequence, produces as output a prediction of the likelihood the biomaterial is a T cell epitope.
material entity;size exclusion column;A size exclusion column is a chromatography column as used in size exclusion chromatography and which enables the separation of mixtures according to differrences in molecular size.
process;characteristic path length calculation;Quantifying subgraph navigability based on shortest-path length averaged over all pairs of subgraph vertices
material entity;fluorine-induced chemiluminescence detector;A gas chromatographic detection system based on the low pressure, gas phase chemiluminescence of the reaction mixture of molecular fluorine with organo-sulfur, -selenium, and -tellurium compounds separated from (gas phase) headspace samples. This detector was originally developed in the research group of John Birks at the University of Colorado, USA and was manufactured and sold by Sievers Instruments (Boulder Colorado, USA). This system can be divided up into three parts: the chromatograph, transfer line, and reaction cell. PMT and photon counting electronics. and the molecular fluorine generator.
process;continuum mass spectrum analysis;A continuum mass spectrum is a data transformation that contains the full profile of the detected signals for a given ion.
material entity;high resolution probe with automatic tuning and matching;The Automatic Tuning and Matching (ATM) option for AVANCE spectrometers is available for double resonance probes in fixed-frequency and broadband tunable configurations with either direct or indirect detection. Thus, for multinuclear operation, as often required for applications in inorganic chemistry, ATM facilitates the accurate setting of 90 degree pulse widths on both observe and decoupling channels for each chosen nucleus and each individual sample - even with full automation. Triple resonance probes in fixed-frequency configurations, as typically used for inverse detection with high-field systems.
process;protein expression profiling assay;An assay that determines protein expression and translation activity using protein extracts collected from a material entity.
process;centroid mass spectrum analysis;A centroid mass spectrum is a data transformation in which many points are used to delineate a mass spectral peak, is converted into mass-centroided data by a data compression algorithm. The centroided mass peak is located at the weighted center of mass of the profile peak. The normalized area of the peak provides the mass intensity data.
material entity;guard column;Guard columns are installed between the injection valve and the analytical or preparative column and here will remove contaminants and prolong the lifetime of the columns.
material entity;Bruker SPE-NMR platform;A Solid Phase Extraction (SPE) system provides an interface between liquid chromatography (LC) and NMR. For the process of LC-SPE NMR a chromatographic separation is done and the peaks of interest are trapped on an individual SPE cartridge after the column. The peak selection is done either by UV detection or by evaluation of the on-line registered MS or MSn spectra.
process;Holm-Bonferroni family-wise error rate correction method;a data transformation that performs more than one hypothesis test simultaneously, a closed-test procedure, that controls the familywise error rate for all the k hypotheses at level  in the strong sense. Objective: multiple testing correction
process;sequence annotation;A planned process that identifies and reports sequence features (e.g. protein coding regions) in sequence data.
generically dependent continuant;scaffold N50;N50 statistic computed for the scaffold produced by the assembly process. The method for computing the value is similar to that of contig N50 but uses scaffold information instead of contig information
material entity;forward PCR primer;A short oligonucleotide complementary to target DNA (5'->3' on plus strand) that acts as the leader for DNA extension in a PCR reaction. The polymerase starts replication at the 3'-end of the primer, and copies the opposite strand. A primer is characterized by its 'melting temperature' (Tm) and pairs of primers should have similar Tm.
material entity;sequence annotation provider;A person or organization reporting the feature annotation results from the analysis of a macromolecular sequence.
generically dependent continuant;sequence assembly name;A textual entity that is used to denote a sequence assembly.
role;sequence annotation reporting role;A reporting party role that is realized by a person or organization who reports the feature annotation results from the analysis of a macromolecular sequence.
material entity;reverse PCR primer;A short oligonucleotide complementary to target DNA (5'->3' on minus strand) that acts as the leader for DNA extension in a PCR reaction. The polymerase starts replication at the 3'-end of the primer, and copies the opposite strand. A primer is characterized by its 'melting temperature' (Tm) and pairs of primers should have similar Tm.
generically dependent continuant;self vs self design;A study design that investigates variance and error estimates in the experimental system, and is where the same extract is compared.
process;flash freezing;A freezing process by which material entities are quickly frozen by subjecting them to cryogenic temperatures, or in direct contact with Liquid nitrogen at -320.8F or -196C.
generically dependent continuant;replicate design;A replicate experimental design type is where a series of replicates are performed to evaluate reproducibility or as a pilot study to determine the appropriate number of replicates for a subsequent experiments.
process;freezing;A planned process with the objective to bring some material entity to a temperature below its freezing point.
generically dependent continuant;dye swap design;An experiment design type where the label orientations are reversed. exact synonym: flip dye, dye flip
process;ChIP assay;An assay in which portions of chromatin, the ordered and organized complex of DNA and its interaction partners that make up a chormosome, is extracted and purified by immunoprecipitation with antibodies or tags, and subsequently analyzed
generically dependent continuant;fractional factorial design;A fractional factorial design is a study design in which only an adequately chosen fraction of the treatment combinations required for the complete factorial experiment is selected to be run
process;NMR spectroscopy assay;An assay that exploits the magnetic properties of certain nuclei (those with a spin) to resonate when placed in particular magnetic field conditions. Instruments recording NMR spectrum and sets of analysis can be used to deduce identity of chemical as well as composition of complex chemical mixtures.
generically dependent continuant;2x2 factorial design;a factorial design which has 2 experimental factors (aka independent variables) and 2 factor levels per experimental factors
material entity;gel permeation column;A gel permeation column is a chromatography column which is used in gel permeation chromatography and which employs as the stationary phase a swollen gel made by polymerizing and cross-linking styrene in the presence of a diluent which is a nonsolvent for the styrene polymer. The polymer to be analyzed is introduced at the top of the column and then is elutriated with a solvent. The polymer molecules diffuse through the gel at rates depending on their molecular size.
generically dependent continuant;factorial design;factorial design is a study design which is used to evaluate two or more factors simultaneously. The treatments are combinations of levels of the factors. The advantages of factorial designs over one-factor-at-a-time experiments is that they are more efficient and they allow interactions to be detected. In statistics, a factorial design experiment is an experiment whose design consists of two or more factors, each with discrete possible values or levels, and whose experimental units take on all possible combinations of these levels across all such factors. Such an experiment allows studying the effect of each factor on the response variable, as well as the effects of interactions between factors on the response variable.
material entity;custom made column;A custom made column ia a chromatography column which is specifically tailored according to the needs of the separation as requested by a scientist or working group.
generically dependent continuant;hyper graeco latin square design;PRS to do
material entity;Bruker micro imaging probe;For medical, biological and material sciences research, avance imaging systems provide optimal object handling and performance with a variety of samples types. Two classes of imaging probes are available: in vivo probes for handling and sustaining live objects such as animals and plants, and conventional imaging probes for materials samples.
generically dependent continuant;graeco latin square design;Greco-Latin square design is a study design which relates to Latin square design
generically dependent continuant;latin square design;Latin square design is a study design which allows in its simpler form controlling 2 levels of nuisance variables (also known as blocking variables).he 2 nuisance factors are divided into a tabular grid with the property that each row and each column receive each treatment exactly once.
generically dependent continuant;reference design;A reference experiment design type is where all samples are compared to a common reference.
process;dimensionality reduction;A dimensionality reduction is data partitioning which transforms each input m-dimensional vector (x 1, x 2, ..., x m) into an output n-dimensional vector (y 1, y 2, ..., y n), where n is smaller than m.
material entity;Bruker solid magic angle spinning probe;Magic angle spinning, nowadays a routine technique for solids NMR, still offers the capability of innovation. The high mechanical performance of MAS probes in conjunction with efficient rf pulse techniques open new exciting fields in solids NMR of biological samples and in the field of quadrupolar nuclei.
process;probabilistic algorithm;A probabilistic algorithm is one which involves an element of probability or randomness in the transformation of the data.
material entity;carbon nanotube column;Carbon nanotubes (CNTs) are known to have high thermal and mechanical stability and have the potential to be high-performance separation media that utilize the nanoscale interactions. CNT can be applied in long capillary tubes for the development of gas chromatography columns. A film of CNTs can be deposited by chemical vapor deposition (CVD) to form the stationary phase in the open tubular format. Altering the CVD conditions can vary the thickness and the morphology of the CNT film, which opens the possibility of selectivity tuning. The ability to fabricate long tubes coated with CNTs can be readily employed in other gas- and liquid-phase separations as well.
process;principal components analysis dimensionality reduction;A principal components analysis dimensionality reduction is a dimensionality reduction achieved by applying principal components analysis and by keeping low-order principal components and excluding higher-order ones.
material entity;quaternary pump system;A pump system that pump and mix up to four different solvents in parallel.
process;global modularity calculation;A network graph quality calculation in which an input data set of subgraph modules and their in-degree and out-degree qualities is used to calculate the average modularity of subgraphs within the network.
process;DNA sequencing assay;A sequencing assay which determines information on the sequence of a DNA molecule.
process;expectation maximization;EM is a probabilistic algorithm used to estimate the maximum likelihood of parameters from existing data where the model involves unobserved latent variables. The input to this method is the data model for which the estimation is performed over and the output is an approximated probability function.
material entity;JEOL ECX NMR spectrometer;The ECX series of NMR spectrometers is designed for any laboratory needing an easy-to-use, reliable, routine NMR system. The ECX NMR series is available from 300 to 500 MHz. The console is designed around a modular, digital NMR electronics chassis controlled by an intelligent acquisition computer. For unprecedented flexibility, the JEOL NMR system offers a Windows XP, Mac OSX or LINUX. Both the workstation and spectrometer may be connected to a standard network, allowing seamless remote operation anywhere in the world.
process;moving average;A moving average is a data transformation in which center calculations, usually mean calculations, are performed on values within a sliding window across the input data set.
material entity;Bruker SampleJet system;Bruker BioSpin introduces the SampleJet, a robot for NMR tube automation. The SampleJet has been consciously designed to meet the growing customer demand for simplicity, versatility and higher throughput in NMR sample tube automation.n The SampleJet utilizes the modern-day industry standard for sample arrangements-the 96 well plate array. Therefore, the samples may be handled by standard lab automation devices before or after the NMR measurement.
process;dye swap merge;A dye swap merge is a replicate analysis which takes as input data from paired two-channel microarray assays where the sample labeled with one dye in the first assay is labeled with the other dye in the second assay and vice versa. The output for each reporter is obtained by combining its (raw or possibly pre-processed) M values in the two assays, where the M value in an assay is defined as the difference of the log intensities in the two channels. This can be used as a normalization step, when appropriate assumptions are met.
role;competitive binding reference ligand role;A positive reference substance role that inheres in a material entity that is known to bind to a target entity, and that is realized in a competitive binding assay that has as specified input the target entity, an evaluant and the positive reference substance, where the binding of the evaluant to the target is measured based on the evaluant's ability to compete with the positive reference substance for binding to the target.
process;b cell epitope prediction;A B cell epitope prediction takes as input an antigen sequence, and through an analysis of this sequence, produces as output a prediction of the likelihood the biomaterial is a B Cell Epitope.
process;assay using chromatin immunoprecipitation;An assay that produces data about protein-DNA interaction or DNA epigenetic modification using immunoprecipitation
process;replicate analysis;A replicate analysis is a data transformation in which data from replicates are combined, e.g. through descriptive statistics calculations, and the results might be utilized for a variety of purposes, like assessing reproducibility, identifying outliers, normalizing, etc.
generically dependent continuant;hardware testing design;A study design that aims to compare different types of hardware for performance, reproducibility, accuracy and precision.
generically dependent continuant;systematic review study design;A study design for identifying in the literature prior studies of a pre-determined phenomenon or set of related phenomena according to certain criteria, extracting findings from these studies, and summarizing these findings and/or attempting to draw new conclusions from them which were not justified by any of the individual, prior studies. Many systematic reviews also assess the quality of the studies so reviewed.
process;mhc binding prediction;An MHC binding prediction takes an input of a biomaterial sequence and through an analysis of this sequence, produces as output a prediction of the likelihood that the biomaterial will bind to an MHC molecule.
process;multiplexed nucleotide library sequencing;A planned process which consists in running a set of samples as a pool on a sequencing instrument, while retaining the ability to associate individual results to each of the individual input samples through the use of a ligated oligonucleotide (the "multiplex identifier sequence"). This oligonucleotide is introduced during the sequence library preparation, and is unique to and specific for all library fragments derived from each sample in a sample pool.
process;taxonomic diversity assessment by targeted gene survey;An assay that dteremines taxonomic and community diversity information by sequencing specific genomic regions used as marker of identity or diversity.
generically dependent continuant;PCR program;a PCR program is a plan specification which is executed during a polymerase chain reaction (PCR) by a thermocycler instrument that will iterate through the changes in temperature and duration of each of the annealing, denaturation, elongation steps for as many times as specified by the program.
generically dependent continuant;target gene specification;is a directive information specifying a coding genomic region which is the focus of a planned process such as an assay, for instance in a environmental gene survey
process;bone profile venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a bone profile order
generically dependent continuant;target subfragment specification;is a directive information specifying a genomic region, possibly located in a coding genomic region, which is the focus of a planned process such as an assay, for instance in a environmental gene survey
process;bone profile venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a bone profile order
generically dependent continuant;decision-theoretic analysis objective;An objective specification which what includes a description of two or more alternative actions to take in a particular situation and a metric that enables comparisons of the two actions. The objective specified is achieved in a planned process which includes a data transformation, the output of which is an identification of the 'best' choice according to the metric.
generically dependent continuant;exclusion criterion;an exclusion criterion (rule) is a *eligibility criterion* which defines and states a condition which, if met, makes an entity unsuitable for a given task or participation in a given process. For instance, in a study protocol, exclusion criteria indicate the conditions that prospective subjects SHOULD NOT meet to be eligible for participation in a study
process;bone profile venous blood phosphate assay;An analyte assay that measures the abundance of phosphate in venous blood as part of a bone profile order
generically dependent continuant;decision analysis study design;a study design that has a decision analysis objective specification as part
generically dependent continuant;inclusion criterion;an inclusion criterion (rule) is a *eligibility criterion* which defines and states a condition which, if met, makes an entity suitable for a given task or participation in a given process. For instance, in a study protocol, inclusion criteria indicate the conditions that prospective subjects MUST meet to be eligible for participation in a study.
process;ABG/electrolytes arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a ABG/electrolytes order
process;DNA methylation profiling assay;An assay that measures the state of methylation of DNA molecules using genomic DNA collected from a material entity using a range of techniques and instrument such as DNA sequencers and often relying on treatment with bisulfites to ensure cytosine conversion.
generically dependent continuant;eligibility criterion;an eligibility criterion (rule) is a selection criterion which defines and states the requirements (positive or negative) for an entity to be considered as suitable for a given task or participation in a process.
material entity;column heater;The glass liner can be fitted with a separate heater and the volatilization temperature can, thus, be controlled. This flash heater system is available in most chromatographs. By using a syringe with a long needle, the tip can be made to penetrate past the liner and discharge its contents directly into the column packing. This procedure is called 'on-column injection' and, as it reduces peak dispersion on injection and thus, provides higher column efficiencies, is often the preferred procedure.
generically dependent continuant;ethical standard compliance rule;an ethical standard compliance rule is a *compliance rule* which enable a *ethical compliance process* to occur
material entity;Bruker Metabolic Profiler;An NMR platform for conducting metabonomics studies, traditional metabolism studies, and analysis of complex mixtures, featuring an Avance NMR spectrometer and a microTOF from Bruker Daltonics. By combining the structural resolving power of NMR with mass accuracy of the microTOF Bruker offers a complete system for metabolic research. The Metabolic Profiler provides a simple, easy to use and inexpensive base-system to acquire the spectroscopic data, needed to do basic metabolic profiling including metabonomic statistical analysis.
generically dependent continuant;standard compliance rule;a standard compliance rule is a compliance rule which defines conformity to a representation standard
material entity;Varian MERCURY spectrometer;MERCURYplus spectrometers provide superior control, stability, and performance for high-productivity environments. Surface-mount electronics enable a small footprint without compromising data quality. Modular design allows flexible configuration. Direct digital synthesis, linear amplifiers, and other innovative RF and digital technologies enable push-button operation.
generically dependent continuant;compliance rule;a compliance rule is a rule which ensures a compliance process occurs
process;hematology assay;An assay that studies blood and blood producing organs using a variety of techniques and instruments
generically dependent continuant;stopping rule;a stopping rule (criterion) is a *rule* which causes a *stopping process* to happen
generically dependent continuant;time series design;Groups of assays that are related as part of a time series.
process;k-means clustering;A k-means clustering is a data transformation which achieves a class discovery or partitioning objective, which takes as input a collection of objects (represented as points in multidimensional space) and which partitions them into a specified number k of clusters. The algorithm attempts to find the centers of natural clusters in the data. The most common form of the algorithm starts by partitioning the input points into k initial sets, either at random or using some heuristic data. It then calculates the mean point, or centroid, of each set. It constructs a new partition by associating each point with the closest centroid. Then the centroids are recalculated for the new clusters, and the algorithm repeated by alternate applications of these two steps until convergence, which is obtained when the points no longer switch clusters (or alternatively centroids are no longer changed).
generically dependent continuant;material separation objective;is an objective to transform a material entity into spatially separated components.
process;modular decomposition;Molecular decomposition is the partition of a network into distinct subgraphs for the purpose of identifying functional clusters. The network data is run through any of several existing algorithms designed to partition a network into distinct subgraphs for the purpose of isolating groups of functionally linked biological elements such as proteins.
material entity;gas purifier;Gas purifiers are instruments used for the removal of gas impurities like hydrocarbons, oxygen, and moisture from carrier gas and fuel gases for GC or GC-MS systems.
process;average linkage hierarchical clustering;An average linkage hierarchical clustering is an agglomerative hierarchical clustering which generates successive clusters based on a distance measure, where the distance between two clusters is calculated as the average distance between objects from the first cluster and objects from the second cluster.
material entity;gas chromatography detector;A gas chromatography detector is a chromatography detector that locates in the dimensions of space and time, the positions of the components of a mixture that has been subjected to a gas chromatographic process and thus permits the senses to appreciate the nature of the separation. There is no LC detector that has an equivalent performance to the flame ionization detector (FID) used in GC. In general, LC detectors have sensitivities of two to three orders of magnitude less than their GC counterparts and linear dynamic ranges one to two orders of magnitude lower. Only highly specific LC detectors have sensitivities that can approach those of GC detectors.
process;hierarchical clustering;A hierarchical clustering is a data transformation which achieves a class discovery objective, which takes as input data item and builds a hierarchy of clusters. The traditional representation of this hierarchy is a tree (visualized by a dendrogram), with the individual input objects at one end (leaves) and a single cluster containing every object at the other (root).
material entity;acquisition computer;A Computer used for NMR, can be divided into central processing unit (CPU), consisting of instruction, interpretation and arithmetic unit plus fast access memory, and peripheral devices such as bulk data storage and input and output devices (including, via the interface, the spectrometer). Under software control, the computer controls the RF pulses and gradients necessary to acquire data, and process the data to produce spectra or images. Note that devices such as the spectrometer may themselves incorporate small computers.
process;single linkage hierarchical clustering;A single linkage hierarchical clustering is an agglomerative hierarchical clustering which generates successive clusters based on a distance measure, where the distance between two clusters is calculated as the minimum distance between objects from the first cluster and objects from the second cluster.
material entity;JEOL CapNMR probe;The JEOL ECA and ECX NMR spectrometers now support the MRM/Protasis CapNMR Probe for well plate-based and microvial-based NMR analysis. The CapNMR probe is available at proton frequencies ranging from 300 MHz to 800 MHz in both indirect configurations (e.g. 1H{13C} and 1H {31P}) and also in triple resonance configurations (e.g. 1H{13C, 15N}, 1H{31P, 15N}). Both employ a high-strength z-directed field gradient. The flowprobes come with the choice of two flowcell volumes: a 5 l flowcell with an NMR active volume of 2.5 l, and a 10 l flowcell with an NMR active volume of 5 l. The fluidic connections are 75 m i.d. and 1/32 o.d. FEP Teflon with hastelloy unions for exceptional solvent compatibility.
process;complete linkage hierarchical clustering;an agglomerative hierarchical clustering which generates successive clusters based on a distance measure, where the distance between two clusters is calculated as the maximum distance between objects from the first cluster and objects from the second cluster.
process;sequence library data demultiplexing;is a data transformation which uses sequence alignment and 'multiplex identifier sequence' information to separate all reads belonging to a given single sample following the sequencing of a multiplexed library
process;ABG/electrolytes arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a ABG/electrolytes order
material entity;multiplexing sequence identifier;A multiplexing sequence identifier is a nucleic acid sequence which is used in a ligation step of library preparation process to allow pooling of samples while maintaining ability to identify individual source material and creation of a multiplexed library
process;ABG/electrolytes arterial blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in arterial blood as part of a ABG/electrolytes order
generically dependent continuant;operational taxonomic unit matrix;Operational Taxonomic Unit matrix is a data item, organized as a table, where organismal taxonomic units, computed by sequence analysis and genetic distance calculation, are counted in a set of biological or environmental samples. The table is used to appraise biodiversity of a population or community of living organism.
process;Benjamini and Yekutieli false discovery rate correction method;A data transformation in which the Benjamini and Yekutieli method is applied with the aim of correcting false discovery rate
process;CBC with automated differential venous blood nucleated RBC count assay;A cytometry assay that measures the count of nucleated RBCs in venous blood as part of a CBC with automated differential order
generically dependent continuant;biodiversity assessment objective;biodiversity assessment objective is an objective of a planned process aimed at producing data item whose interpretation should provide insight about variety of biological species found in a biological sample at macroscopic or microscopic level
process;ABL90 panel venous blood methemoglobin assay;An analyte assay that measures the abundance of methemoglobin in venous blood as part of a ABL90 panel order
process;ABL90 panel arterial blood methemoglobin assay;An analyte assay that measures the abundance of methemoglobin in arterial blood as part of a ABL90 panel order
process;venous blood valproic acid assay;An analyte assay that measures the abundance of valproic acid in venous blood
material entity;multiplexed sequencing library;a multiplexed library is a material entity which is the output of a library preparation process that uses a ligation step to attach a unique multiplexing sequence identifier to a specific sample, then mixes several such tagged samples prior to the library amplification process proper. A multiplexed library allows the sequencing of several samples in one sequencing run.
material entity;Ion 316 Chip v2;An ion semiconductor chip manufactured by Life Technologies which detects polymerase-driven base incorporation to translate into digital form. The 316 chip is compatible with the Ion Torrent PGM and has a run time of: 3.0 hours for 200 bp reads with an output of 30-50 Mb, 4.9 hours for 400 bp reads with an output of 60 Mb-1 Gb.
material entity;Ion 318 Chip v2;An ion semiconductor chip manufactured by Life Technologies which detects polymerase-driven base incorporation to translate into digital form. The 318 chip is compatible with the Ion Torrent PGM and has a run time of: 4.4 hours for 200 bp reads with an output of 60 Mb-1 Gb, 7.3 hours for 400 bp reads with an output of 1.2 Gb-2 Gb.
process;high sensitivity cardiac/neonatal venous blood c-reactive protein assay;An analyte assay that measures the abundance of c-reactive protein in venous blood as part of a high sensitivity cardiac/neonatal order
material entity;ion semiconductor chip;An ion detector that is organized as an electronic circuit whose components, such as transistors and resistors, are etched or deposited on a single slice of semiconductor material to produce a chip. The specific chip detects ion charge induced when an ion passes by or hits a surface.
process;POC arterial blood creatinine assay;An analyte assay that measures the abundance of creatinine in arterial blood as part of a POC order
material entity;Ion 314 Chip v2;An ion semiconductor chip manufactured by Life Technologies which detects polymerase-driven base incorporation to translate into digital form. The 314 chip is compatible with the Ion Torrent PGM and has a run time of: 2.3 hours for 200 bp reads with an output of 30-50 Mb, 3.7 hours for 400 bp reads with an output of 60-100 Mb.
process;GEM4000 ANLCOOX arterial blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in arterial blood as part of a GEM4000 ANLCOOX order
process;GEM4000 ANLCOOX arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a GEM4000 ANLCOOX order
process;hydrogen/deuterium exchange footprinting assay;A footprinting assay that uses a chemical reaction whereby a covalently bonded hydrogen atom is replaced by a deuterium atom, or vice versa in order to gather information about the solvent accessibility of parts of a molecule and thus its tertiary structure.
process;GEM4000 ANLCOOX arterial blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in arterial blood as part of a GEM4000 ANLCOOX order
material entity;atomic emission detector;Instead of measuring simple gas phase (carbon containing) ions created in a flame as with the flame ionization detector, or the change in background current because of electronegative element capture of thermal electrons as with the electron capture detector, the AED has a much wider applicability because it is based on the detection of atomic emissions. The strength of the AED lies in the detector's ability to simultaneously determine the atomic emissions of many of the elements in analytes that elute from a GC capillary column (called eluants or solutes in some books). As eluants come off the capillary column they are fed into a microwave powered plasma (or discharge) cavity where the compounds are destroyed and their atoms are excited by the energy of the plasma. The light that is emitted by the excited particles is separated into individual lines via a photodiode array. The associated computer then sorts out the individual emission lines and can produce chromatograms made up of peaks from eluants that contain only a specific element.
material entity;JEOL ECA NMR spectrometer;The ECA series of NMR spectrometers is a high performance, research grade NMR system configurable to a wide range off applications. The ECA NMR is available from 300 to 930 MHz field strengths and is 1GHz ready. The system is designed around a modular, digital NMR electronics chassis controlled from a UNIX or Windows workstation and acquisition system. Both the workstation and spectrometer may be connected to a standard network, allowing seamless remote operation anywhere in the world.
material entity;indirect detection probe;An NMR probe designed to allow the indirect detection of acquisition nuclei.
process;median centering;A median centering is a data transformation that takes as input an n-dimensional (real) vector, performs a median calculation on its components, and subtracts the resulting median from each component of the input.
generically dependent continuant;data set of features;A data set that is produced as the output of a descriptive statistical calculation data transformation and consists of producing a data set that represents one or more features of interest about the input data set.
process;K-fold cross validation method;K-fold cross-validation randomly partitions the original sample into K subsamples. Of the K subsamples, a single subsample is retained as the validation data for testing the model, and the remaining K - 1 subsamples are used as training data. The cross-validation process is then repeated K times (the folds), with each of the K subsamples used exactly once as the validation data. The K results from the folds then can be averaged (or otherwise combined) to produce a single estimation. The advantage of this method over repeated random sub-sampling is that all observations are used for both training and validation, and each observation is used for validation exactly once. 10-fold cross-validation is commonly used
generically dependent continuant;clustered data set;A data set that is produced as the output of a class discovery data transformation and consists of a data set with assigned discovered class labels.
generically dependent continuant;differential expression analysis objective;A differential expression analysis objective is a data transformation objective whose input consists of expression levels of entities (such as transcripts or proteins), or of sets of such expression levels, under two or more conditions and whose output reflects which of these are likely to have different expression across such conditions.
process;jackknifing method;Jacknifing is a re-sampling data transformation process used to estimate the precision of sampling statistics and is a resampling method
process;leave one out cross validation method;is a data transformation : leave-one-out cross-validation (LOOCV) involves using a single observation from the original sample as the validation data, and the remaining observations as the training data. This is repeated such that each observation in the sample is used once as the validation data
process;cytometry assay;An assay that counts and/or measures characteristics of cells.
process;Benjamini and Hochberg false discovery rate correction method;A data transformation process in which the Benjamini and Hochberg method sequential p-value procedure is applied with the aim of correcting false discovery rate
process;GEM4000 ANLCOOX arterial blood temperature assay;An assay that measures temperature in arterial blood as part of a GEM4000 ANLCOOX order
process;immunoblot assay;An analyte assay that detects specific molecules in an input material by separating it using gel electrophoresis, transfering the separated molecules to a membrane, and staining them with antibodies specific to the analyte molecules.
process;boostrapping;Bootstrapping is a statistical method for estimating the sampling distribution of a statistic by sampling with replacement from the original data, most often with the purpose of deriving robust estimates of standard errors and confidence intervals of a population parameter like a mean, median, proportion, odds ratio, correlation coefficient or regression coefficient
process;GEM4000 ANLCOOX arterial blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in arterial blood as part of a GEM4000 ANLCOOX order
process;fluorescence quenching binding assay;A binding assay in which the proximity of two entities is monitored by measuring a fluorescent signal of one of the entities that gets reduced if the two entities are cliose to each other.
process;GEM4000 ANLCOOX arterial blood potassium assay;An analyte assay that measures the abundance of potassium in arterial blood as part of a GEM4000 ANLCOOX order
process;pareto scaling;A pareto scaling is a data transformation that divides all measurements of a variable by the square root of the standard deviation of that variable.
process;GEM4000 ANLCOOX arterial blood glucose assay;An analyte assay that measures the abundance of glucose in arterial blood as part of a GEM4000 ANLCOOX order
process;GEM4000 ANLCOOX arterial blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in arterial blood as part of a GEM4000 ANLCOOX order
process;GEM4000 ANLCOOX arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a GEM4000 ANLCOOX order
process;GEM4000 ANLCOOX arterial blood sodium assay;An analyte assay that measures the abundance of sodium in arterial blood as part of a GEM4000 ANLCOOX order
process;ionized venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a ionized order
process;venous blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in venous blood
process;CBC with manual differential venous blood megakaryocyte count assay;A cytometry assay that measures the count of megakaryocytes in venous blood as part of a CBC with manual differential order
process;non-cardiac venous blood c-reactive protein assay;An analyte assay that measures the abundance of c-reactive protein in venous blood as part of a non-cardiac order
generically dependent continuant;testable hypothesis;An information content entity that expresses an assertion that is intended to be tested.
generically dependent continuant;conclusion based on data;An information content entity that is inferred from data.
process;linlog transformation;A linlog transformation is a data transformation, described in PMID 16646782, whose input is a matrix [y ik] and whose output is a matrix obtained by applying formula (9) of this paper, where values below an appropriately determined threshold (dependent on the row i) are transformed via a polynomial of degree 1, and values above this threshold are transformed via a logarithm.
process;homogeneous polynomial transformation;A homogeneous polynomial transformation is a polynomial transformation where all the term of the polynomial have the same degree.
process;loess global transformation;A loess global transformation is a loess transformation where only one loess fitting is performed, utilizing one subset of (or possibly all of) the data points in the input so that there is only one resulting loess curve y=f(x) which is used for the transformation.
process;variance stabilizing transformation;A variance stabilizing transformation is a data transformation, described in PMID 12169536, whose input is a matrix [y ik] and whose output is a matrix obtained by applying formula (6) in this paper. One of the goals is to obtain an output matrix whose rows have equal variances. The method relies on various assumptions described in the paper.
generically dependent continuant;specimen identifier assigned by specimen repository;A specimen identifier which is assigned by a specimen repository
process;loess scale group transformation;A loess scale group transformation is a data transformation consisting in the application of a scale adjustment following a loess group transformation, to render the group variances for the second variable (y) similar. Has objective scaling.
process;intraoperative venous blood PTH assay;An analyte assay that measures the abundance of PTH in venous blood as part of a intraoperative order
generically dependent continuant;specimen identifier assigned by sequencing facility;A specimen identifier which is assigned by a sequencing facility
process;loess group transformation;A loess group transformation is a loess transformation where the input is partitioned into groups and for each group a loess fitting is performed, utilizing a subset of (or possibly all of) the data points in that group. Thus, a collection of loess curves y=f i(x) is generated, one per group. Each (x, y) in the input is transformed into (x, y-f i(x)), where f i(x) is the curve corresponding to the group to which that data point belongs.
process;venous blood parathyroid hormone assay;An analyte assay that measures the abundance of parathyroid hormone in venous blood
process;sample preparation for sequencing assay;A sample preparation for assay that preparation of nucleic acids for a sequencing assay
process;total intensity transformation paired;A total intensity transformation paired is a data transformation that takes as input two n-dimensional (real) vectors and multiplies each component of the first vector by a coefficient, where the coefficient is obtained by taking the ratio of the sum of the second input components or of a subset of these by the sum of the first input components or of a subset of these (the same subset is used for the two vectors).
process;total bodily fluid protein assay;An analyte assay that measures the abundance of protein in bodily fluid as part of a total order
generically dependent continuant;email address of specimen provider principal investigator;An email address of the principal investigator providing the specimens for the investigation
process;total intensity transformation single;A total intensity transformation single is a data transformation that takes as input an n-dimensional (real) vector and multiplies each component of this vector by a coefficient, where the coefficient is obtained by taking the sum of the input components or of a subset of these, multiplied by a constant of choice.
process;bodily fluid glucose assay;An analyte assay that measures the abundance of glucose in bodily fluid
process;sequencing service;A service provides sequencing service which is the realization of some sequencing such as RNA and DNA sequencing in which the service provider role is realized.
process;mean centering;A mean centering is a data transformation that takes as input an n-dimensional (real) vector, performs a mean calculation on its components, and subtracts the resulting mean from each component of the input.
material entity;secondary cultured cell population;A cultured cell population that is derived through one or more passages in culture.
process;quantile transformation;A quantile transformation is a data transformation that takes as input a collection of data sets, where each can be thought as an n-dimensional (real) vector, and which transforms each data set so that the resulting output data sets have equal quantiles.
material entity;cancer cell line;An immortal cell line derived from a transformed cell that was part of a malignant tumor.
process;immortalizing cell line transformation;a genetic transformation of a cell line cell with transgenic constructs intended to confer the capability for indefinite propagation in culture
process;count bodily fluid cell count assay;A cytometry assay that measures the count of cells in bodily fluid as part of a count order
process;manual differential bodily fluid segmented neutrophil count assay;A cytometry assay that measures the count of segmented neutrophils in bodily fluid as part of a manual differential order
process;manual differential bodily fluid mesothelial cell count assay;A cytometry assay that measures the count of mesothelial cells in bodily fluid as part of a manual differential order
process;manual differential bodily fluid monocyte count assay;A cytometry assay that measures the count of monocytes in bodily fluid as part of a manual differential order
process;manual differential bodily fluid lymphocyte count assay;A cytometry assay that measures the count of lymphocytes in bodily fluid as part of a manual differential order
process;manual differential bodily fluid macrophage count assay;A cytometry assay that measures the count of macrophages in bodily fluid as part of a manual differential order
material entity;primary cell culture;A cell culture comprised of primary cultured cells and the media in which they are being actively propaged or quiescently stored.
process;manual differential bodily fluid basophil count assay;A cytometry assay that measures the count of basophils in bodily fluid as part of a manual differential order
process;Carbon-copy chromosome conformation capture assay;An assay that measures the organization of chromosomes at the genome-wide scale.
process;loess scale group transformation one-channel;A loess scale group transformation one-channel is a loess scale group transformation consisting in the application of a scale adjustment following a loess group transformation one-channel, to render the M group variances similar.
process;loess scale group transformation two-channel;A loess scale group transformation two-channel is a loess scale group transformation consisting in the application of a scale adjustment following a loess group transformation two-channel, to render the M group variances similar.
process;logical transformation;A logical transformation is a data transformation that, for each (one dimensional) real number input x, outputs an approximation (found, e.g. with the Newton's method) to a solution y of the equation S(y)-x=0, where S denotes an s transformation.
material entity;cell line culture;A cell culture comprised of cell line cells and the media in which they are being actively propagated or quiescently stored.
process;split-scale transformation;A split-scale transformation is a data transformation which is an application of a function f described as follows to a (one dimensional) real number input. f(x)=a*x+b if x=for x>t. where log denotes a logarithmic transformation and a, b, c, d, r, t are real constants, with a, c, d, r, t positive, chosen so that f is continuous with a continuous derivative at the transition point t.
process;manual differential bodily fluid eosinophil count assay;A cytometry assay that measures the count of eosinophils in bodily fluid as part of a manual differential order
material entity;cell freezing medium;A processed material that serves as a liquid vehicle for freezing cells for long term quiescent stroage, which contains chemicls needed to sustain cell viability across freeze-thaw cycles.
process;loess global transformation one-channel;A loess global transformation one-channel is a loess global transformation in the special case where the input is the result of an MA transformation applied to intensities from two related one-channel assays.
process;liver function venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a liver function order
generically dependent continuant;computation run time;computation run time is a time measurement datum which corresponds the time expressed in second, minute, hour necessary for a computer program to complete a process execution, for example genome assembly. It is an important metrics as it indicates the resource occupancy and computer program efficiency.
process;sine transformation;A sine transformation is a data transformation which consists in applying the sine function to a (one dimensional) real number input. The sine function is one of the basic trigonometric functions and a definition is provided, e.g., at http://mathworld.wolfram.com/Sine.html.
process;liver function venous blood alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase in venous blood as part of a liver function order
process;multiplex ligation-mediated amplification;A polymerase chain reaction that amplifies multiple targets with a single primer pair mediated by hybridization of a primer with its target sequence using ligation.
process;loess global transformation two-channel;A loess global transformation two-channel is a loess global transformation in the special case where the input the result of an MA transformation applied to intensities from the two channels of a two-channel assay.
process;DNA replication timing by array assay;An assay which quantifies the timing of DNA replication as a function of genome position using array technology.
process;loess group transformation one-channel;A loess group transformation one-channel is a loess group transformation in the special case where the input is the result of an MA transformation applied to intensities from two related one-channel assays.
generically dependent continuant;DNA replication identification objective;A molecular feature identification objective that aims to examine charateristics of DNA replication, such as replication time.
process;cosine transformation;A cosine transformation is a data transformation which consists in applying the cosine function to a (one dimensional) real number input. The cosine function is one of the basic trigonometric functions and a definition is provided, e.g., at http://mathworld.wolfram.com/Cosine.html.
generically dependent continuant;chromosome conformation identification objective;A molecular feature identification objective that aims to determine spatial organization of chromatin.
process;RNA-binding protein immunoprecipitation array profiling assay;An assay that combines immunoprecipitation of an RNA-binding protein and array technology to identify mRNAs associated with selected RNA binding proteins (RBPs).
process;loess group transformation two-channel;A loess group transformation two-channel is a loess group transformation in the special case where the input is the result of an MA transformation applied to intensities from the two channels of a two-channel assay.
process;liver function venous blood human aspartate aminotransferase assay;An analyte assay that measures the abundance of human aspartate aminotransferase in venous blood as part of a liver function order
process;liver function venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a liver function order
process;liver function venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a liver function order
process;liver function venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a liver function order
process;vitamin B12 and Folate venous blood folic acid assay;An analyte assay that measures the abundance of folic acid in venous blood as part of a vitamin B12 and Folate order
process;bodily fluid cell count assay;A cytometry assay that measures the count of cells in bodily fluid
process;DNA replication timing by sequencing assay;An assay in which timing of DNA replication is quantified as a function of genome position based on genome-wide sequencing.
process;venous blood reticulocyte count assay;A cytometry assay that measures the count of reticulocytes in venous blood
process;RNA-binding protein immunoprecipitation tiling array profiling assay;An RNA-binding protein immunoprecipitation array profiling assay that combines immunoprecipitation of an RNA-binding protein and RNA tiling array to identify mRNAs associated with selected RNA binding proteins (RBPs).
process;bodily fluid cholesterol assay;An analyte assay that measures the abundance of cholesterol in bodily fluid
process;geometric mean calculation;A data transformation in which the mean is calculated by taking the nth root of the product of all of the observations in a data (n being the number of all observations).
process;data transformation;A planned process that produces output data from input data.
process;microRNA profiling by high throughput sequencing assay;A microRNA profiling assay that analyzes the microRNA component of the transcriptome using high throughput sequencing technology.
process;logit-log curve fitting;A logit-log curve fitting is a curve fitting where first the limits y 0 an y infty of y when x->0 and x->infinity, respectively, are estimated from the input data points (x 1, y 1), (x 2,y 2), ..., (x n, y n). Then a curve with equation log((y-y 0)/(y infty-y))=a+b log(x) is obtained, where a and b are determined to optimize its fit to the input data points.
process;TSH reflex Free T4 venous blood thyroid stimulating hormone assay;An analyte assay that measures the abundance of thyroid stimulating hormone in venous blood as part of a TSH reflex Free T4 order
process;protein sequencing by tandem mass spectrometry assay;A sequencing assay that detremines amino acid sequences of proteins using multiple rounds of mass spectrometry and molecule fragmentation.
process;logistic-log curve fitting;A logistic-log curve fitting is a curve fitting where a curve of the form y=d+((a-d)/(1+(x/c)^b)) is obtained, where a, b, c, and d are determined so to optimize its fit to the input data points (x 1, y 1), (x 2, y 2), ..., (x n, y n).
process;direct venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a direct order
process;micrococcal nuclease digestion followed by high throughput sequencing assay;An assay that identifies nucleosome positioning by genome wide sequencing of regions sensitive to digestion by micrococal nuclease
generically dependent continuant;feature extraction objective;A feature extraction objective is a data transformation objective where the aim of the data transformation is to generate quantified values from a scanned image.
process;chromatin immunoprecipitation with exonuclease sequencing assay;A ChIP-seq assay which uses immunoprecipitation to isolate protein bound DNA followed by an exonuclease step to degrade DNA that is not protein bound to provide greater resolution of the DNA binding site
process;log-log curve fitting;A log-log curve fitting is a curve fitting where first a logarithmic transformation is applied both to the x and the y coordinates of the input data points (x 1, y 1), (x 2, y 2), ..., (x n, y n), and then coefficients a and b are determined to optimize the fit of log(y)=a+b*log(x) to these input data points.
process;microRNA profiling assay;A transcription profiling assay that quantifies the microRNA species within a biological sample.
process;box-cox transformation;A box-cox transformation is a data transformation according to the methods of Box and Cox as described in the article Box, G. E. P. and Cox, D.R. (1964) An analysis of transformations. Journal of Royal Statistical Society, Series B, vol. 26, pp. 211-246.
process;biexponential transformation;A biexponential transformation is a data transformation that, for each (one dimensional) real number input x, outputs an approximation (found, e.g. with the Newton's method) to a solution y of the equation B(y)-x=0, where B denotes a b transformation.
process;selection;A planned process with the objective to create a group of entities by applying a predefined criteria to a larger group of entities.
generically dependent continuant;mass value specification;A value specification that specifies the mass of some thing.
process;hyperlog transformation;A hyperlog transformation ia a data transformation that, for each (one dimensional) real number input x, outputs an approximation (found, e.g. with the Newton's method) to a solution y of the equation EH(y)-x=0, where EH denotes an eh transformation.
process;bodily fluid albumin assay;An analyte assay that measures the abundance of albumin in bodily fluid
process;bodily fluid triglyceride assay;An analyte assay that measures the abundance of triglyceride in bodily fluid
process;hemoglobin and hematocrit venous blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in venous blood as part of a hemoglobin and hematocrit order
process;hemoglobin and hematocrit venous blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in venous blood as part of a hemoglobin and hematocrit order
process;venous blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in venous blood
generically dependent continuant;categorical value specification;A value specification that is specifies one category out of a fixed number of nominal categories
process;venous blood temperature assay;An assay that measures temperature in venous blood
generically dependent continuant;scalar value specification;A value specification that consists of two parts: a numeral and a unit label
process;venous blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in venous blood
process;comparing prediction to measurement;A planned process in which predicted values for some thing are compared to measured values for that thing.
process;venous blood oxygen assay;An analyte assay that measures the abundance of oxygen in venous blood
material entity;chromatography consumable;A chromatography consumable is a consumable that is used in a chromatography experiment.
material entity;JEOL NMR instrument;An NMR instrument that is manufactured by JEOL.
process;free venous blood T3 assay;An analyte assay that measures the abundance of T3 in venous blood as part of a free order
material entity;glass column;A glass column is a chromatography column made out of glass that is usually used for larger scale and preparative liquid chromatography separations.
material entity;hydrogen generator;A gas generator that generates hydrogen gas.
material entity;high resolution magic angle spin probe;Samples that are neither solid nor liquid, being of biological, chemical, or pharmaceutical interest, reveal highly resolved spectra when magic angle spinning is applied. The correct solution is a gradient, such that the field varies along the spinner axis. This so-called Magic Angle Gradient is employed in Brukers high resolution Magic Angle Spinning (hr-MAS) probes, and is implemented in such a way that it is compatible with the stator and does not interfere with the sample eject or insert. Bruker BioSpin has developed a series of dedicated probes for standard bore magnets to accommodate the rapidly expanding field of hr-MAS. These probes are available in double (e.g. 1H and 13C) and triple resonance (e.g. 1H, 13C, 15N) modes and come equipped with a deuterium lock channel. The probes have automatic sample ejection and insertion capability, with the availability of an optional sample changer, enabling fully automated sample runs. Probes can be equipped with an optional B0 gradient, directed along the magic angle, so that gradient spectroscopy can be done used.
material entity;open tubular column;An open tubular column is a chromatography column in which the particles of the solid stationary phase or the support coated with a liquid stationary phase are concentrated on or along the inside tube wall leaving an open, unrestricted path for the mobile phase in the middle part of the tube.
material entity;chart recorder;The chart recorder is a device that transduces signal-intensities into a graphical peak output: As the separated components of the gas sample emerge into the detector, the change in voltage in the detecting bridge circuit causes a representative peak to be drawn on a chart recorder. The position of the peak along the time axis of the chart measures the component's retention time, which identifies the component. This is directly related to carrier gas flow rate, temperature and column packing and dimensions. The area under each peak is proportional to the concentration of the component of the sample. The area of the peaks inscribed on the chart recorder can be determined by multiplying the height of the peak in mm, by the width of the peak in mm at 1/2 the peak height. The calibration curves for use with the chart recorder are therefore peak area plotted against concentration.
material entity;detector lamp;A lamp used in a chromatography detector that excites sample molecules at certain frequencies / emission wavelengths, e.g. Mercury Vapor Lamp (253.7 nm), Zinc Vapor Lamp (2123.9 nm and 307.6 nm), Cadmium Vapor Lamp (228.8, 326.1,340.3, and 346.6 nm). To obtain monochromatic light an appropriate light filter would be needed.
material entity;liquid chromatography column;A liquid chromatography column is a chromatography column that is used in liquid chromatography, i.e. a column that is provided with a liquid sample mix.
material entity;column frit;A part of the column content that separates column packing compartments. In radial columns the packing is supported between two cylindrical frits and the gap between represents the bed height or column length. The outer frit is the column inlet and consequently the sample initially has a large area of stationary phase with which to interact. Frits are porous metal products to prevent unwanted particles from entering the chromatography system. These particles may come from the sample, the solvent or debris generated by the chromatography system itself. Such particles entering the system may lead to clogging of capillaries, interference with the chromatography by changing chromatographic parameters or disturbance of the detector function. Characteristics of a frit, besides the diameter and the thickness, is the porosity (pore distribution, density).
generically dependent continuant;value specification;An information content entity that specifies a value within a classification scheme or on a quantitative scale.
process;venous blood osmolality assay;An assay that measures osmolality in venous blood
generically dependent continuant;predicted value;an information content entity that has been generated by a prediction process in which an estimate of a value of an entity is made which can be measured but without performing such a measurement. The value specification is intended to be close to the value a measurement process would produce modulo a prediction error.
generically dependent continuant;predicted mass value;A predicted value where the prediction specifies the mass of some thing.
material entity;molecular-labeled material;a material entity that is the specified output of an addition of molecular label process that aims to label some molecular target to allow for its detection in a detection of molecular label assay
generically dependent continuant;genome coverage;A data item that is the total number of bases in reads, divided by genome size, assumed to be the reference size (for instance of 3.10 Gb for human and 2.73 Gb for mouse) and refers to the percentage of the genome that is contained in the assembly based on size estimates. these are usually based on cytological techniques. Genome coverage of 9095% is generally considered to be good, as most genomes contain a considerable fraction of repetitive regions that are difficult to sequence. So it is not a cause for concern if the genome coverage of an assembly is a bit less than 100%.
material entity;decapitated organism;decapitated organism is an organism which has had it's head removed
material entity;denatured polymer;Is a polymer which has lost secondary or tertiary structure
generically dependent continuant;validated information;an information content entity which results from a validation process aimed at confirming a claim, a finding or a predicted information entity about a material entity or a process by experimental means.
material entity;perfusion station;A device or system in which perfusion units are integrated.
generically dependent continuant;hysterectomy history;A gynecologic surgery history in which a woman has had a hysterectomy.
material entity;SPECT scanner;A nuclear medicine tomographic imaging device that uses gamma rays to provide 3D information, typically presented as cross-sectional slices through the specimen but with the ability to be freely reformatted or manipulated as required.
generically dependent continuant;unilateral oophorectomy history;A gynecologic surgery history in which a woman has had a unilateral oophorectomy.
role;array manufacturer role;a manufacturer role which is played by the person or organization that manufactured the array
generically dependent continuant;exposure to second hand smoke;A clinical history in which there has been second hand exposure to tobacco smoking.
material entity;spot cutter;A robotic device that is used to excise spots from gels.
generically dependent continuant;exposure to second hand smoke in household during childhood;An exposure to second hand smoke that occurred in the (patient's) household when the person was a child.
material entity;microwave synthesis system;A device that is used to apply microwave irradiation to chemical reactions.
generically dependent continuant;exposure to second hand smoke in current household;An exposure to second hand smoke in person's current household.
material entity;densitometer;A device that measures the degree of darkness (the optical density) of a photographic or semitransparent material or of a reflecting surface.
generically dependent continuant;pregnancy history;A clinical history in which a female has had a pregnancy.
material entity;automatic staining machine;A device that is used to automatically stain tissue sections on slides or tissue specimens.
generically dependent continuant;number of pregnancies;A measurement datum of the total number of pregnancies a woman has had.
material entity;automatic tissue processor;A device for processing histological tissue having a tissue carrier basket suspended from a turntable overlying a plurality of beakers suspended from a carrier plate. The turntable is raised, indexed, and lowered by a suitable driving mechanism to move the tissue basket sequentially through the beakers. Timers can each be programmed to control the movement of the turntable to provide various different cycles for processing the tissue. Some of the beakers are received in individual thermal baths to heat and control the temperature of the substances received in the beakers for treating the tissue.
generically dependent continuant;number of live births;A measurement datum of the total number of live births a female has had.
material entity;stereo microscope;An optical microscope that uses two separate optical paths with two objectives and two eyepieces to provide slightly different viewing angles to the left and right eyes.
generically dependent continuant;age when gave birth to first child;An age measurement datum performed on a female when her first biological child was born.
material entity;top loading balance;A balance that consists of a metal plate on which to place an object and a digital readout of the measurement of its mass.
generically dependent continuant;gynecologic surgery history;A clinical history in which a woman has had gynecologic surgery in the past.
material entity;infrared image acquisition device;An image acquisition device that is responsive to an infrared emissive target within a given field of view.
material entity;confocal microscope;A microscope that is used to increase micrograph contrast and/or reconstruct three-dimensional images by using a spatial pinhole to eliminate out-of-focus light in specimens that are thicker than the focal plane.
material entity;scintillation counter;A device that is used to measure ionizing radiation.
material entity;programmable array microscope;A confocal microscope that uses a programmable spatial light modulator for generating an arbitrary pattern of conjugate illumination and detection apertures.
material entity;cryostat;A device consisting of a vessel, similar in construction to a vacuum flask, that is used to maintain cold cryogenic temperatures. FIX THIS DEFINITION
material entity;microtome knife maker;A glass cutting and breaking device that is used to produce glass knives used in ultramicrotomy.
material entity;cryofixation device;A device that is used for the fixation or stabilization of biological materials as the first step in specimen preparation for electron microscopy.
material entity;hybridization oven;A device that creates an appropriate environment for nucleic acid hybridization.
material entity;incubator shaker;An incubating device that provides shaking motion for biomedical applications (e.g., cell cultures).
material entity;small-animal image acquisition device;A device that is used to image small laboratory animals (e.g., rats and mice) in vivo.
process;logarithmic transformation;A logarithmic transformation is a data transformation consisting in the application of the logarithm function with a given base a (where a>0 and a is not equal to 1) to a (one dimensional) positive real number input. The logarithm function with base a can be defined as the inverse of the exponential function with the same base. See e.g. http://en.wikipedia.org/wiki/Logarithm.
process;polynomial transformation;A polynomial transformation is a data transformation that is obtained through a polynomial, where a polynomial is a mathematical expression involving a sum of powers in one or more variables multiplied by coefficients (e.g. see http://mathworld.wolfram.com/Polynomial.html). The number of variables and the degree are properties of a polynomial. The degree of a polynomial is the highest power of its terms, where the terms of a polynomial are the individual summands with the coefficients omitted.
process;exponential transformation;An exponential transformation is a data transformation consisting in the application of the exponential function with a given base a (where a>0 and a is typically not equal to 1) to a (one dimensional) real number input. For alternative definitions and properties of this function see, e.g., http://en.wikipedia.org/wiki/Exponential function and http://en.wikipedia.org/wiki/Characterizations of the exponential function.
process;soft independent modeling of class analogy analysis;Soft independent modeling by class analogy (SIMCA) is a descriptive statistics method for supervised classification of data. The method requires a training data set consisting of samples (or objects) with a set of attributes and their class membership. The term soft refers to the fact the classifier can identify samples as belonging to multiple classes and not necessarily producing a classification of samples into non-overlapping classes.
process;non-negative matrix factorization;Non negative matrix factorization is a data transformation in which factorises a matrix and which forces that all elements must be equal to or greater than zero.
material entity;patch clamp device;A device used in electrophysiology that allows the study of single or multiple ion channels in cells.
process;discriminant function analysis;Discriminant function analysis is a form of discriminant analysis used to determine which variables discriminate between two or more naturally occurring groups. Analysis is used to determine which variable(s) are the best predictors of a particular outcome.
material entity;microhardness tester;A hardness testing device that is used in light-optical microscopes.
material entity;gel imaging system;A device that is used to acquire images of laboratory gels.
material entity;protein separation apparatus;A device that is used for the separation of proteins.
material entity;multichannel electronic pipette;A multichannel pipette that can be programmed by the user to aspirate a volume of liquid reagent or sample and dispense the aspirated volume or a series of aliquots in successive dispensing operations.
material entity;vitrification apparatus;A device that is used to effect the transition of a substance into a glass.
material entity;radiography instrument;An image acquisition device that uses ionizing electromagnetic radiation such as X-rays to view objects.
material entity;radiation measurement device;A device that consists of a radiosensitive detector and a means of recording the effects of radiation on the detector.
material entity;lyophilizer;A device that is used to freeze dry material.
process;Westfall and Young family wise error rate correction;Is a data transformation process in which the Westfall and Young method is applied with the aim of controlling for multiple testing
material entity;tandem mass spectrometer;A mass spectrometer in which ions are subjected to two or more sequential stages of analysis (which may be separated spatially or temporally) according to the quotient mass/charge.
generically dependent continuant;inter-rater reliability objective;a data transformation objective of determining the concordance or agreement between human judges.
generically dependent continuant;survival analysis objective;A data transformation objective which has the data transformation aims to model time to event data (where events are e.g. death and or disease recurrence). the purpose of survival analysis is to model the underlying distribution of event times and to assess the dependence of the event time on other explanatory variables
process;longitudinal data analysis;Longitudinal analysis is a data transformation used to perform repeated observations of the same items over long periods of time.
process;mass spectrometry analysis;A data transformation which has the objective of spectrum analysis.
process;spread calculation data transformation;A spread calculation is a data transformation that has objective spread calculation.
material entity;multimode microplate reader;A microplate reader that can detect multiple types of absorbance, luminescence or fluorescence.
process;multiple testing correction method;A multiple testing correction method is a hypothesis test performed simultaneously on M > 1 hypotheses. Multiple testing procedures produce a set of rejected hypotheses that is an estimate for the set of false null hypotheses while controlling for a suitably define Type I error rate
material entity;mechanical balance;A balance that is used to compare the weights of two bodies, to determine the difference in mass (or weight).
process;Kaplan Meier;a nonparametric (actuarial) data transformation technique for estimating time-related events. It is a univariate analysis that estimates the probability of the proportion of subjects in remission at a particular time, starting from the initiation of active date (time zero), and takes into account those lost to follow-up or not yet in remission at end of study (censored)
material entity;computer cluster;A group of linked computers, working together closely so that in many respects they form a single computer.
material entity;microtome knife sharpener;A device that is used to sharpen knives used in microtomy.
material entity;plate shaker;A device that provides shaking motion for microplates.
material entity;coagulation analyzer;A device for automatically analyzing blood coagulation in a clinical laboratory.
material entity;laser capture microdissection microscope;A microscope that uses low-energy laser beams and special transfer film to lift single cells from a tissue.
material entity;liquid extraction robot;A liquid handling device that provides automatic liquid extraction.
material entity;ultrasound machine;A device that is used to visualize subcutaneous body structures including tendons, muscles, joints, vessels and internal organs.
generically dependent continuant;sequence analysis objective;A sequence analysis objective is a data transformation objective which aims to analyse some ordered biological data for sequential patterns.
material entity;immunoblot scanner;A device that is used for the imaging of immunoblots.
process;network analysis;A data transformation that takes as input data that describes biological networks in terms of the node (a.k.a. vertex) and edge graph elements and their characteristics and generates as output properties of the constituent nodes and edges, the sub-graphs, and the entire network.
process;curve fitting data transformation;A curve fitting is a data transformation that has objective curve fitting and that consists of finding a curve which matches a series of data points and possibly other constraints.
process;loess transformation;A loess transformation is a data transformation that takes as input a collection of real number pairs (x, y) and, after performing (one or more) loess fittings, utilizes the resulting curves to transform each (x, y) in the input into (x, y-f(x)) where f(x) is one of the fitted curves.
process;submatrix extraction;A submatrix extraction is a projection whose input is a matrix and whose output is a matrix obtained by selecting certain rows and columns from the input. (Note that, if one represents the input matrix as a vector obtained by concatenating its rows, then extracting a submatrix is equivalent to projecting this vector into that composed by the entries belonging to the rows and columns of interest from the input matrix.)
process;family wise error rate correction method;A family wise error rate correction method is a multiple testing procedure that controls the probability of at least one false positive.
process;column submatrix extraction;A column submatrix extraction is a submatrix extraction where all the rows of the input matrix are retained and selection only occurs on the columns.
process;row submatrix extraction;A row submatrix extraction is a submatrix extraction where all the columns of the input matrix are retained and selection only occurs on the rows.
generically dependent continuant;descriptive statistical calculation objective;A descriptive statistical calculation objective is a data transformation objective which concerns any calculation intended to describe a feature of a data set, for example, its center or its variability.
process;gating;Gating is a property-based vector selection with the objective of partitioning a data vector set into vector subsets based on dimension values of individual vectors (events), in which vectors represent individual physical particles (often cells) of a sample and dimension values represent light intensity qualities as measured by flow cytometry.
process;arithmetic mean calculation;An arithmetic mean calculation is a descriptive statistics calculation in which the mean is calculated by taking the sum of all of the observations in a data set divided by the total number of observations. It gives a measure of the 'center of gravity' for the data set. It is also known as the first moment.
generically dependent continuant;binding constant;A quantitative binding datum that is expressed as a scalar number and a unit, which can be utilized in equations that model the binding process independent of the specific assay performed.
generically dependent continuant;number of PCR cycles during library construction;A data item that is the number of PCR cycles used during the construction of a sequencing library.
process;3D structure determination of bound molecular complex assay;A 3D molecular structure determination assay in which a complex of 2 or more molecular enties is characterized which provides information on their binding configuration.
generically dependent continuant;number of rounds of amplification;A data item that is the number of times an amplification reaction happened.
process;binding assay;An assay with the objective to characterize the disposition of two or more material entities to form a complex.
role;reference genome role;A reference substance role that is played by a reference genome when used during sequence alignment.
process;cell culture expansion;a process that results in the increase of cell numbers
generically dependent continuant;reference genome-transcriptome alignment algorithm;An algorithm that attempts to align a nucleic acid sequence to a reference genome and transcriptome.
process;gene knock out;a genetic transformation that renders a gene non-functional, e.g. due to a point mutation, or the removal of all, or part of, the gene using recombinant methods.
generically dependent continuant;sequence read length measurement datum;A measurement datum that is the result of the measurement of the number of bases in a DNA or RNA sequence.
process;gene knock in;a genetic transformation that involves the insertion of a protein coding cDNA sequence at a particular locus in an organism's chromosome. Typically, this is done in mice since the technology for this process is more refined, and because mouse embryonic stem cells are easily manipulated. The difference between knock-in technology and transgenic technology is that a knock-in involves a gene inserted into a specific locus, and is a "targeted" insertion.
generically dependent continuant;bcl2fastq software application;A base calling application that implments a base calling algorithm to convert BCL (binary base call) files generated by Illumina sequencing systems to standard FASTQ file formats for downstream analysis.
role;spike-in quality control role;a reference substance role that is borne by a material entity with a known amount which is mixed into the evaluant of assays for quality control or data normalization purposes
generically dependent continuant;date process started;A data item that is the date when a process was initiated.
generically dependent continuant;individual organism identifier;a CRID symbol used to distinguish one individual organism from another.
generically dependent continuant;dbGaP study identifier;A central registered identifier symbol that denotes a specific study in dbGaP.
role;dye swap quality control role;a reference substance role that is borne by a material entity used in a dye swap design experiment for quality control or data normalization purposes
role;material amplification role;A worker role played by the person who runs the enzymatic amplifying process.
material entity;labeled nucleic acid extract;a labeled specimen that is the output of a labeling process and has grain labeled nucleic acid for detection of the nucleic acid in future experiments.
role;material sequencing library preparation role;A worker role played by the person who performs the library preparation process to generate a sequencing library for a sample to be sequenced.
generically dependent continuant;3D structural organization datum;A measurement datum that describes the structural orientation of a material entity in 3D space.
generically dependent continuant;verse algorithm;An alignment counting algorithm that assigns gene features to genomic alignments using a hierarchical assignment scheme, which allows simultaneous quantification of multiple feature types or annotation levels without repeatedly assigning reads.
generically dependent continuant;age since planting measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since planting, the process of placing a plant in media (e.g. soil) to allow it to grow, which excludes sowing.
material entity;microraft;A material separation device also commerically known as Isoraft, that is used to isolate single cells.
generically dependent continuant;age since hatching measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since hatching, the process of emergence from an egg.
material entity;pipette;A device that is a laboratory tool commonly used in chemistry, biology and medicine to transport a measured volume of liquid, often as a media dispenser.
process;age determination assay;An assay that determines the duration of part of the life of an organism, where the initial time point is the beginning of some transitional state (such as birth or when planted).
process;differential medium assay;An organism detection assay that uses a differential medium to achieve its objective.
generically dependent continuant;age since egg laying measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since egg laying, the process of the production of egg(s) by an organism.
generically dependent continuant;sequencing library input quantity measurement datum;A scalar measurement datum that indicates the amount of sequencing library used as input for a sequencer.
process;chromosomal substitution;A genetic transformation in which all, or part, of a chromosome from a donor replaces that of the recipient. It does not include chromosome recombination. For single gene insertion, use the term 'gene knock in'.
material entity;single-end library;A cDNA library that is a collection of short tags from only one end of DNA fragments.
material entity;genetically modified material;a material entity, organism or cell, that is the output of a genetic transformation process.
generically dependent continuant;specimen harvest quantity;A scalar measurement datum that indicates the amount of specimen collected.
process;transfection;a genetic transformation which relies on the use of physical, electrical and chemical phenomena to introduce DNA or RNA into a cell
generically dependent continuant;spike-in dilution factor;A data item that indicates the dilution of spike-in added to a specimen.
generically dependent continuant;genetic transformation objective;a material transformation objective aims to create genetically modified organism or cell
generically dependent continuant;star algorithm;A reference genome transcriptome alignment algorithm that is a standalone RNA-seq alignment algorithm that uses uncompressed suffix arrays and a mapping algorithm similar to those used in large-scale genome alignment tools to align RNA-seq reads to a genomic reference.
process;induced mutagenesis;A genetic transformation that is the modification of the genetic material (either coding or non-coding) of an organism caused by mutagenic processes, compounds, or irradiation.
process;transcript analysis by single-end sequencing assay;A sequencing assay that incorporates single-end reads and sequencing technology to determine transcripts, gene structures, and gene expressions.
generically dependent continuant;validation by real time PCR design;a study design in which the accuracy or the quality of the result of an assay is checked by comparing with real time PCR results
generically dependent continuant;age measurement datum;A time measurement datum that is the result of measurement of age of an organism
generically dependent continuant;age since fertilization measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since fertilization, the process of the union of gametes of opposite sexes during the process of sexual reproduction to form a zygote.
generically dependent continuant;age since birth measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since birth, the process of emergence and separation of offspring from the mother.
generically dependent continuant;medication time value specification;A scalar value specification that specifies the point in time that a human participant under investigation self-administers a medication material
generically dependent continuant;assay validation objective;an objective specification to check the accuracy or the quality of the results of an assay by comparison with independent results
generically dependent continuant;medication dose value specification;A scalar value specification that specifies the value of the quantity of a material entity administered to an organism as a treatment
generically dependent continuant;age since germination measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since germination, the process consisting of physiological and developmental changes by a seed, spore, pollen grain (microspore), or zygote that occur after release from dormancy, and encompassing events prior to and including the first visible indications of growth.
role;case role in case-control study;A role that is borne by a case-control study design participant under investigation that is associated with the outcome mentioned in the study design.
generically dependent continuant;validation by reverse transcription PCR design;a study design in which checks the accuracy or the quality of the result of an assay by comparing with reverse transcription PCR results
role;control role in case-control study;A role that is borne by a case-control study design participant under investigation that is not associated with the outcome mentioned in the study design.
generically dependent continuant;age since eclosion measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since eclosion, the process of emergence of an adult insect from its pupa or cocoon.
generically dependent continuant;age since sowing measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since sowing, the process of placing a seed or spore in some media with the intention to invoke germination.
generically dependent continuant;age since coitus measurement datum;An age measurement datum that is the result of the measurement of the age of an organism since coitus, the process of copulation that occurs during the process of sexual reproduction.
process;RNA sequencing assay;An assay that determines the sequence of an RNA molecule.
process;efficacy of epitope intervention experiment;An assay that tests if inducing an epitope specific immune response in an organism has an effect, such as the ability to prevent, treat or exacerbate diseases in the organism.
process;epitope protection from infectious challenge experiment;An epitope protection experiment in which the ability of the epitope to protect the host from an infection is assessed.
process;reverse transcription polymerase chain reaction assay;An assay that determines the concentration of RNA in a sample in which an RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional or real-time PCR.
generically dependent continuant;half life datum (t 1/2);The time it takes for 50% of a class of stochastic processes to occur.
generically dependent continuant;dose response curve;A data item of paired values, one indicating the dose of a material, the other quantitating a measured effect at that dose. The dosing intervals are chosen so that effect values be interpolated by a plotting a curve.
process;service;A planned process in which a service provider performs a task (i.e. a planned process) for a service consumer.
process;passive immunization;The injection of immune effector material (antibodies, T cells or B cells) into an organism so that the organisms immune system gains its immune effector function to recognize specific antigens.
generically dependent continuant;selective organism creation objective;an objective specification to generate a population or type of organism within species that have some uniform behavioral, morphological, physiological, or genetic characteristics with similarly bred organisms.
process;Individual epitope immunization in vivo;An immunization in which an individual epitope is administered into a host organism.
material entity;microcentrifuge;A type of centrifuge that is designed for small tubes (0.2 ml to 2.0 ml), has a compact design, and has a small footprint.
generically dependent continuant;intravenous drug use exclusion criterion;An exclusion criterion defined as when an individual has a history of intravenous drug abuse for a specific timeframe, which if met, makes the individual unsuitable for a given task or participation in a given process.
material entity;electronic repeater pipette;A micropipette that can be programmed by the user to aspirate a volume of liquid reagent or sample and dispense a series of aliquots in successive dispensing operations.
generically dependent continuant;history of sex with someone with a history of blood borne infection exclusion criterion;An exclusion criterion defined as whether an individual has a history of sex with someone who has been diagnosed or at risk for a blood borne infections disease in a specified time frame, which if met, makes the individual unsuitable for a given task or participation in a given process.
material entity;electron paramagnetic resonance spectrometer;An spectrophotometer that is used to investigate chemical species that have one or more unpaired electrons, such as organic and inorganic free radicals or inorganic complexes possessing a transition metal ion.
generically dependent continuant;history of sex with someone with a history of intravenous drugs exclusion criterion;An exclusion criterion defined as whether an individual has a history of sex with someone who has used intravenous drugs in a specified time frame, which if met, makes the individual unsuitable for a given task or participation in a given process.
material entity;rocker;A device that provides three-dimensional motion for biomedical applications (e.g., gel trays).
generically dependent continuant;HIV exclusion criterion;An exclusion criterion defined as whether an individual has a history of repeatedly reactive screening assays for HIV-1 or HIV-2 antibody regardless of the results of supplemental assays, which if met, makes the individual unsuitable for a given task or participation in a given process.
material entity;analytical balance;A balance with weighing pan(s) inside a transparent enclosure that is used to measure mass to a very high degree of precision and accuracy.
generically dependent continuant;exposure to blood borne infectious disease exclusion criterion;An exclusion criterion defined as whether an individual has been exposed to a blood borne infections disease through needle sticks and/or contact with non-intact skin and/or contact with open wounds and/or contact with mucous membranes, which if met, makes the individual unsuitable for a given task or participation in a given process.
material entity;scanning force microscope;A microscope that forms images of surfaces using a physical probe that scans the specimen.
process;RNA interactome capture;An assay that identifies RNA binding proteins by cross-linking RNA and proteins with UV light, then purifying the bound complexes by oligo(dT) capture. Finally, the complexes are analyzed by mass spectrometry.
material entity;pulsed-field gel electrophoresis system;A gel electrophoresis system in which the gel matrix is subjected to an electric field that periodically changes direction.
process;widefield microscopy assay;A fluorescence microscopy technique where the specimen under investigation is fully bathed in light, as opposed to confocal microscopy in which only a small portion of the specimen is illuminated.
material entity;tissue embedding station;A device that is used to perform paraffin embedding of tissue specimens.
process;nuclear ligation assay;An assay that detects the proximity of chromosomal DNA through the use of a ligation reaction in isolated nuclei.
generically dependent continuant;history of metastatic cancer exclusion criterion;An exclusion criterion defined as whether an individual has ever been diagnosed with metastatic cancer (cancer that spread beyond the initial site such as to other organs like brain bone or liver), which if met, makes the individual unsuitable for a given task or participation in a given process.
material entity;nucleic acid sequencer;An device that is used to determine the order of nucleotides in nucleic acid sequences.
process;chromosome conformation capture assay;A nuclear ligation assay that detects chromosomal interactions between any two genomic loci. Chromatin segments are cross-linked, cut by restriction enzymes, ligated, and finally analyzed by PCR.
material entity;bead array reader;A device that is used to acquire and image bead array data.
material entity;paraffin oven;A device that is used for the warming of paraffin embedding medium.
process;hydroxyl-radical footprinting assay;A footprinting assay that uses the reaction of hydroxyl radicals with side-chain sites in molecules (proteins, DNA, etc) with the resultant mass shift demonstrating the site of modification, used to to asses the accessibility of that site.
material entity;autoclave;A device that is used to sterilize equipment and supplies by subjecting them to high pressure steam at 121 C or more, typically for 15 to 20 minutes depending on the size of the load and the contents.
process;methidiumpropyl-EDTA-iron(II) footprinting assay;A footprinting assay that determines protein-binding sites on DNA by partial cleavage of ligand-protected DNA restriction fragments with methidium-propyl-EDTA (MPE). MPE-Fe(II) in the presence of oxygen efficiently catalyzes the non-specific clevage of DNA.
material entity;microplate washer;A device that is used to wash immunoassays in microwell strips and plates with professional accuracy. WHAT IS PROFESSIONAL ACCURACY??
role;measurand role;A role borne by a material entity and realized in an assay which achieves the objective to measure the magnitude/concentration/amount of the measurand in the entity bearing evaluant role.
material entity;nucleic acid extraction/purification instrument;A device that is used to isolate and collect nucleic acids (DNA or RNA) for subsequent molecular analysis.
process;transcription start site mapping by primer extension assay;A transcription profiling assay in which the transcription start site for a gene is determined by identifying the 5' end of mRNA. A radio-labeled primer is annealed to a complementary mRNA sequence near the 3' end, then cDNA is synthesized until the 5' end is reached.
material entity;ELISA microplate washer;A microplate washer that is used for enzyme-linked immunosorbent assays (ELISA).
generically dependent continuant;proteomic profiling design;A study design in which proteins in a sample are detected, quantified or otherwise analysed.
material entity;vacuum manifold;A device that is used for the vacuum-driven processing of multiwell strips or plates, or spin columns. IS THIS AN INSTRUMENT? IS THE DEFINTION CORRECT - TO DISTRIBUTE PRESSURE EVENLY.
process;suppression subtractive hybridization;An artificially induced nucleic acid hybridization that is performed to compare gene expression in different cell or tissue types based on normalization and suppression, which creates a subtracted cDNA or genomic DNA library.
material entity;DNA extraction/purification instrument;A device that is used to isolate and collect DNA for subsequent molecular analysis.
process;differential screening hybridization;An artificially induced nucleic acid hybridization that is performed to identify differentially expressed genes through hybridization of cDNA probes.
material entity;multichannel pipette;A pipetting system that has a plurality of tip fittings and is used for multi-well plate applications.
process;footprinting assay measuring binding of a B cell epitope:antibody complex;A footprinting assay that detects the binding of an antigen with an antibody.
process;Hi-C assay;A chromosome conformation capture assay that detects genome-wide chromosomal interactions. High-throughput techniques are used to sequence the ligated fragments after cross-linking and cutting with restriction enzymes.
material entity;real-time PCR machine;An PCR instrument that enables both detection and quantification of one or more specific sequences in a DNA sample.
process;physical examination of an organism;An assay that produces a description of the qualities of an organism that has not been transformed, through observation and physical, non-invasive techniques.
material entity;cell harvester;A device that is used to harvest cells from microplates and deposit samples on a filter mat. NOT AN INSTRUMENT?
material entity;diffractometer;A measurement device for analyzing the structure of a material from the scattering pattern produced when a beam of radiation or particles (e.g. X rays or neutrons) interacts with it.
generically dependent continuant;health status inclusion criterion;An inclusion criterion that defines and states one or more clinically significant bodily components, dispositions, and/or bodily processes of an entity that are inferred from relevant clinical findings or self-reported, which, if met, makes the entity suitable for a given task or participation in a given process.
material entity;microdissection instrument;A device that is used for the dissection of tissues under magnification.
generically dependent continuant;clinically relevant lifestyle inclusion criterion;An inclusion criterion that defines and states one or more clinically relevant planned processes that a human being actively participates in , which, if met, makes the human being suitable for a given task or participation in a given process.
material entity;micropipette puller;A device that is used to fabricate glass micropipettes.
generically dependent continuant;clinically relevant exposure inclusion criterion;An inclusion criterion that defines and states one or more clinically relevant histories of exposure of an entity, which, if met, makes the entity suitable for a given task or participation in a given process.
material entity;laser scanning confocal microscope;A confocal microscope that obtains high-resolution optical images with depth selectivity, in which a laser beam passes through a light source aperture and then is focused by an objective lens into a small (ideally diffraction limited) focal volume within or on the surface of a specimen.
generically dependent continuant;gravidity inclusion criterion;An inclusion criterion that defines and states one or more gravidity statuses of an organism, which, if met, makes the entity suitable for a given task or participation in a given process.
material entity;digital microscope;A microscope that uses optics and a charge-coupled device (CCD) camera to output a digital image to a monitor.
process;precision nuclear run-on sequencing assay;An RNA-seq assay that maps the genome-wide distribution of transcriptionally-engaged Pol II at base-pair resolution by using biotin-labeled ribonucleotide triphosphate analogs (biotin-NTP) for nuclear run-on reactions, allowing the efficient affinity purification of nascent RNAs for high throughput sequencing from their 3' ends.
material entity;freeze substitution system;A device or system for dehydrating and then chemically fixing electron microscopy samples at low temperatures in preparation for various treatments including embedding in resins.
process;chromosome conformation capture-on-chip assay;A nuclear ligation assay which uses cross-linking of proteins to proteins and DNA, followed by two rounds of digestion and ligation, inverse PCR, and characterization by microarray or DNA sequencing. This enables unbiased genome-wide screens for DNA contacts made by single genomic sites of interest.
material entity;micropipette;A microinjection device that is used to measure very small volumes of liquids.
process;genotype phasing by Hi-C assay;A genotyping assay in which carbon-copy chromosome conformation is used to detect polymorphism in DNA samples.
material entity;voltage clamp device;A device that is used to measure the ion currents across the membrane of excitable cells, such as neurons, while holding the membrane voltage at a set level.
process;hydroxyl-radical footprinting assay measuring binding of a B cell epitope:antibody complex;A hydroxyl-radical footprinting assay that detects the binding of an antigen with an antibody.
material entity;portable fluorometer;A compact fluorometer that can be carried or moved with ease.
process;ELISA measuring epitope specific interferon-alpha production by T cells;An enzyme-linked immunosorbent assay that detects interferon-alpha production by T cells.
material entity;gel electrophoresis system;An electrophoresis system in which an electric field is applied to a gel matrix
process;assay measuring epitope specific interferon-alpha production by T cells;A T cell epitope specific cytokine production assay that detects interferon-alpha production by T cells.
material entity;denaturing high-performance liquid chromatography instrument;A high performance liquid chromatography instrument that employs temperature-dependent separation of DNA containing mismatched base pairs from PCR-amplified DNA fragments for chromatographic mutation analysis.
generically dependent continuant;SRS identifier;An accession number that applies to a database record for an individual sample object in an NCBI Sequence Read Archive (SRA) submission. These records are imported from the NCBI BioSample database.
material entity;agarose gel electrophoresis system;A gel electrophoresis system that is used to separate DNA or RNA molecules by size, achieved by moving negatively charged nucleic acid molecules through an agarose matrix with an electric field.
generically dependent continuant;age since culture seeding measurement datum;An age measurement datum that is the result of the measurement of the age of a cell since cultured (the process of seeding cells onto a culture dish).
material entity;balance;A measuring instrument that is used to determine the weight or mass of an object.
generically dependent continuant;alignment counting algorithm;An algorithm used to assign aligned sequence reads, resulting from a reference genome transcriptome alignment algorithm, to sequence features (e.g. genes or transcripts).
material entity;surface plasmon resonance instrument;A tool for measuring adsorption of material onto planar metal (typically gold and silver) surfaces or onto the surface of metal nanoparticles.
generically dependent continuant;alignment counting application;A software application that implements an alignment counting algorithm, used to count the overlap of aligned sequencing reads with genes.
material entity;protein sequencer;An device that is used to determine the order of amino acids in protein sequences.
generically dependent continuant;base calling algorithm;An algorithm that assigns nucleotides to temporal or spatial peaks generated by a detector, such as peaks of light intensities generated by a DNA sequencer
material entity;X-ray source;A device that is used to generate X-rays.
generically dependent continuant;base calling application;A base-calling application that implments a base-calling algorithm to convert BCL (binary base call) files, (e.g., those generated by Illumina sequencing systems) to standard FASTQ file formats for downstream analysis.
material entity;liquid chromatography instrument;A chromatography device that dissolves a mixture in liquid mobile phase to separate the analyte to be measured from other molecules in the mixture and allows it to be isolated
generically dependent continuant;defined population inclusion criterion;An inclusion criterion that is based on fitting within the defined characteristics of a population based study design.
material entity;vacuum oven;A device that heats materials in a vacuum.
generically dependent continuant;BCL format;A data format specification that is a binary file containing base calling data. These files are created by sequencing machines during the act of sequencing, and contain data about each of the nucleotide clusters on a sequencing flow cell.
material entity;slide warmer;A device that is used to heat microscope slides.
material entity;ERCC RNA spike-in;A processed material developed by the External RNA Controls Consortium (ERCC) that consists of 92 transcripts, derived and traceable from NIST-certified DNA plasmids.
material entity;capillary electrophoresis instrument;An electrophoresis system that is used to separate ionic species by their charge and frictional forces and mass.
material entity;SIRV RNA spike-in;A processed material that consists of transcript isoforms of 7 spike-in RNA variant (SIRV) genes and possibly the 92 External RNA Controls Consortium (ERCC) RNA spike-in genes.
process;recombination enzyme based cloning;a recombination enzyme based cloning is a recombinant vector cloning process that uses complementary nucleotide sequences in both the insert genetic material and the cloning vector with a recombination enzyme to directly create a recombinant vector
process;venous blood prostate specific antigen assay;An analyte assay that measures the abundance of prostate specific antigen in venous blood
material entity;ABI 377 automated sequencer;is a DNA sequencer which is manufactured by Applied Biosystems corporation (formerly Perkin-Elmer). It allows automated chain termination DNA sequencing. It has part polyacrylamide gel electrophoresis system and a laser -based detection system to detect fluorescence intensity emitted by the dyes attached to the dideoxyterminator nucleotides or to the primers.
process;24 hour total urine volume assay;An assay that measures volume in urine as part of a 24 hour total order
process;immunoprecipitation;is a process which realizes a material separation objective by relying on antibodies to specifically binding to material entity
process;T4 uptake venous blood T4 assay;An analyte assay that measures the abundance of T4 in venous blood as part of a T4 uptake order
process;arterial blood glucose assay;An analyte assay that measures the abundance of glucose in arterial blood
process;CBC with manual differential venous blood cell count assay;A cytometry assay that measures the count of cells in venous blood as part of a CBC with manual differential order
process;hemoglobin oxygen saturation arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a hemoglobin oxygen saturation order
process;hemoglobin oxygen saturation arterial blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in arterial blood as part of a hemoglobin oxygen saturation order
process;inpatient profile venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a inpatient profile order
process;survival assessment assay;An assay that measures the occurrence of death events in one or more organisms over time
process;Helicos sequencing assay;A DNA sequencing by synthesis assay that identifiies the sequnece of billions of DNA molecules immobilized to a surface using DNA polymerase and fluorescently labeled nucleotides added one at a time. The sequencing process does not require an amplification step and is typically able to produce reads of 25 base pair length.
material entity;AB SOLiD System;is a DNA sequencer which is manufactured by Applied Biosystems and which enable DNA sequencing by ligation
process;chain termination sequencing assay;A DNA sequencing assay which rely on the use of dideoxynucleotides used in 4 distinct sequencing reaction on the same DNA sample. The dideoxynucleotides, once incorporated in the complementary DNA strand being synthesized by the DNA polymerase prevent any further chain elongation. The newly generated sequences are resolved on a polyacrylamide gel using electrophoresis and labels (either fluorochrome or radioactivity) are used to determine the nucleotide present at a given position
process;animal feeding;animal feeding is a process in which animals are provided with food
process;MeDIP-seq assay;A DNA methylation profiling assay that identifies methylated sites in genomic DNA and determines the methylation pattern that affect gene transcription using immunoprecipitation of methylated genomic DNA, creation of a library of corresponding DNA fragments (either single or paired-end fragments) and subsequent sequencing using parallelized sequencing methods.
material entity;xenograft;A material entity which results from the transplantation of living cells, tissues or organs from on organism of one species to an organism of another species.
process;inpatient profile venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a inpatient profile order
process;inpatient profile venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a inpatient profile order
material entity;specimen;A material entity that has the specimen role.
process;venous blood folic acid assay;An analyte assay that measures the abundance of folic acid in venous blood
process;count venous blood reticulocyte count assay;A cytometry assay that measures the count of reticulocytes in venous blood as part of a count order
generically dependent continuant;neither hysterectomy nor oophorectomy history;A gynecologic surgery history in which a woman has not had either a hysterectomy or an oophorectomy.
process;venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood
generically dependent continuant;hormonal birth control use history;An information content entity that indicates whether a woman has ever used oral contraceptives in order to block ovulation and prevent the occurrence of pregnancy.
process;venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood
generically dependent continuant;hormonal birth control former use history;A hormonal birth control use history that indicates an individual has previously been a hormonal birth control user but is not a current user.
process;venous blood transferrin assay;An analyte assay that measures the abundance of transferrin in venous blood
generically dependent continuant;hormonal birth control current use history;A hormonal birth control use history that indicates an individual is currently a hormonal birth control user.
process;venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood
generically dependent continuant;no hormonal birth control use history;A hormonal birth control use history that indicates an individual has not ever been a hormonal birth control user.
process;random electrolytes urine sodium assay;An analyte assay that measures the abundance of sodium in urine as part of a random electrolytes order
generically dependent continuant;hormonal replacement therapy history;A clinical history in which an individual has had hormonal replacement therapy in the past.
process;random electrolytes urine potassium assay;An analyte assay that measures the abundance of potassium in urine as part of a random electrolytes order
process;inpatient profile venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a inpatient profile order
material entity;phosphate buffered saline solution;Phosphate buffered saline (abbreviated PBS) is a buffer solution commonly used in biochemistry. It is a salty solution containing sodium chloride, sodium phosphate and in some preparations potassium chloride and potassium phosphate. The buffer helps to maintain a constant pH. The concentration usually matches the human body (isotonic).
material entity;delivery form for hormonal replacement therapy;A processed material used for delivery of hormones in hormone replacement therapy.
process;urine creatinine assay;An analyte assay that measures the abundance of creatinine in urine
material entity;pill delivery form for hormonal replacement therapy;A delivery form for hormonal replacement therapy that is a pill for oral administration.
material entity;patch delivery form for hormonal replacement therapy;A delivery form for hormonal replacement therapy that is a patch for transdermal administration.
material entity;cream delivery form for hormonal replacement therapy;A delivery form for hormonal replacement therapy that is a cream for transdermal administration.
process;cooximitery arterial blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in arterial blood as part of a cooximitery order
generically dependent continuant;menopausal status;An information content entity that indicates the state of a female's cessation of menstruation.
process;cooximitery arterial blood methemoglobin assay;An analyte assay that measures the abundance of methemoglobin in arterial blood as part of a cooximitery order
generically dependent continuant;indeterminate menopausal status;A menopausal status that is neither pre- nor post-menopausal.
process;electrolytes urine sodium assay;An analyte assay that measures the abundance of sodium in urine as part of a electrolytes order
generically dependent continuant;premenopausal status;A menopausal status indicating that less than 6 months has passed since the last menstrual period and there has not been prior bilateral oophorectomy and not on estrogen replacement.
process;electrolytes urine potassium assay;An analyte assay that measures the abundance of potassium in urine as part of a electrolytes order
generically dependent continuant;perimenopausal status;A menopausal status indicating that it has been 6-12 months since last menstrual period.
process;Biosite cardiac panel arterial blood creatine kinase MB assay;An assay that measures creatine kinase MB in arterial blood as part of a Biosite cardiac panel order
generically dependent continuant;postmenopausal status;A menopausal status indicating that it has been more than 12 months since the last menstrual period with no prior hysterectomy or that there has been a prior bilateral oophorectomy.
process;venous blood fibrinogen assay;An assay that measures fibrinogen in venous blood
generically dependent continuant;exposure to environmental and workplace carcinogens history;An information content entity that indicates the exposure of an individual to carcinogens in the workplace or environment.
process;comprehensive metabolic panel venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;exposure to arsenic history;An exposure to environmental and workplace carcinogens history where the carcinogen is arsenic.
process;comprehensive metabolic panel venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a comprehensive metabolic panel order
process;urine osmolality assay;An assay that measures osmolality in urine
process;cooximitery arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a cooximitery order
generically dependent continuant;exposure to asbestos history;An exposure to environmental and workplace carcinogens history where the carcinogen is asbestos.
generically dependent continuant;exposure to diesel exhaust history;An exposure to environmental and workplace carcinogens history where the carcinogen is diesel exhaust.
generically dependent continuant;exposure to chromium history;An exposure to environmental and workplace carcinogens history where the carcinogen is chromium.
generically dependent continuant;exposure to silica history;An exposure to environmental and workplace carcinogens history where the carcinogen is silica.
process;comprehensive metabolic panel venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;indicator of whether an inclusion criterion was met;An information content entity that indicates whether or not an entity has met a specific requirement in order to take part in a given process.
process;comprehensive metabolic panel venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;indicator of whether all inclusion criteria were met;An information content entity that indicates whether or not an entity has met all specific requirements in order to take part in a given process.
process;comprehensive metabolic panel venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;age of majority inclusion criterion;An inclusion criterion that uses the age of majority for a state or institution, where one is generally considered to be an adult, which if met, makes an individual suitable for a given task or participation in a given process.
process;comprehensive metabolic panel venous blood chloride assay;An analyte assay that measures the abundance of chloride in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;chemotherapy treatment exclusion criterion;An exclusion criterion that defines whether chemotherapy was received or is being received for a previous or current cancer, which when met, makes an individual unsuitable for a given task or participation in a given process
process;comprehensive metabolic panel venous blood human aspartate aminotransferase assay;An analyte assay that measures the abundance of human aspartate aminotransferase in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;radiation treatment exclusion criteria;An exclusion criterion that defines whether radiation was received or is being received for a previous or current cancer, which when met, makes an individual unsuitable for a given task or participation in a given process
process;comprehensive metabolic panel venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;chemotherapy treatment within the recent past exclusion criterion;An exclusion criterion that defines whether chemotherapy was received within a certain timeframe, which when met, makes an individual unsuitable for a given task or participation in a given process.
process;comprehensive metabolic panel venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a comprehensive metabolic panel order
generically dependent continuant;radiation treatment within the recent past exclusion criterion;An exclusion criterion that defines whether radiation was received within a certain timeframe, which when met, makes an individual unsuitable for a given task or participation in a given process.
process;comprehensive metabolic panel venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a comprehensive metabolic panel order
process;comprehensive metabolic panel venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a comprehensive metabolic panel order
process;comprehensive metabolic panel venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a comprehensive metabolic panel order
material entity;bronchial alveolar lavage;Group of biomaterials present in the bronchial aveolar space of an organism which are collected through lavage including the reagents used to for the lavage process, organisms, cells, and cellular secretions present in the bronchial aveolar space.
generically dependent continuant;BMI range inclusion criterion;An inclusion criterion that defines and states a Body Mass Index range, which if met, makes an individual suitable for a given task or participation in a given process.
material entity;cultured clonal cell population;A cultured cell population comprised of cells which can all be traced back to a single ancestor cell, and which therefore can be treated as identical.
generically dependent continuant;blood transfusion exclusion criterion;An exclusion criterion that is defined by whether the specimen donor received a whole blood transfusion within a specified time frame prior to death, which if met, makes a specimen donor unsuitable for a given task or participation in a given process.
material entity;screening library;a screening library is a collection of materials engineered to identify qualities of a subset of its members during a screening process?
material entity;synthetic peptide;a synthetic peptide is an material entity which is artificially engineered and results from the synthesis of a chain of amino acids which may also be found in natural protein and be identical in sequence to a protein fragment
material entity;organ section;A processed material which derives from an organ and results from a process of dissection or histological sample preparation a portion(formerly an organ section is portion of an organ removed from the context of the organ)
material entity;cultured cell population;A processed material comprised of a collection of cultured cells that has been continuously maintained together in culture and shares a common propagation history.
material entity;primary cultured cell population;A cultured cell population comprised of cells expanded directly from living tissue prior to being passaged.
process;in vivo intervention experiment;An assay in which the effect of a targeted process (the intervention) on an organism is tested.
process;venous blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in venous blood
process;disease exacerbation in vivo intervention experiment;An in vivo intervention experiment that tests the ability of the intervention to increase the severity of a disease in the host.
process;venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood
process;protection from challenge in vivo intervention experiment;An in vivo intervention experiment that tests the ability of the intervention to prevent occurrence of a disease in a host.
process;blood gas venous blood oxygen assay;An analyte assay that measures the abundance of oxygen in venous blood as part of a blood gas order
process;tolerance induction intervention experiment;An in vivo intervention experiment that tests the ability of the intervention to decrease an immune response.
process;ionized venous blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in venous blood as part of a ionized order
process;treatment intervention experiment;An in vivo intervention experiment in which the ability of the intervention to reduce or cure the effects of a disease are tested.
process;blood gas venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a blood gas order
process;microarray assay;An analyte assay where binding of the analyte to immobilized matrix is measured.
process;blood gas venous blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in venous blood as part of a blood gas order
process;immunohistochemistry;An immunostaining assay to detect and potentially localize antigens within the cells of a tissue section.
process;assay measuring the association constant [KA] of a MHC:ligand complex;A MHC binding constant determination assay measuring equilibrium association constant (KA).
generically dependent continuant;data set of predicted values according to fitted curve;A data set which is the output of a curve fitting data transformation in which the aim is to find a curve which matches a series of data points and possibly other constraints.
material entity;blood specimen;a material entity derived from a portion of blood collected from an organism
quality;device setting;a quality inheres in some device and is concretization of some (device setting specification and is about a quality of the device
generically dependent continuant;fuzzy clustering objective;A fuzzy clustering objective is a data transformation objective where the aim is to assign input objects (typically vectors of attributes) a probability that a point belongs to a class, where the number of class and their specifications are not known a priori.
process;material combination;is a material processing with the objective to combine two or more material entities as input into a single material entity as output.
process;comprehensive metabolic panel venous blood alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase in venous blood as part of a comprehensive metabolic panel order
material entity;urine specimen;a portion of urine collected from an organism
process;venous blood LDH assay;An assay that measures LDH in venous blood
process;differential expression analysis data transformation;A differential expression analysis data transformation is a data transformation that has an objective of differential expression analysis. Frequently this data transformation involves summarizing or otherwise aggregating signals from various samples categorized into groups, and calculating measures of group differences from these aggregated signals.
process;venous blood creatine kinase MB assay;An assay that measures creatine kinase MB in venous blood
process;venous blood lactic acid assay;An assay that measures lactic acid in venous blood
process;specimen collection process;A planned process with the objective of collecting a specimen.
generically dependent continuant;data representational model;An information content entity representing the relationships between data items.
process;assay measuring the dissociation constant [KD] of a MHC:ligand complex;A MHC binding constant determination assay measuring equilibrium dissociation constant (KD).
process;radioactivity detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a purified-MHC:ligand complex;A radioactivity detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation.
process;assay measuring the half maximal effective concentration [EC50] of a MHC:ligand complex;A MHC binding constant determination assay measuring half maximal effective concentration (EC50).
process;non-vented blood gas arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a non-vented blood gas order
process;assay measuring the half maximal inhibitory concentration [IC50] of a MHC:ligand complex;A MHC binding constant determination assay measuring half maximal inhibitory concentration (IC50).
process;non-vented blood gas arterial blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in arterial blood as part of a non-vented blood gas order
process;assay measuring the off rate measurement [koff] of a MHC:ligand complex;A MHC binding constant determination assay measuring binding off rate measurement data item (koff).
process;quantitative venous blood IgG assay;An assay that measures IgG in venous blood as part of a quantitative order
process;assay measuring the MHC ligand binding on rate [kon] of a MHC:ligand complex;A MHC binding constant determination assay measuring binding on rate (kon).
process;quantitative venous blood IgM assay;An assay that measures IgM in venous blood as part of a quantitative order
process;chromatography assay measuring the association constant [KA] of a B cell epitope:antibody complex;An analytical chromatography assay that measures the association constant [KA] of an antigen binding with an antibody.
process;quantitative venous blood IgA assay;An assay that measures IgA in venous blood as part of a quantitative order
process;chromatography assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;An analytical chromatography assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
process;hydrogen/deuterium exchange footprinting assay measuring binding of a B cell epitope:antibody complex;A hydrogen/deuterium exchange footprinting assay that detects the binding of an antigen with an antibody.
process;immunohistochemistry assay measuring binding of a B cell epitope:antibody complex;A immunohistochemistry assay that detects the binding of an antigen with an antibody.
process;background correction data transformation;A background correction data transformation (sometimes called supervised classification) is a data transformation that has the objective background correction.
process;BrdU incorporation assay;A cell proliferation assay in which cells are cultured in the presence of BrdU which is incorporated into newly synthesized DNA of replicating cells (during the S phase of the cell cycle), substituting for thymidine during DNA replication, which can be quantified by BrdU specific antibodies.
process;arterial blood creatinine assay;An analyte assay that measures the abundance of creatinine in arterial blood
process;class prediction data transformation;A class prediction data transformation (sometimes called supervised classification) is a data transformation that has objective class prediction.
process;venous blood tacrolimus assay;An analyte assay that measures the abundance of tacrolimus in venous blood
generically dependent continuant;error corrected data set;A data set that is produced as the output of an error correction data transformation and consists of producing a data set which has had erroneous contributions from the input to the data transformation removed (corrected for).
process;random venous blood vancomycin assay;An analyte assay that measures the abundance of vancomycin in venous blood as part of a random order
process;enzyme-linked immunosorbent assay;An analyte assay where binding of an enzyme linked antibody to a material entity that is immobilized on solid support is detected utilizing a chemiluminescent reaction. Depending on the setup, the enzyme-linked antibody could be binding directly to the analyte, or it serves as a secondary antibody detecting binding of the primary antibody to the analyte.
process;venous blood mycophenolic acid assay;An analyte assay that measures the abundance of mycophenolic acid in venous blood
generically dependent continuant;background corrected data set;A data set that is produced as the output of a background correction data transformation.
process;assay measuring the half life of a MHC:ligand complex;A MHC binding constant determination assay measuring half life of binding.
process;non-vented blood gas arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a non-vented blood gas order
process;tritiated thymidine incorporation assay;A cell proliferation assay in which cells are cultured in the presence of tritiated thymidine which is incorporated into newly synthesized DNA of replicating cells (during the S phase of the cell cycle). The radioactivity of tritiated thymidine in a cell is a proxy for cells that were actively replicating.
process;error correction data transformation;An error correction data transformation is a data transformation that has the objective of error correction, where the aim is to remove (correct for) erroneous contributions from the input to the data transformation.
process;3D molecular structure determination assay of a T cell epitope:MHC:TCR complex;A 3D structure determination of bound molecular complex assay that characterizes the 3-dimensional structure of a T cell epitope:MHC:TCR complex.
material entity;glucose in solution;A scattered aggregate of glucose molecules in a liquid
process;arterial blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in arterial blood
process;arterial blood chloride assay;An analyte assay that measures the abundance of chloride in arterial blood
process;arterial blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in arterial blood
process;GEM premier blood gas venous blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in venous blood as part of a GEM premier blood gas order
generically dependent continuant;portioning objective;A material separation objective aiming to separate material into multiple portions, each of which contains a similar composition of the input material.
generically dependent continuant;reduced dimension data set;A data set that is produced as the output of a data vector reduction data transformation and consists of producing a data set which has fewer vectors than the input data set.
process;arterial blood sodium assay;An analyte assay that measures the abundance of sodium in arterial blood
generically dependent continuant;statistical hypothesis test objective;is a data transformation objective where the aim is to estimate statistical significance with the aim of proving or disproving a hypothesis by means of some data transformation.
process;arterial blood potassium assay;An analyte assay that measures the abundance of potassium in arterial blood
generically dependent continuant;center value;A data item that is produced as the output of a center calculation data transformation and represents the center value of the input data.
process;ionized arterial blood calcium assay;An analyte assay that measures the abundance of calcium in arterial blood as part of a ionized order
process;statistical hypothesis test;A statistical hypothesis test data transformation is a data transformation that has objective statistical hypothesis test.
process;vented blood gas arterial blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in arterial blood as part of a vented blood gas order
process;vented blood gas arterial blood oxygen assay;An analyte assay that measures the abundance of oxygen in arterial blood as part of a vented blood gas order
material entity;sample from organism;a material obtained from an organism in order to be a representative of the whole
process;vented blood gas arterial blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in arterial blood as part of a vented blood gas order
generically dependent continuant;average value;A data item that is produced as the output of an averaging data transformation and represents the average value of the input data.
generically dependent continuant;separation into different composition objective;A material separation objective aiming to separate a material entity that has parts of different types, and end with at least one output that is a material with parts of fewer types (modulo impurities).
process;GEM premier blood gas venous blood lactic acid assay;An assay that measures lactic acid in venous blood as part of a GEM premier blood gas order
material entity;whole organism preparation;A material entity which is the output of a process in which one or more whole organisms are prepared in a way to make it easier to study them, and in which the great majority of organismal parts are maintained
process;GEM premier blood gas venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a GEM premier blood gas order
process;trough venous blood tobramycin assay;An analyte assay that measures the abundance of tobramycin in venous blood as part of a trough order
material entity;454 Genome Sequence 20;is a DNA sequencer first manufactured by 454 Life Science Corporation in 2005, and enables pyrosequencing to be performed. It comprises both optics and fluidics subsystems, which are controlled by a computer subsystem. The fluidics subsystem ensures accurate reagent dispensing. It consists of a reagents cassette (which holds the reagent containers), a sipper manifold, pumps, valves, and debubblers. The fluidics subsystem flows the sequencing reagents across the wells of the PicoTiterPlate device, and moves the spent reagents from the PicoTiterPlate device to the waste receptacle. The optics subsystem consists of a CCD camera and a camera controller. The camera captures the light emitted in the wells of the PicoTiterPlate device during each step of the sequencing cycle, and sends the digital images to the computer subsystem for processing. The computer controls the other Sequencer subsystems, and processes the digital images sent by the camera to extract the DNA sequence information.
generically dependent continuant;rodent care protocol;A rodent care protocol is an animal protocol in which the animals being taken care of are rodents.
process;GEM premier blood gas venous blood ionized calcium assay;An analyte assay that measures the abundance of ionized calcium in venous blood as part of a GEM premier blood gas order
process;nucleotide overhang cloning;Nucleotide overhang cloning is the process of inserting nucleic acid into a vector using nucleotide overhangs used to prevent self ligation
process;GEM premier blood gas venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a GEM premier blood gas order
generically dependent continuant;material combination objective;is an objective to obtain an output material that contains several input materials.
process;GEM premier blood gas venous blood oxygen assay;An analyte assay that measures the abundance of oxygen in venous blood as part of a GEM premier blood gas order
process;creating a mixture of molecules in solution;is a process with the objective to prepare a liquid solution of one or more chemicals at desired concentrations.
process;GEM premier blood gas venous blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in venous blood as part of a GEM premier blood gas order
generically dependent continuant;specimen collection objective;A objective specification to obtain a material entity for potential use as an input during an investigation.
process;GEM premier blood gas venous blood bicarbonate assay;An analyte assay that measures the abundance of bicarbonate in venous blood as part of a GEM premier blood gas order
process;GEM premier blood gas venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a GEM premier blood gas order
process;GEM premier blood gas venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a GEM premier blood gas order
material entity;restriction enzyme;an enzyme that has a specific target cleavage sites within nucleic acids
material entity;recombinant vector;A recombinant vector is created by a recombinant vector cloning process, and contains nucleic acids that can be amplified. It retains functions of the original cloning vector.
process;pyrosequencing assay;A DNA sequencing by synthesis assay which sequences a single strand of DNA by synthesizing the complementary strand along it, one base pair at a time, and detecting which base was actually added at each step. The template DNA is immobilized, and solutions of A, C, G, and T nucleotides are added and removed after the reaction, sequentially. Light is produced only when the nucleotide solution complements the first unpaired base of the template. The sequence of solutions which produce chemiluminescent signals allows the determination of the sequence of the template. ssDNA template is hybridized to a sequencing primer and incubated with the enzymes DNA polymerase, ATP sulfurylase, luciferase and apyrase, and with the substrates adenosine 5-prime phosphosulfate (APS) and luciferin.
process;Student's t-test;Studen't t-test is a data transformation with the objective of a statistical hypothesis test in which the test statistic has a Student's t distribution if the null hypothesis is true. It is applied when the population is assumed to be normally distributed but the sample sizes are small enough that the statistic on which inference is based is not normally distributed because it relies on an uncertain estimate of standard deviation rather than on a precisely known value.
process;restriction enzyme based cloning;restriction enzyme based cloning is a recombinant vector cloning process that has as an input genetic material that was cleaved with restriction enzymes, and a cloning vector that was cleaved with complementary restriction enzymes. It uses ligase to chemically join the input genetic material and the cloning vector to create a recombinant vector.
material entity;cloning vector;A cloning vector is an engineered material that is used as an input material for a recombinant vector cloning process to carry inserted nucleic acids. It contains an origin of replication for a specific destination host organism, encodes for a selectable gene product and contains a cloning site.
material entity;single fragment library;is a collection of short tags from DNA fragments, are extracted and covalently linked as single tag constructs
material entity;NTP-2000;a material consisting of 14.5% protein, 8.5% fat and 9.5% fiber produced to feed rodents
process;DNA sequencing by synthesis assay;A DNA sequencing assay that relies on DNA polymerase activity to perform chain extension during the sequencing reaction step.
process;material sampling process;A specimen gathering process with the objective to obtain a specimen that is representative of the input material entity
process;immune response assay;An assay that determines information about an immune response
material entity;nucleic acid restriction enzyme digest;A nucleic acid digest is a material that is the output of a process in which nucleic acids are combined with a restriction enzyme resulting in digested fragments with defined ends based on the enzymes cleavage site
generically dependent continuant;topologically preserved clustered data set;A clustered data set in which the topology, i.e. the spatial properties between data points, is preserved from the original input data from which it was derived.
role;material sample role;A material sample role is a specimen role borne by a material entity that is the output of a material sampling process.
process;CART;A CART (classification and regression trees) is a data transformation method for producing a classification or regression model with a tree-based structure.
process;bisulfite sequencing assay;A DNA methylation profiling assay which determines the methylation status of genomic DNA using DNA sequencing techniques preceded by a bisulfite based chemical modification of genomic DNA at CpG island location.
material entity;material sample;A material entity that has the material sample role
process;chromatin immunoprecipitation;An immunoprecipitation in which chromatin (i.e. packaged DNA which can include protein and RNA complexes) is cut into short regions, reversibly cross linked, and antibodies or tags are used to select for pieces of chromatin with desired characteristics.
generically dependent continuant;study design dependent variable;dependent variable specification is part of a study design. The dependent variable is the event studied and expected to change when the independent variable varies.
generically dependent continuant;study design independent variable;a directive information entity that is part of a study design. Independent variables are entities whose values are selected to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled
process;random venous blood tobramycin assay;An analyte assay that measures the abundance of tobramycin in venous blood as part of a random order
process;CBC with manual differential venous blood metamyelocyte count assay;A cytometry assay that measures the count of metamyelocytes in venous blood as part of a CBC with manual differential order
process;arterial blood lactic acid assay;An assay that measures lactic acid in arterial blood
process;venous blood 25-hydroxyvitamin D2 assay;An analyte assay that measures the abundance of 25-hydroxyvitamin D2 in venous blood
process;venous blood digoxin assay;An analyte assay that measures the abundance of digoxin in venous blood
material entity;blood plasma specimen;a material entity which corresponds to the liquid component of blood, in which the blood cells are suspended.
material entity;blood serum specimen;A material entity which derives from blood and corresponds to blood plasma without fibrinogen or the other clotting factors.
material entity;chimera;An organism which contains cells or tissues with a different genotype
process;urine protein assay;An analyte assay that measures the abundance of protein in urine
process;venous blood tobramycin assay;An analyte assay that measures the abundance of tobramycin in venous blood
material entity;Epstein Barr virus transformed B cell;A material entity which results from viral transformation process using EBV as transformation agent when applied to B-cell entity
process;CBC with manual differential venous blood myelocyte count assay;A cytometry assay that measures the count of myelocytes in venous blood as part of a CBC with manual differential order
process;SPEP protein electrophoresis venous blood beta-globin assay;An analyte assay that measures the abundance of beta-globin in venous blood as part of a SPEP protein electrophoresis order
process;SPEP protein electrophoresis venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a SPEP protein electrophoresis order
process;SPEP protein electrophoresis venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a SPEP protein electrophoresis order
process;trough venous blood vancomycin assay;An analyte assay that measures the abundance of vancomycin in venous blood as part of a trough order
process;hepatic panel venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a hepatic panel order
process;hepatic panel venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a hepatic panel order
process;hepatic panel venous blood alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase in venous blood as part of a hepatic panel order
process;hepatic panel venous blood human aspartate aminotransferase assay;An analyte assay that measures the abundance of human aspartate aminotransferase in venous blood as part of a hepatic panel order
process;support vector machine;A support vector machine is a data transformation with a class prediction objective based on the construction of a separating hyperplane that maximizes the margin between two data sets of vectors in n-dimensional space.
process;laboratory animal care;a process that realizes an animal care protocol that specifies how animals are kept and maintained
process;decision tree building data transformation;A decision tree building data transformation is a data transformation that has objective decision tree induction.
process;SOLiD sequencing assay;A DNA sequencing by ligation assay that identifies sequence information using primers to hybridize to the P1 adapter sequence within the library template, fluorescently labeled di-base probes to compete for ligation to the sequencing primer, multiple cycles of ligation, detection and cleavage to determine the eventual read length, following a series of ligation cycles, the extension product is removed and the template is reset with a primer complementary to the n-1 position for a second round of ligation cycles.
process;Edman degradation;A sequencing assay in which the amino acid sequence of input peptides or proteins is determined by iteratively cleaving of the amino-terminal (N-terminal) residue without disrupting the peptide bonds and identifying it by e.g. chromatography or electropheresis.
generically dependent continuant;decision tree induction objective;A decision tree induction objective is a data transformation objective in which a tree-like graph of edges and nodes is created and from which the selection of each branch requires that some type of logical decision is made.
material entity;Illumina Genome Analyzer II;is a DNA sequence which is manufactured by Illumina (Solexa) corporation. it support sequencing of single or paired end clone libraries relying on sequencing by synthesis technology
material entity;454 Genome Sequencer FLX;is a DNA sequencer which was first manufactured by 454 Life Science Corporation in 2008 and enables pyrosequencing to be performed. It comprises both optics and fluidics subsystems, which are controlled by a computer subsystem. The fluidics subsystem ensures accurate reagent dispensing. It consists of a reagents cassette (which holds the reagent containers), a sipper manifold, pumps, valves, and debubblers. The fluidics subsystem flows the sequencing reagents across the wells of the PicoTiterPlate device, and moves the spent reagents from the PicoTiterPlate device to the waste receptacle. The optics subsystem consists of a CCD camera and a camera controller. The camera captures the light emitted in the wells of the PicoTiterPlate device during each step of the sequencing cycle, and sends the digital images to the computer subsystem for processing. The computer controls the other Sequencer subsystems, and processes the digital images sent by the camera to extract the DNA sequence information. It has the ability to sequence 400-600 million base pairs per run with 400-500 base pair read lengths.
process;self-organizing map;A self-organizing map (SOM) is an artificial neural network with objective class discovery that uses a neighborhood function to preserve the topological properties of a dataset to produce low-dimensional (typically 2) discretized representation of the training data set. A set of artificial neurons learn to map points in an input space to coordinates in an output space. The input space can have different dimensions and topology from the output space, and the SOM will attempt to preserve these.
process;hepatic panel venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a hepatic panel order
process;hepatic panel venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a hepatic panel order
process;estimated venous blood glomerular filtration assay;An assay that measures glomerular filtration in venous blood as part of a estimated order
process;DT60 venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a DT60 order
material entity;yeast artificial chromosome vector;a double-stranded DNA that was engineered to contain a yeast origin of replication, encodes for a selectable gene product, contains a cloning site, and has yeast telomerase sequences
process;fasting venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a fasting order
process;random venous blood amikacin assay;An analyte assay that measures the abundance of amikacin in venous blood as part of a random order
process;venous blood ammonia assay;An analyte assay that measures the abundance of ammonia in venous blood
process;venous blood GGT assay;An analyte assay that measures the abundance of GGT in venous blood
process;chem11 venous blood phosphate assay;An analyte assay that measures the abundance of phosphate in venous blood as part of a chem11 order
process;chem11 venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a chem11 order
process;chem11 venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a chem11 order
process;library preparation;is a process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors.
material entity;Li-Cor 4300 DNA Analysis System;is a DNA sequencer which is manufactured by Li-Cor corporation and enable automated chain termination based DNA sequencing
process;vaccine production;A planned process with the objective to create a vaccine.
role;pathogen role;pathogen role is a role which inheres in an organism and realized in the process of disease course in the organism bearing host role caused by the organism bearing pathogen role
material entity;HeliScope Single Molecule Sequencer;is a DNA sequencer manufacturer by Helicos Corporation to carry out Single Molecule sequencing using reversible termination chemistry
process;ChIP-seq assay;An assay in which chromatin is immunoprecipitated and subsequently analyzed using a DNA sequencing step to identify which parts of DNA are part of the isolated chromatin
generically dependent continuant;animal care protocol;An animal care protocol is a protocol which specifies the environment in which animals are being kept in captivity for research purposes
generically dependent continuant;graph of vertices;A construct that consists of many nodes connected with edges. The edges represent a relationship between the objects represented by the nodes. A graph can be equivalently represented as a matrix.
generically dependent continuant;GenePattern software;a software that provides access to more than 100 tools for gene expression analysis, proteomics, SNP analysis and common data processing tasks.
process;pathogen challenge;The administration of a live pathogenic organism to a host.
process;chem11 venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a chem11 order
process;chem11 venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a chem11 order
process;chem11 venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a chem11 order
process;chem11 venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a chem11 order
process;chem11 venous blood magnesium assay;An analyte assay that measures the abundance of magnesium in venous blood as part of a chem11 order
process;chem11 venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a chem11 order
process;chem11 venous blood chloride assay;An analyte assay that measures the abundance of chloride in venous blood as part of a chem11 order
process;total venous blood IgE assay;An assay that measures IgE in venous blood as part of a total order
process;chem16 venous blood human aspartate aminotransferase assay;An analyte assay that measures the abundance of human aspartate aminotransferase in venous blood as part of a chem16 order
process;chem16 venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a chem16 order
process;chem16 venous blood magnesium assay;An analyte assay that measures the abundance of magnesium in venous blood as part of a chem16 order
material entity;paired-end library;is a collection of short paired tags from the two ends of DNA fragments are extracted and covalently linked as ditag constructs
process;glucose tolerance test;An assay that measures glucose clearance from blood over time by repeated glucose measurement in blood serum or plasma after the administration of a glucose bolus in-vivo. This assay can be used to evaluate the severity of insulin resistance or the efficiency of glucose clearance.
role;immunologic adjuvant role;The role a material entity plays when it is co-administered with an immunogen in order to enhance the immune response to the immunogen.
material entity;cloning plasmid;A cloning plasmid is a plasmid that was engineered to contain a bacterial origin of replication, encodes for a selectable gene product and contains a cloning site.
process;rodent care;rodent care is the process by which rodents are being provided with a controlled living environment while kept in captivity for the purpose of research.
process;k-nearest neighbors;A k-nearest neighbors is a data transformation which achieves a class discovery or partitioning objective, in which an input data object with vector y is assigned to a class label based upon the k closest training data set points to y. where k is the largest value that class label is assigned.
process;peak matching;Peak matching is a data transformation performed on a dataset of a graph of ordered data points (e.g. a spectrum) with the objective of pattern matching local maxima above a noise threshold
role;host role;host role is a role played by an organism and realized by providing nourishment, shelter or a means of reproduction to another organism within the organism playing the host role
process;Solexa sequencing assay;A DNA sequencing by synthesis assay that identifies sequence information using DNA polymerase and reversible terminator, requiring immobilization of genomic DNA fragments onto a surface and a specific clonal amplification step known as bridge PCR. Reliance on a reversible terminator allows cycles of DNA chain extension by DNA polymerase and imaging without the need of electrophoretic separation of newly synthesized DNA fragment as with Sanger sequencing.
process;DNA sequencing by ligation assay;A DNA sequencing assay that performs chain extension during the sequencing reaction step using DNA ligase
material entity;organism;A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.
process;chem16 venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a chem16 order
process;chem16 venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a chem16 order
process;epitope disease exacerbation experiment;An efficacy of epitope intervention experiment that tests the ability of inducing an epitope immune response to increase the severity of an existing disease in the host.
process;epitope protection experiment based on survival;An epitope protection experiment that determines the success of the epitope intervention based on increased survival of the host.
generically dependent continuant;half maximal effective concentration (EC50);half maximal effective concentration (EC50) is a scalar measurement datum corresponding to the concentration of a compound which induces a response halfway between the baseline and maximum after some specified exposure time.
generically dependent continuant;binding datum;A data item that states if two or more material entities have the disposition to form a complex, and if so, how strong that disposition is.
generically dependent continuant;negative binding datum;A categorical binding datum that states that there is no significant disposition of two or more entities to form a complex.
process;epitope protection from tumor challenge experiment;An epitope protection experiment in which the ability of the epitope to protect the host from developing tumors is assessed.
process;epitope protection experiment;An efficacy of epitope intervention experiment that tests the efficacy of inducing an immune epitope response to prevent disease in a host.
material entity;selectively maintained organism;An organism that is bred to have some uniform behavioral, morphological, physiological, or genetic characteristics with similarly bred organisms
process;epitope protection from infectious challenge experiment based on pathogen burden;An epitope protection from infectious challenge experiment in which the readout is a reduction in the presence of pathogens in the host compared to controls.
process;infectious agent detection assay;An assay that measures the presence or amount of an infectious agent in an evaluant
process;epitope treatment experiment;An epitope intervention experiment that tests the ability of inducing an epitope immune response to treat an existing disease in the host.
generically dependent continuant;in vivo design;A study design that is conducted entirely in a living organism, e.g. a compound treatment in a mouse model.
generically dependent continuant;half maximal inhibitory concentration (IC50);Half maximal inhibitory concentration (IC50) is a scalar measurement datum that measures the effectiveness of a compound to competitively inhibit a given process, and corresponds to the concentration of the compound at which it reaches half of its maximum inhibitory effect.
process;epitope specific immune intervention;An administration in vivo to either actively or passively immunize an organism in order to induce a response against a specific immune epitope
process;epitope specific cytokine production by T cells;A process of cytokine production by T cells resulting from the recognition of a T cell epitope.
process;ELISPOT assay measuring epitope specific transforming growth factor-beta production by T cells;An enzyme-linked immunospot assay that detects transforming growth factor-beta production by T cells.
generically dependent continuant;operator variation design;A study design that assesses the operator performance and relation to data consistency and quality.
process;cytometric bead array assay measuring epitope specific IP-10 production by T cells;A cytometric bead array assay that detects IP-10 production by T cells.
generically dependent continuant;comparative genome hybridization by array design;A study design that detects genomic copy number variations using microarray technology.
process;assay measuring epitope specific interleukin-27 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-27 production by T cells.
generically dependent continuant;FWER adjusted p-value;A quantitative confidence value resulting from a multiple testing error correction method which adjusts the p-value used as input to control for Type I error in the context of multiple pairwise tests
generically dependent continuant;self interaction identification design;A molecular interaction identification design that investigates intra-molecular interactions between two or more regions of a single molecule.
process;basic metabolic panel venous blood chloride assay;An analyte assay that measures the abundance of chloride in venous blood as part of a basic metabolic panel order
process;DNA methylation profiling by high throughput sequencing assay;A DNA methylation profiling assay in which the methylation state of DNA is determined and can be compared between samples using sequencing based technology
process;chromosome conformation capture sequencing assay;A chromosome conformation capture-on-chip assay quantitates the products with multiplexed high-throughput sequencing.
process;basic metabolic panel venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a basic metabolic panel order
process;epitope specific transforming growth factor-beta production by T cells;A process of transforming growth factor-beta production by T cells resulting from the recognition of a T cell epitope.
process;inverse polymerase chain reaction;A polymerase chain reaction which amplifies DNA with only one known sequence from which primers may be designed. A series of restriction digestions and ligations result in a looped DNA fragment which can be primed for PCR.
process;basic metabolic panel venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a basic metabolic panel order
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-12 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-12 production by T cells.
material entity;swab specimen;A specimen that is stored on a swab as the output of a collecting specimen with swab process.
process;assay measuring epitope specific cytotoxic T cell degranulation;A T cell epitope dependent biological activity assay that detects cytotoxic T cell degranulation.
process;liver evaluation venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a liver evaluation order
generically dependent continuant;molecular interaction identification design;A study design that investigates the features of interaction between molecules.
process;liver evaluation venous blood globulin assay;An analyte assay that measures the abundance of globulin in venous blood as part of a liver evaluation order
process;ELISA measuring epitope specific interleukin-3 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-3 production by T cells.
generically dependent continuant;colocalization identification design;A molecular interaction identification design that investigates the co-occurence and correlation of two or more molecules.
process;liver evaluation venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood as part of a liver evaluation order
process;ELISA measuring epitope specific interleukin-1 alpha production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-1 alpha production by T cells.
generically dependent continuant;genetic interaction identification design;A molecular interaction identification design that investigates a phenotype that is the result of two or more genetic perturbations, and is not explained by the individual genetic perturbations alone.
process;liver evaluation venous blood human aspartate aminotransferase assay;An analyte assay that measures the abundance of human aspartate aminotransferase in venous blood as part of a liver evaluation order
process;epitope specific interleukin-27 production by T cells;A process of interleukin-27 production by T cells resulting from the recognition of a T cell epitope.
generically dependent continuant;functional association identification design;A molecular interaction identification design that investigates a relationship that is the result of intermediate steps between two or more molecules that are not necessarily in direct contact with each other.
process;liver evaluation venous blood alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase in venous blood as part of a liver evaluation order
process;in vivo assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response;A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance a T cell response.
generically dependent continuant;direct interaction identification design;A molecular interaction identification design that investigates the influence of molecules, which are in direct contact, on one another.
process;liver evaluation venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a liver evaluation order
process;assay measuring epitope specific transforming growth factor-beta production by T cells;A T cell epitope specific cytokine production assay that detects transforming growth factor-beta production by T cells.
generically dependent continuant;enzymatic reaction identification design;A direct interaction identification design that investigations a biological reaction on a molecule which has been triggered by an enzyme.
process;liver evaluation venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a liver evaluation order
process;assay measuring epitope specific chemokine (C-C motif) ligand 1 production by T cells;A T cell epitope specific cytokine production assay that detects production of chemokine (C-C motif) ligand 1 by T cells.
process;venous blood iron assay;An analyte assay that measures the abundance of iron in venous blood
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-2 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-2 production by T cells.
process;CBC with manual differential venous blood band neutrophil count assay;A cytometry assay that measures the count of band neutrophils in venous blood as part of a CBC with manual differential order
generically dependent continuant;DNA methylation profiling by array design;A study design in which the methylation state of DNA is determined and is compared between samples using array technology.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-22 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-22 production by T cells.
material entity;upper respiratory tract specimen;A specimen that is derived from some upper respiratory tract
material entity;nasopharynx specimen;A specimen that is derived from some nasopharynx
material entity;semen specimen;A specimen that is derived from some semen
material entity;bodily fluid specimen;A specimen that is derived from some bodily fluid
process;basic metabolic panel venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a basic metabolic panel order
process;basic metabolic panel venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood as part of a basic metabolic panel order
process;cell culture analyte detection bioassay measuring epitope specific transforming growth factor-beta production by T cells;A reporter cell line analyte detection bioassay that detects transforming growth factor-beta production by T cells.
process;basic metabolic panel venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a basic metabolic panel order
process;RNA-seq assay;An RNA sequencing assay that determines an RNA sequence by analyzing the transcibed regions of the genome and or to quantitate transcript abundance.
process;basic metabolic panel venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a basic metabolic panel order
process;ELISPOT assay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;An enzyme-linked immunospot assay that detects tumor necrosis factor superfamily cytokine production by T cells.
process;venous blood creatine kinase assay;An analyte assay that measures the abundance of creatine kinase in venous blood
process;cell culture analyte detection bioassay measuring epitope specific interleukin-5 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-5 production by T cells.
process;venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood
process;genotyping by array assay;A genotyping assay that uses an array
process;venous blood ferritin assay;An assay that measures ferritin in venous blood
process;epitope specific interleukin-16 production by T cells;A process of interleukin-16 production by T cells resulting from the recognition of a T cell epitope.
process;total venous blood calcium assay;An analyte assay that measures the abundance of calcium in venous blood as part of a total order
material entity;cervical mucus specimen;A specimen that is derived from some cervical mucus
material entity;throat specimen;A specimen that is derived from some throat
material entity;eye specimen;A specimen that is derived from some eye
material entity;respiratory system specimen;A specimen that is derived from some respiratory system
material entity;uterine cervix specimen;A specimen that is derived from some uterine cervix
material entity;urethra specimen;A specimen that is derived from some urethra
process;ELISA measuring epitope specific lymphotoxin A production by T cells;An enzyme-linked immunosorbent assay that detects lymphotoxin A production by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-5 production by T cells;A cytometric bead array assay that detects interleukin-5 production by T cells.
process;assay measuring epitope specific interleukin-16 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-16 production by T cells.
process;ELISA measuring epitope specific IP-10 production by T cells;An enzyme-linked immunosorbent assay that detects IP-10 production by T cells.
process;translation profiling assay;An assay in which surface-bound, translationally competent ribosome complexes are used to generate a translation profile for mRNA, which mRNA may be a single molecular species, or a combination of species, including complex mixtures such as those found in the set of mRNAs isolated from a cell or tissue. One or more components of the surface-bound ribosome complex may be labeled at specific positions to permit analysis of multiple or single molecules for determination of ribosomal conformational changes and translation kinetics. Translation profiles are used as the basis for comparison of an mRNA or set of mRNA species. The translation profile can be used to determine such characteristics as kinetics of initiation, kinetic of elongation, identity of the polypeptide product, and the like. Analysis of translation profiles may be used to determine differential gene expression, optimization of mRNA sequences for expression, screening drug candidates for an effect on translation.
process;ELISA measuring epitope specific interleukin-15 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-15 production by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-12 production by T cells;A cytometric bead array assay that detects interleukin-12 production by T cells.
generically dependent continuant;in vitro design;A study design that is done in a test tube or a culture dish, e.g. A bacterial invasion assay in an established cell culture.
generically dependent continuant;RNAi profiling by array design;A study design in which experiment double stranded RNA is synthesized with a sequence complementary to a gene(s) of interest and introduced into a cell or organism, where it is recognized as exogenous genetic material and activates the RNAi pathway resulting in knockdown of the transcripts and providing a means to study downstream changes in gene expression.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-21 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-21 production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-5 production by T cells;A flow cytometry assay that detects interleukin-5 production by T cells.
generically dependent continuant;transcription profiling by array design;A study design that identifies forms and abundance of transcripts in the genome using microarray technology.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-17 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-17 production by T cells.
process;assay measuring epitope specific interleukin-15 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-15 production by T cells.
generically dependent continuant;disease state design;A study design in which the pathological condition of a part, organ, or system of an organism is studied. The etiology may be from infection, genetic defect, or environmental stress.
generically dependent continuant;wild type organism genotype information;a genotype information about an organism and includes information that there are no known modifications to the genetic background. Generally it is the genotype information of a representative individual from a class of organisms.
process;assay measuring epitope specific interleukin-17 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-17 production by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-17 production by T cells;A cytometric bead array assay that detects interleukin-17 production by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-10 production by T cells;A cytometric bead array assay that detects interleukin-10 production by T cells.
process;ChIP-chip by SNP array assay;A ChIP-ChIP assay in which immunoprecipitated chromatin is run on a SNP array to detect polymorphism specific DNA elements in the isolated chromatin
material entity;testis specimen;A specimen that is derived from testis.
process;ELISA measuring epitope specific RANTES production by T cells;An enzyme-linked immunosorbent assay that detects RANTES production by T cells.
material entity;uterus specimen;A specimen that is derived from uterus.
process;cytometric bead array assay measuring epitope specific interleukin-1 beta production by T cells;A cytometric bead array assay that detects interleukin-1 beta production by T cells.
material entity;vagina specimen;A specimen that is derived from vagina.
generically dependent continuant;age group inclusion criterion;An inclusion criterion that defines and states an age bracket which, if met, makes an entity suitable for a given task or participation in a given process.
generically dependent continuant;genetic population background information;a genetic characteristics information which is a part of genotype information that identifies the population of organisms
generically dependent continuant;minimum age value specification;A value specifcation that specifies the youngest age when specifying an age range.
generically dependent continuant;environmental history design;A study design in which some aspect of the organism's environmental history is studied, such as exposure to teratogen, radiation, climate etc.
generically dependent continuant;maximum age value specification;A value specifcation that specifies the oldest age when specifying an age range.
process;ELISPOT assay measuring epitope specific interleukin-6 production by T cells;An enzyme-linked immunospot assay that detects interleukin-6 production by T cells
generically dependent continuant;use of medication inclusion criterion;An inclusion criterion that defines and states a a set of medications, which, if used by an entity, makes that entity suitable for a given task or participation in a given process.
process;in vivo assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response;A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance an antibody response.
generically dependent continuant;hospital patient inclusion criterion;An inclusion criterion defines that a human being has to be a hospital patient to be suitable for a given task or participation in a given process.
material entity;sigmoid colon specimen;A specimen that is derived from sigmoid colon.
process;cell culture analyte detection bioassay measuring epitope specific interleukin-10 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-10 production by T cells.
material entity;suprapubic skin specimen;A specimen that is derived from suprapubic skin.
process;plasmon resonance assay measuring the dissociation constant [KD] of a T cell epitope:MHC:TCR complex;A surface plasmon resonance binding assay that measures the dissociation constant [KD] of an epitope:MHC complex binding with a T cell receptor.
process;assay measuring epitope specific RANTES production by T cells;A T cell epitope specific cytokine production assay that detects RANTES production by T cells.
generically dependent continuant;ethnicity inclusion criterion;An inclusion criteria that defines and states one or more ethnicities which, if met, makes an entity suitable for a given task or participation in a given process.
process;assay measuring epitope specific granulocyte macrophage colony stimulating factor production by T cells;A T cell epitope specific cytokine production assay that detects granulocyte macrophage colony stimulating factor production by T cells.
process;histopathology assay;A histological assay that is intended to check for the presence or level of a specific disease.
generically dependent continuant;epigenetic modification identification objective;A molecular feature identification objective that aims to detect epigenetic modifications, such as DNA methylation, histone modifications.
process;adapter-sequence trimming;A data transformation in which adapter sequences at the end of a molecular sequence are cut (removed).
process;transcription profiling by tiling array assay;A transcription profiling by array assay that uses a tiling path array.
process;file merge;A data transformation in which data contained in 2 or more files are merged into a single file.
process;ELISA measuring epitope specific interleukin-22 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-22 production by T cells.
process;sequence alignment;A data transformation in which one or more sequences (reads) are positioned on a reference sequence template (often a reference set of genes), according to the genetic base-pairing paradigm.
process;assay measuring epitope specific interleukin-21 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-21 production by T cells.
process;sequence data feature count tabulation;The counting of features (typically, genes) within aligned sequence data, and organization of these counts into one or more tables.
process;ELISA measuring epitope specific interleukin-9 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-9 production by T cells.
generically dependent continuant;trimmed sequence data;The results of a data transformation of sequence data in which (e.g., low quality) read bases are removed, to achieve some specific objective.
generically dependent continuant;transcription profiling by high throughput sequencing design;A study design in which sequencing technology (e.g. Solexa/454) is used to generate RNA sequence, analyse the transcibed regions of the genome, and/or to quantitate transcript abundance
generically dependent continuant;family status inclusion criterion;An inclusion criterion that defines and states one or more family statuses, which, if met, makes a human being suitable for a given task or participation in a given process.
process;assay measuring epitope specific interleukin-5 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-5 production by T cells.
generically dependent continuant;sex inclusion criterion;An inclusion criterion that defines and states one or more sexes which, if met, makes an entity suitable for a given task or participation in a given process.
process;ELISA measuring epitope specific transforming growth factor-beta production by T cells;An enzyme-linked immunosorbent assay that detects transforming growth factor-beta production by T cells.
generically dependent continuant;country of residence inclusion criteria;An inclusion criterion that defines and states one or more countries of residence which, if met, makes a human being suitable for a given task or participation in a given process.
process;cytometric bead array assay measuring epitope specific monocyte chemotactic protein-1 production by T cells;A cytometric bead array assay that detects monocyte chemotactic protein-1 production by T cells.
process;RNA extraction with polyA depletion;A RNA extraction process in which only RNAs lacking a polyA tail are retained
process;ELISA measuring epitope specific interleukin-23 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-23 production by T cells.
process;isoform sequencing;A method for sequencing isoforms by enriching a cDNA library for full-length reads spanning entire transcript isoforms.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific perforin release;A detection of specific nucleic acids with complementary probes assay that detects epitope specific perforin release by T cells.
process;ELISA measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;An enzyme-linked immunosorbent assay that detects tumor necrosis factor superfamily cytokine production by T cells.
process;genotyping by high throughput sequencing assay;A genotyping assay that uses a high througput sequencer
generically dependent continuant;adapter sequence data;Nucleotide sequences of molecules that are ligated to assay samples prior to sequencing of these samples. these sequences are provided by assay kit manufacturers and typically used to combine sequencing of multiple samples in one assay run.
material entity;reticulocyte specimen;A specimen that is derived from some reticulocytes
process;ChIP-chip assay;An assay in which chromatin is immunoprecipitated and subsequently analyzed using a DNA microarray to identify which parts of DNA are part of the isolated chromatin
generically dependent continuant;adapter-trimmed sequence data;The results of a data transformation of sequence data in which reference subsequences corresponding to ligated library adapters are removed.
material entity;leukocyte specimen;A specimen that is derived from some leukocytes
process;epitope specific T cell tolerance induction;A process of T cell tolerance induction resulting from the recognition of a T cell epitope.
material entity;nCounter Mouse miRNA Expression array;A mouse array which is manufacutred by NanoString Technologies. Built upon color-coded molecular barcodes technology, the array profiles miRNA with increased specificity and sensitivty than microarrays.
process;intracellular cytokine staining assay measuring epitope specific interleukin-6 production by T cells;A flow cytometry assay that detects interleukin-6 production by T cells.
process;polyA-selected RNA sequencing assay;An RNA-seq assay to study transcriptomes through the enrichment of polyadenylated transcripts or removal of ribosomal RNA prior to high-throughput sequencing.
process;cell culture analyte detection bioassay measuring epitope specific interleukin-4 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-4 production by T cells.
process;polyA-depleted RNA sequencing assay;An RNA-seq assay to study non-polyadenylated transcripts, such as, but not exclusive to unspliced and circular isoforms, through the depletion of polyadenylated transcripts prior to high-throughput sequencing.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific tumor necrosis factor alpha production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects tumor necrosis factor alpha production by T cells.
material entity;polyA depleted RNA extract;A RNA extract that is the output of an extraction process in which RNA molecules lacking poly A tails at thier 3' ends are purified.
material entity;arterial blood specimen;A specimen that is derived from some arterial blood
material entity;venous blood specimen;A specimen that is derived from some venous blood
material entity;capillary blood specimen;A specimen that is derived from some capillary blood
material entity;erythrocyte specimen;A specimen that is derived from some erythrocytes
material entity;chorionic villus specimen;A specimen that is derived from some chorionic villus
material entity;meconium specimen;A specimen that is derived from some meconium
material entity;umbilical cord blood specimen;A specimen that is derived from some umbilical cord blood
process;epitope specific interleukin-3 production by T cells;A process of interleukin-3 production by T cells resulting from the recognition of a T cell epitope.
process;sequence trimming;A data transformation in which subsequences of a molecular sequence are cut (removed).
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-5 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-5 production by T cells.
material entity;digital acquisition card;The digital acquisition card acts as the interface between the computer and a measurement device via the computer bus. It converts the signal generated by a measurement device (output from device) to a digital signal via an analog-to-digital converter, ADC. It also converts a digital signal to an analog signal via a digital-to-analog converter, DAC. This analog signal (e.g., stimulus) is fed to a measurement device (input to device).
process;epitope specific lymphotoxin A production by T cells;A process of lymphotoxin A production by T cells resulting from the recognition of a T cell epitope.
process;machine learning;A planned process with the objective to give a computer the ability to use patterns in data to progressively improve its performance on a specific task, achieved by using statistical techniques instead of explicitly programming the ability.
process;epitope specific interleukin-1 alpha production by T cells;A process of interleukin-1 alpha production by T cells resulting from the recognition of a T cell epitope.
process;supervised machine learning;A machine learning process using a function that maps an input to an output based on example input-output pairs. It infers a function from labeled training data consisting of a set of training examples.
generically dependent continuant;ChIP-seq design;A study design which aims to identify protein and DNA interactions using a combination of chromatin immunoprecipitation and high throughput sequencing. Massively parallel sequence analyses are used in conjunction with whole-genome sequence databases to analyze the interaction pattern of any protein with DNA, or the pattern of any epigenetic chromatin modifications.
process;unsupervised machine learning;A machine learning process that infers a function describing the structure of "unlabeled" data (i.e. data that has not been classified or categorized).
generically dependent continuant;translational bias design;A study design that characterizes the association of transcripts and translation machinery.
generically dependent continuant;aligned sequence data;The results of a sequence alignment.
generically dependent continuant;merged aligned sequence data;The results of a data transformation of sequence data in which files containing aligned sequence data are merged together
process;assay measuring epitope specific interleukin-13 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-13 production by T cells.
generically dependent continuant;sequence library feature count data;The results of a sequence data feature count tabulation.
generically dependent continuant;array platform variation design;A study design in which the array platform is compared, e.g. Agilent versus Affymetrix.
generically dependent continuant;DNA methylation profiling data;The results of a DNA methylation profiling assay
process;assay measuring interleukin-9 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-9 production by T cells.
generically dependent continuant;differential expression analysis data;The results of a differential expression analysis.
material entity;synovial fluid specimen;A specimen that is derived from synovial fluid.
process;carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide
material entity;vitreous humor specimen;A specimen that is derived from vireous humor.
process;sodium(1+) assay;An analyte assay that measures the abundance of sodium(1+)
material entity;bone marrow specimen;A specimen that is derived from bone marrow.
process;creatinine assay;An analyte assay that measures the abundance of creatinine
material entity;placenta specimen;A specimen that is derived from placenta.
process;potassium(1+) assay;An analyte assay that measures the abundance of potassium(1+)
material entity;peritoneal fluid specimen;A specimen that is derived from peritoneal fluid.
process;basophil count assay;A cytometry assay that measures the count of basophils
material entity;pleural fluid specimen;A specimen that is derived from pleural fluid.
process;neutrophil count assay;A cytometry assay that measures the count of neutrophils
material entity;brain specimen;A specimen that is derived from brain.
process;eosinophil count assay;A cytometry assay that measures the count of eosinophils
material entity;hair specimen;A specimen that is derived from hair.
process;lymphocyte count assay;A cytometry assay that measures the count of lymphocytes
material entity;prostate gland specimen;A specimen that is derived from prostate gland.
process;monocyte count assay;A cytometry assay that measures the count of monocytes
material entity;skeletal muscle tissue specimen;A specimen that is derived from skeletal muscle.
process;chloride assay;An analyte assay that measures the abundance of chloride
material entity;heart specimen;A specimen that is derived from heart.
process;erythrocyte count assay;A cytometry assay that measures the count of erythrocytes
material entity;renal medulla specimen;A specimen that is derived from renal medulla.
process;platelet count assay;A cytometry assay that measures the count of platelets
material entity;adrenal gland specimen;A specimen that is derived from adrenal gland.
process;leukocyte count assay;A cytometry assay that measures the count of leukocytes
material entity;breast specimen;A specimen that is derived from breast.
process;hemoglobin assay;An analyte assay that measures the abundance of hemoglobin
material entity;urinary bladder specimen;A specimen that is derived from urinary bladder.
process;phosphate ion assay;An analyte assay that measures the abundance of phosphate ion
material entity;tibial artery specimen;A specimen that is derived from tibial artery.
process;alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase
material entity;skin of body specimen;A specimen that is derived from skin.
process;alkaline phosphatase (human) assay;An analyte assay that measures the abundance of alkaline phosphatase (human)
material entity;pancreas specimen;A specimen that is derived from pancreas.
process;bilirubin IXalpha assay;An analyte assay that measures the abundance of bilirubin IXalpha
material entity;stomach specimen;A specimen that is derived from stomach.
process;aspartate aminotransferase (human) assay;An analyte assay that measures the abundance of aspartate aminotransferase (human)
material entity;pituitary gland specimen;A specimen that is derived from pituitary gland.
material entity;adipose tissue specimen;A specimen that is derived from adipose tissue.
process;magnesium cation assay;An analyte assay that measures the abundance of magnesium cation
generically dependent continuant;genotyping by high throughput sequencing design;A study design that classifies an individual or group of individuals on the basis of alleles, haplotypes, SNPs using high througput sequencing techniques.
material entity;cortex of kidney specimen;A specimen that is derived from cortex of kidney.
process;albumin assay;An analyte assay that measures the abundance of albumin
process;epitope specific tolerance induction by T cells;A process of tolerance induction by T cells resulting from the recognition of a T cell epitope.
material entity;esophagus mucosa specimen;A specimen that is derived from esophagus mucosa.
process;protein assay;An analyte assay that measures the abundance of protein
generically dependent continuant;innate behavior design;A study design in which the innate behavior of the organism is examined, e.g. path finding in bees.
material entity;colon specimen;A specimen that is derived from colon.
process;calcium cation assay;An analyte assay that measures the abundance of calcium cation
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific transforming growth factor-beta production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects transforming growth factor-beta production by T cells.
material entity;lung specimen;A specimen that is derived from lung.
process;creatine kinase assay;An analyte assay that measures the abundance of creatine kinase
material entity;SNP microarray;A DNA microarray used to detect polymorphisms in DNA samples
material entity;esophagus muscularis mucosa specimen;A specimen that is derived from esophagus muscularis mucosa.
process;nucleate erythrocyte count assay;A cytometry assay that measures the count of nucleate erythrocytes
generically dependent continuant;cell component comparison design;A study design that compares samples from different cell components.
material entity;cerebral cortex specimen;A specimen that is derived from cerebral cortex.
process;segmented neutrophil of bone marrow count assay;A cytometry assay that measures the count of segmented neutrophil of bone marrows
process;ELISPOT assay measuring epitope specific granulocyte macrophage colony-stimulating factor production by T cells;An enzyme-linked immunospot assay that detects granulocyte macrophage colony stimulating factor production by T cells.
material entity;thyroid gland specimen;A specimen that is derived from thyroid gland.
process;lactate dehydrogenase complex assay;An assay that measures lactate dehydrogenase complex
process;glucose assay;An analyte assay that measures the abundance of glucose
process;epitope specific macrophage inflammatory protein-1 alpha production by T cells;A process of macrophage inflammatory protein-1 alpha production by T cells resulting from the recognition of a T cell epitope.
material entity;cerebellum specimen;A specimen that is derived from cerebellum.
process;ANOVA;A statistical hypothesis test in which the means of several groups are all equal.
process;triglyceride assay;An analyte assay that measures the abundance of triglyceride
process;epitope specific T cell activation;A process of T cell activation resulting from the recognition of a T cell epitope.
material entity;tibial nerve specimen;A specimen that is derived from tibial nerve.
process;chi square test;The chi-square test is a data transformation with the objective of statistical hypothesis testing, in which the sampling distribution of the test statistic is a chi-square distribution when the null hypothesis is true, or any in which this is asymptotically true, meaning that the sampling distribution (if the null hypothesis is true) can be made to approximate a chi-square distribution as closely as desired by making the sample size large enough.
process;assay measuring epitope specific interleukin-10 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-10 production by T cells.
process;cytometric bead array assay measuring epitope specific transforming growth factor-beta production by T cells;A cytometric bead array assay that detects transforming growth factor-beta production by T cells
material entity;spleen specimen;A specimen that is derived from spleen.
process;low-density lipoprotein cholesterol assay;An analyte assay that measures the abundance of low-density lipoprotein cholesterol
generically dependent continuant;ex vivo design;A study design where all or part of an organism is removed and studied in vitro, e.g. part of a mouse is removed and cultured in vitro. A cell culture with an established cell line is an in vitro experiment.
material entity;aorta specimen;A specimen that is derived from aorta.
process;thyroid stimulating hormone assay;An analyte assay that measures the abundance of thyroid stimulating hormone
process;epitope specific type IV hypersensitivity by T cells;A process of type IV hypersensitivity by T cells resulting from the recognition of a T cell epitope.
material entity;atrial appendage specimen;A specimen that is derived from the atrium auricular region.
process;prostate-specific antigen assay;An analyte assay that measures the abundance of prostate-specific antigen
material entity;esophagogastric junction specimen;A specimen that is derived from the esophagogastric junction.
process;thyroxine assay;An analyte assay that measures the abundance of thyroxine
generically dependent continuant;normalization testing design;A study design that tests different normalization procedures.
material entity;ileum specimen;A specimen that is derived from ileum.
process;elemental oxygen assay;An analyte assay that measures the abundance of elemental oxygen
process;intracellular material detection assay measuring epitope specific perforin release;A flow cytometry assay that detects epitope specific perforin release by T cells.
material entity;liver specimen;A specimen that is derived from liver.
process;folic acids assay;An analyte assay that measures the abundance of folic acids
process;cell culture analyte detection bioassay measuring epitope specific interleukin-2 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-2 production by T cells.
material entity;minor salivary gland specimen;A specimen that is derived from minor salivary gland.
process;reticulocyte count assay;A cytometry assay that measures the count of reticulocytes
process;assay measuring epitope specific interleukin-22 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-22 production by T cells.
material entity;omentum specimen;A specimen that is derived from omentum.
process;osmolality assay;An assay that measures osmolality
process;high-density lipoprotein cholesterol assay;An analyte assay that measures the abundance of high-density lipoprotein cholesterol
material entity;coronary artery specimen;A specimen that is derived from coronary artery.
process;cholesterol assay;An analyte assay that measures the abundance of cholesterol
process;assay measuring epitope specific interleukin-8 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-8 production by T cells.
material entity;ovary specimen;A specimen that is derived from female gonad.
process;epitope specific chemokine (C-C motif) ligand 1 production by T cells;A process of chemokine (C-C motif) ligand 1 production by T cells resulting from the recognition of a T cell epitope.
process;hydrogencarbonate assay;An analyte assay that measures the abundance of hydrogencarbonate
process;vancomycin assay;An analyte assay that measures the abundance of vancomycin
process;tobramycin assay;An analyte assay that measures the abundance of tobramycin
process;3,3',5'-triiodothyronine assay;An analyte assay that measures the abundance of 3,3',5'-triiodothyronine
process;C-reactive protein assay;An analyte assay that measures the abundance of C-reactive protein
process;megakaryocyte count assay;A cytometry assay that measures the count of megakaryocytes
process;mesothelial cell count assay;A cytometry assay that measures the count of mesothelial cells
process;methemoglobin assay;An analyte assay that measures the abundance of methemoglobin
process;cytosolic creatine kinase complex, MB-type assay;An assay that measures cytosolic creatine kinase complex, MB-type
process;rac-lactic acid assay;An assay that measures rac-lactic acid
process;panel5 venous blood creatinine assay;An analyte assay that measures the abundance of creatinine in venous blood as part of a panel5 order
process;panel5 venous blood potassium assay;An analyte assay that measures the abundance of potassium in venous blood as part of a panel5 order
process;automated differential venous blood basophil count assay;A cytometry assay that measures the count of basophils in venous blood as part of a automated differential order
process;automated differential venous blood neutrophil count assay;A cytometry assay that measures the count of neutrophils in venous blood as part of a automated differential order
process;automated differential venous blood eosinophil count assay;A cytometry assay that measures the count of eosinophils in venous blood as part of a automated differential order
process;automated differential venous blood lymphocyte count assay;A cytometry assay that measures the count of lymphocytes in venous blood as part of a automated differential order
material entity;fluorescently labeled MHC multimer;A complex of two or more linked MHC molecules including a fluorescent label that can be loaded with a ligand, and is used in flow cytometry assay to bind to T cell receptors of T cells specific for the ligand
process;human antithrombin-III in blood assay;An assay that measures the amount of antithrombin III in blood.
generically dependent continuant;study design controlled variable;Controlled variable specification is a part of a study design. They are the entities that could vary, but are kept constant to prevent their influence on the effect of the independent variable on the dependent.
material entity;anticoagulant-containing test tube;A 'blue top' test tube that contains anticoagulant for storing blood specimens'
process;macrophage count assay;A cytometry assay that measures the count of macrophages
process;3-hydroxybutyric acid assay;An analyte assay that measures the abundance of 3-hydroxybutyric acid
process;panel5 venous blood carbon dioxide assay;An analyte assay that measures the abundance of carbon dioxide in venous blood as part of a panel5 order
process;panel5 venous blood sodium assay;An analyte assay that measures the abundance of sodium in venous blood as part of a panel5 order
generically dependent continuant;survival rate;A measurement data that represents the percentage of people or animals in a study or treatment group who are alive for a given period of time after diagnosis or initiation of monitoring.
generically dependent continuant;multiple testing correction objective;A multiple testing correction objectives is a data transformation objective where the aim is to correct for a set of statistical inferences considered simultaneously
process;CBC with automated differential venous blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in venous blood as part of a CBC with automated differential order
process;recombinant BAC cloning;Recombinant BAC cloning is a process with the objective to insert genetic material into an F plasmid based bacterial artificial chromosome for future replication of the inserted material
process;CBC with automated differential venous blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in venous blood as part of a CBC with automated differential order
process;venous blood phosphate assay;An analyte assay that measures the abundance of phosphate in venous blood
process;liver injury venous blood alanine aminotransferase assay;An analyte assay that measures the abundance of alanine aminotransferase in venous blood as part of a liver injury order
process;liver injury venous blood human alkaline phosphatase assay;An analyte assay that measures the abundance of human alkaline phosphatase in venous blood as part of a liver injury order
process;recombinant phage cloning;Recombinant phage cloning is the process of using a phage plus some insert nucleic acid for the purposes of amplification of the insert material achieved by phage assembly in vitro.
material entity;capsule shell;a small rounded gelatinous container
generically dependent continuant;purification objective;The objective to separate a material entity into different compositions of which one or more have are purified fractions that contain higher concentration of a desired component, while others contain impurities and are not of interest
process;automated differential venous blood monocyte count assay;A cytometry assay that measures the count of monocytes in venous blood as part of a automated differential order
material entity;glucometer;A measurement device with the function to measure and record the level/amount of glucose in a blood sample
process;venous blood chloride assay;An analyte assay that measures the abundance of chloride in venous blood
process;CBC with automated differential venous blood RBC count assay;A cytometry assay that measures the count of RBCs in venous blood as part of a CBC with automated differential order
process;double blind study execution;A double blind study execution is defined as any study execution in which neither the subjects nor the investigators are informed of which study arm the subjects are part of during the portion of the trial when the subjects are being treated
process;CBC with automated differential venous blood platelet count assay;A cytometry assay that measures the count of platelets in venous blood as part of a CBC with automated differential order
process;statistical model validation;A data transformation which assesses how the results of a statistical analysis will generalize to an independent data set.
process;CBC with automated differential venous blood WBC count assay;A cytometry assay that measures the count of WBCs in venous blood as part of a CBC with automated differential order
process;CBC venous blood hematocrit assay;A cytometry assay that measures the proportion of red blood cells in venous blood as part of a CBC order
process;CBC venous blood platelet count assay;A cytometry assay that measures the count of platelets in venous blood as part of a CBC order
process;CBC venous blood hemoglobin assay;An analyte assay that measures the abundance of hemoglobin in venous blood as part of a CBC order
material entity;amniotic fluid specimen;A specimen that is derived from amniotic fluid.
process;corrected venous blood leukocyte count assay;A cytometry assay that measures the count of leukocytes in venous blood as part of a corrected order
material entity;bile specimen;A specimen that is derived from bile.
material entity;cerebrospinal fluid specimen;A specimen that is derived from cerbrospinal fluid.
material entity;feces specimen;A specimen that is derived from feces.
material entity;digestive system fluid or secretion specimen;A specimen that is derived from digestive system fluid or secretion.
process;liver injury venous blood bilirubin assay;An analyte assay that measures the abundance of bilirubin in venous blood as part of a liver injury order
process;liver injury venous blood human aspartate aminotransferase assay;An analyte assay that measures the abundance of human aspartate aminotransferase in venous blood as part of a liver injury order
process;venous blood glucose assay;An analyte assay that measures the abundance of glucose in venous blood
process;venous blood magnesium assay;An analyte assay that measures the abundance of magnesium in venous blood
process;CBC venous blood RBC count assay;A cytometry assay that measures the count of RBCs in venous blood as part of a CBC order
process;CBC venous blood WBC count assay;A cytometry assay that measures the count of WBCs in venous blood as part of a CBC order
material entity;milk specimen;A specimen that is derived from milk.
material entity;pericardial fluid specimen;A specimen that is derived from pericardial fluid.
material entity;saliva specimen;A specimen that is derived from saliva.
material entity;sputum specimen;A specimen that is derived from sputum.
material entity;sweat specimen;A specimen that is derived from sweat.
process;western blot assay;An analyte assay that detects specific peptides in an input material by separating it using gel electrophoresis, transfering the separated molecules to a membrane, and staining them with antibodies specific to the analyte molecules.
generically dependent continuant;record of missing knowledge;An information content entity created to indicate that information about something is not available to the person recording it.
process;cytoplasmic RNA extraction;A RNA extraction process in which the desired output material is RNA in the cytoplasm.
generically dependent continuant;record of unknown sex;a record indicating that the biological sex of an organism is not known.
role;complementary nucleotide probe role;A role played by a nucleic acid molecule that is used in a planned process for its ability to bind a nucleic acid molecules with complementary nucleotide sequence
process;total RNA extraction;A RNA extraction process in which total cellular and organelle RNA are extracted.
process;96-well neutralization assay;A serum neutralization of viral infectivity assay which is performed in a 96-well plate.
material entity;nuclear RNA extract;A RNA extract that is the output of an extraction process in which RNA molecules found in the nucleus, including mRNA precursors (pre-mRNA), are extracted.
process;Likelihood-ratio test;Likelihood-ratio is a data transformation which tests whether there is evidence of the need to move from a simple model to a more complicated one (where the simple model is nested within the complicated one). tests of the goodness-of-fit between two models.
process;northern blot assay;An assay that determines the presence of gene transcripts by hybridizing labeled RNA or DNA probes against messenger RNAs isolated from tissue or cell cultures, resolved on denaturing gel, transfered by a blotting procedure to a solid support. Detection of hybridization signals is carried out by immunofluorescence or radioactivity measurements using photographic films or digital imaging devices such as Phosphor Imager.
material entity;polyA RNA extract;A RNA extract that is the output of an extraction process in which RNA molecules with poly A tail at its 3' end are purified.
generically dependent continuant;pattern matching objective;A pattern matching objective aims to detect the presence of the constituents of a given pattern. In contrast to pattern recognition, the pattern is rigidly specified. Patterns are typicall sequences or trees.
process;establishing cancer cell line;is a planned process in which the objective is to generate a cell line from a natural population of cancer cells which are already immortal
material entity;cytoplasmic RNA extract;A RNA extract that is the output of a RNA extraction process in which RNA molecules found in the cytoplasm are extracted.
process;viral hemagglutination inhibition assay;An assay that measures the ability of an evaluant to inhibit hemagglutination by a virus. Hemagglutinin is a viral protein which binds to sialic acid receptors on cells or to erythrocytes, causing the cells to clump. Loss of clumping indicates that the evaluant blocks binding of hemagglutinin to sialic acid receptors.
process;detection of specific nucleic acid polymers with complementary probes;An analyte assay in which a specified input material (the evaluant) is examined for the presence or quantity of specified nucleic acid polymers, which are identified based on the use of complementary nucleic acid probes.
material entity;pre-mortem specimen;a specimen that was taken from a live organism
process;serum neutralization of viral infectivity assay;An analyte assay that measures virus-neutralizing abilities of different sera. Different dilutions of serum are mixed with virus and used to infect cells. At the lower dilutions, antibodies will block infection, but at higher dilutions, there will be too few antibodies to have an effect.The neutralization titer is expressed as the reciprocal of the highest dilution at which virus infection is blocked.
process;viral hemagglutination assay;An assay that quantifies viruses by their hemagglutination activity.
process;single-nucleotide-resolution nucleic acid structure mapping assay;An assay that provides information about the secondary structure of nucleic acids using chemical or enzymatic probing to establish the extent of base-pairing or solvent accessiblity.
process;random primed DNA labeling;a labeling in which random primers are used to uniformly label input DNA
process;cell line immortalization;an establishing cell line process whereby a mortal cell line is intentionally genetically modified to be capable of indefinite propagation and re-established as a new immortal cell line
quality;secondary structure of sequence macromolecule;A quality inhering in a molecule that refers to general three-dimensional form of local segments of biopolymers such as proteins and nucleic acids (DNA/RNA). It does not, however, describe specific atomic positions in three-dimensional space, which are considered to be tertiary structure. Secondary structure was introduced by Kaj Ulrik Linderstrm-Lang in the 1952 Lane medical lectures at Stanford.
process;in vivo cell killing assay;A cell killing assay that measures if and how many target cells are killed within an organism.
process;cell-cell killing assay;A cytometry assay that monitors a cell population to track how many are killed by other cells.
material entity;RNA extract;an extract which is the output of an extraction process in which RNA molecules are isolated from a specimen.
generically dependent continuant;survival curve;A survival curve is a report graph which is a graphical representation of data where the percentage of survival is plotted as a function of time.
process;nuclear RNA extraction;A RNA extraction process in which the desired output material is RNA in the nucleus.
process;enzymatic DNA replication;the use of enzymes to duplicate DNA molecule any process used to make additional copies of a biomaterial
process;enzymatic amplification;the use of enzymes to increase the number of molecules of a biomaterial
process;DNA transduction;a genetic transformation which relies on the use of lysogenic infection to transfer DNA sequences into an organism
process;electrophoresis;a protocol application that uses an electrical potential to move material through a defined matrix in order to separate it by its resistance to movement and its charge
process;selection by survival;the use of environmental conditions to select for the organism or cells that have a certain trait
process;DNA restriction enzyme digestion;A specific enzymatic cleavage of DNA molecules using endonucleases that cleave DNA molecules at specific sites based on the surrounding nucleotide sequence
process;protease cleavage;protease cleavage is an enzymatic cleavage which relies on enzyme with protease activity to act on proteins and produce polypeptides (protein fragments).
process;informed consent process;A planned process with the objective to inform a person or their legal representative of legally and ethically relevant facts about a process that the person in question is asked to participate in, and which results in a documented decision as to whether the person in question will participate.
generically dependent continuant;specimen collection time post disease onset;A specimen collection time measurement datum that is the measure of a time when specimens are collected after the onset of disease in a host.
generically dependent continuant;specimen collection time post infection;A specimen collection time measurement datum that is the measure of a time when specimens are collected after an infection starts.
generically dependent continuant;laboratory postal address;A postal address used as a directive to deliver something to a laboratory.
material entity;laboratory-based population;A population where the collection of individuals is located and maintained in a laboratory, research, or production facility.
process;autofluorescence assay;A fluorescence detection assay in which the light that is naturally emitted by a sample is visualized after excitation of the sample with light at a suitable wavelength.
process;autofluorescence microscopy assay;An autofluorescence assay in which the light that is naturally emitted by a sample is visualized via microscopy after excitation of the sample with light at a suitable wavelength.
process;bulk assay for transposase-accessible chromatin using sequencing;An assay for transposase-accessible chromatin using sequencing in which the sample that is sequenced is derived from a collection of cells, such as a tissue sample or entire cell culture, and therefore provides results representative of the aggregate of sample cells.
process;calibration;A planned process with the objective to establish the relationship between data produced by a measurement device and physical qualities. This is done by using the measurement device under defined conditions, and either tuning it to adjust the measured output, or record the output and use it as a reference in future measurements.
material entity;fucoidan;Fucoidan is a sulfated polysaccharide (MW: average 20,000) found mainly in various species of brown seaweed such as kombu, limu moui,bladderwrack, wakame, mozuku, and hijiki (variant forms of fucoidan have also been found in animal species, including the sea cucumber).
material entity;micro electrode;An electrode of very fine caliber consisting usually of a fine wire or a glass tube of capillary diameter drawn to a fine point and filled with saline or a metal used in physiological experiments to stimulate or record action currents of extracellular or intracellular origin in the nervous system.
material entity;Berichrom(r) Antithrombin III (A) Kit;For the chromogenic determination of antithrombin III. Autoanalyzer method for undiluted samples. For the quantitative chromogenic determination of the functional activity of antithrombin III in plasma on autoanalyzers for the diagnosis of diminished AT III synthesis, increased consumption, and for monitoring substitution therapy. Berichrom(r) Antithrombin III (A) is used for the rapid determination of the physiologically active antithrombin III and permits the diagnosis of congenital and acquired antithrombin III deficiency, a condition frequently associated with an increased risk of thrombosis. Acquired antithrombin III deficiencies frequently occur due to consumption following major operations or due to disseminated intravascular coagulation (DIC) in cases of septicaemia, nephroses, liver parenchymal damage (hepatitis, drug intoxication, alcoholism) and estrogen-containing contraceptives. The test permits early detection of patients at increased risk for thrombosis. Kit contains: 6 x for 5.0 mL Thrombin (bovine), 3 x for 3.0 mL Substrate Reagent, 1 x 30.0 mL Buffer Solution
material entity;guar gum;Guar gum, also called guaran, is a galactomannan. It is primarily the ground endosperm of guar beans. The guar seeds are dehusked, milled and screened to obtain the guar gum.[1] It is typically produced as a free flowing, pale, off-white colored, coarse to fine ground powder.
process;bulk RNA-seq assay;An RNA-seq assay in which the sample that is sequenced is derived from a collection of cells, such as a tissue sample or entire cell culture, and therefore provides results representative of the aggregate of sample cells.
role;to be treated with active ingredient role;A study subject role which begins to exist when a subject is assigned to be one of those who will receive active ingredient, and is realized in a study execution in which they receive the active ingredient
process;multiplexed fluorescent antibody imaging assay;An imaging assay in which multiple cycles consisting of fluorescent labeling, imaging, and fluorophor deactivation are used to detect multiple proteins and their locations in a given sample of tissues or cells.
process;measuring neural activity in the caudate nucleus assay;An assay that measures neural activity in the caudate nucleus
process;Cell DIVE multiplexed imaging assay;A multiplexed fluorescent antibody imaging assay that involves an iterative staining, imaging and dye inactivation workflow for over 60 biomarkers on a single fixed tissue section.
generically dependent continuant;primary structure of DNA macromolecule;a quality of a DNA molecule that inheres in its bearer due to the order of its DNA nucleotide residues.
process;co-detection by indexing assay;A multiplexed fluorescent antibody imaging assay that involves a highly multiplexed analysis of up to 40 proteins in a tissue using cyclic detection of DNA-indexed antibody panels.
process;DNA transfection;a transfection which relies on the use of physical, electrical and chemical phenomena to introduce DNA into a cell
process;vector mediated expression;vector mediated expression sis the generation of copies of biomaterial by in a cell culture modified for this purpose by insertion of an expression vector
process;anticoagulant tube storage of blood specimen;Storage of a blood specimen in a tube with anticoagulant
process;recombinant vector cloning;a planned process with the objective to insert genetic material into a cloning vector for future replication of the inserted material
process;specific labeling;a labeling in which the labeling reagent used has a specificity to bind only certain components of the input material
material entity;filled capsule;A pill in the form of a small rounded gelatinous container with medicine inside.
process;fluorescence in-situ hybridization assay;An in-situ hybridization assay in which fluorescently labeled molecules are used to localize specific DNA or RNA sequences.
process;activated partial thromboplastin time assay;An assay that evaluates blood coagulation by measuring the time required for the appearance of fibrin strands following the mixing blood or plasma with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of blood coaguation . It is used as a screening test and to monitor heparin therapy.
process;decoding amplified targeted transcripts with fluorescence in situ hybridization assay;A fluorescence in-situ hybridization assay which involves multiplex in situ digital quantification of targeted RNA transcripts in fresh or frozen tissue providing an understanding of the spatial organization of different cell types.
process;imaging mass cytometry assay;A cytometry time of flight assay in which molecules of interest on or in cells are imaged through a system in which samples are labeled with multiple different rare-earth tagged antibodies. The sample is then ablated with a laser and the labeled material is detected by cytometry time of flight mass spectrometry.
process;liquid chromatography mass spectrometry assay;A mass spectrometry assay where a sample mixture is first separated by liquid chromatography before being converted into ions which are characterized by using mass spectrometry based on their mass-to-charge ratio and relative abundance.
process;lightsheet fluorescence microscopy assay;A fluorescence microscopy that involves capturing of photons emitted by fluorophores excited with a thin sheet of laser light in a sample only in a relatively narrow plane by a detection objective oriented perpendicularly to the light sheet and imaged onto a detection device such as a CCD camera.
process;matrix assisted laser desorption ionization imaging mass spectrometry assay;A mass spectrometry assay that involves collection of spatially resolved mass spectra of a sample during microscopy where a pulse laser is used to produce both ionisation and vaporization. The sample is held in a matrix (such as dihydrobenzoic acid) to protect it from direct laser illumination and to separate the sample molecules. The spectra are used to visualise the spatial distribution of biomolecules by their molecular masses.
material entity;research organization;An organization formed with a goal to have its members conduct investigations
material entity;pill;A dose of medicine or placebo in the form of a small pellet.
process;treatment portion of study execution;A planned process, part of a study design execution, during which the treatment of subjects is ongoing
role;to be treated with placebo role;A study subject role which begins to exist when a subject is assigned to be one of those who will receive a placebo, and realized in a study execution in which they receive the placebo
process;recombinant YAC cloning;Recombinant YAC cloning is a process with the objective to insert genetic material into a yeast artificial chromosome vector for future replication of the inserted material
process;thrombin time assay;An assay that measures the time between the addition of the thrombin and the clot formation in plasma.
process;single blind study execution;A single blind study execution is defined as any study execution in which the subjects are not informed of which study arm they are part of during the portion of the trial when the subjects are being treated
process;establishing cell culture;a process through which a new type of cell culture or cell line is created, either through the isolation and culture of one or more cells from a fresh source, or the deliberate experimental modification of an existing cell culture (e.g passaging a primary culture to become a secondary culture or line, or the immortalization or stable genetic modification of an existing culture or line).
process;cell culture splitting;The act of taking part of a homogeneous cell culture and creating one or more additional separate cultures of similar qualities. input: cell culture, output cell culture min cardinality 2. part of cell culturing
process;CBC with manual differential venous blood WBC count assay;A cytometry assay that measures the count of WBCs in venous blood as part of a CBC with manual differential order
process;addition of molecular label;a material processing technique intended to add a molecular label to some input material entity, to allow detection of the molecular target of this label in a detection of molecular label assay
process;CBC with manual differential venous blood eosinophil count assay;A cytometry assay that measures the count of eosinophils in venous blood as part of a CBC with manual differential order
process;enzyme-linked immunospot assay;A cytometry assay in which cells are cultured on a surface coated with a capture antibody binding a secretory material of interest which subsequently gets stained resulting in a spot for each cell producing the secretory material of interest.
process;CBC with manual differential venous blood lymphocyte count assay;A cytometry assay that measures the count of lymphocytes in venous blood as part of a CBC with manual differential order
process;artificially induced DNA repair;a protocol application to repair damaged DNA molecules
process;CBC with manual differential venous blood nucleated RBC count assay;A cytometry assay that measures the count of nucleated RBCs in venous blood as part of a CBC with manual differential order
process;cell permeabilization;A protocol application to permeabilize cell membranes, allowing molecules to more easily pass through the membrane than was possible prior to the protocol application
process;CBC with manual differential venous blood monocyte count assay;A cytometry assay that measures the count of monocytes in venous blood as part of a CBC with manual differential order
process;precipitation;a protocol application to cause a material to precipitate (becoming a solid) out of solution. Input is a solution, output is a solution plus a solid component (the precipitate)
process;CBC with manual differential venous blood segmented neutrophil count assay;A cytometry assay that measures the count of segmented neutrophils in venous blood as part of a CBC with manual differential order
material entity;measurement device;A device in which a measure function inheres.
quality;DNA residue methylation;a quality of a DNA residue that has a methyl group attached to it
process;artificially induced methylation;A planned process of adding methyl groups to polymers
material entity;labeled oligonucleotide;a labeled oligonucleotide is a short nucleic acid which underwent a labeling process resulting in a radioactive isotope such as P32 or P33 added to its backbone for instance by end labeling with polynucleotide kinase which added radiolabeled ATP to the 5' end of oligonucleotide
process;material maintenance;A planned process with the objective to maintain some or all of the characteristics of an input material over time.
process;oral ingestion of pill;An adding a material entity to target with the entity is a pill and the target is the mouth
material entity;test tube;A test tube is a device consisting of a glass or plastic tubing, open at the top, usually with a rounded U-shaped bottom which has the function to contain material
material entity;manufacturer;A person or organization that has a manufacturer role.
material entity;high molecular weight DNA extract;The output of an extraction process in which DNA molecules above a molecular weight cutoff are purified in order to exclude DNA from organellas.
process;CBC with manual differential venous blood basophil count assay;A cytometry assay that measures the count of basophils in venous blood as part of a CBC with manual differential order
process;venous blood albumin assay;An analyte assay that measures the abundance of albumin in venous blood
process;synthesis;the construction of a biomaterial from simpler biomaterials
process;cardiac enzymes venous blood creatine kinase assay;An analyte assay that measures the abundance of creatine kinase in venous blood as part of a cardiac enzymes order
process;concentrate;a protocol application to create an output material with an increased density of a material of interest that is part of the input material by separating other parts of the input material
process;venous blood haptoglobin assay;An analyte assay that measures the abundance of haptoglobin in venous blood
process;preparative chromatography;the use of a biomaterial's preferential affinity for either the mobile phase or the stationary phase to separate it from other materials of differing affinity
process;sequencing assay;An assay the uses chemical or biochemical means to infer the sequence of a biomaterial
process;venous blood lactate dehydrogenase assay;An assay that measures lactate dehydrogenase in venous blood
process;vector mediated amplification;The process of creating a copy of some biological entity in cell culture
process;venous blood prealbunin assay;An analyte assay that measures the abundance of prealbunin in venous blood
process;DNA polymerase amplification;DNA polymerase amplification is an enzymatic amplification which uses DNA polymerase enzyme to make copies of a DNA contained in biomaterial used as input
process;lipid panel venous blood triglyceride assay;An analyte assay that measures the abundance of triglyceride in venous blood as part of a lipid panel order
process;recombinant plasmid cloning;the insertion of a particular DNA fragment into a plasmid in order to make copies of a biomaterial
process;lipid panel venous blood high density lipoprotein assay;An analyte assay that measures the abundance of high density lipoprotein in venous blood as part of a lipid panel order
process;genetic transformation;the introduction. alteration or integration of genetic material into a cell or organism
process;lipid panel venous blood cholesterol assay;An analyte assay that measures the abundance of cholesterol in venous blood as part of a lipid panel order
process;lavage;A protocol application to separate cells and/or cellular secretions from an anatomical space by the introduction and removal of fluid
process;lipid panel venous blood low density lipoprotein assay;An analyte assay that measures the abundance of low density lipoprotein in venous blood as part of a lipid panel order
process;3D structure determination assay;An assay that determines the 3-dimensional configuration of an input material.
process;venous blood hemoglobin A1c assay;An assay that measures hemoglobin A1c in venous blood
material entity;Sysmex CA-6000 Coagulation Analyzer;The Sysmex CA-6000 automated coagulation analyzer is a random access instrument that is capable of performing 20 clot-based and chromogenic assays
process;informing subject of study arm;A planned process with the objective to make the subject aware of which study arm they are participating in.
process;subject agrees they understand informed consent document;A planned process in which a subject receives an informed consent document and agrees that they have understood it.
process;unblinding process;A planned process that is the part of the study execution in which the subjects are told what study arm they are in and in which the investigators are told which subjects are in which trials.
process;organellar RNA extraction;A RNA extraction process in which the desired output material is RNA in the organelle(s).
process;polyA RNA extraction;A RNA extraction process typically involving the use of poly dT oligomers in which the desired output material is polyA RNA.
role;test substance role;A role born by a material entity and realized in a process where the substance is used as specified as the independent variable for an investigation
generically dependent continuant;primary structure of RNA molecule;The primary structure of an RNA molecule that is completely defined by the set of its nucleic residue parts and the linear order induced by the peptide bonds that hold them together
process;venous blood uric acid assay;An analyte assay that measures the abundance of uric acid in venous blood
process;specific enzymatic cleavage;an enzymatic cleavage that uses an enzyme with a strong affinity for specific cleavage sites in the input material
process;total venous blood protein assay;An analyte assay that measures the abundance of protein in venous blood as part of a total order
process;gradient separation;a protocol application that uses different concentrations of materials in a defined order to create a gradient to facilitate the separation of an input material into its components with specific qualities
process;venous blood thyroid stimulating hormone assay;An analyte assay that measures the abundance of thyroid stimulating hormone in venous blood
process;dialysis;a protocol application that uses diffusion through a semi-permeable membrane to separate an input material into two fractions of different composition
process;information acquisition;An acquisition in which possession of information is gained.
material entity;BG-lure scent dispenser;A device manufactured by BioGents that is designed for operation with the BG-Sentinel trap and releases an attractant that mimics the scent of human skin.
process;material component separation;a material processing in which components of an input material become segregated in space
material entity;hand-held sweep net;A device that consists of a network of mesh and is designed to capture adult arthropods.
process;group assignment;group assignment is a process which has an organism as specified input and during which a role is assigned
process;pooling specimens;physical combination of several instances of like material
process;material acquisition;An acquisition in which possession of a material entity is gained.
process;acclimatization;A protocol application in which an object is left in an environment for some period of time, until some qualities of interest are in equilibrium with that environment.
process;environmental material collection process;environmental material collection is an acquisition where an object is taken from an environment and put into a storage container. Roles include, environment, thing collected, container, acquirer.
process;blood assay;An assay that has a blood specimen as evaulant.
process;falcivax rapid diagnostic test;A parasite detection assay that can quickly establish the diagnosis of P. falciparum or P. vivax malaria infection by detecting the antigens in a person's blood.
process;optimal-IT rapid diagnostic test;A parasite detection assay that is rapid, sensitive, and able to differentiate between P. falciparum and other malaria parasites.
process;urine assay;An assay that has a urine specimen as evaluant.
process;assay detecting a molecular label;An assay that detects the presence or a quality of a molecular label which is a proxy for the detection of the molecular target to which the label is attached
process;parasite species identification by PCR assay;A parasite detection by PCR assay that identifies the species of parasite.
process;material portioning;a material processing in which the input substance is partitioned into a number of portions that are similar in composition.
process;parasite detection by PCR assay;A parasite detection assay that uses PCR.
process;non-specific labeling;The addition of a reagent labeling the entire input biomaterial enabling future detection of the output biomaterial
material entity;free-standing window trap;An arthropod trap that consists of a transparent window placed in a box that holds a liquid solution deadly to arthropods. This trap is designed to stop an arthropod in flight, causing it to fall into the liquid and die.
process;maintaining cell culture;A planned process with the objective to keep cells alive in a defined environment outside of an organism.
process;substance detection assay;An assay that detects a specified substance
process;longitudinal mass measurement assay;An assay that measures the mass of a material at two or more time points
process;artificially induced cell membrane lysis;a material transformation to break the membranes of cells, releasing the cells contents. input=>cells. output=>cell lysate
process;histological assay;An assay that uses visual examination of cells or tissue (or images of them) to make an assessment regarding a quality of the cells or tissue. This assay can include steps of staining, imaging, and judgement.
process;cell fixation;a protocol application to preserve defined qualities of cells or tissues (sample) which may otherwise change over time
process;excision;the use physical means to remove a portion of a substance from the rest
process;non specific enzymatic cleavage;an enzymatic cleavage that uses an enzyme without a strong affinity for specific cleavage sites in the input material
material entity;Centers for Disease Control and Prevention gravid trap;A gravid trap that consists of a pan holding a hay infusion, motorized fan, and collection bag. This trap is designed to attract gravid female arthropods to the infused material, which would serve as an oviposition medium, and then draw them into the bag with the current generated by the fan.
process;egg specimen collection process;An arthropod specimen collection process in which the arthropods are in the embryo stage.
process;larval specimen collection process;An arthropod specimen collection process in which the arthropods are in the larval stage.
process;pupal specimen collection process;An arthropod specimen collection process in which the arthropods are in the pupal stage.
material entity;blood specimen in vacutainer;A blood specimen that is located in a vacutainer.
process;artificially induced reverse transcription;a protocol with the objective to transcribe single-stranded RNA into complementary DNA (cDNA)
material entity;blood specimen on filter paper;A blood specimen that is located on a filter paper.
process;isolation of cell culture supernatant;a protocol which results in the separation of supernatant material from a cell culture
generically dependent continuant;proportion mapped reads;A sequence datum that is the specified output of a read mapping and is the ratio of the count of mapped reads to the total count of reads.
process;antibiotic administration process;Administering substance in vivo where an antibiotic substance is administered to a living organism.
process;RNA extraction;A RNA extraction is a nucleic acid extraction where the desired output material is RNA
process;nucleic acid extraction;a material separation to recover the nucleic acid fraction of an input material
process;experimental disease induction;a protocol application to induce a specific disease in an organism
generically dependent continuant;sequencing protocol;A protocol that, when concretized, is realized in an assay that uses chemical or biological means to infer the sequence of a biomaterial.
generically dependent continuant;insecticide resistance datum;A data item that is about resistance to an insecticide.
generically dependent continuant;organism detection datum;A data item that is the specified output of an organism detection assay.
generically dependent continuant;easting coordinate measurement datum;A one dimensional Cartesian spatial coordinate datum that is the eastward component of a distance from a point on a map projection.
generically dependent continuant;northing coordinate measurement datum;A one dimensional Cartesian spatial coordinate datum that is the northward component of a distance from a point on a map projection.
material entity;clinical study center;Organization that undertakes a clinical study at some point in time.
generically dependent continuant;specimen collection protocol;A protocol that specifies processes to fulfill a specimen collection objective.
generically dependent continuant;participant identifier;A symbol that denotes a participant under investigation.
process;tumor grading;An assay that determines the grade (severity/stage) of a tumor sample, used in cancer biology to describe abnormalities/qualities of tumor cells or tissues. Values can be described by terms from NCI Thesaurus.
process;human subject enrollment;A planned process with the objective to obtain a population of human subjects to participate in an investigation by determining eligibility of subjects and obtaining informed consent.
process;collecting specimen from organism;a process with the objective to obtain a material entity that was part of an organism for potential future use in an investigation
process;adding substance to cell culture;is process in which a material substance is added to a cell culture
generically dependent continuant;axillary temperature measurement datum;A temperature measurement datum that is about an axilla.
generically dependent continuant;organismal body temperature measurement datum;A temperature measurement datum that is about an organism.
generically dependent continuant;common name of organism;A textual entity refers to a taxon or organism that is based on the normal language of everyday life. this kind of name is often contrasted with the scientific name for the same organism, which is Latinized.
generically dependent continuant;age since birth at time of enrollment;An age since birth measurement datum at the time of subject enrollment.
generically dependent continuant;age since birth at time of visit;An age since birth measurement datum at the time of a clinical visit.
process;killing;A protocol application in which an organism is intentionally put to death
generically dependent continuant;entomological data item;A data item that is about a collection of insects.
process;administering substance in vivo;A process by which a substance is intentionally given to an organism resulting in exposure of the organism to that substance.
process;acquisition;A planned process with the objective of gaining possession of an entity.
generically dependent continuant;temperature measurement datum;A scalar measurement datum that is the result of measuring temperature.
process;exposure of material to environment;a planned process in which an input material is exposed to a defined set of conditions in a controlled environment. The environment is a specified input.
process;presentation of stimulus;A planned process with the objective to expose an organism to a stimulus.
generically dependent continuant;material maintenance objective;An objective specification maintains some or all of the qualities of a material over time.
process;antithrombin-III berichrome assay;An antithrombin-III (AT-III) assay in which exogenous bovine thrombin and heparin are added to test plasma to form a thrombin-heparin-AT complex. The residual thrombin not bound then hydrolyzes the p-nitroalanine substrate to produce a yellow color, which is read at 405 nm. The intensity of color produced is inversely proportional to the AT present. A calibration is done with standard human plasma reagent and results for a given specimen are reported as a percentage relative to the standard
process;informing investigator of subject study arm;A planned process with the objective to make the investigator aware of which study arm a patient is participating in.
process;denaturing;Is a process in which the tertiary or secondary structure of a polymer is disrupted
process;prothrombin time assay;An assay that measures the prothrombin ratio, which is the prothrombin time for a patient, divided by the result for control plasma. Most commonly the test is preformed using blood plasma. Blood is drawn into a test tube containing liquid citrate, which acts as an anticoagulant. An excess of calcium is added to enable the blood to clot again.Tissue factor (also known as factor III or thromboplastin) is added, and the time the sample takes to clot is measured optically as the prothrombin time, which is compared to a control sample.
process;organismal body temperature measurement assay;An assay that detects body temperature of an organism.
generically dependent continuant;spike train datum;A measurement datum which represents information about an ordered series of action potentials in an organism's CNS measured over time.
generically dependent continuant;extraction date;A time measurement datum that specifies when some material was extracted from an input material.
process;cross linking;A process in which bonds are created that link one polymer to another
generically dependent continuant;extraction duration time;A time measurement datum that is the result of measuring the duration of an extraction process.
material entity;amplified DNA;DNA that has been produced in an enzymatic amplification process
process;spectrolyse heparin antifactor-Xa assay;An assay that quantitatively measures heparin in human plasma using Factor Xa and Antithrombin III in excess, where the rate of Factor Xa inhibition is directly proportional to the heparin concentration. The residual Factor Xa activity, measured with a Factor Xa-specific chromogenic substrate, is inversely proportional to the heparin concentration.
process;landing arthropod specimen collection process;An arthropod specimen collection process that occurs while the arthropods land on a surface.
process;flying adult arthropod collection process by passive interception;An adult arthropod specimen collection process that has the objective of collecting arthropods capable of flight, through the use of a barrier trap.
material entity;device for collection of resting adult arthropods;A device that is designed to provide a solid surface that is attractive to an arthropod as a place to rest during a period of inactivity.
material entity;well net for arthropod immatures;A device that is designed for the collection of arthropod larvae or pupae from water and consists of a conical net.
material entity;arthropod trap containing small non-human animal bait;An arthropod trap that uses as attractant an animal that is not human and is the size of a chicken or smaller.
material entity;trap for emerging adult arthropods;An arthropod trap that is designed to trap an arthropod as it emerges from water at the beginning of its adult stage.
process;ferritin assay;An assay that measures ferritin
process;resting flight-capable arthropod specimen collection process;An arthropod specimen collection process that occurs while an arthropod that is capable of flight is resting outdoors during a period of inactivity.
process;daytime arthropod specimen collection by aspiration;An arthropod specimen collection by aspiration that occurs in the daytime.
process;arthropod resting in human house specimen collection by aspiration;An arthropod specimen collection by aspiration that catches specimens resting inside a human house.
process;uric acid assay;An analyte assay that measures the abundance of uric acid
process;globulin assay;An analyte assay that measures the abundance of globulin
process;myelocyte assay;A cytometry assay that measures the abundance and/or characteristics of myelocytes
process;metamyelocyte assay;A cytometry assay that measures the abundance and/or characteristics of metamyelocytes
process;hematocrit assay;A cytometry assay that measures the proportion of red blood cells
process;promyelocyte assay;A cytometry assay that measures the abundance and/or characteristics of promyelocytes
process;fibrinogen assay;An assay that measures fibrinogen
process;iron assay;An analyte assay that measures the abundance of iron
process;ionized calcium assay;An analyte assay that measures the abundance of ionized calcium
process;transferrin assay;An analyte assay that measures the abundance of transferrin
process;monocyte assay;A cytometry assay that measures the abundance and/or characteristics of monocytes
process;reticulocyte assay;A cytometry assay that measures the abundance and/or characteristics of reticulocytes
process;macrophage assay;A cytometry assay that measures the abundance and/or characteristics of macrophages
process;platelet assay;A cytometry assay that measures the abundance and/or characteristics of platelets
role;barcode target locus role;An evaluant role that is realized in a taxonomic diversity assessment by targeted gene survey involving sequencing a small defined region of genome amplified by PCR.
process;basophil assay;A cytometry assay that measures the abundance and/or characteristics of basophils
process;neutrophil assay;A cytometry assay that measures the abundance and/or characteristics of neutrophils
process;eosinophil assay;A cytometry assay that measures the abundance and/or characteristics of eosinophils
process;lymphocyte assay;A cytometry assay that measures the abundance and/or characteristics of lymphocytes
process;Plasmodium gametocyte detection assay;An assay that detects Plasmodium gametocytes in a specimen.
process;malaria rapid diagnosis assay;An assay that is quick and easy in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood.
process;parasite detection assay;An assay that detects parasite in a specimen.
process;feces microbiology assay;An organism detection assay that detects microorganisms in a feces specimen.
material entity;oligonucleotide primer set;A processed material that consists of oligonucleotides that bear a primer role.
process;fluorogenic PCR assay;A polymerase chain reaction assay that uses target specific probes labeled with fluorogenic chromophores.
process;genotyping by PCR assay;A genotyping assay that uses polymerase chain reaction.
process;cleavage under targets and release using nuclease assay;A type of DNA sequencing assay employing in situ chromatin profiling in which antibody-targeted controlled cleavage by micrococcal nuclease releases specific protein-DNA complexes into the the supernatant for sequencing.
process;cleavage under targets and tagmentation;A type of DNA sequencing assay employing in situ chromatin profiling in which a chromatin protein is bound in situ by a specific antibody, which then tethers to a protein A-Tn5 hyperactive transposase fusion protein (pA-Tn5) loaded with sequence adapters. Activation of pA-Tn5 results in factor-targeted tagmentation, generating fragments ready for PCR enrichment and DNA sequencing.
process;coma severity assay;A physical examination of an organism that has the objective to determine the severity of coma in a patient.
generically dependent continuant;ratio of collected to emitted light;A measurement datum measuring the amount of light collected s compared to the total amount of emitted light in the detector component of a flow cytometer instrument. The datum has a qualitative role
process;epitope specific monocyte chemotactic protein-1 production by T cells;A process of monocyte chemotactic protein-1 production by T cells resulting from the recognition of a T cell epitope.
generically dependent continuant;genotyping by array design;A study design that classifies an individual or group of individuals on the basis of alleles, haplotypes, SNPs using microarray technology.
material entity;microarray platform;A microarray platform is a platform that contains the instruments, software and reagents needed to perform a microarray protocol. definition source: OBI.
process;assay measuring epitope specific interleukin-1 alpha production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-1 alpha production by T cells.
material entity;liquid chromatography mass spectrometry platform;A liquid chromatography mass spectrometry platform is a platform that is the collection of instrument, software and reagents needed to perform a liquid chromatography mass spectrometry protocol. definition source: OBI.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-6 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-6 production by T cells.
process;assay measuring epitope specific interleukin-18 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-18 production by T cells.
material entity;gamma counter;A processed material which measures gamma radiation
process;epitope specific interleukin-23 production by T cells;A process of interleukin-23 production by T cells resulting from the recognition of a T cell epitope.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-27 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-27 production by T cells.
process;allotransplantation;is the transplantation of organs between members of the same species.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific IP-10 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects IP-10 production by T cells.
role;notified body role;Notified body is regulator of consumables and medical devices charged by the Competent Authority with verifying compliance of medical devices (not drugs) with the applicable Essential Requirements stated in the Medical Device Directive
process;cell culture analyte detection bioassay measuring epitope specific interleukin-3 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-3 production by T cells.
generically dependent continuant;software optimization objective;Software optimization is a software testing objective role describing a study designed to identify the best software or parameters of the software.
process;intracellular cytokine staining assay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;A flow cytometry assay that detects tumor necrosis factor superfamily cytokine production by T cells.
material entity;polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether;triton X100 is a chemical entity which belongs to the group of The pluronics which are triblock copolymers of ethylene oxide and propylene oxide. Triton x-100 is used as detergent due to its non-ionic surfactant properties
process;cytometric bead array assay measuring epitope specific granulocyte colony stimulating factor production by T cells;A cytometric bead array assay that detects granulocyte colony stimulating factor production by T cells.
role;positive reference substance role;a reference role in which the characteristics or responses elicited by the substance playing the reference substance role are used to establish a "100%" response
generically dependent continuant;protein and DNA interaction identification objective;A sequence feature identification objective that aims to characterize the interactions between protein and DNA which includes identification of transcription factor binding sites.
process;epitope specific interleukin-22 production by T cells;A process of interleukin-22 production by T cells resulting from the recognition of a T cell epitope.
role;trial monitor role;a responsible party involved in planning, overseeing the conduct of a study or study component, and interpreting data from a study
process;assay measuring epitope specific interferon-beta production by T cells;A T cell epitope specific cytokine production assay that detects interferon-beta production by T cells.
process;assay measuring epitope specific interleukin-12 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-12 production by T cells.
process;in vivo assay measuring epitope specific T cell killing;An in vivo cell killing assay that measures the killing of antigen presenting cells (APC) by T cells whose TCR recognizes an epitope presented by the APC.
process;comparative genomic hybridization by array assay;An assay that measures changes in DNA sequence copy number using a microarray. For example the analysis of LOH in tumor cells vs a non diseased sample or the comparison of clinical isolated of disease causing bacteria.
role;reporting party role;a study personnel role played by a party who reports the outcome of a study component
process;epitope specific cytotoxic T cell degranulation;A process of cytotoxic T cell degranulation resulting from the recognition of a T cell epitope.
role;evaluant role;a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-23 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-23 production by T cells.
process;investigation;a planned process that consists of parts: planning, study design execution, documentation and which produce conclusion(s).
generically dependent continuant;stimulus or stress design;A study design in which the response of an organism(s) to the stress or stimulus is studied, e.g. osmotic stress, heat shock, radiation exposure, behavioral treatment etc.
process;unplanned occurrence effecting an investigation;a process which is external in origin to the investigation that has an impact on the outcome.
process;periodic acid-Schiff staining assay;A histological assay which is used on tissue samples to demonstrate the presence of carbohydrates and carbohydrate compounds such as polysaccharides, mucin, glycogen, or fungal cell wall components.
generically dependent continuant;diagnosis textual entity;diagnosis is an assessment of a disease or injury, its likely prognosis and treatment.
process;nanodroplet processing in one pot for trace samples assay;A protein expression profiling assay in which proteomics sample processing is performed in nanoliter volumes. Flow cytometry or laser microdissection is employed to isolate a small population or single cells into a nanoPOTS chip. Then, liquid chromatography mass spectrometry is used to measure the global protein expression.
process;single-cell combinatorial indexing RNA sequencing assay;A single-cell RNA sequencing assay that involves single cell combinatorial indexing ('sci-') strategy to profile the transcriptomes of single cells or nuclei without single cell isolation.
process;sample preparation for assay;A sample preparation for assay is a protocol application including material enrollments and biomaterial transformations. definition source: OBI.
process;single cell combinatorial indexing assay for transposase-accessessable chromatin using sequencing;An assay for transposase-accessible chromatin that uses sequencing which involves single cell combinatorial indexing ('sci-') strategy where nucleic acids from each of many cells are uniquely tagged through several rounds of split-pool barcoding which enables identification of single cells without single cell isolation.
process;slide-seq assay;An RNA-seq assay that involves transfer of RNA from tissue sections onto a surface covered in DNA-barcoded beads with known positions, allowing the locations of the RNA to be inferred by sequencing.
generically dependent continuant;quantitative confidence value;A data item which is used to indicate the degree of uncertainty about a measurement.
process;sequential fluorescence in-situ hybridization assay;A fluorescence in-situ hybridization assay that involves ultra-resolution imaging of cell activity by targetting thousands of single molecules with fluorescent probes which find and hybridize with complementary DNA or RNA sequences in the tissue sample, thus enabling identification of those molecules directly in single cells with their spatialcontext preserved.
process;assay;A planned process that has the objective to produce information about a material entity (the evaluant) by examining it.
process;single-nucleus RNA sequencing assay;A RNA-seq assay that is used for profiling gene expression in individual nuclei with optimized next generation sequencing (NGS) technologies. This allows the RNA-seq profiling of cell types that are more vulnerable to the tissue dissociation process, and that are therefore underrepresented in the final data set in single cell sequencing.
process;single-nucleus chromatin accessibility and mRNA expression sequencing assay;A single-nucleus RNA sequencing assay that involves joint profiling of accessible chromatin and RNA within the same cells which enables direct matching of transcriptional regulation to its outputs.
material entity;culture medium;a processed material that provides the needed nourishment for microorganisms or cells grown in vitro.
generically dependent continuant;eMedical record;An eMedical record is a digital document derived from a computer system used primarily for patient care in a clinical setting. Not required to be compliant with requirements of 21 CFR Part 11.
process;nanospray desorption electrospray ionization assay;A mass spectrometry assay that analyzes organic and biological molecules on a substrate by desorption of an analyte into a solvent bridge formed between two capillaries and the analysis surface. One capillary supplies solvent to create and maintain the bridge, while the second capillary transports the dissolved analyte from the bridge to the mass spectrometer. A high voltage applied between the inlet of mass spectrometer and the primary capillary creates a self-aspirating nanospray.
process;multiplexed ion beam imaging assay;A cytometry time of flight assay in which molecules of interest on or in cells are imaged through a system in which samples are labeled with multiple different rare-earth tagged antibodies. A primary ion beam is ued to rasterize sections under vacuum, releasing showers of secondary ions detected by cytometry time of flight mass spectrometry.
material entity;Illumina MiniSeq;A small benchtop DNA sequencer which is manufactured by the Illumina corporation with integrated cluster generation, sequencing and data analysis. The sequencer accommodates various flow cell configurations and can produce up to 25M single reads or 50M paired-end reads per run.
role;reagent role;A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer.
process;proximity extension assay;An analyte assay that uses quantitative polymerase chain reaction (qPCR) technology to determine the concentration/presence of an analyte or analyte complex.
process;antibody detection by cytometric bead array assay;A cytometric bead array assay that detects antigen-specific antibodies. In the assay a series of beads are coated with antigens which capture antibodies specific to the antigens. Fluorescent labeled secondary antibodies are used to detect the antibodies of interest.
material entity;polystyrene tube;A polystyrene tube is a test tube made of polystyrene
process;antigen detection by cytometric bead array assay;A cytometric bead array assay in which a series of beads are coated with antibodies specific to antigens of interest. Antigens of interest attach to antibodies on the beads. Fluorescent labeled secondary antibodies are used to detect the antigens of interest.
generically dependent continuant;electronic case report tabulation;An electronic case report tabulation is a digital document containing tabular data about multiple trial participants which is part of a clinical regulatory submission. An eCRT has the property that it can be audited and compliant with requirements of 21 CFR Part 11 and has format suited to review by regulators.
process;electron-microscopy 3D molecular structure determination assay;A 3D molecular structure determination assay that uses electron microscopy imaging.
process;3D molecular structure determination assay;An assay that determines the 3-dimensional configuration of a molecular entity or molecular complex.
material entity;antigen:antibody complex;A complex of molecular entitites which is the result of an antibody binding to an antigen.
process;gas chromatography mass spectrometry assay;A mass spectrometry assay combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determination of compounds.
role;role of regulator of chemical manufacturer;a regulator involved with making and enforcing legislation and governmental orders relevant to chemical manufacture
process;Olink assay;A proximity extension assay that uses quantitative polymerase chain reaction (qPCR) technology to determine the concentration/presence of proteins using a high-multiplex, high-throughput protein biomarker platform. The assay utilizes two distinct oligonucleotide-labeled antibodies (probes) that bind at different sites for each detected protein. When the two probes are in close proximity, a new PCR target sequence is formed by a proximity-dependent DNA polymerization event. The resulting sequence is subsequently detected and quantified using standard real-time PCR.
process;SOMAscan assay;An analyte assay that uses aptamers to detect protein analytes in serum.
generically dependent continuant;fluorescent reporter intensity;A measurement datum that represents the output of a scanner measuring the intensity value for each fluorescent reporter.
process;intracellular cytokine staining assay measuring epitope specific interleukin-21 production by T cells;A flow cytometry assay that detects interleukin-21 production by T cells.
material entity;enrichment culture medium;A culture medium that is designed to favor the growth of a particular microorganism or cells over others, enriching a sample for the microorganism or cells of interest.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific monocyte chemotactic protein-1 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects monocyte chemotactic protein-1 production by T cells.
generically dependent continuant;case series design;A study design that samples only subjects who have experienced a particular event (outcome or exposure). Such a design, in contrast to a cohort study, does not permit calculation of absolute risk as non-case subjects are not included.
process;ELISA measuring epitope specific monocyte chemotactic protein-1 production by T cells;An enzyme-linked immunosorbent assay that detects monocyte chemotactic protein-1 production by T cells.
process;massively parallel reporter assay;An assay in which multiplexing the construction and interrogation of larger libraries of reporter constructs allows measurement of the transcriptional regulatory activities of thousands to hundreds of thousands of DNA sequences.
process;assay measuring epitope specific chemokine (C-C motif) ligand 4 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-C motif) ligand 4 production by T cells.
process;in vivo assay measuring a T cell epitope specific response after adoptive transfer of epitope specific T cells;An efficacy of T cell epitope intervention experiment that is performed after adoptive transfer of epitope specfic T cells.
process;ELISA measuring epitope specific interleukin-21 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-21 production by T cells.
process;in vivo assay measuring a B cell epitope specific response after adoptive transfer of epitope specific antibodies or B cells;An efficacy of B cell epitope intervention experiment that is performed after adoptive transfer of epitope specific antibodies or B cells.
process;in vivo assay measuring T cell epitope specific disease exacerbation resulting from the adoptive transfer of epitope specific T cells;An efficacy of T cell epitope intervention experiment that uses a disease exacerbation in vivo intervention experiment after adoptive transfer of epitope specfic T cells.
process;in vivo skin test assay measuring T cell epitope specific type IV hypersensitivity;An efficacy of T cell epitope intervention experiment that detects epitope specific type IV hypersensitivity.
material entity;vacuum-assisted biopsy needle;A core biopsy needle integrated with a vacuum system which facilitates the collection of specimen material.
process;cytometric bead array assay measuring epitope specific interleukin-13 production by T cells;A cytometric bead array assay that detects interleukin-13 production by T cells.
role;material supplier role;a role realized through the process of supplying materials such as animal subjects, reagents or other materials used in an investigation.
role;regulatory role;a role which inheres in material entities and is realized in the processes of making, enforcing or being defined by legislation or orders issued by a governmental body.
role;regulation-assigned role;Regulation-assigned role is a regulatory role defined by legislation or governmental orders
generically dependent continuant;biological feature identification objective;Biological feature identification objective is an objective role carried out by the proposition defining the aim of a study designed to examine or characterize a particular biological feature.
role;regulator role;a regulatory role involved with making and/or enforcing relevant legislation and governmental orders
process;assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response resulting from the adoptive transfer of epitope specific T cells;A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance a T cell response after adoptive transfer of epitope specfic T cells.
process;in vivo assay measuring epitope specific T cell killing resulting from the adoptive transfer of epitope specific T cells;An in vivo cell killing assay that detects the killing of an antigen presenting cell (APC) by a T cell whose TCR recognizes an epitope presented by the APC after adoptive transfer of epitope specific T cells.
process;planned process;A process that realizes a plan which is the concretization of a plan specification.
process;cell culture analyte detection bioassay measuring epitope specific granulocyte macrophage colony-stimulating factor production by T cells;A reporter cell line analyte detection bioassay that detects granulocyte macrophage colony stimulating factor production by T cells.
process;ELISA measuring epitope specific perforin release by T cells;An enzyme-linked immunosorbent assay that detects epitope specific perforin release by T cells.
generically dependent continuant;list-mode data file;A list-mode data file is a binary digital entity where events are stored sequentially, parameter by parameter.
process;cytometric bead array assay measuring epitope specific tumor necrosis factor alpha production by T cells;A cytometric bead array assay that detects tumor necrosis factor alpha production by T cells.
process;nested polymerase chain reaction;A polymerase chain reaction with modification intended to reduce non-specific binding in products due to the amplification of unexpected primer binding sites. The nested polymerase chain reaction (PCR) involves the use of two primer sets and two successive PCR reactions. The first set of primers are designed to anneal to sequences upstream from the second set of primers and are used in an initial PCR reaction.
role;contract research organization role;a worker role of carrying out the study according to the protocol document or study plan delivered by the PI, under the control of the study director. This role cannot make decisions about the study execution
process;ELISPOT assay measuring epitope specific interleukin-17 production by T cells;An enzyme-linked immunospot assay that detects interleukin-17 production by T cells.
process;immunoelectrophoresis;An electrophoresis that separates and characterize proteins based on reaction with antibodies.
process;counter current immunoelectrophoresis;An electrophoresis in which antigen and antibody move in opposite directions and form precipitates in the area between the cells where they meet in concentrations of optimal proportions.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interferon-beta production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interferon-beta production by T cells.
process;ligase detection reaction;A linear amplification that uses a thermostable ligase to amplify a piece of DNA. Because the enzyme retains activity after multiple thermal cycles, the ligations may be repeated to linearly increase product.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific granulocyte macrophage colony-stimulating factor production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects granulocyte macrophage colony stimulating factor production by T cells.
process;loop-mediated isothermal amplification;An enzymatic amplification in which a piece of DNA is amplified at a constant temperature of 60 - 65 degree C using either two or three sets of primers and a polymerase with high strand displacement activity in addition to a replication activity. This amplification does not need thermal cyclers and may be a low cost alternative to PCR.
generically dependent continuant;post-transcriptional modification design;A study design in which a modification of the transcriptome, proteome (not genome) is made, for example RNAi, antibody targeting.
generically dependent continuant;detection of pathogenic organisms objective;An organism feature identification objective that aims to detect whether an organism contains pathogenic organisms.
process;ELISA measuring epitope specific interleukin-8 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-8 production by T cells.
role;centrifuge pellet role;pellet role is a role which inheres in a material entity and is realized by a material separation process using gravitational force generated by a centrifuge in which the material bearing the pellet role is the heavier or heaviest component of the output material..
role;cytological stain role;A dye role that is realized when the stain is used to colour cells and or cellular components for the purposes of visualization
role;reference substance role;a role inhering in a material entity that is realized when characteristics or responses elicited by the substance are used for comparison or reference.
process;pseudovirus entry assay;An assay that measures the entry in target cells of reporter viral particles that express an envelope protein of a different virus of interest.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interferon-gamma production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interferon-gamma production by T cells.
material entity;glass bottle;A container with a narrow neck that is made of glass.
generically dependent continuant;classified data set;A data set that is produced as the output of a class prediction data transformation and consists of a data set with assigned class labels.
process;epitope specific tumor necrosis factor superfamily cytokine production by T cells;A process of tumor necrosis factor superfamily cytokine production by T cells resulting from the recognition of a T cell epitope.
material entity;glass bottle coated with insecticides;A glass bottle that coated with material designed to control insects.
generically dependent continuant;allele information;a genetic alteration information that about one of two or more alternative forms of a gene or marker sequence and differing from other alleles at one or more mutational sites based on sequence. Polymorphisms are included in this definition.
process;short interspersed nuclear elements polymerase chain reaction;A polymerase chain reaction that amplifies short interspersed nuclear elements (SINEs).
role;clinical research coordinator role;a worker role comprised of handling the administrative duties of a trial or study.
generically dependent continuant;genetic alteration information;a genetic characteristics information that is about known changes or the lack thereof from the genetic background, including allele information, duplication, insertion, deletion, etc.
process;insecticide resistance assay;An assay that aims to detect the presence and/or frequency of resistance to insecticides in an organism or organism population.
generically dependent continuant;cellular process design;A study design that aims to study the processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
process;insecticide resistance by monitoring known mutations assay;An insecticide resistance assay that detects, in a population, presence and frequency of mutant alleles for previously characterized mutations with insecticide resistance phenotypes.
process;epitope specific RANTES production by T cells;A process of RANTES production by T cells resulting from the recognition of a T cell epitope.
process;insecticide resistance by detecting enzyme activity assay;An insecticide resistance assay that is based on determination the catalytic activity of an enzyme associated with insecticide resistance phenotypes.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-10 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-10 production by T cells.
process;insecticide resistance bioassay;An insecticide resistance assay that is typically conducted to measure the effects of a substance on a living organism.
process;cytometric bead array assay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;A cytometric bead array assay that detects tumor necrosis factor superfamily cytokine production by T cells.
process;insecticide resistance by detecting alpha esterase activity assay;An insecticide resistance by detecting enzyme activity assay that measures activity of alpha esterase.
generically dependent continuant;wild type allele information;an allele information that is about the allele found most frequently in natural populations, or in standard laboratory stocks for a given organism.
material entity;chromatography column;Chromatography column in chemistry is a tube and contents (typically glass) used to purify individual chemical compounds from mixtures of compounds. It is often used for preparative applications on scales from micrograms up to kilograms.
generically dependent continuant;insecticide resistance detection objective;An organism feature identification objective that aims to detect insecticide resistance of an insect.
process;cytometric bead array assay measuring epitope specific interleukin-6 production by T cells;A cytometric bead array assay that detects interleukin-6 production by T cells.
material entity;arthropod meal of blood specimen;A specimen of the blood ingested by an arthropod.
process;transcription profiling by RT-PCR assay;A transcription profiling assay that uses reverse transcription PCR (RT-PCR).
process;polymerase chain reaction assay;An assay that uses polymerase chain reaction technique to amplify DNA.
role;supernatant role;supernatant role is a role which inheres in a material entity and is realized by a material separation process using gravitational force in which the material bearing the supernatant role is the liquid component of the output material.
process;epitope specific chemokine (C-C motif) ligand 4 production by T cells;A process of chemokine (C-C motif) ligand 4 production by T cells resulting from the recognition of a T cell epitope.
process;restriction fragment length polymorphism assay;An assay that uses digestion of DNA with specific restriction enzymes followed by gel electropheresis to detect differences in the sizes of the generated fragments that are due to genetic differences (polymorphisms) in homologous sequences.
process;assay measuring epitope specific interleukin-23 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-23 production by T cells.
process;DNA fingerprinting assay;An assay to identify a specific individual organism from a DNA specimen by looking at unique patterns in their DNA.
process;xenotransplantation;is the transplantation of living cells, tissues or \norgans from one species to another such as from pigs to humans
process;intracellular cytokine staining assay measuring epitope specific interleukin-3 production by T cells;A flow cytometry assay that detects interleukin-3 production by T cells.
material entity;pump valve switch;A pump valve switch is a cardinal part of a liquid chromatography instrument that controls the flow.
generically dependent continuant;organism status comparison design;A study design that compares samples from live and dead organisms.
role;drug role;a role borne by a molecular entity and is realized in a process of absorption by an organism alters, or effects (or is assumed to effect) a function(s) which inhere in an organism
process;ELISA measuring epitope specific chemokine (C-C motif) ligand 4 production by T cells;An enzyme-linked immunosorbent assay that detects chemokine (C-C motif) ligand 4 production by T cells.
process;cytometric bead array assay measuring epitope specific interferon-gamma production by T cells;A cytometric bead array assay that detects interferon-gamma production by T cells.
material entity;mass spectrometer;A mass spectrometer is an instrument which is used to measure the mass to charge ratio of ions. All mass spectrometers consist of three basic parts: an ion source, a mass analyzer, and a detector system. The stages within the mass spectrometer are: 1. Production of ions from the sample 2. Separation of ions with different masses 3. Detection of the number of ions of each mass produced 4.Collection of data to generate the mass spectrum
material entity;chromatography device;A device that facilitates the separation of mixtures. The function of a chromatography device involves passing a mixture dissolved in a "mobile phase" through a stationary phase, which separates the analyte to be measured from other molecules in the mixture and allows it to be isolated.
process;intracellular cytokine staining assay measuring epitope specific chemokine (C-C motif) ligand 4 production by T cells;A flow cytometry assay that detects chemokine (C-C motif) ligand 4 production by T cells.
material entity;processed material;Is a material entity that is created or changed during material processing.
process;epitope specific granzyme B production by T cells;A process of granzyme B production by T cells resulting from the recognition of a T cell epitope.
process;waiting;A planned process where an agent does not take any new actions towards a particular objective for a period of time until a set of conditions is met.
process;epitope specific interleukin-8 production by T cells;A process of interleukin-8 production by T cells resulting from the recognition of a T cell epitope.
material entity;physical document;A physical document is an object serving as a record of information by means of symbolic marks.
generically dependent continuant;injury design;A study design in which the response of an organism(s) to injury or damage is studied.
material entity;Illumina NovaSeq 6000;A DNA sequencer which is manufactured by the Illumina corporation, with two flow cells and an output of up to 6000 Gb (32-40 B reads per run). The sequencer utilizes synthesis technology and patterned flow cells to optimize throughput and even spacing of sequencing clusters.
process;cytometric bead array assay measuring epitope specific interleukin-2 production by T cells;A cytometric bead array assay that detects interleukin-2 production by T cells.
process;single-cell RNA sequencing assay;An RNA sequencing assay that uses RNA extracts as input that can be traced to a single cell of origin.
process;cell culture analyte detection bioassay measuring epitope specific interleukin-16 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-16 production by T cells.
material entity;PacBio Sequel;A DNA sequencer built upon single molecule real-time sequencing technology, optimized for generation with long reads and high consensus accuracy, and manufactured by the Pacific Biosciences corporation
process;ELISA measuring epitope specific macrophage inflammatory protein-1 alpha production by T cells;An enzyme-linked immunosorbent assay that detects macrophage inflammatory protein-1 alpha production by T cells.
material entity;PacBio Sequel II;A DNA sequencer built upon single molecule real-time sequencing technology, optimized for generation of highly accurate ("HiFi") long reads, and which is manufactured by the Pacific Biosciences corporation.
process;intracellular cytokine staining assay measuring epitope specific granulocyte macrophage colony-stimulating factor production by T cells;A flow cytometry assay that detects granulocyte macrophage colony stimulating factor production by T cells.
process;in vivo assay measuring B cell epitope specific disease exacerbation resulting from the adoptive transfer of epitope specific antibodies or B cells;An efficacy of B cell epitope intervention experiment that uses a disease exacerbation in vivo intervention experiment after adoptive transfer of epitope specific antibodies or B cells.
process;RNAi profiling by array assay;An assay in which double stranded RNA is synthesized with a sequence complementary to a gene(s) of interest and introduced into a cell or organism, where it is recognized as exogenous genetic material and activates the RNAi pathway resulting in knockdown of the transcripts and providing a means to study downstream changes in gene expression.
process;in vivo assay measuring T cell epitope specific disease reduction resulting from the adoptive transfer of epitope specific T cells;An efficacy of T cell epitope intervention experiment that detects a decrease in disease after adoptive transfer of epitope specfic T cells.
generically dependent continuant;genotype information;a genetic characteristics information that is about the genetic material of an organism and minimally includes information about the genetic background and can in addition contain information about specific alleles, genetic modifications, etc.
process;in vivo assay measuring B cell epitope specific disease reduction resulting from adoptive transfer of epitope specific antibodies or B cells;An efficacy of B cell epitope intervention experiment that detects a decrease in disease after adoptive transfer of epitope specific antibodies or B cells.
generically dependent continuant;RNA stability design;A study design that examines the stability and/or decay of RNA transcripts.
process;in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells;An efficacy of T cell epitope intervention experiment that uses a epitope protection experiment after adoptive transfer of epitope specfic T cells.
material entity;tiling microarray;A DNA microarray which has short fragments of nucleic acid immobilized on a substrate. These are designed to cover the whole genome of the target species. Tiling arrays are used to determine genome binding in ChIP assays or to identify transcribed regions.
process;in vivo assay measuring B cell epitope specific protection from challenge resulting from adoptive transfer of epitope specific antibodies or B cells;An efficacy of B cell epitope intervention experiment that uses a epitope protection experiment after adoptive transfer of epitope specific antibodies or B cells.
process;assay measuring epitope specific IP-10 production by T cells;A T cell epitope specific cytokine production assay that detects IP-10 production by T cells.
process;in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on pathogen burden;An in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using pathogen burden.
process;intracellular cytokine staining assay measuring epitope specific interleukin-13 production by T cells;A flow cytometry assay that detects interleukin-13 production by T cells.
process;in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on pathogen burden;An in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using pathogen burden.
generically dependent continuant;species comparison design;A study design that assays differences between distinct species.
process;in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells based on survival;An in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells using survival.
process;X-ray crystallography assay determining the 3D structure of a T cell epitope:MHC:TCR complex;A X-ray crystallography 3D molecular structure determination assay that characterizes the 3-dimensional molecular structure of a T cell epitope:MHC:TCR complex.
process;in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival;An in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using survival.
process;in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on tumor burden;An in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells using tumor burden.
generically dependent continuant;transcription profiling by RT-PCR design;A study design which aims to examine the transcriptome of a biological sample by reverse transcription PCR (RT-PCR).
process;in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on tumor burden;An in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using tumor burden.
process;epitope specific T cell enhancement of B cell mediated immune response;A process of T cell enhancement of B cell mediated immune response resulting from the recognition of a T cell epitope.
process;in vivo assay measuring T cell epitope specific tolerance induction resulting from the adoptive transfer of epitope specific T cells;An efficacy of T cell epitope intervention experiment that uses a tolerance induction intervention experiment after adoptive transfer of epitope specfic T cells.
process;ELISA measuring epitope specific chemokine (C-C motif) ligand 1 production by T cells;An enzyme-linked immunosorbent assay that detects chemokine (C-C motif) ligand 1 production by T cells.
process;in vivo assay measuring B cell epitope specific tolerance induction resulting from the adoptive transfer of epitope specific antibodies or B cells;An efficacy of B cell epitope intervention experiment that uses a tolerance induction intervention experiment after adoptive transfer of epitope specific antibodies or B cells.
process;epitope specific interleukin-21 production by T cells;A process of interleukin-21 production by T cells resulting from the recognition of a T cell epitope.
process;Giemsa stain assay;An assay that uses a Giemsa stain to characterize cells.
process;flow cytometry assay measuring cell-cell binding of a T cell epitope:MHC:TCR complex;A flow cytometry assay that measures the cell-cell binding of an epitope:MHC complex binding with a T cell receptor.
material entity;individual organism specimen;A specimen composed of an individual organism to be studied in an investigation.
process;proteomic profiling by array assay;An assay that detects proteins in a sample (quantified or otherwise analyzed), e.g. antibody profiling using an array based technology.
process;blood microbiology assay;An organism detection assay that detects microorganisms in a blood specimen.
process;cell culture analyte detection bioassay measuring epitope specific interferon-gamma production by T cells;A reporter cell line analyte detection bioassay that detects interferon-gamma production by T cells.
process;image guided biopsy;A biopsy which uses an imaging procedure to guide a needle biopsy.
process;computed tomography assisted biopsy;A needle biopsy guided by real-time computed tomography (CT) scan images.
process;ELISPOT assay measuring epitope specific granzyme B release by T cells;An enzyme-linked immunospot assay that detects epitope specific granzyme B release by T cells.
process;ultrasound-guided needle biopsy;A needle biopsy guided by ultrasound visualization.
generically dependent continuant;microRNA profiling by array design;A study design in which a microRNA array is used to analyse the microRNA component of the transcriptome.
process;needle biopsy;A biopsy that uses a hollow needle to extract cells.
process;in vivo assay measuring T cell epitope specific tolerance induction;An efficacy of T cell epitope intervention experiment that uses a tolerance induction intervention experiment.
process;fine needle aspiration biopsy;A biopsy that uses a thin needle to extract cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific RANTES production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects RANTES production by T cells.
process;core needle biopsy;A biopsy that uses a hollow tube to collect a core of tissue.
process;cytometric bead array assay measuring epitope specific interleukin-4 production by T cells;A cytometric bead array assay that detects interleukin-4 production by T cells
process;surgical biopsy;A biopsy involving a surgical incision into an organism to access the biopsy material.
process;assay measuring epitope specific lymphotoxin A production by T cells;A T cell epitope specific cytokine production assay that detects lymphotoxin A production by T cells.
process;biopsy;A specimen collection that obtains a sample of tissue or cell from a living multicellular organism body for diagnostic purposes by means intended to be minimally invasive.
generically dependent continuant;organism development design;A study design that assays events associated with development. Development applies to organism(s) acquiring a mature state.
generically dependent continuant;family history design;A study design in which the family history such as traits, characteristics, susceptibility to disease is studied.
generically dependent continuant;transcription profiling identification objective;A molecular feature identification objective that aims to characterize the abundance of transcripts
process;bone marrow biopsy;A biopsy where a small amount of bone and a small amount of fluid and bone marrow are collected.
process;DNA methylation profiling by array assay;A DNA methylation profiling assay in which the methylation state of DNA is determined and can be compared between samples using array technology
process;skinpunch biopsy;A biopsy that involves the collection of a cylinder of skin (including epidermis, dermis and superficial fat) using a punch tool.
process;assay measuring epitope specific macrophage inflammatory protein-1 alpha production by T cells;A T cell epitope specific cytokine production assay that detects macrophage inflammatory protein-1 alpha production by T cells.
process;cytometric bead array assay measuring epitope specific interleukin-15 production by T cells;A cytometric bead array assay that detects interleukin-15 production by T cells.
process;epitope specific granulocyte colony stimulating factor production by T cells;A process of granulocyte colony stimulating factor production by T cells resulting from the recognition of a T cell epitope.
process;cytometric bead array assay measuring epitope specific interleukin-16 production by T cells;A cytometric bead array assay that detects interleukin-16 production by T cells.
process;microRNA profiling by array assay;An assay that analyses the microRNA component of the transcriptome using a microRNA array.
process;in vivo assay measuring B cell epitope specific induction of hypersensitivity resulting from the adoptive transfer of epitope specific antibodies or B cells;An efficacy of B cell epitope intervention experiment that detects a hypersensitivity response by monitoring skin reactions after adoptive transfer of epitope specific antibodies or B cells.
generically dependent continuant;quality control testing design;A study design in which some aspects of the experiment is quality controlled for the purposes of quality assurance.
process;in vivo skin test assay measuring T cell epitope specific type IV hypersensitivity resulting from the adoptive transfer of epitope specific T cells;An efficacy of T cell epitope intervention experiment that detects epitope specific type IV hypersensitivity after adoptive transfer of epitope specfic T cells.
generically dependent continuant;clinical history design;A study design that the organism's clinical history of diagnosis, treatments, e.g. vaccinations, surgery etc. is studied.
process;in vivo assay measuring epitope specific proliferation of T cells resulting from the adoptive transfer of epitope specific T cells;A T cell epitope specific proliferation assay that is performed in vivo after adoptive transfer of epitope specfic T cells.
process;assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response resulting from the adoptive transfer of epitope specific T cells;A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance an antibody response after adoptive transfer of epitope specfic T cells.
role;role of being consumer safety officer;the role of a human being that is realized by enforcing regulations to ensure consumer safety
process;abdominal wall fat pad biopsy;A biopsy involving the collection of a small part of the abdominal wall fat pad.
process;ELISA measuring epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;An enzyme-linked immunosorbent assay that detects chemokine (C-X-C motif) ligand 9 production by T cells.
process;tail biopsy;A biopsy involving the collection of the tip of a mamallian tail.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-4 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-4 production by T cells.
process;DEPC structure mapping assay;A single-nucleotide-resolution nucleic acid structure mapping assay which determines nucleic acid secondary structure at a nucleotide resolution scale using DEPC as reagent and chemical probe
quality;secondary structure of RNA molecule;
material entity;total RNA extract;A RNA extract that is the output of an extraction process in which total celluar and organelle RNA molecules are isolated from a specimen.
material entity;protein extract;a protein extract is the output of an extraction process from tissues or cell cultures resulting in a solution of cellular and/or organellar proteins in buffer solution used to prevent degradation,
process;real time polymerase chain reaction assay;An assay, based on the PCR, that amplifies and simultaneously quantifies a specific DNA molecule based on the use of complementary probes/primers. It enables both detection and quantification (as absolute number of copies or relative amount when normalized to DNA input or additional normalizing genes) of one or more specific sequences in a DNA sample.
process;Southern blot assay;An analyte assay that detects the presence of a specific sequence in a DNA sample, which has been digested by restriction enzymes, resolved by gel electrophoresis, and blotted to a solid support, followed by hybridization of a probe raised against a specific sequence and detected with fluorescence or radioactivity.
process;cell proliferation assay;A cytometry assay which measures the degreee to which input cells are replicating.
material entity;organellar RNA extract;A RNA extract that is the output of an extraction process in which RNA molecules found in an organelle, e.g., mitochondrion, ER, or chloroplast, excluding the nucleus, are extracted.
process;collecting specimen with swab;A specimen collection process that uses a swab as the collection device. A swab is an absorbent material (e.g. cotton) on a rod (e.g., wooden stick).
generically dependent continuant;demultiplexed sequence data;Sequence data in which an identifier subsequence has been used to categorize each reads by source.
generically dependent continuant;multiplexed sequence data;Sequence data from a sequence library generated from at least two different sources, where each read in the sequence data includes base calls from a multiplex identifier sequence that can be used to trace the source of the read to its source.
material entity;areolar swab specimen;A specimen that is collected with a swab from the surface of an areola of a breast.
material entity;breast swab specimen;A specimen that is collected with a swab from the surface of a breast.
material entity;cheek swab specimen;A specimen that is collected with a swab from the cheek portion of the inside surface of a mouth.
material entity;nasopharyngeal swab specimen;A specimen that is collected with a swab from the surface of a nasopharynx.
material entity;oral swab specimen;A specimen that is collected with a swab from the inside surface of a mouth.
material entity;oropharyngeal swab specimen;A specimen that is collected with a swab from the surface of a oropharynx.
material entity;rectal swab specimen;A specimen that is collected with a swab from the surface of a rectum.
material entity;tongue swab specimen;A specimen that is collected with a swab from the surface of a tongue.
material entity;vagina swab specimen;A specimen that is collected with a swab from the surface of a vagina.
material entity;fecal swab specimen;A specimen that is collected with a swab from the surface of a feces.
material entity;environmental swab specimen;A specimen that is collected with a swab from the surface of an environmenal material.
generically dependent continuant;birth cohort study design;A cohort study design for which the subjects are followed from the time of birth usually including information about gestation and follow up.
generically dependent continuant;disease specific study design;A study design for which material and information is collected from subjects that have already developed a particular disease.
generically dependent continuant;genealogical record;A document about the family relationships of persons related as members of a domestic group linked through descent from a common ancestor, marriage, or adoption.
generically dependent continuant;national registry;An information content entity that contains information about a nationwide group of individuals.
generically dependent continuant;national biomedical registry;A national registry that contains information about individuals that was accumulated for a biomedical purpose, such as diagnoses, treatments, or outcomes.
process;site-directed mutagenesis;An induced mutation in which a specific base change is programmed into the sequence of a synthetic primer.
process;random mutagenesis;An induced mutation that produces a random mutation, either by introducing the organism to mutagens, or through a process such as error-prone PCR.
process;reconstitution assay;An assay in which a cellular process is replicated from the bottom-up using isolated components in order to observe how the components work together.
process;in vitro transcription reconstitution assay;A reconstitution assay in which RNA synthesis is investigated using RNA polymerase II transcription systems replicated in vitro from their base components.
process;whole metagenome sequencing assay;A DNA sequencing assay that intends to provide information on the DNA sequences of multiple genomes (a metagenome) from different organisms present in the same input sample.
generically dependent continuant;case-control study design;A study design that entails the creation of two types of roles, such that each participant under investigation bears one or the other. What distinguishes the two types of roles is an 'outcome', which is associated with participants that have the case role but not associated with participants that have the control role. A case-control study examines the hypothesis that the presence of the outcome in case participants is associated with an 'exposure' that is not associated with control participants.
process;gene knockdown;A genetic transformation which reduces the expression of a specific gene or genes in an organism.
process;RNAi gene knockdown;A gene knockdown that silences genes through artificially-induced RNA interference. This is accomplished by introducing small double-stranded interfering RNA complementary to the target mRNA to be silenced, which is then cleaved by a ribonuclease.
material entity;ribosomal RNA-depleted RNA extract;An extract of RNA which is produced through rRNA (ribosomal RNA) depletion (the removal of highly abundant rRNA species).
process;RNAi knockdown assay;A gene knockdown assay in which RNAi gene knockdown is used to disrupt gene transcripts.
process;direct RNA sequencing assay;An assay to study transcription through direct RNA sequence determination, without prior conversion of RNA molecules to cDNA.
process;cell-cell binding detection by flow cytometry assay;A binding assay which uses a flow cytometer to detect pairs of cells that are bound to each other by staining them with different fluorescent labels.
generically dependent continuant;sequence data;A measurement datum that representing the primary structure of a macromolecule(it's sequence) sometimes associated with an indicator of confidence of that measurement.
material entity;fresh specimen;a specimen that is output of a specimen creation process used for an investigation without storage.
generically dependent continuant;scalar score from composite inputs;A measurement datum which is the result of combining multiple datum. For example, a mean or summary score.
process;in container assay;An assay in which a measurement is made by observing entities located in a container.
process;paraffin storage;a storage process with input organism or anatomical entity and paraffin and output material embedded in paraffin for long term storage
generically dependent continuant;handedness categorical measurement datum;A datum used to record the answer to a self assessment of whether a person uses their left hand, right hand primarily or each hand equally
generically dependent continuant;growth condition intervention design;A study design in which the independent variable is the environmental condition in which the specimen is growing
generically dependent continuant;dose;A measurement datum that measures the quantity of something that may be administered to an organism or that an organism may be exposed to. Quantities of nutrients, drugs, vaccines and toxins are referred to as doses.
process;intranasal mucosal administration;The administration of a substance into the intranasal mucosis of an organism
material entity;computed tomography scanner;An image acquisition device that generates a three-dimensional image of the inside of an object from a large series of two-dimensional X-ray images taken around a single axis of rotation.
material entity;agar stab specimen;a specimen that is output of a process that cell culture inoculated into agar for long term storage.
material entity;PCR instrument;A device that is used to amplify a single or few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence.
material entity;growth environment;The collection of material entities and their qualities that are located near a live organism, tissue or cell and can influence its growth.
generically dependent continuant;device creation objective;an objective which aims to create a device with a specified function
process;administration of material to specimen;The directed combination of a material entity with a specimen.
process;intravenous injection;is the injection of a material entity (bearing the administered substance role) into the vein (bearing the target role) of an organism using a syringe
generically dependent continuant;service provision objective;An objective which is fulfilled by the provision of some service e.g. a training service
process;DNA sequencing service;A DNA sequencing process provided as a service - which is the realization of some DNA sequencing in which the service provider role is realized.
generically dependent continuant;Edinburgh score;A score that measures the dominance of a person's right or left hand in everyday activities.
material entity;electron microscope;A microscope that produces an image of an object by targeting it with an electron beam
process;insecticide resistance by detecting beta esterase activity assay;An insecticide resistance by detecting enzyme activity assay that measures activity of beta esterase.
process;insecticide resistance by detecting acetylcholinesterase activity assay;An insecticide resistance by detecting enzyme activity assay that measures activity of acetylcholinesterase.
process;insecticide resistance by detecting glutathione S-transferase activity assay;An insecticide resistance by detecting enzyme activity assay that measures activity of glutathione S-transferase (GST).
process;insecticide resistance by detecting carboxylic ester hydrolase activity assay;An insecticide resistance by detecting enzyme activity assay that measures activity of carboxylic ester hydrolase using p-nitrophenyl acetate as a substrate.
process;insecticide resistance by detecting mixed-function oxidase assay;An insecticide resistance by detecting enzyme activity assay that measures whether mixed-function oxidase activity present.
process;direct insecticide resistance bioassay;An insecticide resistance bioassay without the use of any synergist.
process;topical application insecticide resistance bioassay;An insecticide resistance bioassay by adding insecticide directly to the thorax of the insect.
process;direct insecticide resistance diagnostic assay;A direct insecticide resistance assay that at preset insecticide dosage scoring mortality to determine resistance of a population.
process;insecticide resistance dose response assay;A direct insecticide resistance assay in which an insect population is exposed to a range of insecticide dosage scoring mortality to determine resistance.
process;insecticide resistance time response assay;A direct insecticide resistance assay to determine resistance as a consequence of the time of exposure to insecticide.
process;study intervention;A planned process that is the part of the execution of an intervention design study which is varied between two or more subjects in the study.
material entity;calorimeter;A measurement device that is used to calculate the heat flow of a chemical reaction or physical change.
process;training process;a process that achieves a training objective
generically dependent continuant;categorical measurement datum;A measurement datum that is reported on a categorical scale.
material entity;micromanipulator;A device that is used to physically interact with a sample under a microscope, where a level of precision of movement is necessary that cannot be achieved by the unaided human hand.
process;intramuscular injection;is the injection of a material entity (bearing the administered substance role) into the muscle (bearing the target role) of an organism using a syringe
material entity;positron emission tomography scanner;A device that produces a three-dimensional image or picture of functional processes in the body. It detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule.
material entity;material separation device;A device with a separation function realized in a planed process
process;intradermal injection;is the injection of a material entity (bearing the administered substance role) into the dermis (bearing the target role) of an organism using a syringe
role;service consumer role;a role which inheres in a person who uses a service
material entity;optical microscope;A microscope that produces an image of an object by targeting it with an electro-magnetic beam in the visible frequency range
role;accessed material role;is realized in a planned process where the bearer participates
material entity;oscilloscope;A device that measures and displayes signal voltages, usually as a two-dimensional graph of one or more electrical potential differences (vertical axis) plotted as a function of time or of some other voltage (horizontal axis).
role;service provider role;is a role which inheres in a person or organization and is realized in in a planned process which provides access to training, materials or execution of protocols for an organization or person
function;sterilization function;a function to remove viable organisms from an input material
material entity;vibration isolation table;A device that supports another device such as a precision instrument by isolating it from vibration that is transmitted from the floor.
process;handedness assay;An assay that measures the unequal distribution of fine motor skill between the left and right hands typically in human subjects by means of some questionnaire and scoring procedure.
process;chemical cleavage;chemical cleavage is a protocol application relying on a chemical compound to cause the fragmentation of an input material that is susceptible to that chemical agent
material entity;processed specimen;A specimen that has been intentionally physically modified.
process;oral administration;An administering substance in vivo into the mouth of an organism
generically dependent continuant;compound treatment design;an intervention design in which the treatment is the administration of a compound
material entity;paraffin specimen;a specimen that is output of a paraffin storage process in which specimen is embedded in paraffin
material entity;vibrotome;A preparation device that uses a vibrating razor blade to cut through tissue.
process;self reported handedness assessment;An assay where a person makes a statement that indicates what handedness he has from a choice of different categories.
material entity;electrode puller;A device used in the first step in making electrodes, that applies constant tension on a glass capillary tube and eventually breaks it while heating it. this produces a very fine point on the capillary tube.
process;subcutaneous injection;is the injection of a material entity (bearing the administered substance role) into the hypodermis (bearing the target role) of an organism using a syringe
process;in live cell assay;An assay in which a measurement is made by observing entities located in a live cell.
generically dependent continuant;categorical label;A label that is part of a categorical datum and that indicates the value of the data item on the categorical scale.
generically dependent continuant;training objective;An objective specification which is fulfilled by the provision of some training.
function;addition of molecular tracer function;A reagent application function that is realized when a molecular tracer, such as an antibody or probe is automatically transferred to a biological specimen.
function;reagent application function;A function that is realized when a reagent is automatically added to some research material.
generically dependent continuant;dose specification;a directive information entity that describes the dose that will be administered to a target
material entity;device;A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.
material entity;container;A device that can be used to restrict the location of material entities over time
process;in live organism assay;An assay in which a measurement is made by observing entities located in an organism.
material entity;lyophilized specimen;a specimen that is output of a lyophilization storage process in which specimen is lyophilized for storage.
process;potassium(1+) concentration assay;A potassium(1+) assay that measures the concentration of potassium(1+) in a specimen.
process;metamyelocyte count assay;A metamyelocyte assay that measures the number of metamyelocytes in a specimen.
process;lymphocyte percentage assay;A lymphocyte assay that measures the percentage of lymphocytes in a specimen.
process;methemoglobin percentage assay;A methemoglobin assay that measures the percentage of methemoglobin in a specimen.
process;metamyelocyte percentage assay;A metamyelocyte assay that measures the percentage of metamyelocytes in a specimen.
process;myelocyte count assay;A myelocyte assay that measures the number of myelocytes in a specimen.
process;monocyte percentage assay;A monocyte assay that measures the percentage of monocytes in a specimen.
process;phosphate ion concentration assay;A phosphate ion assay that measures the concentration of phosphate ions in a specimen.
process;neutrophil percentage assay;A neutrophil assay that measures the percentage of neutrophils in a specimen.
process;reticulocyte percentage assay;A reticulocyte assay that measures the percentage of reticulocytes in a specimen.
process;thyroid stimulating hormone concentration assay;A thyroid stimulating hormone assay that measures the concentration of thyroid stimulating hormone in a specimen.
process;sodium(1+) concentration assay;A sodium(1+) assay that measures the concentration of sodium(1+) in a specimen.
process;3,3',5'-triiodothyronine concentration assay;A 3,3',5'-triiodothyronine assay that measures the concentration of 3,3',5'-triiodothyronine in a specimen.
process;triglyceride concentration assay;A triglyceride assay that measures the concentration of triglycerides in a specimen.
process;free thyroxine concentration assay;A thyroxine assay that measures the concentration of free thyroxine in a specimen.
process;fibrinogen concentration assay;A fibrinogen assay that measures the concentration of fibrinogen in a specimen.
process;total thyroxine concentration assay;A thyroxine assay that measures the concentration of total thyroxine in a specimen.
process;induced hemagglutination;The clumping or clustering of red blood cells caused by certain viruses, antibodies, or other substances
generically dependent continuant;sequence feature annotation;Information about a sequence region
process;reporter cell line analyte detection bioassay;An analyte assay in which a cell line whose growth is known to be affected by the presence of a specific type of material (the anlyte) is cultured in the presence of an input material (the evaluant) in order to detect presence of the analyte in the evaluant.
process;in vitro cell killing assay;A cell killing assay that measures if and how many target cells are actively killed by other cells in a cell culture.
material entity;post mortem specimen;a specimen that was taken from a dead organism
process;indirect bilirubin concentration assay;A bilirubin IXalpha assay that measures the concentration of indirect bilirubin in a specimen.
process;direct bilirubin concentration assay;A bilirubin IXalpha assay that measures the concentration of direct bilirubin in a specimen.
material entity;cloacal specimen;A specimen obtained by inserting a swab deeply into the vent of the cloaca of an organism and vigorously swabbing the wall. The swab should be deeply stained with fecal material and is then placed in transport medium.
material entity;labeled DNA extract;a labeled specimen that is the output of a labeling process and has grain labeled DNA to be able to detect DNA in future experiments.
process;supplying;A planned process with the objective to provide material entities to be used in an investigation.
process;mean cell hemoglobin assay;A hemoglobin assay that measures the average concentration of hemoglobin in a population of erythrocytes.
process;total bilirubin concentration assay;A bilirubin IXalpha assay that measures the concentration of total bilirubin in a specimen.
process;mean platelet volume assay;A platelet assay that measures the average volume of platelets in a specimen.
process;mean cell hemoglobin concentration assay;A hemoglobin assay that measures the concentration of hemoglobin in a specimen.
process;immature neutrophil percentage assay;An neutrophil assay that measures the percentage of immature neutrophils in a specimen.
process;immature neutrophil count assay;A neutrophil assay that measures the number of immature neutrophils in a specimen.
process;mean cell volume assay;An erythrocyte assay that measures the average volume of erythrocytes in a specimen.
process;nucleated erythrocyte percentage assay;An erythrocyte assay that measures the percentage of nucleated erythrocytes in a specimen.
material entity;nasal swab specimen;A specimen obtained using a cotton swab on a stick, passed up the nostril to obtain a sample of exudate and epithelial debris for microbiological or cellular examination.
process;flow cytometry assay;A cytometry assay in which an input cell population is put in solution, is passed by a laser, and optical sensors are used to detect scattering of the laser light and/or fluorescence of specific markers to count and characterize the particles in solution.
process;freezing storage;A storage process in temperature that maintenance the frozen status of the stored entities.
material entity;nasopharyngeal aspirate specimen;A speciemn which derives from nasopharyngeal mucosa after aspiration.
process;promoter activity detection by reporter gene assay;An assay in which the activity of a promoter in a cell is monitored by using a reporter gene that was inserted in a genomic location under control of the promoter and whose expression can be easily detected based on qualities or functions of the gene.
process;erythrocyte assay;A cytometry assay that measures the abundance and/or characteristics of erythrocytes.
process;X-ray crystallography 3D molecular structure determination assay;A 3D molecular structure determination assay in which the diffraction of pattern of X-ray beams in a crystal of purified material entities is used to resolve the 3-dimensional structure of the material entity of interest.
process;real time reverse-transcription polymerase chain reaction assay;An assay that uses a reverse transcription step (an RNA strand is reverse transcribed into its DNA complement using the enzyme reverse transcriptase) before a PCR assay.
process;adiponectin assay;An analyte assay that measures the abundance of adiponectin
process;radio immuno assay;An assay in which a radioactive labeled antigen or antibody is used to determine the interaction between an antigen and its receptor. This can be used to detect the presence of an antigen of interest in an input sample or determine the specificity of an input antibody.
process;manual hematocrit assay;A hematocrit assay that measures the percentage of erythrocytes in a specimen by manual processes.
process;animal euthanization;A process in which is the end of life of animal is brought about in accordance with local regulations on treatment of animal subjects and using a method which causes minimal pain and distress to the animal subject
material entity;Dulbecco's modified Eagle medium;A culture medium containing iron, phenol red, amino acids, salts, glucose and vitamins.
process;cytometric bead array assay;An analyte assay in which a series of beads coated with antibodies, antigens, or other small molecules are used to detect an analyte of interest.
process;creatine assay;An analyte assay that measures the abundance of creatine
process;adiponectin concentration assay;An adiponectin assay that measures the concentration of adiponectin in a specimen.
process;estradiol assay;An analyte assay that measures the abundance of estradiol
process;creatine concentration assay;A creatine assay that measures the concentration of creatine in a specimen.
process;estradiol concentration assay;An estradiol assay that measures the concentration of estradiol in a specimen.
function;material combination function;A material separation function is a function that decreases the resolution between two or more material entities.
process;lyophilization storage;a storage process with input material entity and output freeze dried material for long time storage
material entity;infectious agent;is a material entity bearing the disposition to infect an organism
material entity;labeled specimen;A specimen that has been modified in order to be able to detect it in future experiments
process;surface plasmon resonance binding assay;A binding assay that uses the detection of electromagnetic waves in a surface to detect material entities adsorbed to the surface, which change the local optical index of refraction.
material entity;frozen specimen;A specimen that has been frozen in order to store it.
material entity;labeled RNA extract;a labeled specimen that is the output of a labeling process and has grain labeled RNA to be able to detect RNA in future experiments.
process;mosaicism with repeat frameshift genetic sparse labeling;A 3D neural cell structure determination assay where sparse and stochastic methods are used to label genetically-defined neurons.
role;participant under investigation role;A role that is realized through the execution of a study design in which the bearer of the role participates and in which data about that bearer is collected.
process;neuron morphology assay;A 3D neural cell structure determination assay that determines the 3-dimensional configuration of a neuron.
generically dependent continuant;protocol testing objective;Protocol testing objective is a methodology testing objective role describing a study designed to examine the effects of using different protocols.
process;B cell epitope assay;An immune epitope assay that characterizes the structrue of an antibody-epitope complex, or measures the binding of an antibody receptor to epitope, or the immune response process resulting from such a binding event or the recognition of the epitope.
process;neuron morphology reconstruction assay;A neuron morphology assay where the morphology or structure of a neuron is represented. Often, this assay is a combination of different assays (sparse labelling, fluorescent labeling, fMOST).
process;material processing;A planned process which results in physical changes in a specified input material
process;chemical mutagenesis;A form of random mutagenesis that produces a mutation by introducing the organism to a chemical mutagen.
role;patient role;a role which inheres in a person and is realized by the process of being under the care of a physician or health care provider
process;T cell epitope assay;An immune epitope assay that characterizes the structrue of an epitope-T cell receptor complex, or measures the binding of a T cell receptor to epitope, or the immune response process resulting from such a binding event or the recognition of the epitope.
role;role of certified IRB professional;a role of which inheres in a Homo sapiens and realized during administration and oversight of the daily activities of Institutional Review Boards (IRBs) in the USA
role;detector reagent role;a role which inheres in a molecular entity and is realized by the process of recording or registering a stimulus.
material entity;MHC:ligand complex;A complex of molecular entities which is the result of a MHC molecule binding with a ligand.
material entity;epitope:MHC:TCR complex;A complex of molecular entities which is the result of a T cell receptor binding to a MHC-epitope complex.
process;3D neural cell structure determination assay;A 3D cell structure determination assay that determines the 3-dimensional configuration of a neural cell.
process;3D cell structure determination assay;A 3D structure determination assay that determines the 3-dimensional configuration of a cell.
process;transgenic mutagenesis;A form of random mutagenesis that produces a mutation by introducing a construct into the genome of an organism in a random or semi-random fashion.
process;zinc finger mediated mutagenesis;An endonuclease mediated mutagenesis in which synthetic zinc-finger proteins designed to target specific DNA sequences are used to introduce a mutation at a specific location in the genome.
process;enhancer-trap mutagenesis;A transgenic mutagenesis that produces a mutation by introducing a construct designed to monitor transcriptionally active regions when inserted into the genome of an organism by inserting a reporter gene that requires cis-acting DNA sequences in the genome to activate reporter gene expression.
process;gene-trap mutagenesis;A transgenic mutagenesis that produces a mutation by introducing a construct designed to capture the expression of an endogenous gene by creating a spliced fusion transcript when inserted into the genome of an organism.
process;targeted mutagenesis;A directed mutation in which a construct is used to introduce a mutation into a specific genome location through homologous recombination.
process;irradiation mutagenesis;A form of random mutagenesis that produces a random mutation by exposing the organism to radiation.
process;endonuclease mediated mutagenesis;A directed mutagenesis in which guide RNAs and an endonuclease (cas9, TALEN) are used to introduce a mutation at a specific location in a gene.
process;directed mutagenesis;An induced mutation in which a specific gene(s) or part of a gene(s) is altered.
process;TALEN mediated mutagenesis;An endonuclease mediated mutagenesis in which guide RNAs and transcription activator-like effector nucleases (TALENs) are used to introduce a mutation at a specific location in the genome.
process;cas mediated mutagenesis;An endonuclease mediated mutagenesis in which guide RNAs and cas are used to introduce a mutation at a specific location in the genome.
process;assay measuring quantitative binding of an epitope:MHC:TCR complex;An assay that detects the binding of a MHC:epitope complex with a T cell receptor, and produces a quantitative measurement of the binding as an output.
process;assay measuring quantitative binding of an antigen:antibody complex;An assay that detects the binding of an antigen with an antibody, and produces a quantitative measurement of the binding as an output.
process;basophil percentage assay;A basophil assay that measures the percentage of basophils in a specimen.
process;albumin concentration assay;An albumin assay that measures the concentration of albumin in a specimen.
generically dependent continuant;categorical binding datum;A binding datum that is expressed as a categorical value.
process;transposon-induced mutagenesis;A random mutagenesis in which expression of a transposase causes the mobilization of an artificial or modified transposable element with the insertion of the element into the genome creating a mutation.
generically dependent continuant;EC50 binding datum;A quantitative binding datum that is expressed as a half-maximal effective concentration (EC50).
generically dependent continuant;quantitative binding datum;A binding datum that is expressed using numbers.
process;assay measuring quantitative binding of a MHC:ligand complex;An assay that detects the binding of a MHC molecule with a ligand, and produces a quantitative measurement of the binding as an output.
generically dependent continuant;IC50 binding datum;A quantitative binding datum that is expressed as a half-maximal inhibitory concentration (IC50).
process;iron concentration assay;An iron assay that measures the concentration of iron cation in a specimen.
process;high-density lipoprotein cholesterol concentration assay;A high-density lipoprotein cholesterol assay that measures the concentration of high-density lipoprotein cholesterol in a specimen.
process;low-density lipoprotein cholesterol concentration assay;A low-density lipoprotein cholesterol assay that measures the concentration of low-density lipoprotein cholesterol in a specimen.
process;calcium cation concentration assay;A calcium cation assay that measures the concentration of calcium cations in a specimen.
process;cholesterol concentration assay;A cholesterol assay that measures the concentration of cholesterol in a specimen.
process;chloride concentration assay;A chloride assay that measures the concentration of chloride in a specimen.
process;eosinophil percentage assay;An eosinophil assay that measures the percentage of eosinophils in a specimen.
process;creatinine concentration assay;A creatinine assay that measures the concentration of creatinine in a specimen.
process;hemoglobin concentration assay;A hemoglobin assay that measures the amount of hemoglobin in a specimen.
process;globulin concentration assay;A globulin assay that measures the concentration of globulin in a specimen.
generically dependent continuant;p-value;A quantitative confidence value that represents the probability of obtaining a result at least as extreme as that actually obtained, assuming that the actual value was the result of chance alone.
process;leptin assay;An analyte assay that measures the abundance of leptin
role;study group role;a study population role where the bearer is a population of material entities and the role is realized in the implementation of a study design wherein the entities bearing the study population role are observed or subjected to intervention according to the study design and are biological replicates, i.e. they receive the same treatment under the protocol
process;lipoprotein concentration assay;An analyte assay that measures the abundance of lipoprotein
generically dependent continuant;parameter threshold;A measurement datum measuring the minimal signal that must be detected to generate an electrical event, as compared to the maximal detected signal in a flow cytometer instrument. The datum has a qualitative role
process;leptin concentration assay;An leptin assay that measures the concentration of leptin in a specimen.
process;autotransplantation;is the transplantation of tissue from one part of \nthe body to another in the same individual. )
process;low-density lipoprotein concentration assay;A lipoprotein concentration assay that measures the concentration of low-density lipoprotein in a specimen.
process;high-density lipoprotein concentration assay;A lipoprotein concentration assay that measures the concentration of high-density lipoprotein in a specimen.
process;luteinizing hormone assay;An analyte assay that measures the abundance of luteinizing hormone
process;very-low-density lipoprotein concentration assay;A lipoprotein concentration assay that measures the concentration of very-low-density lipoprotein in a specimen.
process;luteinizing hormone concentration assay;A luteinizing hormone assay that measures the concentration of luteinizing hormone in a specimen.
generically dependent continuant;protocol optimization objective;Protocol optimization is a protocol testing objective role describing a study designed to identify the best protocol. This may be carried out by comparing different protocols or by modifying the parameters used within a single protocol.
process;phospholipid concentration assay;A phospholipid assay that measures the concentration of phospholipids in a specimen.
process;imaging assay;An assay that produces a picture of an entity.
process;phospholipid assay;An analyte assay that measures the abundance of phospholipid
process;progesterone concentration assay;A progesterone assay that measures the concentration of progesterone in a specimen.
process;progesterone assay;An analyte assay that measures the abundance of progesterone
process;NMR 3D molecular structure determination assay;A 3D molecular structure determination assay that uses magnetic properties of atomic nuclei to determine the 3D structure and dynamics of molecules in the input sample.
process;testosterone concentration assay;A testosterone assay that measures the concentration of testosterone in a specimen.
material entity;population;a population is a collection of individuals from the same taxonomic class living, counted or sampled at a particular site or in a particular area
process;testosterone assay;An analyte assay that measures the abundance of testosterone
process;bile salt concentration assay;A bile salt assay that measures the concentration of bile salt in a specimen.
process;bile salt assay;An analyte assay that measures the abundance of bile salt
role;role of pathology review board;a worker role comprised of providing a confirmed and consensus diagnosis for histopathology results obtained during the investigation
process;nitrite concentration assay;A nitrite assay that measures the concentration of nitrite in a specimen.
process;nitrite assay;An analyte assay that measures the abundance of nitrite
process;follicle stimulating hormone assay;An analyte assay that measures the abundance of follicle stimulating hormone
role;role of impartial witness;a role which inheres in a Homo sapiens and is realized during a clinical trial - the impartial witness is independent of the trial and cannot be unfairly influenced by people involved with the trial
process;insulin concentration assay;A insulin assay that measures the concentration of insulin in a specimen.
process;total lymphocyte count assay;A lymphocyte assay that measures the number of lymphocytes and large unstained cells in a specimen.
process;follicle stimulating hormone concentration assay;A follicle stimulating hormone assay that measures the concentration of follicle stimulating hormone in a specimen.
process;fluorescent immunospot assay;A cytometry assay that detects the presence of cells that secrete a material of interest (analyte). In the assay, a plate is coated with an antibody specific to the analyte of interest. These antibodies capture the analytes secreted by the cells. The analytes are then detected using fluorescent labeled secondary antibodies.
material entity;microtiter plate;A microtiter plate is a flat plate with multiple wells used as small test tubes.
process;total lymphocyte percentage assay;A lymphocyte assay that measures the percentage of lymphocytes and large unstained cells in a specimen.
process;plasma proteomics assay;A proteomics profiling assay that detects proteins in a blood plasma specimen.
process;fatty acid assay;An analyte assay that measures the abundance of fatty acid
process;insulin assay;An analyte assay that measures the abundance of insulin
role;biological replicate role;a reference participant role realized by equivalent treatment of participants
process;free fatty acid concentration assay;A fatty acid assay that measures the concentration of free fatty acids in a specimen.
process;lung assay;An assay that has a lung specimen as evaluant.
process;induced sputum assay;An assay that has an induced sputum specimen as evaluant.
process;feces assay;An assay that has a feces specimen as evaluant.
process;milk assay;An assay that has a milk specimen as evaluant.
process;saliva assay;An assay that has a saliva specimen as evaluant.
process;umbilical cord blood assay;An assay that has an umbilical cord blood specimen as evaluant.
process;leukapheresis;A blood harvesting process in which white blood cells are separated from a blood specimen.
process;T cell activation induced marker assay;A flow cytometry assay that detects the presence/amount of antigen-specific T cells without the need to identify their cytokine production. Instead, antigen-specific T cells are detected on the basis of upregulation of TCR stimulation-induced surface markers.
process;endotracheal aspirate assay;An assay that has an endotracheal aspirate specimen as evaluant.
process;cerebrospinal fluid assay;An assay that has a cerebrospinal fluid specimen as evaluant.
generically dependent continuant;molecular feature identification objective;Molecular feature identification objective is a biological feature identification objective role describing a study designed to examine or characterize molecular features of a biological system, e.g. expression profiling, copy number of molecular components, epigenetic modifications.
process;transcription profiling by array assay;A transcription profiling assay that uses array technology.
material entity;reusable patient gown;A patient gown intended to be reused after being laundered.
generically dependent continuant;strain comparison design;A study design that assays differences between multiple strains, cultivars, serovars, isolates, lines from organisms of a single species.
material entity;disposable patient gown;A patient gown intended for a single period of continuous use and then disposed of.
process;assay measuring epitope specific monocyte chemotactic protein-1 production by T cells;A T cell epitope specific cytokine production assay that detects monocyte chemotactic protein-1 production by T cells.
material entity;medical gown;A personal protective clothing item which is a gown worn by a medical professional in order to provide a barrier between patient and professional.
process;intracellular cytokine staining assay measuring epitope specific interleukin-12 production by T cells;A flow cytometry assay that detects interleukin-12 production by T cells.
material entity;apron;A garment which is worn over other clothing and covers mainly the front of the body.
process;in vivo assay measuring T cell epitope specific disease exacerbation;An efficacy of T cell epitope intervention experiment that uses a disease exacerbation in vivo intervention experiment.
material entity;surgical gown;A medical gown which is subjected to a sterilization process and which is intended to be worn by a medical professional during surgical procedures.
material entity;cell specimen;A specimen primarily composed of a cell or cells collected from a multicellular organism or a cell culture.
material entity;personal protective glove;A personal protective device which is a glove.
process;monospecific T cell recognition assay measuring MHC ligand processing and presentation;A MHC ligand processing and presentation assay in which the presence of a specific ligand in an eluate is detected using the response of T cells that are known to be monospecific for that ligand as a readout.
material entity;incubator;A device in which environmental conditions (light, photoperiod, temperature, humidity, etc.) can be controlled
material entity;N95 respirator;A face mask that meets the U.S. National Institute for Occupational Safety and Health (NIOSH) N95 classification of air filtration, meaning that it filters at least 95% of incoming airborne particles.
generically dependent continuant;hardware testing objective;Hardware testing objective is a methodology testing objective role describing a study designed to examine the effects of using different hardware, e.g. scanner.
generically dependent continuant;genetic modification design;A study design in which an organism(s) is studied that has had genetic material removed, rearranged, mutagenized or added, such as in a knock out.
material entity;face shield;A personal protective device used to protect the wearer's entire face (or part of it) from hazards such as flying objects and road debris, chemical splashes, or alternately potentially infectious materials.
process;ELISA measuring epitope specific granzyme B release by T cells;An enzyme-linked immunosorbent assay that detects epitope specific granzyme B release by T cells.
material entity;patient gown;A personal protective clothing item which is a gown designed for use by a patient to facilitate caregiving by medical staff.
process;epitope specific IP-10 production by T cells;A process of IP-10 production by T cells resulting from the recognition of a T cell epitope.
material entity;scrubs;A personal protective clothing item which is sterilized and which is worn by a health care professional. It can reference a shirt and pants or dress, and depending on medical protocol, may include a medical cap.
process;lowess group transformation;A lowess transformation where a potentially different normalization curve is generated and used for two or more groups (delineated by some criteria). criteria could include blocks (e.g. print-tip groups) on an array, or the day on which mass spectrometry was performed.
process;in vivo assay measuring T cell epitope specific protection from infectious challenge based on pathogen burden;An in vivo assay measuring T cell epitope specific protection from pathogen challenge using pathogen burden.
process;phage display binding assay;A binding assay in which a collection of phages expressing a library of different peptides or protein fragnments is used to infect cells, followed by screening for cells that bind a protein of interest, and identifiying the sequence of infecting phages to determine a suitable binding partner.
process;lowess transformation;A data transformation of normalizing ratio data by using a locally weighted polynomial regression (typically after a log transformation). The regression can be performed on log ratios resulting from the relation of two data sets versus the average log intensity data from the same two data sets or it can be performed on raw or log transformed values from one data set versus values from another. The goal could be to remove intensity-dependent dye-specific effects from the set of pair wise ratios. This method can be applied globally, or limited by one or more specified criteria.
process;mass spectrometry assay measuring MHC ligand processing and presentation;A MHC ligand processing and presentation assay that uses a mass spectrometry assay to identify eluted ligands
material entity;specimen from organism;A specimen that derives from an anatomical part or substance arising from an organism. Examples of tissue specimen include tissue, organ, physiological system, blood, or body location (arm).
material entity;supernatant collection system harvesting frame;A device that is designed for collecting 90% of the supernatant in a microplate well and separating the living cell with no stress, eliminating centrifugation and other similar techniques. It can be used in a variety of release assays with different radioactive isotopes, such as Cr51 or I125.
process;epitope specific interleukin-17F production by T cells;A process of interleukin-17F production by T cells resulting from the recognition of a T cell epitope.
role;pathologist role;a worker role of being responsible for making the histopathology diagnoses associated with data from a study. this activity occurs outside the study timeline
process;T cell epitope specific immune intervention;An epitope specific immune intervention in which the induced response targets a T cell epitope
role;role of independent data monitoring committee;a trial monitor role charged recommending whether to continue, modify, or end the trial
material entity;specimen with known storage state;A specimen for which it is known whether it has been subjected to storage of a specified type.
role;baseline participant role;a reference participant role which is realized by making the reference to qualities at the start of the study or intervention
process;in vivo assay measuring T cell epitope specific protection after tumor burden challenge;An in vivo assay measuring T cell epitope specific protection from tumor challenge using tumor burden.
process;cell co-culturing;A material combination in which cell cultures of two or more different types are are combined and allowed to culture as one.
material entity;purified MHC molecule preparation;A mixture containing MHC molecules that was purified to remove non-MHC molecular entities.
disposition;disposition to be bound by an MHC protein complex;Is the disposition borne by a material entity that is realized in a process of being bound in the antigen binding grove of an MHC protein complex.
material entity;filter paper;A device manufacture with the intent to provide a porous unsized paper used for filtering.
process;B cell epitope specific immune intervention;An epitope specific immune intervention in which the induced response targets a B cell epitope
process;epitope tolerance induction experiment;An efficacy of epitope intervention experiment that tests the ability of the intervention to decrease an existing immune response
process;mass spectrometry assay measuring MHC ligand processing and presentation of MHC ligands eluted from cellular MHC;A mass spectrometry of MHC ligands assay that identifies eluted ligands from cell bound MHC.
generically dependent continuant;eSource document;an eSource document is a digital document consisting of a logical collection of Source data and other eSource documents that can be presented in an ordered way and capture the time of completion, change, and any signatures
process;phage display library panning;Phage display library panning is a process in which a diverse collection of phages encoding peptides or proteins are screened and the ones encoding active peptides/proteins are selected in an iterative process similar to natural selection.
process;lowess global transformation;A lowess transformation where the same normalization curve is used for all members of the data set. e.g. Features on an array, picked spots on a gel, or measured metabolites in a sample.
process;intracellular cytokine staining assay measuring epitope specific transforming growth factor-beta production by T cells;A flow cytometry assay that detects transforming growth factor-beta production by T cells.
process;cell collecting;A planned process that collects cells from culture.
role;role of Institutional Review Board;the role of a organization that is realized by members reviewing study designs for their agreement with regulations
process;assay measuring T cell epitope specific in vivo activity;A T cell epitope dependent biological activity determination assay that uses an in vivo intervention experiment.
material entity;clonal cDNA library;Mixed population of cDNAs (complementaryDNA) made from mRNA from a defined source, usually a specific cell type. This term should be associated only to nucleic acid interactors not to their proteins product. For instance in 2h screening use living cells (MI:0349) as sample process. ALT DEF (PRS):: a cDNA library is a collection of host cells, typically E.Coli cells but not exclusively. modified by transfer of plasmid DNA molecule used as vector containing a fragment or totality of cDNA molecule (the insert) . cDNA library may have an array of role and applications.
process;intracellular cytokine staining assay measuring epitope specific interleukin-22 production by T cells;A flow cytometry assay that detects interleukin-22 production by T cells.
role;radiolabel role;a molecular label role which inheres in a material entity which is realized by the process of radioactivity detection
process;assay measuring epitope specific perforin release by T cells;A T cell epitope specific cytotoxic T cell degranulation assay that detects perforin release by T cells.
role;complete nutrient role;A nutrient role that inheres in a material entity and is realized in the use of that material entity by an organism to provide all needed nourishment.
material entity;atmosphere;A growth environment pertaining to the atmospheric conditions that is used to culture or grow an organism.
role;crossover population role;a role realized when a participant serves as reference to itself
process;binding assay using fluorescence detection;A binding assay that uses fluorescence detection as an indicator of binding.
process;cytometric bead array measuring epitope specific granulocyte macrophage colony-stimulating factor production by T cells;A cytometric bead array assay that detects granulocyte macrophage colony stimulating factor production by T cells.
role;placebo role;a negative reference substance is a reference role in which the substance playing the reference substance role is physically similar in appearance to the test substance
process;binding assay using radioactivity detection;A binding assay that uses radioactivity detection as an indicator of binding.
process;in vivo assay measuring T cell epitope specific protection based on survival;An in vivo assay measuring T cell epitope specific protection from other challenge using survival.
generically dependent continuant;electronic case report form;An electronic case report form is a digital document used to record all of the protocol required information to be reported for each trial subject. An eCRF has the property that it can be audited and compliant with requirements of 21 CFR Part 11.
process;cell bound MHC competitive binding assay of a MHC:ligand complex using T cell epitope recognition;A cell bound MHC binding assay that uses a T cell epitope recognition assay.
process;linear amplification;An enzymatic amplification which amplifies nucleic acid sequence by making many copies off the same template.
process;in vivo assay measuring epitope specific T cell helper activity;A T cell epitope dependent biological activity assay that detects the ability of epitope specific helper T cells to enhance either B cell or T cell adaptive immune response function.
material entity;Oxford Nanopore MinION;A portable DNA sequencer which is manufactured by the Oxford Nanopore Technologies corporation, that uses consumable flow cells producing up to 30 Gb of DNA sequence data per flow cell. The sequencer produces real-time results and utilizes nanopore technology with up to 512 nanopore channels in the sensor array.
process;epitope specific helper T cell enhancement of T cell mediated immune response;A process of helper T cell enhancement of T cell mediated immune response resulting from the recognition of a T cell epitope.
material entity;Oxford Nanopore GridION Mk1;A DNA sequencer that is manufactured by the Oxford Nanopore Technologies corporation, that can run and analyze up to five individual flow cells producing up to 150 Gb of data per run. The sequencer produces real-time results and utilizes nanopore technology with the option of running the flow cells concurrently or individually.
process;epitope specific interferon-beta production by T cells;A process of interferon-beta production by T cells resulting from the recognition of a T cell epitope.
material entity;Oxford Nanopore PromethION;A DNA sequencer that is manufactured by the Oxford Nanopore Technologies corporation, capable of running up to 48 flow cells and producing up to 7.6 Tb of data per run. The sequencer produces real-time results and utilizes Nanopore technology, with each flow cell allowing up to 3,000 nanopores to be sequencing simultaneously.
generically dependent continuant;organism part comparison design;A study design that compares tissues, regions, organs within or between organisms
process;PRO-cap;Precision nuclear run-on and sequencing to detect Pol II initiation sites
process;intracellular material detection measuring epitope specific granzyme B release by T cells;A flow cytometry assay that detects epitope specific granzyme B release by T cells
material entity;cDNA library;A collection of DNA molecules with sequences complementary to a specified set of mRNA molecules and commonly developed by enzymatic reverse transcription.
generically dependent continuant;protein binding site identification design;A study design that investigates protein binding sites on nucleic acids.
generically dependent continuant;ordinal value specification;A categorical value specification in which the available categories were created with an explicit order.
generically dependent continuant;sex comparison design;A study design that assays differences associated with an organism's sex, gender or mating type.
generically dependent continuant;transcription profiling by tiling array design;A study design in which gene expression on a genome-wide basis is evaluated, without bias toward coding or noncoding regions, using tiling arrays containing oligonucleotides that are either overlapping or spaced at regular intervals.
process;ribosomal RNA-depleted RNA sequencing assay;An RNA-seq assay in which highly abundant ribosomal RNAs are removed from total RNA before sequencing, resulting in more efficient transcript/gene detection.
generically dependent continuant;cell differentiation design;A study design that assays events associated with cell development or differentiation.
generically dependent continuant;transcription profiling design;A study design that identifies forms and abundance of transcripts in the genome.
process;lipid profiling assay;An analyte assay assay that detects and identifies lipids resulting from biochemical and cellular metabolism.
process;single-nucleus ATAC-seq;An ATAC-seq assay in which single nuclei are isolated from frozen tissue samples, through a protocol designed to maximally preserve nucleus integrity during sample processing and optimize transposase-mediated fragmentation of chromatin in individual nuclei.
generically dependent continuant;operon identification design;A study design that identifies locations and members of operons in a genome.
process;16s ribosomal gene sequencing assay;An amplicon sequencing assay in which the amplicon is derived from universal primers used to amplify the 16S ribosomal RNA gene from isolate bacterial genomic DNA or metagenomic DNA from a microbioal community. Resulting sequences are compared to reference 16S sequence databases to identify or classify bacteria present within a given sample.
process;radio immuno assay measuring epitope specific interferon-gamma production by T cells;A radio immuno assay that detects interferon-gamma production by T cells.
process;single-cell ATAC-seq;An ATAC assay designed to robustly map the accessible genome of individual cells, using sequencing integrated into a programmable microfluidics platform, in order to provide insights into cell-to-cell variation in accessibility profiles.
process;microbiome protein expression profiling assay;A protein expression profiling assay of microbial proteins extracted from a microbioal community of mixed species from a given microbiome.
generically dependent continuant;DNA methylation profiling by high throughput sequencing design;A study design in which the methylation state of DNA is determined and is compared between samples using high throughput sequencing technology.
process;cytokine assay;An analyte assay to study presence, concentration, or amount of cytokines.
process;assay measuring epitope specific granzyme B release by T cells;A T cell epitope specific cytotoxic T cell degranulation assay that detects granzyme B release by T cells.
process;amplicon sequencing assay;A sequencing assay in which a DNA or RNA input molecule is amplified by PCR and the product sequenced.
process;intracellular cytokine staining assay measuring epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;A flow cytometry assay that detects chemokine (C-X-C motif) ligand 9 production by T cells.
process;whole virome sequencing assay;A whole metagenome sequencing assay that intends to provide information on multiple genome sequences from different viruses present in the same input sample.
process;transplantation;a protocol application to replace an organ or tissue of an organism
role;principal investigator role;a responsible party role played by a person responsible for the overall conduct of a study
role;responsible party role;a study personnel role played by a party who is accountable for the execution of a study component and can make decisions about the conduct of the study
generically dependent continuant;measured expression level;A measurement datum that is the outcome of the quantification of an assay for the activity of a gene, or the number of RNA transcripts.
process;metatranscriptome sequencing assay;An RNA-seq assay that determines the RNA sequence of microbial transcripts from a microbioal community of mixed species from a given microbiome.
process;ELISA measuring epitope specific macrophage inflammatory protein-1 gamma production by T cells;An enzyme-linked immunosorbent assay that detects macrophage inflammatory protein-1 gamma production by T cells.
generically dependent continuant;karyotype information;A genetic characteristics information that is about the number and appearance of chromosomes in the nucleus of an eukaryotic cell.
process;epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;A process of chemokine (C-X-C motif) ligand 9 production by T cells resulting from the recognition of a T cell epitope.
generically dependent continuant;proteomic profiling by array design;A study design in which proteins in a sample are detected, quantified or otherwise analysed, through an array-based technology.
generically dependent continuant;presence or over-threshold value specification;An ordinal value specification that indicates that either a) an analyte or mesaurand is present in an evaluant, or b) that the amount of analyte/measurand detected is over some predetermined threshold.
generically dependent continuant;q-value;A quantitative confidence value that measures the minimum false discovery rate that is incurred when calling that test significant. To compute q-values, it is necessary to know the p-value produced by a test and possibly set a false discovery rate level.
process;single-value binding of antibody with reporter to antigen assay;An assay that detects the linking of antigens and antibodies via special signaling mechanisms, such as EIA, ELISA, chemiluminescence, etc. that produces one measure (quantitative or qualitative) of the analyte of interest
material entity;platelet-poor plasma specimen;A blood plasma specimen that is the output of some platelet-poor plasma preparation and is the portion of plasma that contains fewer than 10,000 platelets per microliter.
generically dependent continuant;genotyping design;A study design that classifies an individual or group of individuals on the basis of alleles, haplotypes, SNPs.
process;platelet-poor plasma preparation process;A material component separation process in which (1) whole blood is first centrifuged to separate red blood cells from blood plasma, which forms the supernatant, and (2) the blood plasma is then centrifuged to separate platelets from the plasm.
process;assay measuring epitope specific interleukin-2 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-2 production by T cells.
process;cytometry analysis by automated gating;A gating in which the output of a flow- or mass- cytometry experiment is separated into gates that were set by an algorithm in order to quantify the frequency of different cell populations of interest.
process;epitope specific interleukin-15 production by T cells;A process of interleukin-15 production by T cells resulting from the recognition of a T cell epitope.
process;cytometry analysis by manual gating;A gating in which the output of a flow- or mass- cytometry experiment is separated into gates that were set by a human operator in order to quantify the frequency of different cell populations of interest.
process;epitope specific macrophage inflammatory protein-1 gamma production by T cells;A process of macrophage inflammatory protein-1 gamma production by T cells resulting from the recognition of a T cell epitope.
material entity;tracheal aspirate specimen;A specimen that is collected with a suctioning tube from the trachea.
generically dependent continuant;individual genetic characteristics comparison design;A study design where genotype, haplotype, or other individual genetic characteristics are compared.
material entity;mid-turbinate nasal swab specimen;A specimen that is collected with a mid-turbinate nasal swab from the turbinate area of the nasal cavity.
process;Bernoulli trial;An assay where the output data is a datum with one of two values denoting success and failure.
role;worker role;a personnel role played by a party who executes a component of the study plan. this can occur before, during, after or outside the study timeline
generically dependent continuant;intervention design;An intervention design is a study design in which a controlled process applied to the subjects (the intervention) serves as the independent variable manipulated by the experimentalist. The treatment (perturbation or intervention) defined can be defined as a combination of values taken by independent variable manipulated by the experimentalists are applied to the recruited subjects assigned (possibly by applying specific methods) to treatment groups. The specificity of intervention design is the fact that independent variables are being manipulated and a response of the biological system is evaluated via response variables as monitored by possibly a series of assays.
generically dependent continuant;sequence feature identification objective;Sequence feature identification objective is a biological feature identification objective role describing a study designed to examine or characterize molecular features exhibited at the level of a macromolecular sequence, e.g. nucleic acid, protein, polysaccharide.
role;specimen role;a role borne by a material entity that is gained during a specimen collection process and that can be realized by use of the specimen in an investigation
generically dependent continuant;partial karyotype information;A karyotype information that is about the structural variation of partial genome rather than whole genome.
role;pH indicator dye role;the role of a dye that is realized when the dye is used in an experiment to measure the pH in a material entity
generically dependent continuant;all pairs design;A study design in which all specimens are compared to every other specimen.
generically dependent continuant;full karyotype information;A karyotype information that is about the structural variation of the whole genome.
generically dependent continuant;number of particles in subset;A measurement datum measuring the number of subjects in a defined subset in a flow cytometer instrument. The datum has a qualitative role
generically dependent continuant;gene list;A data set of the names or identifiers of genes that are the outcome of an analysis or have been put together for the purpose of an analysis.
process;assay measuring epitope specific interleukin-1 beta production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-1 beta production by T cells.
process;cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor alpha production by T cells;A reporter cell line analyte detection bioassay that detects tumor necrosis factor alpha production by T cells.
material entity;lower respiratory tract specimen;A specimen that is derived from the lower respiratory tract.
process;intracellular cytokine staining assay measuring epitope specific lymphotoxin A production by T cells;A flow cytometry assay that detects lymphotoxin A production by T cells.
material entity;anterior nasal swab specimen;A specimen that is derived from the anterior nasal wall
generically dependent continuant;pathogenicity design;A study design in which an infective agent such as a bacterium, virus, protozoan, fungus etc. infects a host organism(s) and the infective agent is assayed.
process;aspiration specimen collection;Procedure using suction, usually with a thin needle and syringe, to remove bodily fluid or tissue.
process;ELISPOT assay measuring epitope specific interleukin-5 production by T cells;An enzyme-linked immunospot assay that detects interleukin-5 production by T cells.
material entity;personal protective device;A device which is a wearable garment designed to protect the wearer's body from injury or infection.
process;assay measuring epitope specific macrophage inflammatory protein-1 gamma production by T cells;A T cell epitope specific cytokine production assay that detects macrophage inflammatory protein-1 gamma production by T cells.
material entity;face mask;A personal protective device worn over the nose and mouth as a respiratory filter to inhibit the flow of particles.
process;cytometric bead array assay measuring epitope specific interleukin-8 production by T cells;A cytometric bead array assay that detects interleukin-8 production by T cells.
material entity;non-medical mask;A face mask not manufactured according to medical equipment standards.
material entity;medical mask;A face mask manufactured according to a recognized medical equipment standard.
process;assay measuring epitope specific chemokine (C-X-C motif) ligand 9 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-X-C motif) ligand 9 production by T cells.
generically dependent continuant;number of lost events electronic;A measurement datum measuring the number of analysis events lost due to errors in data acquisition electronic coincidence in a flow cytometer instrument. The datum has a qualitative role.
material entity;nasal aspirate specimen;A specimen that is collected with a suctioning tube from the nasal cavity.
process;assay measuring epitope specific interleukin-4 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-4 production by T cells.
material entity;lower respiratory tract aspirate specimen;A specimen that is collected with a suctioning tube from the lower respiratory tract.
process;assay measuring epitope specific interleukin-6 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-6 production by T cells.
material entity;upper respiratory specimen;A specimen that is derived from the upper respiratory tract
role;calibration substance role;A reference substance role that is realized when characteristics or responses elicited by the bearer are used to ensure an instrument is within protocol specification of accuracy or performance
process;Centre for Disease Control and Prevention bottle bioassay;A direct insecticide resistance diagnostic assay performs in a glass bottle coated with insecticides for detecting resistance to insecticides in vector populations.
process;WHO cone kit diagnostic assay;A direct insecticide resistance diagnostic assay uses WHO cone kit.
process;WHO paper kit diagnostic assay;A direct insecticide resistance diagnostic assay uses WHO paper kit.
process;WHO larvicide diagnostic assay;A direct insecticide resistance diagnostic assay tests survival of larvae in a medium supplemented with insecticide.
process;insecticide resistance dose response by bottle assay;An insecticide resistance dose response assay that performs in a glass bottle coated with insecticides.
process;insecticide resistance dose response by survival of larvae assay;An insecticide resistance dose response assay that tests survival of larvae in a medium supplemented with insecticide.
process;insecticide resistance dose response by WHO paper kit assay;An insecticide resistance dose response assay using WHO paper kit.
process;insecticide resistance time response by bottle assay;An insecticide resistance time response assay that is performed in a glass bottle coated with insecticides, with the presence of a synergist.
process;insecticide resistance time response by WHO paper kit assay;An insecticide resistance time response assay using WHO paper kit, with the presence of a synergist.
process;insecticide resistance by amplification refractory mutation system assay;An insecticide resistance by monitoring known mutations assay that detects any mutation involving single base changes or small deletions using amplification refractory mutation system (ARMS). The ARMS is based on the use of sequence-specific PCR primers that allow amplification of test DNA only when the target allele is contained within the sample. Following an ARMS reaction the presence or absence of a PCR product is diagnostic for the presence or absence of the target allele. It can be used to analyze human genomic DNA for one or more mutations.
process;insecticide resistance by primer introduced restriction analysis PCR assay;An insecticide resistance by monitoring known mutations assay that detects Single Nucleotide Polymorphisms (SNPs) using PCR technique and mismatched primers that is close to the mutation of interest and digested the PCR productions using restriction enzymes.
process;insecticide resistance by nested polymerase chain reaction assay;An insecticide resistance by monitoring known mutations assay that detects gene mutation based on nested polymerase chain reaction technique.
process;insecticide resistance by ligase detection reaction assay;An insecticide resistance assay that is based on monitoring known mutations using ligase detection reaction exquisitely discriminate between a mismatched and complementary DNA helix.
process;insecticide resistance by ligase detection reaction-fluorescent microsphere assay;An insecticide resistance by ligase detection reaction assay that uses fluorescently labeled conserved probes in ligase detection reaction.
process;insecticide resistance by PCR amplification of specific alleles assay;An insecticide resistance assay that is based on monitoring known mutations by PCR amplification of specific alleles to detect polymorphic or mutant alleles.
process;insecticide resistance by fluorogenic PCR assay;An insecticide resistance assay that is based on monitoring known mutations by PCR technique that uses target specific probes labeled with fluorogenic chromophores to detect gene mutation.
process;insecticide resistance by PCR-RFLP assay;An insecticide resistance by monitoring known mutations assay based on restriction fragment length polymorphism assay.
process;insecticide resistance by short interspersed elements PCR assay;An insecticide resistance assay that is based on monitoring known mutations by PCR amplification of short interspersed elements (SINEs).
process;pathogen detection assay;An organism detection assay that detects pathogens.
process;VectorTest assay;A pathogen detection assay that identifies the presence or absence of specific peptide epitopes of circumsporozoite (CS) protein of the most important Plasmodium falciparum and two strains (variants 210 and 247) of the more widespread Plasmodium vivax using a dipstick wicking test strip.
process;pathogen detection by Rapid Analyte Measurement Platform assay;A pathogen detection assay that is based on Rapid Analyte Measurement Platform (RAMP) technology to quantify immunologically active substances.
process;assay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;A T cell epitope specific cytokine production assay that detects tumor necrosis factor superfamily cytokine production by T cells.
process;pathogen detection by loop-mediated isothermal amplification assay;A pathogen detection assay that is based on loop-mediated isothermal amplification.
generically dependent continuant;protocol optimization design;A study design where different protocols or protocol parameters are compared aims to find an optimized protocol
process;blood meal assay;An assay that analyzes the specimen taken from blood meal fed organism, such as insect.
process;promoter activity detection by reporter gene assay measuring epitope specific interleukin-2 production by T cells;A promoter activity detection by reporter gene assay that detects interleukin-2 production by T cells.
process;blood meal by counter current immunoelectrophoresis assay;A blood meal assay that uses a counter current immunoelectrophoresis technique.
generically dependent continuant;ChIP-chip design;A study design which aims to identify protein binding sites in genomic DNA by a combination of chromatin immunoprecipitation and DNA microarray (chip) assays.
process;DNA based blood meal finger printing assay;A DNA fingerprinting assay that uses DNA extracted from blood meal fed organism, such as insect.
generically dependent continuant;genetic characteristics information;a data item that is about genetic material including polymorphisms, disease alleles, and haplotypes.
process;organism detection by size assay;An organism detection assay that is based on the size of organism.
process;cytometric bead array assay measuring epitope specific macrophage inflammatory protein-1 alpha production by T cells;A cytometric bead array assay that detects macrophage inflammatory protein-1 alpha production by T cells.
process;organism detection by cross mating assay;An organism detection assay that is based on genetic crossings between specimens collected in the field to determine whether fertile progeny is produced.
process;assay measuring epitope specific interleukin-3 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-3 production by T cells.
process;organism detection by cytological chromosome examination assay;An organism detection assay that is based on analysis of polytene chromosomes through cytological examination of the banding pattern of the species.
process;assay measuring epitope specific T cell activation;A T cell epitope dependent biological activity assay that detects T cell activation.
process;organism detection by isoenzyme electrophoresis assay;An organism detection assay that is based on electrophoresis to determine the isozymes that are present in a specific population to determine the species.
generically dependent continuant;imprinting design;A study design where differences in genetic imprinting of maternally- and paternally-inherited chromosomes (e.g., due to in vivo differences in chemical modification and/or chromatin structure) are compared.
process;organism detection by morphological examination assay;An organism detection assay that is based on examination of morphology and the use of specific taxonomic keys to determine the species of the specimen.
generically dependent continuant;cell cycle design;A study design that assays events that occur in relation to the cell cycle, which is the period between the formation of a cell, by division of its mother cell and the time when the cell itself divides to form two daughter cells.
process;organism detection by PCR assay;An organism detection assay that is based on PCR.
generically dependent continuant;translation profiling design;A study design in which surface-bound, translationally competent ribosome complexes are used to generate a translation profile for mRNA, where mRNA may be a single molecular species, or a combination of species, including complex mixtures such as those found in the set of mRNAs isolated from a cell or tissue. One or more components of the surface-bound ribosome complex may be labeled at specific positions to permit analysis of multiple or single molecules for determination of ribosomal conformational changes and translation kinetics. Translation profiles are used as the basis for comparison of an mRNA or set of mRNA species. The translation profile can be used to determine such characteristics as kinetics of initiation, kinetic of elongation, identity of the polypeptide product, and the like. Analysis of translation profiles may be used to determine differential gene expression, optimization of mRNA sequences for expression, screening drug candidates for an effect on translation.
process;organism detection by specific DNA hybridization assay;An organism detection assay that is based on DNA hybrdization.
generically dependent continuant;cell type comparison design;A study design that compares cells of different type, for example different cell lines.
process;organism detection by salinity tolerance assay;An organism detection assay of mosquito species that is on the basis of mosquito survival depending on the salt concentration in the water used to lay their eggs to differentiate between morphologically very similar species.
process;cytometric bead array assay measuring epitope specific RANTES production by T cells;A cytometric bead array assay that detects RANTES production by T cells.
role;molecular label role;A reagent role inhering in a molecular entity intended to associate with some molecular target to serve as a proxy for the presence, abundance, or location of this target in a detection of molecular label assay.
process;cell culture analyte detection bioassay measuring epitope specific interleukin-6 production by T cells;A reporter cell line analyte detection bioassay that detects interleukin-6 production by T cells.
material entity;molecular label;A molecular reagent intended to associate with some molecular target to serve as a proxy for the presence, abundance, or location of this target in a detection of molecular label assay
process;assay measuring epitope specific interferon-gamma production by T cells;A T cell epitope specific cytokine production assay that detects interferon-gamma production by T cells.
process;vacuum-assisted biopsy;A biopsy performed with a needle augmented with a vacuum device.
process;epitope specific interleukin-9 production by T cells;A process of interleukin-9 production by T cells resulting from the recognition of a T cell epitope.
material entity;induced sputum specimen;A sputum specimen that is collected from an organism following its inhalation of a nebulized salt solution.
process;assay measuring epitope specific tumor necrosis factor alpha production by T cells;An assay of epitope specific tumor necrosis factor alpha production by T cells that detects tumor necrosis factor production.
process;passage process;A material processing that consists of first growing an organism in an environmental system and then removing the organism to be grown in another environmental system, a process which may be repeated with the objective of altering the organism or increasing its number.
generically dependent continuant;ChIP-chip by tiling array design;A study design which aims to identify protein binding sites in genomic DNA by a combination of chromatin immunoprecipitation and tiling microarray (chip) assays.
generically dependent continuant;passage history record;A data item that is about the sequence of environmental systems in each of which is grown an organism in a passage process.
generically dependent continuant;dose response design;A study design that examines the relationship between the size of the administered dose and the extent of the response.
process;ChIP-chip by tiling array assay;A ChIP-ChIP assay in which immunoprecipitated chromatin is run on a tiling array that covers stretches of DNA to to detect which elements in those stretches are present in the isolated chromatin
material entity;personal protective clothing item;A personal protective device which consists of a garment that serves in place of or in addition to regular body clothing.
material entity;laboratory coat;A personal protective clothing item which is an overcoat worn by medical or laboratory professionals.
material entity;medical glove;A personal protective glove which is disposable and is used during medical examinations and procedures to help prevent cross-contamination between caregivers and patients.
material entity;nitrile glove;A personal protective glove which is made out of nitrile rubber.
material entity;transparent droplet barrier;A device which is a transparent constructed barrier, usually made out of acrylic (Plexiglass) or polycarbonate plastic, installed in facilities to intercept respiratory droplets, encourage physical distancing requirements.
material entity;footwear cover;A personal protective device which is an impermiable material which covers a shoe or boot in order to prevent spread of specific environmental contaminants.
material entity;disposable footwear cover;A footwear cover which is designed for a single period of continuous use and then disposed of.
material entity;reusable footwear cover;A footwear cover which is designed for repeated use.
material entity;surgical N95 respirator;A N95 respirator which has been approved by the FDA as a surgical mask.
material entity;protective coverall;A personal protective clothing item which is a loose fitting coverall for ease of movement, with sleeves, full leggings and often a hood to cover the head. These can also include overshoe pieces to cover footwear and protect against contamination.
material entity;protective sleeve;A personal protective clothing item which is a protective cover worn over the arm.
material entity;protective apron;A personal protective clothing item which is an apron.
material entity;medical cap;A personal protective device which is worn on the head that helps prevent transmission of contaminants contained in hair and scalp.
material entity;specimen collection device;A device used to collect a specimen.
material entity;chromatography vial;A vial with cap and container material suited to optical, sanitary and handling requirements of chromatography.
material entity;specimen pad;A sample collection device consisting of a soft flexible, absorbent pad usually made from natural material such as gauze or cotton, used to absorb specimen fluid or particulate matter.
material entity;specimen collection swab stick;A specimen collection device which is a specimen pad attached to a long handle used to collect specimen material.
material entity;cotton swab;A device which is a cotton pad mounted on one or both ends of a stick.
material entity;drag swab;A specimen collection device consisting of a specimen pad made of sterile gauze which is aseptically attached to a pole by clips or to a string
material entity;pre-moistened swab stick;A specimen collection swab stick that is pre-moistened with liquid prior to sampling.
material entity;surface wipe;A sample collection device consisting of a thin, less absorbent sheet, used to collect material from surfaces.
material entity;mosquito membrane feeding device;A device that contains blood in a membrane penetrable to mosquitoes, designed to feed mosquitoes without the need for an animal host.
process;lung microbiology assay;An organism detection assay that detects microorganisms in a lung specimen.
generically dependent continuant;eukaryota in umbilical cord blood datum;An umbilical cord blood microbiology datum that is about eukaryota.
process;umbilical cord blood microbiology assay;An organism detection assay that detects microorganisms in an umbilical cord blood specimen.
process;pleural fluid microbiology assay;An organism detection assay that detects microorganisms in a pleural fluid specimen.
process;urine microbiology assay;An organism detection assay that detects microorganisms in a urine specimen.
process;nasopharyngeal or oropharyngeal swab microbiology assay;An organism detection assay that detects microorganisms in a nasopharyngeal or oropharyngeal swab specimen.
process;multiplex real time reverse-transcription polymerase chain reaction assay;A real time reverse-transcription polymerase chain reaction assay in which multiple DNA sequences are amplified in a single cycle.
process;multiplex real time polymerase chain reaction assay;A real time polymerase chain reaction assay in which multiple DNA sequences are amplified in a single cycle.
generically dependent continuant;in silico design;A study design that is executed primarily on a computer.
process;mosquito membrane feeding assay;An assay that evaluates host-to-mosquito transmission of a parasite organism by feeding a specimen of host blood infected with the parasite organism to a collection of mosquitoes through a mosquito membrane feeding device and, after a given time, dissecting the mosquitoes and counting the number of parasite organisms within them.
process;cytometric bead array assay measuring epitope specific perforin release by T cells;A cytometric bead array assay that detects epitope specific perforin release by T cells.
process;cytometric bead array assay measuring epitope specific granulysin release by T cells;A cytometric bead array assay that detects epitope specific granulysin release by T cells.
generically dependent continuant;positive binding datum;A categorical binding datum that states that there is a significant disposition of two or more entities to form a complex.
process;modified acid-fast stain microscopy assay;A microscopy assay that uses staining to identify acid-fast organisms in a specimen and does not require heating.
process;tyramide signal amplification sequencing assay;A DNA sequencing assay that uses tyramide signal amplification (TSA) to assess distance of DNA regions to a targeted nuclear compartment or protein, typically on a scale of 100-1000 nm.
process;antibodies from lymphocyte secretions assay;An assay that evaluates a blood specimen for antibodies currently being produced by lymphocytes in the specimen, by separating peripheral blood mononuclear cells, culturing them, and then collecting the supernatant containing the antibodies secreted from those cells.
process;DamID-seq;A DNA adenine methyltransferase identification (DamID) assay in which DamID-generated DNA fragments undergo high-throughput sequencing to determine a protein's DNA-binding site.
process;DNA adenine methyltransferase identification assay;An assay for identifying DNA binding sites for a protein by fusing it to Dam methylase, and expressing it so that bound DNA gets methylated. The methylated DNA can then be isolated and analyzed.
generically dependent continuant;feces microbiology datum;An organism detection datum that is the specified output of a feces microbiology assay.
generically dependent continuant;feces assay datum;A data item that is the specified output of a feces assay.
generically dependent continuant;urine microbiology datum;An organism detection datum that is the specified output of a urine microbiology assay.
generically dependent continuant;urine assay datum;A data item that is the specified output of a urine assay.
generically dependent continuant;induced sputum assay datum;A data item that is the specified output of a induced sputum assay.
process;cerebrospinal fluid microbiology assay;An organism detection assay that detects microorganisms in a cerebrospinal fluid specimen.
process;induced sputum microbiology assay;An organism detection assay that detects microorganisms in an induced sputum specimen.
process;endotracheal tube aspirate microbiology assay;An organism detection assay that detects microorganisms in an endotracheal aspirate specimen.
generically dependent continuant;blood microbiology datum;An organism detection datum that is the specified output of a blood microbiology assay.
generically dependent continuant;blood assay datum;A data item that is the specified output of a blood assay.
generically dependent continuant;nasopharyngeal or oropharyngeal swab microbiology datum;An organism detection datum that is the specified output of a nasopharyngeal or oropharyngeal swab microbiology assay.
generically dependent continuant;lung microbiology datum;An organism detection datum that is the specified output of a lung microbiology assay.
generically dependent continuant;umbilical cord blood assay datum;A data item that is the specified output of an umbilical cord blood assay.
generically dependent continuant;pleural fluid microbiology datum;An organism detection datum that is the specified output of a pleural fluid microbiology assay.
generically dependent continuant;induced sputum microbiology datum;An organism detection datum that is the specified output of an induced sputum microbiology assay.
material entity;biomedical laboratory organization;An organization that performs assays, processes specimens, analyses data and conducts planned processes relevant to the life sciences.
generically dependent continuant;cerebrospinal fluid microbiology datum;An organism detection datum that is the specified output of a cerebrospinal fluid microbiology assay.
generically dependent continuant;cerebrospinal fluid assay datum;A data item that is the specified output of a cerebrospinal fluid assay.
generically dependent continuant;endotracheal tube aspirate microbiology datum;An organism detection datum that is the specified output of an endotracheal tube aspirate microbiology assay.
generically dependent continuant;endotracheal aspirate assay datum;An organism detection datum that is the specified output of an endotracheal aspirate assay.
generically dependent continuant;bacteria in induced sputum datum;An induced sputum microbiology datum that is about bacteria.
generically dependent continuant;eukaryota in urine datum;A urine microbiology datum that is about eukaryota.
generically dependent continuant;eukaryota in induced sputum datum;An induced sputum microbiology datum that is about eukaryota.
generically dependent continuant;umbilical cord blood microbiology datum;An organism detection datum that is the specified output of an umbilical cord blood microbiology assay.
generically dependent continuant;virus in blood datum;A blood microbiology datum that is about a virus.
generically dependent continuant;bacteria in blood datum;A blood microbiology datum that is about bacteria.
generically dependent continuant;bacteria in feces datum;A feces microbiology datum that is about bacteria.
generically dependent continuant;eukaryota in blood datum;A blood microbiology datum that is about eukaryota.
generically dependent continuant;virus in feces datum;A feces microbiology datum that is about a virus.
generically dependent continuant;eukaryota in feces datum;A feces microbiology datum that is about eukaryota.
generically dependent continuant;eukaryota in pleural fluid datum;A pleural fluid microbiology datum that is about eukaryota.
generically dependent continuant;bacteria in pleural fluid datum;A pleural fluid microbiology datum that is about bacteria.
generically dependent continuant;bacteria in endotracheal tube aspirate datum;An endotracheal tube aspirate microbiology datum that is about bacteria.
generically dependent continuant;virus in induced sputum datum;An induced sputum microbiology datum that is about a virus.
generically dependent continuant;eukaryota in lung datum;A lung microbiology datum that is about eukaryota.
generically dependent continuant;bacteria in lung datum;A lung microbiology datum that is about bacteria.
generically dependent continuant;bacteria in nasopharyngeal or oropharyngeal swab datum;A nasopharyngeal or oropharyngeal swab microbiology datum that is about bacteria.
generically dependent continuant;virus in lung datum;A lung microbiology datum that is about a virus.
generically dependent continuant;virus in nasopharyngeal or oropharyngeal swab datum;A nasopharyngeal or oropharyngeal swab microbiology datum that is about a virus.
generically dependent continuant;eukaryota in nasopharyngeal or oropharyngeal swab datum;A nasopharyngeal or oropharyngeal swab microbiology datum that is about eukaryota.
generically dependent continuant;virus in pleural fluid datum;A pleural fluid microbiology datum that is about a virus.
process;high throughput multiplexed assay measuring binding of a B cell epitope:antibody complex;A B cell epitope assay that measures the binding of an antibody receptor to an epitope using a high throughput multiplexed assay.
material entity;P815 cell line;A cell line derived from mouse mastocytoma.
process;high throughput multiplexed assay measuring binding of a MHC:ligand complex;A MHC ligand assay that detects the binding of a ligand to an MHC molecule using a high throughput multiplexed assay.
process;high throughput multiplexed assay measuring binding of a T cell epitope:MHC:TCR complex;A T cell epitope assay that measures the binding of T cell receptor to an epitope using a high throughput multiplexed assay.
generically dependent continuant;image data set;A data set that is comprised of multidimensional structured measurements and metadata required for a morphological representation of an entity. An image data set can be the source from which an image (such as a 2D image using pixels or a 3D image using voxels) is produced.
process;transcription factor binding site assay;An assay tthat determines DNA regions specifically recognized by proteins that function as transcription factors
process;high throughput multiplexed assay measuring MHC ligand processing and presentation;A MHC ligand assay that determines what ligands are processed and loaded onto MHC molecules by eluting ligands and identifying them using a high throughput multiplexed assay.
material entity;magnetic resonance imaging participant;The subject being scanned in an MRI study, and bearor of data derived from that study.
generically dependent continuant;magnetic resonance image data set;An image data set whose information content originates from some MR imaging assay and is about some MRI participant.
process;venous blood microbiology assay;A blood microbiology assay that detects a microorganism in a venous blood specimen.
process;granulysin release during T cell degranulation;The release of granulysin during cytotoxic T cell degranulation.
process;environmental proximity to infectious agent;Is a process in which an infectious agent comes close enough to a potential host organism in its habitat that a contact can result
process;contact to pathogen carrying biological vector;a process in which a vector carrying an infectious agent comes close enough to a potential host organism that a contact can result
material entity;splenocyte specimen;A cell specimen comprised of a mixed cell population obtained by processing whole spleen into individual cells, typically performed using a sieve or blender. This population includes T cells, B cells, macrophages, and other cell types.
material entity;Illumina HiSeq 2500;A DNA sequencer which is manufactured by the Illumina corporation, with two flow cells and a throughput of up to 160 Gb per day. Built upon sequencing by synthesis technology, the machine is optimized for generation of data for batching multiple samples or rapid results on a few samples.
generically dependent continuant;reconstructed magnetic resonance image data set;An image data set that is the direct output of a raw magnetic resonance image data set reconstruction or a transformation of another MR image data set.
material entity;cultured antigen presenting cell population;a cell culture including cells that have an antigen presentation function
material entity;Illumina MiSeq;A DNA sequencer which is manufactured by the Illumina corporation. Built upon sequencing by synthesis technology, the machine provides an end-to-end solution (cluster generation, amplification, sequencing, and data analysis) in a single machine.
generically dependent continuant;computed image data set;An image data set that is the output of an image data set analysis.
material entity;cultured effector T cell population;A cell culture including cells that have an effector T cell function
material entity;Methylation 450K BeadChip;A methylation BeadChip which is manufactured by the Illumina corporation. Built upon BeadChip tehcnology, the array interrogates ~ 485,000 methylation sites per sample at single-nucleotide resolution.
generically dependent continuant;functional magnetic resonance image data set;An magnetic resonance image data set collected as a 4D time series representing changes in brain metabolism (i.e. BOLD), typically used as a proxy for brain activity.
material entity;material to be added;A material entity that is added to another material entity in an adding a material entity into a target process.
material entity;Methylation 27K BeadChip;A methylation BeadChip which is manufactured by the Illumina corporation. Built upon BeadChip tehcnology, the array interrogates ~ 27,000 CpG sites per sample at single-nucleotide resolution.
generically dependent continuant;diffusion weighted magnetic resonance image data set;A type of magnetic resonance image data set collected using at least three diffusion gradients of some factor "b," which is a function of the amplitude, duration, and interval of the gradiants.
material entity;target of material addition;A material entity that receives the addition of another material entity in an adding a material entity into a target process.
material entity;1M-Duo Infinium HD BeadChip;A BeadChip which is manufactured by the Illumina corporation. Built upon BeadChip tehcnology, the array integrates ~ 1 million markers per sample for genotyping, and copy number variation (CNV) and Cytogenetic analysis.
generically dependent continuant;task-based functional magnetic resonance image data set;A type of functional MRI in which the participant is given a task or tasks, which are timed with the acquisition
material entity;SOLiD 3 Plus System;A DNA sequencer which is manufacted by the Applied Biosystems corporation. Built upon SOLiD sequencing technology, the machine generates greater than 1 billion mappable reads per run.
generically dependent continuant;resting state functional magnetic resonance image data set;A type of functional MRI in which the participant is not given a task, but just rests during acquisision
material entity;Mouse 385K Whole Genome CGH Tiling Array;A tiling array which is manufactured by the Nimblegen corporation. Built to analyze DNA sequence copy number by comparative genomic hybridization for mouse DNA against 385,000 features.
material entity;Mouse 3x720K Whole Genome CGH Tiling Array;A tiling array which is manufactured by the Nimblegen corporation. Built to analyze DNA sequence copy number by comparative genomic hybridization for mouse DNA against 3x720,000 features.
generically dependent continuant;perfusion weighted magnetic resonance image data set;An magnetic resonance image data set that captures volume and flow of blood in the brain.
role;magnetic resonance imaging evaluant role;An evaluant role that inheres in a material entity that is realized in a MR imaging assay in which MR imaging data is generated about the bearer of the evaluant role.
material entity;Illumina Genome Analyzer IIx;An Illumina Genome Analyzer II which is manufactured by the Illumina corporation. It supports sequencing of single, long or short insert paired end clone libraries relying on sequencing by synthesis technology. The Genome Analyzer IIx is the most widely adopted next-generation sequencing platform and proven and published across the broadest range of research applications.
generically dependent continuant;magnetic resonance pulse sequence protocol;The NMR/MRI machine protocol about the radiofrequency pulse sequence.
material entity;Illumina HiSeq 2000;A DNA sequencer which is manufactured by the Illumina corporation, with two flow cells and a throughput of up to 55 Gb per day. Built upon sequencing by synthesis technology, the machine is optimized for generation of data for multiple samples in a single run.
generically dependent continuant;raw image data set;An image data set that encodes measurement values produced by some instrument before undergoing a data transformation.
material entity;nCounter Human miRNA Expression array;A human array which is manufacutred by NanoString Technologies. Built upon color-coded molecular barcodes technology, the array profiles miRNA with increased specificity and sensitivty than microarrays.
generically dependent continuant;baseline high resolution T1 weighted magnetic resonance image data set;A T1w image data set collected at an evaluant's first visit in a study.
process;DNA methylation profiling by ChIP-chip assay;An epigenetic modification assay that identifies sites of DNA methylation using ChIP-chip technologies.
generically dependent continuant;high resolution T1 weighted magnetic resonance image data set;A T1-weighted image data set acquired from an NMR/MRI machine with at least a 3 Tesla magnet and in which the voxel size is isotropic.
process;transcription profiling by MPSS assay;A transcription profiling assay that uses Massive Parallel Signature Sequencing (MPSS).
generically dependent continuant;T1 weighted SE magnetic resonance image data set;A T1 weighted image data set acquired using a spin echo sequence.
process;histone modification identification by ChIP-chip assay;An epigenetic modification assay that identifies regions containing specific histones and their modifications using ChIP-chip techniques.
generically dependent continuant;follow-up high resolution T1 weighted magnetic resonance image data set;A T1w image data set collected at a later time than the evaluant's first scan.
process;histone modification identification by ChIP-Seq assay;An epigenetic modification assay that identifies regions containing specific histones and their modifications using ChIP-Seq techniques.
generically dependent continuant;T2 weighted FLAIR magnetic resonance image data set;A T2 weighted image data set collected using a FLAIR sequence.
process;transcription factor binding site identification by ChIP-chip assay;A transcription factor binding site assay that utilizes ChIP-chip technology.
generically dependent continuant;T2 weighted magnetic resonance image data set;A magnetic resonance image produced by a T2 weighted magnetic resonance image acquisition sequence.
process;transcription factor binding site identification by ChIP-Seq assay;A transcription factor binding site assay that utilizes ChIP-seq technology.
generically dependent continuant;T1 weighted magnetic resonance image data set;An magnetic resonance image acquired using a T1 weighted magnetic resonance image acquisition sequence.
material entity;Human 3x720K Whole Genome CGH Tiling Array;A tiling array which is manufactured by the Nimblegen corporation. Built to analyze DNA sequence copy number by comparative genomic hybridization for human DNA against 3x720,000 features.
generically dependent continuant;proton density magnetic resonance image data set;An magnetic resonance image data set in which the contrast emphasizes density of protons, supressing T1 and T2 effects
material entity;Human 2.1M Whole-Genome CGH Tiling Array v2.0;A tiling array which is manufactured by the Nimblegen corporation. Built to analyze DNA sequence copy number by comparative genomic hybridization for human DNA against 2.1 million features.
generically dependent continuant;T1 weighted GRE magnetic resonance image data set;T1 weighted image data set collected using a gradient recall echo sequence.
material entity;PacBio RS II;A DNA sequencer which is manufactured by the Pacific Biosciences corporation. Built upon single molecule real-time sequencing technology, the machine is optimized for generation with long reads and high consensus accuracy.
generically dependent continuant;post-Gd T1 weighted magnetic resonance image data set;A T1 weighted image data set where gadolidium contrast agent has been administered to the participant before image acquistion.
process;assay measuring epitope specific T cell killing;A T cell epitope dependent biological activity assay that detects the killing of an antigen presenting cell (APC) by a T cell whose TCR recognizes an epitope presented by the APC.
process;assay measuring epitope specific proliferation of T cells;A T cell epitope dependent biological activity assay that detects T cell proliferation.
material entity;SOLiD 4 System;An AB SOLid System which is manufacted by the Applied Biosystems corporation. Built upon SOLiD sequencing technology, the machine generates greater than 1 billion mappable reads per run.
process;raw magnetic resonance image data set reconstruction;A process that transforms raw magnetic resonance image data from an NMR/MRI machine into a reconstructed magnetic resonance image data set.
process;immune epitope assay;An assay that detects the binding of an epitope to an adaptive immune receptor, or an immune process resulting from such a binding event, or characterizes the structrue of the complex resulting from such a binding event.
material entity;Human Exon 1.0 ST tilling array;A tiling microarray which is manufactured by the Affymetrix corporation. Built to analyze 3' DNA sequence copy number by comparative genomic hybridization for human DNA against 28,000 genes. It can be used for gene expression and alternative splicing assay
process;image data set analysis;The process of deriving a data item from an image data set using computer algorithms. The produced data item can be an image data set, data measurement, or any other data item.
process;assay measuring epitope specific cytokine production by T cells;A T cell epitope assay that detects cytokine production by T cells.
material entity;Human Genome U133 tiling array;A tiling array which is manufactured by the Affymetrix corporation. Built to analyze DNA sequence copy number by comparative genomic hybridization for human DNA against 39,000 transcripts and variants.
generically dependent continuant;probabilistic brain region atlas image dataset;A brain atlas consisting of weighted values that respresent the probability that a voxel X is part of some brain component Y, typically derived from multiple image data sets.
material entity;Illumina Genome Analyzer IIe;An Illumina Genome Analyzer II which is manufactured by the Illumina corporation. It supports sequencing of single, long or short insert paired end clone libraries relying on sequencing by synthesis technology. The Genome Analyzer IIe makes industry-leading next-generation sequencing technology accessible to more laboratories.
generically dependent continuant;brain region atlas image data set;An image data set consisting of values computed from multiple image data sets encoded to represent the spatial location of individual functional or structural regions of a canonical brain.
process;SAGE ditag library preparation;A library preparation in which tags identifiying transcripts are created, ligated to form ditags, amplified, concatemerized and ligated into a vector to create a library.
process;serial analysis of gene expression assay;A transcription profiling assay that quantifies RNA through creating short signature tags of the messages and ligating them into a larger molecule than was sequenced.
generically dependent continuant;deterministic brain region atlas image data set;A brain atlas consisting of discrete integer values where a value X denotes a voxel is part of some brain component Y.
generically dependent continuant;T2 weighted FSE magnetic resonance image data set;T2 weighted image collected using a fast/turbo spin echo sequence.
process;epigenetic modification assay;An assay that identifies epigenetic modifications including histone modifications, open chromatin, and DNA methylation.
generically dependent continuant;T2 weighted STIR magnetic resonance image data set;A T2 weighted magnetic resonance image data set collected using a STIR sequence to suppress the signal coming from fat.
material entity;Illumina NextSeq 500;A DNA sequencer which is a desktop sequencer ideal for smaller-scale studies manufactured by the Illumina corporation. It supports sequencing of single, long or short insert paired end clone libraries relying on sequencing by synthesis technology.
generically dependent continuant;T2 weighted SE magnetic resonance image data set;A type of T2-weighted image in which the acquisition is performed using a 2D spin-echo technique
material entity;Illumina HiSeq 1000;A DNA sequencer which is manufactured by the Illumina corporation, with a single flow cell and a throughput of up to 35 Gb per day. It supports sequencing of single, long or short insert paired end clone libraries relying on sequencing by synthesis technology.
generically dependent continuant;raw magnetic resonance image data set;An image data set that is the direct output of an magnetic resonance imaging assay and whose values encode spatial frequencies produced by the NMR or MRI instrument.
material entity;Human Genome U133 Plus 2.0 tiling array;A tiling array which is a comprehensive whole human genome expression array manufactured by the Affymetrix corporation. Built to analyze DNA sequence copy number by comparative genomic hybridization for human DNA against 47,000 transcripts and variants.
generically dependent continuant;T2* weighted GRE magnetic resonance image data set;T2* weighted image data set collected using a gradient echo sequence.
role;assay antigen role;An antigen role that is realized as part of an assay, where immune recognition of the material with the assay antigen role is being detected as part of the assay.
process;pathologic process;abnormal, harmful processes caused by or associated with a disease
process;assay measuring qualitative binding of a T cell epitope:MHC:TCR complex;An assay that detects the binding of a MHC:epitope complex with a T cell receptor, and produces a qualitative measurement of the binding as an output.
process;assay measuring MHC ligand processing and presentation;A MHC ligand assay that determines what ligands are processed and loaded onto MHC molecules by eluting ligands and identifying them.
process;assay measuring binding of a MHC:ligand complex;A MHC ligand assay that detects the binding of a ligand to an MHC molecule.
process;assay measuring binding of a B cell epitope:antibody complex;A B cell epitope assay that measures the binding of an antibody receptor to an epitope.
role;cohort role;a cohort role is a biological replicate role played by a group of study participants who share a common characteristic of interest to the study.
process;phage display binding assay measuring binding of a purified-MHC:ligand complex;A phage display binding assay that detects direct binding of a purified-MHC molecule with a ligand.
generically dependent continuant;cluster;A data set which is a subset of data that are a similar to each other in some way.
process;cytometric bead array assay measuring epitope specific interleukin-7 production by T cells;A cytometric bead array assay that detects interleukin-7 production by T cells.
role;dye role;A molecular label role which inheres in a material entity and which is realized in the process of detecting a molecular dye that imparts color to some material of interest.
process;radioactivity detection assay measuring half life to determine direct binding of a purified-MHC:ligand complex;A radioactivity detection assay that measures half life to detect the direct binding of a purified-MHC molecule with a ligand.
process;assay measuring epitope specific interleukin-7 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-7 production by T cells.
process;binding;The process of material entities forming complexes.
process;intracellular cytokine staining assay measuring epitope specific interleukin-17A production by T cells;A flow cytometry assay that detects interleukin-17A production by T cells.
process;PCR-SSCP assay;An assay that identifies DNA sequence variation (mutation, deletion, insertions) in target DNA sequences amplified using polymerase chain reaction using gel electrophoresis and denaturating conditions
process;comet assay;An assay that measures DNA damage (DNA breakage) in eucaryotic cells exposed to a challenge by determining the size and shape of DNA migration by detecting fluorescently labeled DNA from a cell placed in an electric field using gel electrophoresis
process;DNA extraction;A DNA extraction is a nucleic acid extraction where the desired output material is DNA.
process;material transport service;A service in which a service provider facilitates the transport of some material entity to a specified destination for the service consumer.
generically dependent continuant;equilibrium dissociation constant (KD) approximated by EC50;A measurement of an EC50 value under specific assay conditions approximates KD, namely the binding reaction is at an equilibrium, and the concentration of the receptor must be much less than the KD for the ligand.
role;solute role;solute role is a role played by a chemical entity which is dissolved by another chemical entity (the solvent) when creating a solution
role;solvent role;solvent role is a role which inheres in a molecular entity capable of ensuring the dissolution of another chemical entity and realized by the process of solvation
process;artificially induced nucleic acid hybridization;Is a material transformation in which strands of nucleic acids that are (somewhat) complementary form a double-stranded molecule. Has input at least two single stranded molecules of nucleic acid molecules.
generically dependent continuant;half life of binding datum;A half life datum of the time it takes for 50% of bound complexes in an ensemble to disassociate in absence of re-association.
role;buffer role;a role which inheres in some molecular entity realized during the process of buffering
process;51 chromium assay measuring epitope specific T cell killing;A chromium release assay that detects the killing of an antigen presenting cell (APC) by a T cell whose TCR recognizes an epitope presented by the APC.
process;ELISA measuring epitope specific interferon-gamma production by T cells;An enzyme-linked immunosorbent assay that detects interferon-gamma production by T cells.
process;ELISA measuring epitope specific interleukin-2 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-2 production by T cells.
process;ELISA measuring epitope specific interleukin-4 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-4 production by T cells.
process;ELISA measuring epitope specific interleukin-5 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-5 production by T cells.
process;ELISA measuring epitope specific tumor necrosis factor alpha production by T cells;An enzyme-linked immunosorbent assay that detects tumor necrosis factor alpha production by T cells.
process;ELISA measuring epitope specific interleukin-10 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-10 production by T cells.
process;ELISA measuring epitope specific granulocyte macrophage colony-stimulating factor production by T cells;An enzyme-linked immunosorbent assay that detects granulocyte macrophage colony stimulating factor production by T cells.
process;ELISA measuring epitope specific interleukin-6 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-6 production by T cells.
process;ELISA measuring epitope specific interleukin-13 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-13 production by T cells.
process;X-ray crystallography assay determining the 3D structure of a MHC:ligand complex;A X-ray crystallography 3D molecular structure determination assay that characterizes the 3-dimensional molecular structure of a MHC:ligand complex.
generically dependent continuant;PDB file chain;A 3D structural organization datum that is part of a PDB file and has a specific chain identifier that identifies the entire information on a subset of the material entities.
process;cell bound MHC competitive binding assay measuring half maximal inhibitory concentration [IC50] of a MHC:ligand complex using T cell epitope recognition;A cell bound MHC ligand binding half maximal inhibitory concentration (IC50) determination assay that uses a T cell epitope recognition assay to measure ligand binding.
realizable entity;plan;A plan is a realizable entity that is the inheres in a bearer who is committed to realizing it as a planned process.
process;data maintenance service;A maintenance service in which a service provider actively manages or maintains data or a database for the service consumer. Maintenance of the data is performed to maintain its integrity or enhance its quality or utility for the consumer, but new data is not generated as a result of the maintenance.
process;radioactivity detection assay measuring competitive binding of a cell-bound-MHC:ligand complex;A radioactivity detection assay that detects loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.
generically dependent continuant;number of lost events computer;A measurement datum recording the number of measurement events lost due to overloading of the analysis chip in a flow cytometer instrument. The datum has a qualitative role
generically dependent continuant;organism feature identification objective;Organism feature identification objective is a biological feature identification objective role describing a study designed to examine or characterize a biological feature monitored at the level of the organism, e.g. height, weight, stage of development, stage of life cycle.
process;fluorescence detection assay measuring direct binding of a purified-MHC:ligand complex;A fluorescence detection assay that detects direct binding of a purified-MHC molecule with a ligand.
process;direct binding assay;A binding assay that measures the formation or disassociation of a complex of 2 material entities directly without use of a competitve ligand.
process;fluorescence detection assay measuring half maximal effective concentration [EC50] to determine direct binding of a purified-MHC:ligand complex;A fluorescence detection assay that measures half maximal effective concentration (EC50) to detect direct binding of a purified-MHC molecule with a ligand.
process;competitive inhibition of binding assay;A binding assay that detects the inhibition of binding between 2 material entities known to form a complex by the addition of a third material entity of interest. Inhibition of binding between the 2 materials reflects binding by the third material.
process;fluorescence detection assay measuring competitive binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that detects loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.
material entity;chemical solution;A material entity that is made up of at least 2 scattered molecular aggregates, one playing the role of solvent and the other one playing the role of solute.
process;adding a material entity into a target;is a process with the objective to place a material entity bearing the 'material to be added role' into a material bearing the 'target of material addition role'.
process;DNase Hi-C assay;A Hi-C assay in which DNase I is used for digesting DNA fragments rather than a restriction enzyme, which can result in a higher resolution of mapped chromosome contacts.
role;role of regulator of consumables and medical devices;a regulator involved with making and enforcing legislation and governmental orders relevant to the development, testing, manufacture and use of food, drugs and medical devices
process;nucleolus-associated domain sequencing assay;A DNA sequencing assay in which nucleoli are isolated and the DNA associated with them is sequenced to identify nucleoli-associating domains.
generically dependent continuant;protocol;A plan specification which has sufficient level of detail and quantitative information to communicate it between investigation agents, so that different investigation agents will reliably be able to independently reproduce the process.
process;single cell combinatorial indexing Hi-C assay;A Hi-C assay performed on massively multiplexed single-cell samples.
process;micro-C assay;A Hi-C assay which uses micrococcal nuclease digestion in place of the restriction enzyme digestion step.
process;single cell Hi-C assay;A Hi-C assay performed on a single cell.
process;single nucleus Hi-C assay;A Hi-C assay performed on isolated nuclei.
process;multi-contact Hi-C assay;A Hi-C assay that assesses interactions between multiple DNA fragments rather than only pairwise interactions as in traditional Hi-C. The experimental procedure of cross-linking, digestion, and ligation is performed similarly to traditional Hi-C, but after DNA is purified a long-read library is produced in which many ligated fragments may be contained in a single molecule. The library is then sequenced on a long read sequencer.
process;bulk Hi-C assay;A Hi-C assay in which the sample that is sequenced is derived from a collection of cells, such as a tissue sample or entire cell culture, and therefore provides results representative of the aggregate of sample cells.
process;disease stage;a part of an occurrence of a disease process which is associated with position in the normal progression of the disease
role;analyte role;A measurand role borne by a molecular entity or an atom and realized in an analyte assay which achieves the objective to measure the magnitude/concentration/amount of the analyte in the entity bearing evaluant role.
process;ELISPOT assay measuring epitope specific interleukin-10 production by T cells;An enzyme-linked immunospot assay that detects interleukin-10 production by T cells.
process;ELISPOT assay measuring epitope specific interleukin-13 production by T cells;An enzyme-linked immunospot assay that detects interleukin-13 production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interferon-gamma production by T cells;A flow cytometry assay that detects interferon-gamma production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-2 production by T cells;A flow cytometry assay that detects interleukin-2 production by T cells.
process;intracellular cytokine staining assay measuring epitope specific tumor necrosis factor alpha production by T cells;A flow cytometry assay that detects tumor necrosis factor alpha production by T cells.
process;transposase-mediated analysis of chromatin looping assay;A DNA sequencing assay designed to detect interacting genomic regions. Rather than the traditional Hi-C approach of digestion and proximity ligation, the procedure involves transposase-mediated insertion of an oligonucleotide linker between the pair of interacting regions.
process;intracellular cytokine staining assay measuring epitope specific interleukin-4 production by T cells;A flow cytometry assay that detects interleukin-4 production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-10 production by T cells;A flow cytometry assay that detects interleukin-10 production by T cells.
process;intracellular cytokine staining assay measuring epitope specific interleukin-17 production by T cells;A flow cytometry assay that detects interleukin-17 production by T cells.
process;MHC tetramer/multimer assay measuring binding of a T cell epitope:MHC:TCR complex;A MHC tetramer/multimer assay that measures the binding of an epitope:MHC complex binding with a T cell receptor.
process;RNA-DNA split-pool recognition of interactions and tag extension assay;A split-pool recognition of interactions and tag extension (SPRITE) assay in which RNA in the cross-linked complexes is converted to cDNA before the initial splitting step, allowing analysis of RNA-DNA interactions.
process;DNA split-pool recognition of interactions and tag extension assay;A split-pool recognition of interactions and tag extension (SPRITE) assay that only assays interactions between regions of genomic DNA.
process;mapping RNA-genome interactions assay;A nuclear ligation assay for probing RNA-DNA interactions in the nucleus. Nuclei are crosslinked, and RNA fragments are ligated to proximal DNA fragments via a special linker molecule. After reverse transcription, high-throughput sequencing is performed.
process;genome architecture mapping assay;A DNA sequencing assay designed to analyze 3D chromatin structure without relying on digestion and ligation. The procedure involves cryosectioning samples in random orientation, and then single nuclear profiles are isolated by laser microdissection. Each nuclear profile then undergoes high-throughput sequencing, and subsequent analysis can generate a matrix of inferred proximity between genomic regions.
process;intraperitoneal injection;is the injection of a material entity (bearing the administered substance role) into the peritoneum (bearing the target role) of an organism using a syringe
process;ELISA measuring epitope specific amphiregulin production by T cells;An enzyme-linked immunosorbent assay that detects amphiregulin production by T cells.
process;assay measuring epitope specific amphiregulin production by T cells;A T cell epitope specific cytokine production assay that detects amphiregulin production by T cells.
process;granzyme A release during T cell degranulation;The release of granzyme A during cytotoxic T cell degranulation.
process;perforin release during T cell degranulation;The release of perforin during cytotoxic T cell degranulation.
process;protein-protein interaction detection assay;An assay that determines interactions between proteins, such as protein-protein binding.
process;split-pool recognition of interactions and tag extension assay;A sequencing assay designed to detect multi-way interactions between nucleic acids. The procedure involves crosslinking nuclei, and then splitting the lysate among wells in a 96-well or other multi-well plate. A different barcode is ligated to the fragments in each well, and the lysates are pooled together again. This sequence of splitting, tagging, and re-combining is repeated several times so that fragments with the same sequences of barcodes represent fragments that have co-associated throughout the experiment. Finally, a sequencing library is constructed and high-throughput sequencing is performed.
material entity;precipitate;a precipitate is a material entity which is output of a precipitation process
process;ELISA measuring epitope specific interleukin-12 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-12 production by T cells.
process;ELISA measuring epitope specific interleukin-1 beta production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-1 beta production by T cells.
process;ELISA measuring epitope specific interleukin-17 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-17 production by T cells.
process;ELISA measuring epitope specific interleukin-18 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-18 production by T cells.
process;granzyme B release during T cell degranulation;The release of granzyme B during cytotoxic T cell degranulation.
process;ELISPOT assay measuring epitope specific interleukin-4 production by T cells;An enzyme-linked immunospot assay that detects interleukin-4 production by T cells.
process;ELISPOT assay measuring epitope specific tumor necrosis factor alpha production by T cells;An enzyme-linked immunospot assay that detects tumor necrosis factor alpha production by T cells
process;fluorescence detection assay measuring binding on rate [kon] to determine direct binding of a purified-MHC:ligand complex;A fluorescence detection assay measuring binding on rate (kon) to detect direct binding of a purified-MHC:ligand complex.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-13 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-13 production by T cells.
process;fluorescence detection assay measuring equilibrium dissociation constant [KD] to determine direct binding of a purified-MHC:ligand complex approximated by EC50;A fluorescence detection assay that measures equilibrium dissociation constant (KD) to detect direct binding of a purified-MHC molecule with a ligand and provides EC50 values determined under assay conditions where the EC50 approximates a KD value.
process;radioactivity detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a cell-lysate-MHC:ligand complex;A radioactivity detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to cell-lysate-MHC due to competition by the ligand under investigation.
process;intracellular cytokine staining assay measuring epitope specific macrophage inflammatory protein-1 alpha production by T cells;A flow cytometry assay that detects macrophage inflammatory protein-1 alpha production by T cells.
process;comparative phenotypic assessment;Interpreting data from assays that evaluate the qualities or dispositions inhering in an organism or organism part and comparing it to data from other organisms to make a conclusion about a phenotypic difference
process;material analysis service;A service in which a service consumer provides some input material and a service provider performs some analysis of this material to generate data that is returned to the service consumer.
role;role of legally acceptable representative;a role which inheres in a human or organization who are able subject to applicable law to consent, on behalf of a prospective subject, to the subject`s participation in as clinical trial.
role;negative reference substance role;a reference role in which the characteristics or responses elicited by the substance playing the reference substance role are used to establish a "no effect" response
generically dependent continuant;fluorescence compensation matrix;A fluorescence compensation matrix is a square matrix which is used as the left multiplier of the vector of fluorescence values while performing digital fluorescence compensation. Also, fluorescence compensation matrix is the inverse of the fluorescence spillover matrix.
role;proxy respondent role;Proxy respondent is a worker role of describing patient's symptoms or condition to medical personnel
generically dependent continuant;analytical cytology data file;A digital entity intended to capture data in analytical cytology domain.
process;epitope specific IL-12 release by T cells;A biological process where T cells produce IL-12 resulting from the recognition of a T cell epitope.
process;epitope specific IL-13 release by T cells;A biological process where T cells produce IL-13 resulting from the recognition of a T cell epitope.
process;epitope specific IL-17 release by T cells;A biological process where T cells produce IL-17 resulting from the recognition of a T cell epitope.
generically dependent continuant;cellular feature identification objective;Cellular feature identification objective is a biological feature identification objective role describing a study designed to examine or characterize a biological feature monitored at the cellular level, e.g. stage of cell cycle, stage of differentiation.
generically dependent continuant;investigation results report;An investigation report is a report on the results of an investigation.
process;epitope specific IL-18 release by T cells;A biological process where T cells produce IL-18 resulting from the recognition of a T cell epitope.
process;epitope specific IL-1b release by T cells;A biological process where T cells produce IL-1b resulting from the recognition of a T cell epitope.
generically dependent continuant;equilibrium association constant (KA);A binding constant defined as the ratio of koff over kon (off-rate of binding divided by on-rate)
process;radioactivity detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a cell-bound-MHC:ligand complex;A radioactivity detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.
process;epitope specific IL-4 release by T cells;A biological process where T cells produce IL-4 resulting from the recognition of a T cell epitope.
process;access service;A service in which a service consumer receives the right to use a resource (instrument, database, software, etc) that is owned or managed by a service provider. Ownership of the accessed resource remains with the service provider during and after provision of service.
process;intracellular cytokine staining assay measuring epitope specific tumor necrosis factor (ligand) superfamily member 11 production by T cells;A flow cytometry assay that detects tumor necrosis factor (ligand) superfamily member 11 production by T cells.
process;assay measuring a binding constant of a MHC:ligand complex;A MHC:ligand binding assay that measures a binding constant.
generically dependent continuant;rate measurement datum;A scalar measurement datum that represents the number of events occuring over a time interval
process;assay measuring binding of a purified-MHC:ligand complex;A qualitative binding assay that detects the binding of a purified-MHC molecule with a ligand.
process;radioactivity detection assay measuring direct binding of a cell-lysate-MHC:ligand complex;A radioactivity detection assay that detects direct binding of a cell-lysate-MHC molecule with a ligand.
process;material storage service;A storage service in which a service consumer provides some material as input which a service provider stores and returns as output.
process;radioactivity detection assay measuring half life to determine direct binding of a cell-bound-MHC:ligand complex;A radioactivity detection assay that measures half life to detect the direct binding of a cell-bound-MHC molecule with a ligand.
process;data encoding;a documenting process to encode an information entity into a digital document
role;sub-investigator role;a worker role authorized to make study-related decisions and carry out tasks related to the study. this role occurs during the study timeline
role;vital dye role;A dye role that is realized when used to detect live cells in an experiment
role;reference subject role;a reference subject role which inheres in an organism or entity of organismal origin so that the characteristics or responses of the participant playing the reference participant role are used for comparison or reference
process;assay measuring binding of a cell-bound-MHC:ligand complex;A qualitative binding assay that detects the binding of a cell-bound-MHC molecule with a ligand.
process;3H-thymidine assay measuring epitope specific proliferation of T cells;A tritiated thymidine incorporation assay that detects T cell epitope specific proliferation in vitro.
process;BrdU assay measuring epitope specific proliferation of T cells;A BrdU incorporation assay that detects T cell epitope specific proliferation in vitro.
process;epitope specific T cell proliferation;A biological process where T cells proliferate resulting from the recognition of a T cell epitope.
process;epitope specific GM-CSF release by T cells;A biological process where T cells produce GM-CSF resulting from the recognition of a T cell epitope.
process;epitope specific IFN-g release by T cells;A biological process where T cells produce IFNg resulting from the recognition of a T cell epitope.
process;fluorescence detection assay measuring half life to determine direct binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures half life to detect the direct binding of a cell-bound-MHC molecule with a ligand.
process;epitope specific IL-10 release by T cells;A biological process where T cells produce IL-10 resulting from the recognition of a T cell epitope.
process;intracellular cytokine staining assay measuring epitope specific interleukin-17F production by T cells;A flow cytometry assay that detects interleukin-17F production by T cells.
process;material processing service;A service in which a service provider makes physical changes to a specified input material entity with the objective of producing a new material entity form input materials, or modifying the input material entity, and returning this as output to the service consumer.
process;radioactivity detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a purified-MHC:ligand complex approximated by IC50;A radioactivity detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation and provides IC50 values determined under assay conditions where the IC50 approximates a KD value.
process;radioactivity detection assay measuring half life to determine direct binding of a cell-lysate-MHC:ligand complex;A radioactivity detection assay that measures half life to detect the direct binding of a cell-lysate-MHC molecule with a ligand.
generically dependent continuant;50% dissociation of binding temperature (Tm);A quantitative binding datum that specifies the temperature at which half of the binding partners are forming a complex and the other half are unbound.
process;surveillance process;An investigation in which some entity is monitored, and data concerning that entity collected, interpreted, and disseminated, for the purpose of managing, directing, or protecting that entity, or some other entity.
process;radioactivity detection assay measuring binding off rate [koff] to determine direct binding of a cell-lysate-MHC:ligand complex;A radioactivity detection assay that measures binding off rate [koff] to detect direct binding of a cell-lysate-MHC molecule with a ligand.
role;cluster study group role;A study group role that is the result of the allocation of a cluster of study-defined groupings of people in a clinical trial to receive a specific intervention/treatment, or no intervention, according to the trial's protocol.
process;radioactivity detection assay measuring half maximal inhibitory concentration [IC50] to determine competitive binding of a purified-MHC:ligand complex;A radioactivity detection assay that measures half maximal inhibitory concentration (IC50) to detect the loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation.
role;compound study group role;A study group role that is the result of the allocation of a compound of geographically-proximate households with a shared component in a clinical trial to receive a specific intervention/treatment, or no intervention, according to the trial's protocol.
process;fluorescence detection assay measuring binding off rate [koff] to determine direct binding of a purified-MHC:ligand complex;A fluorescence detection assay that measures binding off rate [koff] to detect direct binding of a purified-MHC molecule with a ligand.
role;antigen role;A role of a material entity that is being recognized in whole or in part by receptors of the immune system such as antibodies or T cell receptors.
generically dependent continuant;standard error;A quantitative confidence value which is the standard deviations of the sample in a frequency distribution, obtained by dividing the standard deviation by the total number of cases in the frequency distribution.
role;trial statistician role;a worker role that analyzes data obtained during a trial or study. this role occurs after the trial or study is completed or terminated.
generically dependent continuant;hardware optimization objective;Hardware optimization is a hardware testing objective describing a study designed to identify the best hardware.
process;enzymatic cleavage;a material processing that digests the fraction of input material that is susceptible to that enzyme
process;fluorescence detection assay measuring half maximal effective concentration [EC50] to determine direct binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures half maximal effective concentration (EC50) to detect direct binding of a cell-bound-MHC molecule with a ligand.
generically dependent continuant;DNA sequence data;A sequence data item that is about the primary structure of DNA
process;assigning gene property based on phenotypic assessment;Interpreting data from assays that evaluate the qualities or dispositions inhering in an organism or organism part and comparing it to data from other organisms that have a defined genetic difference, and assigning a property to the product of the targeted gene as a result.
process;cytometric bead array assay measuring epitope specific intracellular cytokine staining (ICS) IL-22 production by T cells;A cytometric bead array assay that detects interleukin-22 production by T cells.
process;ELISA measuring epitope specific vascular endothelial growth factor production by T cells;An enzyme-linked immunosorbent assay that detects vascular endothelial growth factor production by T cells.
process;assay measuring binding of a cell-lysate-MHC:ligand complex;A qualitative binding assay that detects the binding of a cell-lysate-MHC molecule with a ligand.
role;technical replicate role;technical replicate role is realized when two portions from one evaluant are used in replicate runs of an assay
role;feed role;a role that inheres in a material entity and is realized in the use of that material entity by lab animal to provide all needed nourishment.
material entity;organization;An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members.
process;assay measuring epitope specific vascular endothelial growth factor production by T cells;A T cell epitope specific cytokine production assay that detects vascular endothelial growth factor production by T cells.
role;sponsor role;a responsible party role involved with any of the following activities: initiating, managing and funding a study
generically dependent continuant;equilibrium dissociation constant (KD) approximated by IC50;A measurement of an IC50 value under specific assay conditions approximates KD, namely the binding reaction is at an equilibrium, there is a single population of sites on the receptor that competitor and ligand are binding to, and the concentration of the receptor must be much less than the KD for the competitor and the ligand. In this case, according to Cheng and Prussoff, KD = IC50 / (1 + Lstot / KDs), in which Lstot is the total concentration of the labeled competitor and KDs is the KD value of that competitor.
generically dependent continuant;software testing objective;Software testing objective is a hardware optimization role describing a study designed to examine the effects of using different software or software parameters, e.g. data processing software.
material entity;catheter;A device which is a flexible tube inserted into a body and which enables transfer of fluids into or out of a body.
process;coelution assay measuring MHC ligand processing and presentation using T cell recognition of HPLC fractionated eluate compared to synthetic ligand;A MHC ligand processing and presentation assay in which an HPL chromatography is run to separate an input mixture of ligands eluted from MHC into fractions. These fractions are tested for recognition by T cells and compared to the recognition of a synthetic ligand that is presumed to be the recognized epitope. Identical HPLC fractionation and T cell recognition patterns confirm that the specific ligand was presented by MHC molecules.
process;fluorescence detection assay;An assay in which a material's fluorescence is determined.
process;epitope specific perforin production by T cells;The production of perforin, an immune mediator molecule involved in T cell degranulation, resulting from the recognition of a T cell epitope.
process;MHC protein complex binding to ligand;The process in which a ligand binds to an MHC molecule to form a stable complex.
process;dissection;A planned process that separates and isolates tissues for surgical purposes, or for the analysis or study of their structures.
process;purification;A planned process to separate a material entity into different compositions of which one or more have are purified fractions that contain higher concentration of a desired component, while others contain impurities and are not of interest
material entity;specimen with pre- or post-mortem status;A specimen that has been established to be taken from a live (pre-mortem) or dead (post-mortem) organism.
process;in vivo assay measuring T cell epitope specific treatment of disease;An efficacy of T cell epitope intervention experiment that detects a decrease in disease.
generically dependent continuant;sampling time measurement datum;A time measurement datum when an observation is made or a sample is taken from a material as measured from some reference point.
process;Edman degradation assay measuring MHC ligand processing and presentation;A MHC ligand processing and presentation assay that uses Edman degradation to identify the eluted ligands
process;mass spectrometry assay measuring MHC ligand processing and presentation of MHC ligands eluted from secreted MHC;A mass spectrometry of MHC ligands that identifies eluted ligands from secreted MHC.
disposition;disposition to be a product of antigen processing and presentation;A disposition of a material entity to be presented by MHC molecules on the cell surface as a result of antigen processing by an antigen presenting cell.
process;cytometric bead array assay measuring epitope specific interleukin-17A production by T cells;A cytometric bead array assay that detects interleukin-17A production by T cells.
process;radioactivity detection assay measuring competitive binding of a purified-MHC:ligand complex;A radioactivity detection assay that detects loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation.
generically dependent continuant;minimal inhibitory concentration;A scalar measurement datum that indicates the lowest concentration at which a specific compound significantly inhibits a process from occurring compared to in the absence of the compound.
process;material maintenance service;A material processing service in which a service provider makes physical modifications to a specified input material, such that at least one of the specified outputs of this process is a modified version of a specified input material.
process;radioactivity detection assay measuring half maximal effective concentration [EC50] to determine direct binding of a cell-lysate-MHC:ligand complex;A radioactivity detection assay that measures half maximal effective concentration (EC50) to detect the direct binding of a cell-lysate-MHC molecule with a ligand.
process;radioactivity detection assay measuring half maximal inhibitory concentration [IC50] to determine competitive binding of a cell-bound-MHC:ligand complex;A radioactivity detection assay that measures half maximal inhibitory concentration (IC50) to detect the loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.
process;epitope specific tumor necrosis factor (ligand) superfamily member 11 production by T cells;A process of tumor necrosis factor (ligand) superfamily member 11 production by T cells resulting from the recognition of a T cell epitope.
process;fluorescence detection assay measuring direct binding of a cell-lysate-MHC:ligand complex;A fluorescence detection assay that detects direct binding of a cell-lysate-MHC molecule with a ligand.
process;fluorescence detection assay measuring half maximal inhibitory concentration [IC50] to determine competitive binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures half maximal inhibitory concentration (IC50) to detect the loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.
process;ELISA measuring epitope specific granulocyte colony stimulating factor production by T cells;An enzyme-linked immunosorbent assay that detects granulocyte colony stimulating factor production by T cells.
generically dependent continuant;sequence assembly algorithm;An algorithm used to assemble individual sequence reads into larger contiguous sequences (contigs). Assembly details include but are not limited to assembler type (overlap-layout-consensus, deBruijn), assembler version, and any relevant quality control information such as per cent known genes/ESTs captured.
process;cytometric bead array assay measuring epitope specific interleukin-17F production by T cells;A cytometric bead array assay that detects interleukin-17F production by T cells.
process;fluorescence detection assay measuring equilibrium association constant [KA] to determine direct binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures equilibrium association constant (KA) to detect the direct binding of a cell-bound-MHC molecule with a ligand.
generically dependent continuant;PDB file;A 3d structural organization datum capturing the results of X-ray crystallography or NMR experiment that is formatted as specified by the Protein Databank (http://www.wwpdb.org/docs.html). A PDB file can describe the structure of multiple molecules, each of which has a different chain identifier assigned.
process;epitope specific interleukin-17A production by T cells;A process of interleukin-17A production by T cells resulting from the recognition of a T cell epitope.
process;support service;A service in which the service provider assists the consumer in activities directly or indirectly associated with the production and analysis of experimental research data.
process;material service;A service which has a material entity as specified input and/or specified output.
process;data analysis service;A service in which a service consumer provides some input data and a service provider transforms, models, or interprets the input data and returns this generated data as output.
process;data service;A service that has some information content entity as input and output.
process;fluorescence detection assay measuring half life to determine direct binding of a purified-MHC:ligand complex;A fluorescence detection assay that measures half life to detect the direct binding of a purified-MHC molecule with a ligand.
process;cytometric bead array assay measuring epitope specific interleukin-9 production by T cells;A cytometric bead array assay that detects interleukin-9 production by T cells.
process;data storage service;A storage service in which a service consumer provides data as input which a service provider stores and returns as output in its original form.
process;fluorescence detection assay measuring competitive binding of a purified-MHC:ligand complex;A fluorescence detection assay that detects loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation.
process;epitope specific interleukin-7 production by T cells;A process of interleukin-7 production by T cells resulting from the recognition of a T cell epitope.
generically dependent continuant;equilibrium dissociation constant (KD);A binding constant defined as the ratio of kon over koff (on-rate of binding divided by off-rate)
role;nutrient role;a role that inheres in a material entity and is realized in the use of that material entity by an organism when it is used in that organism's metabolism and provides nourishment.
role;investigation agent role;A role borne by an entity and that is realized in a process that is part of an investigation in which an objective is achieved. These processes include, among others: planning, overseeing, funding, reviewing.
process;radioactivity detection;An assay that measures the amount of radiation in the radioactive spectrum (alpha, beta or gamma rays) emitted from an input material.
generically dependent continuant;methodology testing objective;Methodology testing objective is an objective role carried out by a proposition defining the aim of the study is to examine the effect of using different methodologies.
process;fluorescence detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a purified-MHC:ligand complex;A fluorescence detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation.
process;training service;A service in which the service provider offers educational materials or events, such as courses, workshops or graduate programs, to the service consumer.
process;fluorescence detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.
process;arthropod resting outdoors on natural support specimen collection by aspiration;An arthropod resting outdoors specimen collection by aspiration that occurs while the arthropod rests on an unprocessed material such as a plant.
material entity;cell pellet;A material entity which results from the aggregation of cells produced by the application of centrifugal force to a liquid containing cells in suspension
process;arthropod resting outdoors specimen collection by aspiration;An animal-biting arthropod specimen collection by aspiration that occurs while the arthropod is resting outside a building during a period of inactivity.
material entity;cell culture supernatant;Supernatant of a cell culture is a material entity which contains media, supplements, and secreted products of the cells and becomes the environment of cultivated cell.
process;arthropod specimen collection by aspiration;A live arthropod specimen collection process that involves the use of an aspirator, a device which draws an arthropod by suction into a container.
process;arthropod specimen collection process;A specimen collection process that has the objective of collecting arthropods as specimens.
process;human-biting arthropod specimen collection by aspiration;An arthropod specimen collection by aspiration that occurs while the arthropod is biting a human.
process;human-biting indoor arthropod specimen collection by aspiration;An arthropod specimen collection by aspiration that occurs while the arthropod is biting a human inside a building.
process;human-biting outdoor arthropod specimen collection by aspiration;An arthropod specimen collection by aspiration designed to catch specimens that are in the process of biting a human outside a building.
process;knockdown arthropod specimen collection by pyrethrum spray;A knockdown arthropod specimen collection process in which the pesticide is pyrethrum.
material entity;phage display library;a phage display library is a collection of materials in which a mixture of genes or gene fragments is expressed and can be individually selected and amplified.
process;knockdown arthropod specimen collection process;An arthropod specimen collection process that involves exposing arthropods to pesticide, then collecting them once they become dead or immobilized.
process;live arthropod specimen collection process;An arthropod specimen collection process meant to collect live specimens.
material entity;arthropod trap;A device designed to catch arthropods.
material entity;artificial pit shelter;An arthropod trap, consisting of a pit dug in the ground to provide a space for arthropods to rest and be collected.
material entity;baited net trap;An arthropod trap designed to work with an animal (which could be human) inside a netted structure. This structure is designed so that an arthropod, attracted by the animal, can fly into the netted structure but can neither escape nor reach the animal.
material entity;barrier trap;An arthropod trap consisting of a static physical barrier designed to funnel arthropods in flight into a container.
material entity;BG-Counter;A device manufactured by BioGents that is designed to count mosquitoes passing through the device, differentiating the mosquitoes from other arthropods.
material entity;BG-Sentinel trap;An arthropod trap that is manufactured by Biogents and is designed to attract arthropods through the use of a motorized fan to mimic convection currents produced by a human. The current also pulls arthropods into the trap, where a layer of gauze prevents the arthropods from escaping along with the air current.
material entity;Centers for Disease Control and Prevention light trap;A light trap that is designed similarly to the New Jersey trapin that it uses motorized suction and light attractantand is powered by a six-volt battery.
material entity;dipper for arthropod immatures;A device that is designed for the collection of arthropod larvae or pupae from water and has the shape of a ladle or a pan.
material entity;encephalitis virus surveillance trap;A light trap that uses carbon dioxide as attractant. The trap consists of a container of dry ice with holes in the bottom to allow the carbon dioxide to flow downward into a separate container, in which a motorized fan creates suction to collect arthropods.
material entity;gravid trap;An arthropod trap that is designed to collect gravid female arthropods or their eggs.
material entity;light trap;An arthropod trap that uses light as an attractant.
process;assay measuring epitope specific granulocyte colony stimulating factor production by T cells;A T cell epitope specific cytokine production assay that detects granulocyte colony stimulating factor production by T cells.
material entity;light trap for indoor use;A light trap designed to be placed inside a building.
process;cytometric bead array assay measuring epitope specific intracellular cytokine staining (ICS) IL-21 production by T cells;A cytometric bead array assay that detects interleukin-21 production by T cells.
material entity;light trap for outdoor use;A light trap designed to be placed outside a building.
process;radioactivity detection assay measuring direct binding of a cell-bound-MHC:ligand complex;A radioactivity detection assay that detects direct binding of a cell-bound-MHC molecule with a ligand.
material entity;Mosquito Magnet Pro trap;An arthropod trap that is powered by propane and is designed to emit a combination of carbon dioxide, heat, water, and oct-1-en-3-ol attractants while simultaneously using suction to trap arthropods.
generically dependent continuant;binding off rate measurement datum (koff);A rate measurement datum of how quickly bound complexes disassociate
material entity;MosquiTRAP;A gravid trap consisting of an arthropod attractant and adhesive surface.
process;fluorescence detection assay measuring 50% dissociation of binding temperature [Tm] of a purified-MHC:ligand complex;A fluorescence detection assay that measures the 50% dissociation of binding temperature of a purified-MHC molecule with a ligand.
material entity;New Jersey light trap;A light trap that is designed to use motorized suction to trap arthropods in a collection bag once they approach the light attractant.
generically dependent continuant;binding on rate measurement datum (kon);A rate measurement datum of how quickly bound complexes form
material entity;Onderstepoort Veterinary Institute light-suction trap;A light trap that is designed to use motorized suction to trap arthropods in a collection bag once they approach the attractant. The light is supplied by an 8 watt tube, and the fan providing the suction has an 11-centimeter diameter.
process;fluorescence detection assay measuring direct binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that detects direct binding of a cell-bound-MHC molecule with a ligand.
material entity;outlet window trap;An arthropod trap that is positioned adjacent to a window of a building and is designed to collect arthropods flying out of the building.
process;assay measuring epitope specific tumor necrosis factor (ligand) superfamily member 11 production by T cells;An assay of epitope specific tumor necrosis factor (ligand) superfamily member 11 production by T cells that detects tumor necrosis factor production.
material entity;ovitrap;An arthropod trap that consists of a container holding a mesh layer above water and is designed to trap arthropods hatched from eggs dropped over the water by gravid females.
process;radioactivity detection assay measuring direct binding of a purified-MHC:ligand complex;A radioactivity detection assay that detects direct binding of a purified-MHC molecule with a ligand.
material entity;resting arthropod trap;An arthropod trap that is designed to be attractive to an arthropod as a place to rest during a period of inactivity.
process;intracellular cytokine staining assay measuring epitope specific interleukin-8 production by T cells;A flow cytometry assay that detects interleukin-8 production by T cells.
material entity;resting box trap;An arthropod trap that consists of a box that is open on one end. The placement of the box and modifications to it are done in such a way that it becomes attractive to an arthropod as a place to rest during a period of inactivity.
process;cytometric bead array assay measuring epitope specific intracellular cytokine staining (ICS) IL-23 production by T cells;A cytometric bead array assay that detects interleukin-23 production by T cells.
material entity;resting bucket;An arthropod trap that consists of a bucket, which is lined with fabric and placed on its side, and a wet cloth inside the bucket. The placement of the box and modifications to it are done in such a way that it becomes attractive to an arthropod as a place to rest during a period of inactivity (not actively seeking a host).
material entity;Shannon trap;An arthropod trap that is made of cloth and netting and is designed to be suspended from above (e.g. from a tree). It is also designed so that the arthropod enters the trap from beneath, being attracted to some bait, and is prevented from escaping upward by the suspended cloth, which allows them to be collected from the upper interior of the trap.
process;epitope specific vascular endothelial growth factor production by T cells;A process of vascular endothelial growth factor production by T cells resulting from the recognition of a T cell epitope.
material entity;sticky resting bucket;An arthropod trap that consists of a bucket, which is lined with adhesive and placed on its side, and a wet cloth inside the bucket. The placement of the box and modifications to it are done in such a way that it becomes attractive to an arthropod as a place to rest during a period of inactivity. The trap is designed for arthropods to become caught in the adhesive so that they can be collected.
process;fluorescence detection assay measuring half maximal inhibitory concentration [IC50] to determine competitive binding of a purified-MHC:ligand complex;A fluorescence detection assay that measures half maximal inhibitory concentration (IC50) to detect the loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation.
material entity;sticky trap;An arthropod trap that is designed to capture arthropods resting on a surface by coating the surface with adhesive.
generically dependent continuant;GenBank ID;A CRID symbol uniquely indentifies the submitted GeneBank sequence record.
generically dependent continuant;population based design;A study design where the selection of the individuals that are included into the study are intended to be representative of all individuals in the a priori defined specific population and is done at the population level or among the population groups, generally to find the cause, incidence or spread of the disease or to see the response to the treatment, nutrition or environment.
generically dependent continuant;investigation description;A textual entity that describes an investigation.
process;fluorescence imaging-based apoptosis assay;A type of cytometry assay in which fluorescent dyes are used to label and detect proteins or structures associated with molecular processes of apoptosis.
generically dependent continuant;specimen identifier;A CRID symbol denotes a specimen and used to distinguish one specimen from another in an investigation.
process;fluorescence imaging-based cell proliferation assay;A type of cell proliferation assay in which fluorescent dyes are ued to label and detect proteins or structures that can be used to count cells.
generically dependent continuant;PubMed ID;A CRID symbol that is sufficient to look up a citation from the PubMed, a literature database of life sciences and biomedical information.
process;fluroescence imaging-based cell cycle state assay;A type of cytometry assay in which fluorescent dyes are used to label and detect proteins or structures associated with particular cell cycle states.
generically dependent continuant;average depth of sequence coverage;An average value of the depth of sequence coverage based both on external (e.g. Cot-based size estimates) and internal (average coverage in the assembly) measures of genome size.
process;fluorescence imaging-based cell viability assay;A type of cytometry assay in which fluorescent dyes are used to label and detect proteins or structures associated with cell viability.
generically dependent continuant;specimen collection time measurement datum;A time measurement datum that is the measure of the time when the specimens are collected.
material entity;transgenic organism;a transgenic organism is material entity which derives from an organism which has been modified to express a gene not normally part of it
material entity;whole mount tissue;A whole organism preparation resulting from a histological preparation known as whole mount preparation where the whole specimen is mounted or spread on the microscope (glass) slide
material entity;peptide construct;a material entity synthesized to contain a number of peptides conjugated together in a non-linear fashion
material entity;cell lysate;a cell lysate is a material entity which is output of a cell lysis process
material entity;ultraviolet light source;A light source that provides ultraviolet (UV) light for use in a distant area using a delivery system.
process;arthropod resting outdoors on artificial support specimen collection by aspiration;An arthropod resting outdoors specimen collection by aspiration that occurs while the arthropod rests on a processed material such as a wall or furniture.
material entity;visible light source;A light source that provides visible light for use in a distant area using a delivery system.
material entity;solar light source;A light source that light is produced from solar energy.
process;adult arthropod specimen collection process;A live arthropod specimen collection process in which the arthropods are in the adult stage.
process;animal-biting arthropod specimen collection by aspiration;An arthropod specimen collection by aspiration that occurs while the arthropod is biting an animal.
process;animal-biting outdoor arthropod specimen collection by aspiration;An animal-biting arthropod specimen collection by aspiration that occurs outside a building.
process;aquatic arthropod specimen collection process;An arthropod specimen collection process that has the objective of collecting mosquitoes from an aquatic environment.
process;arthropod resting in animal house specimen collection by aspiration;An arthropod specimen collection by aspiration that catches specimens resting inside an animal house.
material entity;specimens collected in one encounter;A collection of specimens that is collected from one source (e.g. one organism) during a time period which for the purpose of the study can be considered to be taken at the same sampling time.
process;in vitro assay measuring epitope specific proliferation of T cells;A T cell epitope specific proliferation assay that is performed on cells in vitro.
process;assay measuring qualitative binding of a MHC:ligand complex;An assay that detects the binding of a MHC molecule with a ligand, and produces a qualitative measurement of the binding as an output.
process;in vivo assay measuring T cell epitope specific protection from challenge;An efficacy of T cell epitope intervention experiment that uses a epitope protection experiment.
process;assay measuring T cell epitope specific suppression in vitro;T cell epitope dependent biological activity assay that detects suppression of an in vitro response.
process;MHC ligand assay;An immune epitope assay that characterizes the structrue of a MHC-ligand complex, or detects the processing and presentation of a ligand by an antigen presenting cell, or the binding of a ligand to an MHC molecule.
material entity;collection of specimens;A material entity that has two or more specimens as its parts.
material entity;specimens derived from shared ancestor;A collection of specimens derived from one common specimen via one or more material processing process(es).
process;specimen set collection process;A specimen collection process that generates multiple specimens from one source (e.g. one organism) during a time period which for the purpose of the study can be considered to be taken at the same sampling time.
material entity;human specimen set;A specimen set that is collected from one person during a time period which for the purpose of the study can be considered to be taken at the same sampling time.
material entity;specimens collected longitudinally;A collection of specimens that was derived from the same source material entity at different time points in order to observe changes in that entity.
process;reporter gene assay;An assay that detects expression of a reporter gene that was inserted under the control of a regulatory sequence of interest.
process;enhancer activity detection by reporter gene assay;A reporter gene assay that detects expression of a reporter gene that was inserted under the control of an enhancer of interest.
process;transcription cofactor activity region identification by ChIP-Seq assay;A ChIP-seq assay that identifies regions of chromatin bound to a chromatin modifying protein, e.g. a histone acetyltransferase.
process;transcript expression location detection by hybridization chain reaction assay;An in situ hybridization assay in which the location (e.g. anatomical/tissue) of a transcript is detected by a multiplexed fluorescent in situ hybridization, based on orthogonal amplification with hybridization chain reactions (HCR). RNA probes complementary to mRNA targets trigger chain reactions in which fluorophore-labeled RNA hairpins self-assemble into tethered fluorescent amplification polymers.
process;Tet-assisted bisulfite sequencing assay;A bisulfite sequencing assay that identifies genomic methylation patterns by using a bisulfite based protocol with the Tet enzyme to differentiate 5-hydroxylmethylcytosine (5hmC) from 5-methylcytosine (5mC) through a step-wise oxidative demethylation of 5mC, converting it to 5-carboxylcytosine (5caC) while keeping 5hmC protected.
function;containing a specimen function;A contain function that involves physical contact with a specimen. This function is typically performed in such a way that the specimen is usable for an investigation or assay.
material entity;specimen container;A container with the function of containing a specimen.
material entity;physical store;A container with an environmental control function.
material entity;analog-to-digital converter;An analog-to-digital converter is an instrument that converts an infinite resolution analog signal to a finite resolution digital signal.
material entity;A40-MiniFCM;A A40-MiniFCM is a flow cytometer analyser that allows for the choice of one of four lasers (375nm, 405nm,488nm, 532nm, 635nm), and PMTs and filters for collecting up to four parameters. It uses digital electronics. A military version of this cytometer is available as well. The A40-MiniFCM is geared towards the most demanding applications such as archaea, bacteria and large virus.
material entity;A10-Analyzer;A A10 is a flow cytometer analyser manufactured by Apogee. It uses an arc lamp as a light source, with choices of 75W Xe, 75W Xe/Hg or 100W Hg arc lamps. It has filters and collectors for up to three fluorescent parameters and two scatter parameters. It uses analog electronics. The A10 can be used for measuring the properties of individual cells.
process;rapid amplification of cDNA ends;A reverse transcribed polymerase chain reaction that is used to amplify a mRNA sequence between a defined internal site and the 5' or 3' end of the mRNA.
process;5' rapid amplification of cDNA ends;A rapid amplication of cDNA ends to amplify a mRNA sequence between a defined internal site and the 5' end of the mRNA.
material entity;arc lamp;Arc lamp is a light source that produces light by an electric arc (or voltaic arc). The lamp consists of two electrodes typically made of tungsten which are separated by a gas. The type of lamp is often named by the gas contained in the bulb. including neon, argon, xenon, krypton, sodium, metal halide, and mercury. The electric arc in an arc lamp consists of gas which is initially ionized by a voltage and is therefore electrically conductive. To start an arc lamp, usually a very high voltage is needed to ignite or strike the arc. This requires an electrical circuit sometimes called an igniter, which is part of a larger circuit called the ballast. The ballast supplies a suitable voltage and current to the lamp as its electrical characteristics change with temperature and time. Older cytometers may use arc lamps to irradiate particles at the interrogation point.
process;3' rapid amplification of cDNA ends;A rapid amplication of cDNA ends to amplify a mRNA sequence between a defined internal site and the 3' end of the mRNA.
material entity;flow cytometer analyzer;An analyser is a flow cytometer that is used to measure properties of particles (whole cells, nuclei, chromosomes, diatoms, plankton, bacteria, viruses) by moving these particles through a detection chamber. An analyser is used to collect data for analysis.
process;5' RNA ligase mediated rapid amplification of cDNA ends;A 5' rapid amplification pf cDNA ends that uses RNA ligase to add an RNA adapter oligonucleotide to intact 5' mRNA ends, allowing the amplification of cDNA only from full-length, capped mRNA.
material entity;pool of specimens;A pool of specimens is a mixture of a population of samples which have been gathered from one or more sample populations, obtained by the physical process of mixing individual specimens, e.g. mixing the DNA collected from the individual fish.
process;MethylC-Capture sequencing assay;A bisulfite sequencing assay in which a whole-genome sequencing library is prepared, bisulfite converted and amplified, followed by a capture enriching for targeted bisulfite-converted DNA fragments that are are subsequently identified by DNA sequencing.
process;specimen family creation;A material processing that has as its input a specimen and as its output a collection of specimens.
process;carboxyfluorescein succinimidyl ester staining assay measuring epitope specific proliferation of T cells;A CFSE assay that detects T cell epitope specific proliferation in vitro.
process;assay measuring the dissociation constant [KD] of a T cell epitope:MHC:TCR complex;A T cell epitope binding constant determination assay that measures the dissociation constant KD.
process;assay measuring the on rate [kon] of a T cell epitope:MHC:TCR complex;A T cell epitope binding constant determination assay that measures the on rate.
process;assay measuring the off rate [koff] of a T cell epitope:MHC:TCR complex;A T cell epitope binding constant determination assay that measures the off rate.
process;peptide mass fingerprinting assay;A mass spectrometry assay that measures the absolute mass of the cleaved peptides derived from an unknown protein of interest. These masses are then compared to values for known protein sequences to identify the unknown protein.
generically dependent continuant;diagnosis of an organism;A conclusion based on data about that an organism has a disease, disorder, or syndrome of a certain type, or none of these.
process;array based nucleic acid structure mapping assay;An assay which aims to provide information about the in vivo organization/structure of nucleic acids using chemical or enzymatic probes using a microarray.
process;organism diagnostic process;A drawing a conclusion based on data that involves the interpretation of data about a given organism (human, animal, or plant) and the assertion to the effect that the organism has or had a disease, disorder, or syndrome of a certain type, or none of these as output.
process;micrococcal nuclease digestion followed by tiling array assay;An array based nucleic acid structure mapping assay that identifies nucleosome positions genome wide, by detection of regions protected by nucleosomes from digestion by micrococal nuclease using tiling array assays
material entity;assay kit;A device that consists of reagents and devices that enable the performance of a specific type of assay, which could, in addition, require specific instruments not included in the kit.
process;ribosomal profiling by sequencing assay;A RNA-seq assay that sequences only mRNA protected by the ribosome during translation.
process;detection technique;An assay (A) that is part of another assay (B), where the target entities of A and B are disjoint, and the target entity of A is a proxy for the target of assay B.
process;assay for transposase-accessible chromatin using sequencing;An assay to capture the location of open chromatin, DNA-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution by Tn5 transposase insertion.
generically dependent continuant;lesion mask;An image data set where voxel intensity values greater than zero encode the location of some brain lesion and voxels outside the lesion have an intensity value of zero.
process;genotyping by tiling array assay;A genotyping by array assay that uses tiling array technology.
generically dependent continuant;image segmentation map;An image data set of integer values in which each value corresponds to some shared characteristic or computed property. The values often belong to a group of pixels or voxels that share the same characteristic, such as a tissue type or anatomical region.
process;genotyping by SNP array assay;A genotyping by array assay that uses SNP array technology.
generically dependent continuant;T2 FLAIR lesion mask;A lesion mask where the lesions are derived from a T2 FLAIR image data set.
process;parallel analysis of RNA structure assay;A single-nucleotide-resolution nucleic acid structure mapping assay that performs simultaneous in vitro profiling of the secondary structure of thousands of RNA species at single nucleotide resolution using enzymatic probing based on deep sequencing fragments of RNAs that were treated with structure-specific enzymes
generically dependent continuant;T1 lesion mask;A lesion mask where the lesions are derived from a T1 weighted image data set.
process;translation-associated transcript leader sequencing assay;An RNA-seq assay that combines TL-seq with polysome fractionation
generically dependent continuant;milk assay datum;A data item that is the specified output of a milk assay.
process;transcript leader sequencing assay;An RNA-seq assay that combines enzymatic capture of m(7)G-capped mRNA 5' ends with high-throughput sequencing.
material entity;FACS Scan;A FACS Scan is a flow cytometer analyser manufactured by Becton Dickinson. IT features analog electronics, one 488 nm solid state laser, and the filters and PMTs to collect up to three fluorescent parameters The FACS Scan is usually used for research applications.
material entity;FACS Canto2;A FACS Canto2 is a flow cytometer analyser manufactured by BD. It features digital electronics, two solid state lasers at 488 and 633 nm with the option for a third 405 nm laser, and filters and collectors for measuring up to 8 fluorescent paramters with either the 2 or 3 laser option. The FACS Canto2 is an analyser usually used in clinical applications.
material entity;FACS Canto;A FACS Canto is a flow cytometer analyser manufactured by Becton Dickinson. It features digital electronics, a solid state 488 nm, and a HeNe 633 nm lasers, and filters and PMTs for collecting up to 6 fluorescent parameters. The FACS Canto is an analyser usually used in clinical applications.
material entity;differential pressure gauge;Part of the fluidics subsystem. The differential pressure gauge monitors the difference between sample and sheath fluid pressures in systems where pressure is used to force the sample fluid to flow in the center of the sheath fluid. A differential pressure gauge can be used by the operator to make sure that the sample fluid is at a greater pressure than the sheath fluid, which maintains a core of sample fluid.
material entity;dichroic mirror;A dichroic mirror is an optical filter which is used to selectively reflect light of a small range of colors while passing other colors. A dichroic filter passes the specified range of light whereas a dichroic mirror reflects the specified range of light.
material entity;dichroic filter;A dichroic filter is an optical filter which is used to selectively pass light of a small range of colors while reflecting other colors. A dichroic filter passes the specified range of light whereas a dichroic mirror reflects the specified range of light.
material entity;FACS Calibur;The FACS Calibur is one of the most popular cytometers in use for research.
material entity;dye laser;A dye laser is a laser in which the lasing medium is a fluorescent dye, usually dissolved in an organic solvent such as ethanol or ethylene glycol. The particular dye used determines the wavelengths the laser can emit. The laser medium is places between two parallel mirrors for light emission amplification.
material entity;diode laser;A diode laser is a laser in which the active medium is a p-n junction semiconductor laser diode, similar to that found in a light-emitting diode. Laser diodes emit at wavelengths from 375 nm to 1800 nm, and wavelengths of over 3 micrometer have been demonstrated. A diode laser can by used to irradiate cells in a flow cytometer.
material entity;surface plasmon resonance sensor chip;A device that is used as a binding surface for ligand during a surface plasmon resonance assay, consisting of a glass plate to which a metal film is attached
material entity;enzyme-linked antibody;A processed material that is comprised of an antibody that is covalently linked to an enzyme through bioconjugation. The enzyme can be used as a detection method when the enzyme's reaction produces a detectable signal, for example a color change when the substrate is added.
material entity;Illumina HiSeq 3000;A DNA sequencer manufactured by Illumina corporation, with a single flow cell and a throughput of more than 200 Gb per day.
material entity;Illumina HiSeq 4000;A DNA sequencer manufactured by Illumina corporation, with two flow cell and a throughput of more than 400 Gb per day.
material entity;Guava Personal Cell Analysis;A Guava Personal Cell Analysis System is a flow cytometer analyser that includes a single 532 nm laser, and filters and PMTs to collect up to 2 fluorescent parameters. It includes a photodiode forward scatter collector. Guava cytometers use aspiration instead of fluid systems to transport cells within the machine. The PCA96 uses only tubes to introduce specimen. The Guava PCA cytometer is a small portable cytometer particularly useful for field measurement.
process;chromatin isolation by RNA purification sequencing assay;A detection of specific nucleic acids with complementary probes assay that measures regions of the genome which are bound by a specific RNA (or a by a ribonucleoprotein containing the RNA of interest) using high-throughput sequencing.
process;assay measuring epitope specific lymphotactin production by T cells;A T cell epitope specific cytokine production assay that detects lymphotactin production by T cells.
process;self-transcribing active regulatory region sequencing assay;An RNA-seq assay that identifies the sequences that act as transcriptional enhancers in a direct, quantitative, and genome-wide manner from sheared genomic DNA.
process;epitope specific XCL1 release by T cells;A biological process where T cells produce XCL1 resulting from the recognition of a T cell epitope.
process;carbon-copy chromosome conformation capture assay followed by sequencing assay;A carbon-copy chromosome conformation capture assay to analyze the organization of chromosomes in an unbiased, genome-wide manner using high throughput sequening following carbon-copy chromosome conformation capture.
process;remote patient assessment;An organism diagnostic process which involves a remote assessment of a patient by a clinician.
process;individual-nucleotide resolution cross-linking and immunoprecipitation sequencing assay;A cross-linking immunoprecipitation high-throughput sequencing assay that identifies protein-RNA interactions using UV light to covalently bind proteins and RNA molecules, allowing for a very stringent purification of the linked protein-RNA complexes.
process;ELISA measuring epitope specific lymphotactin production by T cells;An enzyme-linked immunosorbent assay that detects lymphotactin production by T cells.
process;RNA Bind-n-Seq assay;An RNA-seq assay that comprehensively characterizes sequence and structural specificity of RNA binding proteins (RBPs).
process;polyA-site sequencing assay;A RNA-seq assay that quantitatively profiles RNA polyadenylation at the transcriptome level.
material entity;Guava EasyCyte Plus;A Guava EasyCyte Plus System is a flow cytometer analyser that includes a single 488 nm laser, and filters and PMTs to collect up to 4 fluorescent parameters. It includes a photodiode forward scatter collector and an optional photodiode for side scatter collection.Guava cytometers use aspiration instead of fluid systems to transport cells within the machine. The EasyCyte plus accepts 96 well plates as well as tubes. The Guava EasyCyte Plus cytometer is a small portable cytometer particularly useful for field measurement.
material entity;Guava EasyCyte Mini;A Guava EasyCyte Mini is a flow cytometer analyser that includes a single 488 nm laser, and filters and PMTs to collect up to 3 fluorescent parameters. It includes a photodiode forward scatter collector and an optional photodiode for side scatter collection.Guava cytometers use aspiration instead of fluid systems to transport cells within the machine. The mini accepts tubes only for inputting cells or beads. The Guava EasyCyte Mini cytometer is a small portable cytometer particularly useful for field measurement.
material entity;flow cell;Aparatus in the fluidic subsystem where the sheath and sample meet. Can be one of several types. jet-in-air, quartz cuvette, or a hybrid of the two. The sample flows through the center of a fluid column of sheath fluid in the flow cell.
material entity;FC 500;A FC 500 is a flow cytometer analyser manufactured by Beckman Coulter. It features digital electronics, 488 nm and 635 nm lasers, filters and PMTs for 5 fluorescent parameters, a diode for collecting side scatter and a solid state detector for forward scatter. The FC 500 is an analyser usually used for either research or clinical applications.
material entity;FACSvantage;The FACSvantage is a flow cytometer sorter manufactured by Becton Dickinson. It has analog electronics, three lasers (several options are available), and the filters and PMTs to collect 6 fluorescent parameters and side scatter, and a photodiode to collect forward scatter. The FACSvantage can be used to analyse, sort and collect cells.
material entity;FACSAria;A FASCSAria is a flow cytometer sorter manufactured by Becton Dickinson. It features digital electronics, a solid state 488 nm blue laser, a solid state 407 nm violet laser, and a HeNe (633 nm) ion laser. The Aria has the filters and PMTs to collect side scatter and 9 fluorescent parameters. The Aria has a photodiode detector for forward scatter collector. The flow cell is Quartz cuvette. The FACSAria is a sorter used to collect and analyse cells using up to 11 parameters.
material entity;gas laser;A gas laser is a laser in which the lasing medium is a gas. The laser medium is places between two parallel mirrors for light emission amplification. The gas is excited to emit light via an external light source or an electric current discharging through the gas.
material entity;fluid pressure regulator;Part of the fluidic subsystem. The fluid pressure regulator maintains constant pressure within the sheath and or sample lines by filling the lines with enough gas to push the fluid at the desired rate. The gas is usually air, and less frequently nitrogen. In the sheath line, the gas is pushed into the sheath tank. In the sample line the gas is pushed into the collection tube. Fluid pressure regulators maintain great enough pressure to push sample fluid out of the tube and sheath fluid out of the sheath tank.
material entity;flow cytometer;A flow cytometer is an instrument for counting, examining and sorting microscopic particles in suspension. It allows simultaneous multiparametric analysis of the physical and/or chemical characteristics of single cells flowing through an optical and/or electronic detection apparatus. A flow cytometer is an instrument that can be used to quantitatively measure the properties of individual cells in a flowing medium.
process;assay measuring epitope specific macrophage migration inhibitory factor (MIF) production by T cells;A T cell epitope specific cytokine production assay that detects macrophage migration inhibitory factor (MIF) production by T cells.
material entity;Agilent-030493 SurePrint G3 Mouse Exon 4x180K Microarray;A DNA microarray manufactured with Agilent 60-mer SurePrint Technology for studying exon-level gene expression changes. The SurePrint G3 Mouse Exon 4x180K Microarray include probes targeting individual exons. Each glass slide formatted with four 180K arrays.
process;assay measuring epitope specific oncostatin M production by T cells;A T cell epitope specific cytokine production assay that detects oncostatin M production by T cells.
material entity;Agilent-026655 Whole Mouse Genome Microarray 4x44K v2;A DNA microarray manufactured with Agilent 60-mer SurePrint Technology .The SurePrint G3 Mouse Gene Expression 4x44K v2 Microarray provide full coverage of the mouse transcriptome using the latest annotation databases, including long non-coding RNA(lncRNA). Each glass slide is formatted with four high-definition 44K arrays.
process;assay measuring a binding constant of a T cell epitope:MHC:TCR complex;A T cell epitope recognition assay that quantitavely characterizes the binding of a TCR with a ligand by determining a binding constant.
process;placental blood microbiology assay;A blood microbiology assay that detects microorganisms in a placental blood specimen.
process;3D molecular structure determination assay of a MHC:ligand complex;A 3D structure determination of bound molecular complex assay that characterizes the 3-dimensional structure of a MHC:ligand complex.
material entity;placental blood specimen;A specimen that is derived from placental blood.
process;in vivo assay measuring B cell epitope specific protection from infectious challenge based on pathogen burden;An in vivo assay measuring B cell epitope specific protection from pathogen challenge using pathogen burden.
generically dependent continuant;eukaryota in placental blood datum;A placental blood microbiology datum that is about eukaryota.
process;in vivo assay measuring B cell epitope specific protection after tumor burden challenge;An in vivo assay measuring B cell epitope specific protection from tumor challenge using tumor burden.
generically dependent continuant;placental blood microbiology datum;An organism detection datum that is the specified output of a placental blood microbiology assay.
process;microarray assay measuring binding of a B cell epitope:antibody complex;A microarray assay that detects the binding of an antigen with an antibody.
process;NMR assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A B cell epitope equilibrium dissociation constant (KD) determination assay that uses a nuclear magnetic resonance assay.
process;synaptosome preparation process;A material component separation process where a synaptic terminal is isolated from a neuron by mild homogenization of nervous tissue under isotonic conditions and subsequent fractionation using differential and density gradient centrifugation.
process;assay measuring biological activity resulting from T cell epitope:MHC:TCR binding;A T cell epitope recognition assay that measures the immune response process resulting from the binding of a T cell receptor to epitope or the recongition of the epitope.
material entity;Illumina NextSeq 550;A DNA sequencer manufactured by the Illumina corporation, which provides the increased flexibility of microarray scanning in addition to sequencing.
process;assay measuring epitope specific chemokine (C-C motif) ligand 17 production by T cells;A T cell epitope specific cytokine production assay that detects production of chemokine (C-C motif) ligand 17 production by T cells.
material entity;Illumina HiSeq 1500;A DNA sequencer which is manufactured by the Illumina corporation, with a single flow cell. Built upon sequencing by synthesis technology, the machine employs dual surface imaging and offers two high-output options and one rapid-run option.
material entity;Cell Lab Quanta SC;A Cell Lab Quanta SC is a flow cytometer analyser manufactured by Becman Coulter. It features a mercury arc lamp optimized at 366, 405, and 435 nm, and a 488 nm laser diode. It has filters and PMTs to collect up to 3 fluorescent parameters, and a photodiode for side scatter detection. This cytometer uses Couter-Volume for cell size measurements. The Cell Lab Quanta SC can be used for measuring the properties of individual cells.
material entity;BioSorter500;A BioSorter500 is a flow cytometer sorter manufactured by Union Biometrica. It includes analog electronics, 488/514 nm multi-line Argon-ion laser for fluorescence and a light stabilized 670 nm forward scatter laser for extinction and time-of-flight. It has filters and PMTs for 3 fluorescent parameters and photodiodes for scatter, time of flight, and extinction. The flow cell is quartz cuvette. The BioSorterTM 500 is an instrument for analyzing and sorting objects from 100-250 microns in diameter and less than 2mm in length.
material entity;BioSorter250;A BioSorter250 is a flow cytometer sorter manufactured by Union Biometrica. It includes analog electronics, 488/514 nm multi-line Argon-ion laser for fluorescence and a light stabilized 670 nm forward scatter laser for extinction and time-of-flight. It has filters and PMTs for 3 fluorescent parameters and photodiodes for scatter, time of flight, and extinction. The flow cell is quartz cuvette. The BioSorterTM 250 is an instrument for analyzing and sorting objects from 40-200 microns in diameter.
material entity;BioSorter2000;A BioSorter2000 is a sorter manufactured by Union Biometrica. It includes analog electronics, 488/514 nm multi-line Argon-ion laser for fluorescence and a light stabilized 670 nm forward scatter laser for extinction and time-of-flight. It has filters and PMTs for 3 fluorescent parameters and photodiodes for scatter, time of flight, and extinction. The flow cell is quartz cuvette. The BioSorterTM 2000 is an instrument for analyzing and sorting objects from 500 microns to 1.5 millimeters in diameter.
material entity;Agilent-074809 SurePrint G3 Mouse GE v2 8x60K Microarray;A DNA microarray manufactured with Agilent 60-mer SurePrint technology which provides comprehensive coverage of genes and transcripts using the latest annotation databases. The SurePrint G3 Mouse Gene Expression 8x60K v2 Microarray features complete coverage of established RefSeq coding transcripts (NM) from the latest build and updated long non-coding RNA (lncRNA) content to ensure relevant research.Each glass slide formatted with eight high-definition 60K arrays.
material entity;charge plate;Part of the fluidics subsystem. Charge plates are used or sorters. They create an charged electric field when particles deemed to be desired for further analysis are shaken form the piexo electric crystal. The charged particles are drawn toward the charged plate, and the altered drop location causes the particles to fall into a collection tube. Charge plates enable sorting.
material entity;argon ion laser;An argon-ion laser is an ion laser that uses argon ions as the lasing medium. These lasers are used primarily to emit light at wave lengths of 458 nm, 488 nm or 514.5 nm, though it is possible to use them to emit several wavelengths of blue and green light. Argon-ion lasers can emit light at many different wave lenghts, and excite a number of different flourochromes.
material entity;BioSorter1000;A BioSorter1000 is a flow cytometer sorter manufactured by Union Biometrica. It includes analog electronics, 488/514 nm multi-line Argon-ion laser for fluorescence and a light stabilized 670 nm forward scatter laser for extinction and time-of-flight. It has filters and PMTs for 3 fluorescent parameters and photodiodes for scatter, time of flight, and extinction. The flow cell is quartz cuvette. The BioSorterTM 1000 is an instrument for analyzing and sorting objects from 200-600 microns in diameter.
material entity;band pass filter;A band pass filter is an optical filter that passes wavelengths of light within a certain range and rejects (attenuates) frequencies outside that range. The passed wavelengths are indicated in the specifications of the filter and its name. A 480/20 band-pass filter pass light with at wavelengths of 460 to 500 nm and attenuates all others.
material entity;Bactiflow;A Bactiflow is a flow cytometer analyser manufactured by Chemunex SA. It is a cell counter for bacteria and other micro organisms. Bacteria are stained with a fluorochrome and the number of particles that fluoresce are counted. The system uses digital electronics, a single laser and a single detector. An ALS version is available as well - Automatic Labeling System. The Bactiflow is specialized cytometer used exclusively for counting microbes.
material entity;avalanche photodiode;An avalanche photodiode is typically used to collect photons emitted by forward scatter because it is far less sensitive, and less likely o be burned out, than a PMT. A photodiode with high quantum efficiency and a mechanism for producing gains as high as a few thousand.
process;cytometric bead array assay measuring epitope specific oncostatin M production by T cells;A cytometric bead array assay that detects oncostatin M production by T cells.
process;ELISPOT assay measuring epitope specific perforin release by T cells;An enzyme-linked immunospot assay that detects epitope specific perforin release by T cells.
material entity;Affymetrix Clariom S Assay, Human;A DNA microarray manufactured by Affymetrix, to obtain a gene-level view of the human transcriptome. The assay design covers >20,000 well-annotated genes, providing researchers with the ability to perform gene-level expression profiling studies, to identify expression biomarkers , and to quickly assess changes in key genes and pathways.
process;epitope specific TNF release by T cells;A biological process where T cells produce TNF resulting from the recognition of a T cell epitope.
process;assay detecting IFN-gamma production;An assay that determines information about the production of the cytokine interferon gamma
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific chemokine (C-C motif) ligand 17 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects chemokine (C-C motif) ligand 17 production by T cells.
material entity;Affymetrix Mouse Genome 430A 2.0 Array;A DNA microarray manufactured by Affymetrix for gene expression analysis focusing on approximately 14,000 well-characterized genes in the transcribed mouse genome using single-array cartridge. Sequences used in the design of the array were selected from GenBank, dbEST, and RefSeq. The sequence clusters were created from the UniGene database.
process;cytometric bead array assay measuring epitope specific chemokine (C-C motif) ligand 22 production by T cells;A cytometric bead array assay that detects chemokine (C-C motif) ligand 22 production by T cells.
material entity;Affymetrix Mouse Genome 430 2.0 Array;A DNA microarray manufactured by Affymetrix, which includes complete coverage of the GeneChip Mouse Expression Set 430, for analysis of over 39,000 transcripts and variants from more than 34,000 well-characterized mouse genes and UniGene clusters, on a single array. The sequences for this array were selected from GenBank, dbEST, and RefSeq., and sequence clusters cretaed from the UniGene database.
process;in vitro assay measuring epitope specific T cell killing;An in vitro cell killing assay that measures the killing of antigen presenting cells (APC) by T cells whose TCR recognizes an epitope presented by the APC.
material entity;Affymetrix Mouse Gene 2.1 ST Array;A DNA microarray manufactured by Affymetrix, which is a whole-transcript array that includes probes to measure both messenger (mRNA) and long intergenic non-coding RNA transcripts (lincRNA).To supplement the lincRNA data contained in RefSeq, we used sequence and transcript data from lncRNA db.
process;cytometric bead array assay measuring epitope specific granzyme A release by T cells;A cytometric bead array assay that detects epitope specific granzyme A release by T cells.
material entity;Affymetrix Mouse Gene 1.0 ST Array;A DNA microarray manufactured by Affymetrix, which is a whole-transcript array that includes probes to measure both messenger (mRNA) and long intergenic non-coding RNA transcripts (lincRNA). This whole-transcript array design provides a complete expression profile of mRNA as well as the intermediary lincRNA transcripts that impact the mRNA expression profile.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific granzyme A release by T cells;A detection of specific nucleic acids with complementary probes assay that detects epitope specific granzyme A release by T cells.
material entity;Affymetrix Human Transcriptome Array 2.0;A DNA microarray manufactured by Affymetrix, to go beyond gene-level expression profiling to accurately detect all known transcript isoforms produced by a gene. The array design covers >245,000 coding transcripts, >40,000 non-coding transcripts and >339,000 probe sets covering exon-exon junctions, thus ensuring uniform coverage of the transcriptome.
process;cytometric bead array assay measuring epitope specific granzyme B release by T cells;A cytometric bead array assay that detects epitope specific granzyme B release by T cells.
material entity;Affymetrix Rhesus Macaque Genome Array;A DNA microarray manufactured by Affymetrix,which is a single-labeled high-density oligonucleotide array, designed to study gene expression in the rhesus animal model and to interrogate rhesus transcripts orthologous to the 3' end of human transcripts. The array consists of over 52,000 probe sets representing more than 20,000 genes, and several relevant viral organisms for studying host-disease immune response.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific granzyme B release by T cells;A detection of specific nucleic acids with complementary probes assay that detects epitope specific granzyme B release by T cells
material entity;Affymetrix Human Gene 2.0 ST Array;A DNA microarray manufactured by Affymetrix, which provides the most accurate, sensitive, and comprehensive measurement of protein coding (mRNA) and long intergenic non-coding RNA (lincRNA) transcripts. The array design covers >33,500 coding transcripts and >11,000 lincRNA transcripts thus enabling researchers to understand whole-transcriptome gene expression at the gene and exon levels, which allows the study of transcript variants and alternative splicing events.
process;cytometric bead array assay measuring epitope specific macrophage migration inhibitory factor (MIF) production by T cells;A cytometric bead array assay that detects macrophage migration inhibitory factor (MIF) production by T cells.
material entity;Affymetrix Human Genome U219 Array;A DNA microarray manufactured by Affymetrix, which comprises more than 530,000 probes covering more than 36,000 transcripts and variants, which represent more than 20,000 genes mapped through RefSeq or via UniGene annotation. Sequences used in the design of the array were selected from the RefSeq version 36, UniGene database 219, and full-length human mRNAs from GenBank.
material entity;CytoSub;A CytoSub is a flow cytometer analyser manufactured by Cyto Buoy Inc. They are a single laser, multi parameter instrument. Various types of micro-laser are offered. available measuring parameters are forward light scatter, side scatter, and fluorescence (max. 9 colour bands). The current series have 5 parameters. The CytoSub is the submersible version equipped with a high pressure sample inlet loop and a high pressure housing to allow underwater operation down to 200 m, lowered on a cable or mounted on a flooded underwater vehicle.
material entity;CytoSence;A CytoSense is a flow cytometer analyser manufactured by Cyto Buoy Inc. They are a single laser, multi parameter instrument. Various types of micro-laser are offered. available measuring parameters are forward light scatter, side scatter, and fluorescence (max. 9 colour bands). The current series have 5 parameters. The CytoSense is the basic instrument, which can be used for normal laboratory applications, as well as for autonomous monitoring with internal data logging or direct data transmission. The special instrument design and its splashproof housing allow operation on moving platforms and outdoor sites.
material entity;CytoBuoy flow cytometer analyzer;A flow cytometer analyser which is manufactured by Cyto Buoy Inc. They are the buoy mounted version of the CytoSense, equipped with wireless transmission of control and data files. They are a single laser, multi parameter instrument. Various types of micro-laser are offered. available measuring parameters are forward light scatter, side scatter, and fluorescence (max. 9 colour bands). The current series have 5 parameters.
material entity;CyFlow Space;A CyFlow Space is a flow cytometer sorter manufactured by Partec. Its specs are: 8optical parameters, 6 colours:FSC, SSC, FL1-FL6 , 3laser light sources: 200mW@488nm blue solid state laser 25mW@635nm red diode laser 50mW@405nm violet or 8mW@375nm ultraviolet diode laser ultracompact desktop high end instrument. Parallel 16bit digital pulse processing. The CyFlow Space is a 6-Colour FCM System and Cell Sorter for Clinical Routine and Research.
process;in vivo assay measuring epitope specific proliferation of T cells;A T cell epitope specific proliferation assay that is performed in vivo.
material entity;cell sorter collection tube;Part of the fluidics subsystem. The collection tube is a vessel for capturing cells of interest that have been identified by a sorter. The collection tube is the end location of sorted cells.
material entity;CyFlow SL3;A CyFlow Sl3 is a flow cytometer analyser manufactured by Partec. Its specs are: ultracompact and fully equipped mobile/portable instrument, dimensions [cm]: L 43 x H 16 x D 37 , highest stability/robustness and highest precision, 5 optical parameters: FSC, SSC, FL-1, FL-2, FL-3, 20mW@488nm blue solid state laser, other laser light sources optional (UV, violet, green, red), WindowsTM XP FloMax (software for real time data acquisition, data display, and data evaluation), parallel 16 bit digital pulse processing. The CyFlow SL3 is a compact and dedicated portable Flow Cytometer for accurate and affordable cell analysis and true volumetric absolute counting in HIV Monitoring and AIDS patient follow-up by precise and direct CD4 and CD4% measurement.
material entity;allergen;A material entity bearing the disposition to cause an allergic reaction
material entity;CyFlow SL;a flow cytometer analyser manufactured by Partec. Its specs are: ultracompact and fully equipped mobile/portable instrument, dimensions [cm]: L 43 x H 16 x D 37, highest stability/robustness and highest precision, 5 optical parameters: FSC, SSC, FL-1, FL-2, FL-3, 20mW@488nm blue solid state laser , other laser light sources optional (UV, violet, green, red), WindowsTM XP FloMax (software for real time data acquisition, data display, and data evaluation), parallel 16 bit digital pulse processing Compact mobile Flow Cytometer for any kind of cell analysis and absolute volumetric counting. The CyFlow SL allows to analyze forward and side scatter signals in combination with up to 3 fluorescence channels.
process;epitope specific IL-5 release by T cells;A biological process where T cells produce IL-5 resulting from the recognition of a T cell epitope.
material entity;CYFlow ML;A CyFlow ML is a flow cytometer analyser manufactured by Partec. It is a digital machine which uses 4 light sources: triple laser configurations including new powerful 200mW@488nm blue solid state laser + 100W UV lamp for highest resolution DNA analysis, and can collect 16 optical parameters: FSC1, FSC2, SSC, FL1-FL13. Ultracompact high end desktop multilaser Flow Cytometer for all applications in cell analysis and absolute counting.
process;epitope specific IL-6 release by T cells;A biological process where T cells produce IL-6 resulting from the recognition of a T cell epitope.
material entity;Cyan;A Cyan is a flow cytometer analyser manufactured by Dako Cytomation. It features include digital electronics, three lasers: 488 nm, 635 nm, and 405 nm, and filters and collectors for nine fluorescent parameters and two scatter parameters. The Cyan can be used for measuring the properties of individual cells.
process;epitope specific killing by T cells;A biological process where T cells lyse antigen presenting cells resulting from the recognition of a T cell epitope on MHC molecules of the antigen presenting cell.
process;small RNA sequencing assay;An RNA-seq assay which is targeting small RNA (< 200 bp) sequences such as, but not exclusive to, miRNAs using, for example, small RNA library preparation kits.
process;bromouridine labeling and sequencing assay;An RNA-seq assay to identify spans of nascent transcription in the genome through isolation of recent bromouridine (Bru) labelled RNAs.
process;bromouridine pulse-chase and sequencing assay;An RNA-seq assay to identify RNA populations of specific ages through isolation of RNAs first labelled with bromouridine (Bru) followed by chasing in uridine for different periods of time.
process;cytometry time of flight assay;A cytometry assay in which the presence of molecules of interest on or in cells is indicated by binding of antibodies labeled with rare earth element tags which are detected by time-of-flight mass spectrometry.
process;high performance liquid chromotography assay;An analytical chromatography assay that utilizes a high performance liquid chromatography instrument for separation of compounts in a solution.
material entity;photodiode;A photodiode is a semiconductor photodetector used to detect light and generate an electrical current. Typically used in forward scatter (FSC) detection. The photodiode collects the forward light scatter in a cytometer.
process;whole genome sequencing assay;A DNA sequencing assay that intends to provide information about the sequence of an entire genome of an organism.
material entity;photodetector;A photodetector is a device used to detect and measure the intensity of radiant energy through photoelectric action. In a cytometer, photodetectors measure either the number of photons of laser light scattered on impact with a cell (for example), or the flourescence emitted by excitation of a fluorescent dye.
process;exome sequencing assay;A DNA sequencing assay that intends to provide information about the sequence of the protein coding components of a genome (exons).
material entity;particle delivery vessel;Part of the fluidics subsystem. A particle delivery vessel is used to introduce either a single sample or multiple samples to a flow cytometer. The most common particle delivery vessel is a sample tube.
process;microscopy assay;An imaging assay that utilizes a microscope to magnify features of the visualized material of interest that are not visible to naked eye.
material entity;optical subsystem;A device or part of a device that deals with the behavior and properties of light and the interaction of light with matter. Commonly optical subsystems consist of an excitation optics and collection optics. The excitation optics of a flow cytometer optical subsystem consist of the laser and lenses that are used to shape and focus the laser beam. The collections optics consist of a collection lens to collect light emitted from the particle laser beam interaction and a system of optical mirrors and filters to route specified wavelengths of the collected light to designated optical detectors. The optical subsystem in a flow cytometer consists of the equipment used to irradiate particles, and collect the light either emitted or scattered by those particles.
generically dependent continuant;digital object identifier;A centrally registered identifier symbol used to uniquely identify objects given by International DOI Foundation. The DOI system is particularly used for electronic documents such as journal articles.
process;enhanced cross-linking immunoprecipitation high-throughput sequencing assay;An iCLIP assay that is enhanced to robustly identify protein-RNA interactions with high efficiency through improvements in library preparation of RNA fragments.
material entity;multi-well plate;A particle deliver vessel. A multi-well plate is a vessel that can deliver multiple samples to a flow cytometer in a specified order. It must be used with a plate loader.
material entity;MoFlo;A MoFlo is a flow cytometer sorter manufactured by Dako Cytomation. It features digital electronics, the option to include several lasers (solid state 488 nm, 635 nm, and a 351 nm diode laser), and has the filtering and collection capacity for up to 10 flouresecent parameters. The MoFlo is an instrument that can be used to both analyze quantitatively and collect cells in a flowing medium.
material entity;mixed argon-krypton gas laser;A mixed argon krypton gas laser is an ion laser in which the lasing medium is a mixture of argon and krypton. A mixed argon-krypton laser can by used to irradiate cells in a flow cytometer.
material entity;metal vapor laser;A metal vapor laser is a gas laser in which the lasing medium is metal vapor. A metal vapor laser can by used to irradiate cells in a flow cytometer.
material entity;optical filter;An optical filter is an optical subsystem that selectively transmits light having certain properties (often, a particular range of wavelengths, that is, range of colours of light), while blocking the remainder. They are commonly used in photography, in many optical instruments, and to colour stage lighting Optical filters can be arranged to segregate and collect light by wave length.
material entity;obscuration bar;An obscuration bar is a an optical subsystem which is a strip of metal or other material that serves to block out direct light from the illuminating beam. The obscuration bar prevents the bright light scattered in the forward directions from burning out the collection device.
material entity;neodymium-YAG laser;A Neodymium-YAG (yttrium aluminum garnet) laser is a solid state laser in which the lasing medium is a solid rod of crystalline material pumped by a flash lamp or a diode laser. Typical output wavelengths are 355, 532, and 1064 nm. A neodymium-YAG laser can by used to irradiate cells in a flow cytometer.
process;IHC slide staining;A staining using labeled antibodies, i.e. the analytical part of immunohistochemistry. The staining is applied to fixed specimens on slides to identify biomarkers in tissues.
process;tumor challenge;The administration of a malignant cell to a host.
process;H&E slide staining;A staining using hematoxylin and eosin. The staining is applied to fixed specimens on slides to observe the whole structure and morphology of cells in a tissue. nuclei are stained dark blue/purple while cytoplasm is stained pink.
material entity;Mosquito Magnet Liberty Plus trap;An arthropod trap that is designed to emit a combination of carbon dioxide, heat, water, and oct-1-en-3-ol attractants while simultaneously using suction to trap arthropods. This trap has the same design as the Mosquito Magnet Pro trap but is smaller, is more lightweight, and uses a main line electricity supply instead of propane to power itself. Both use propane to produce the arthropod attractor.
material entity;H&E-stained fixed tissue slide specimen;A fixed tissue slide specimen that is the output of H&E slide staining.
process;epitope protection from infectious challenge experiment based on survival;An epitope protection from infectious challenge experiment that determines the success of the epitope intervention based on increased survival of the host compared to controls.
material entity;IHC-stained fixed tissue slide specimen;A fixed tissue slide specimen that is the output of immunohistochemistry slide staining.
process;in vivo challenge;The administration of a challenge to a live host.
material entity;single cell specimen;A cell specimen that contains only one cell.
process;epitope protection from tumor challenge experiment based on survival;An epitope protection from tumor challenge experiment that determines the success of the epitope intervention based on increased survival of the host compared to controls.
material entity;sheath tank;Part of the fluidics system. The sheath tank is the vessel that holds the sheath fluid at a constant pressure, allowing for it to be pushed into the flow chamber at a constant rate. The sheath tank holds the pressurized sheath fluid.
material entity;Illumina Genome Analyzer;A DNA sequencer manufactured by Solexa as one of its first sequencer lines, launched in 2006, and capable of sequencing 1 gigabase (Gb) of data in a single run.
process;epitope protection from tumor challenge experiment based on burden;An epitope protection from tumor challenge experiment in which the readout is a reduction in the presence of malignant cells in the host compared to controls.
material entity;Illumina HiSeq X Ten;A DNA sequencer that consists of a set of 10 HiSeq X Sequencing Systems.
material entity;cytometer sample tube;A particle delivery vessel. The cytometer sample tube is a vessel in which the sample is introduced to the cytometer. Frequently the tube is placed on the cytometer in such a manner that a seal is formed between the tube and cytometer, and gas is used to create enough pressure to push the sample out of the tube and into the cytometer.
process;mixed lymphocyte reaction assay;A cytometry assay where lymphocytes from two individuals are co-cultured with the lymphocytes from one of the allogeneic individuals (Responders) being labeled (with 3H Thymidine or BrdU) and the proliferation of the labeled cells is measured, which is thought to reflect recognition of histocompatibility antigens on the unlabeled cells (stimulators).
process;killer cell immunoglobulin-like receptor typing assay;A genotyping assay in which the alleles of genes encoding for killer cell immunoglobulin-like receptors are determined.
process;major histocompatibility typing assay;A genotyping assay in which the alleles of genes encoding for major histocompatibility complex molecules are determined.
material entity;preamplifier;A preamplifier is part of the electronics subsystem. It converts the current output from its associated detector to a voltage. The preamplifier is the first stage in analog electronics signal processing.
material entity;plate loader;Part of the fluidics system. A plate loader positions the wells of a multi-well plate under the aspiration tube is a preset order. A plate loader is used for high throughput applications.
material entity;piezo electric crystal;Apparatus in the fluidic subsystem of sorters that vibrates to break up the stream coming out of the flow chamber into droplets for sorting. The peizo electric crystal vibrates in a manner that breaks off droplets at regular intervals. Not all droplets contain a cell.
material entity;photomultiplier tube;A photomultiplier is a device that is normally in the form of a tube, that uses a photocathode to convert photons into photoelectrons which are then amplified. PMTs are typically used to detect SSC and fluorescent parameters. Cytometers have a PMT for each color they can collect.
material entity;Reflection;A Reflection is a sorter manufactured by iCyte. It uses digital signal processing, and can be configured with lasers of the users choice from among these excitation wavelengths: 355, 405,488, 532, 635nm. It accommodates up to 48 traditional PMTs. Options include an acousto-optical tunable filter (AOTF) and 16 channel spectrometer (370 to 730 nm). The various detection components can be uniquely configured across multiple Highly Automated Parallel Sorting (HAPS) modules. The Reflection can be used to analyse, sort, and collect cells.
material entity;quartz cuvette flow chamber;A flow cell in which the laser irradiates the cell as it passes through a quartz cuvette. A quartz cuvette flow chamber can be used to allow the laser to irradiate cells.
process;assay measuring epitope specific chemokine (C-C motif) ligand 20 production by T cells;A T cell epitope specific cytokine production assay that detects chemokine (C-C motif) ligand 20 production by T cells.
process;in vivo assay measuring B cell epitope specific protection from tumor challenge;An in vivo assay measuring B cell epitope specific protection from tumor challenge.
process;in vivo assay measuring B cell epitope specific protection from pathogen challenge;An in vivo assay measuring B cell epitope specific protection from pathogen challenge.
process;RNA Integrity Number calculation;A data transformation using the RIN algorithm to generate a quality measure of RNA based on features from an electrophoretic trace.
process;in vivo assay measuring B cell epitope specific survival after pathogen challenge;An in vivo assay measuring B cell epitope specific protection from pathogen challenge using survival.
generically dependent continuant;RNA Integrity Number value specification;A value specification that specifies the value of the RNA Integrity Number as a real value between 1 (most degraded) and 10 (most intact).
process;in vivo assay measuring B cell epitope specific protection from other challenge;An in vivo assay measuring B cell epitope specific protection from a challenge other than pathogen, infection, or tumor.
generically dependent continuant;temperature value specification;A value specification that specifies the temperature of some thing.
site;jet in air flow chamber;A flow cell in which the cells are pinched off as droplets and allowed to drop through the air. The laser intersects with the cell in mid-air. A jet in air flow chamber allows the laser to intersect with the cells without any intermittent media other than air.
generically dependent continuant;volume value specification;A value specification that specifies the volume of some thing.
process;in vivo assay measuring B cell epitope specific survival after tumor challenge;An in vivo assay measuring B cell epitope specific protection from tumor challenge using survival.
material entity;ion laser;An ion laser is a gas laser which uses an ionized gas as its lasing medium.
process;in vivo assay measuring T cell epitope specific protection from pathogen challenge;An in vivo assay measuring T cell epitope specific protection from pathogen challenge.
material entity;Illumina Infinium Omni5Exome-4 Kit;An Illumina BeadChip which is an array that interrogates over 4.3 million whole-genome variants for genotyping and copy number variation.
process;in vivo assay measuring T cell epitope specific protection from other challenge;An in vivo assay measuring T cell epitope specific protection from a challenge other than pathogen, infection, or tumor.
material entity;Illumina Infinium MethylationEPIC v1.0 BeadChip;An Illumina methylation BeadChip which is an array that interrogates ~ 850,000 methylation sites per sample at single-nucleotide resolution.
process;in vivo assay measuring T cell epitope specific protection from tumor challenge;An in vivo assay measuring T cell epitope specific protection from tumor challenge.
process;pulse stable isotope labeling by amino acids in cell culture;An assay that detects differences in protein abundance using samples that have been metabolically labeled in vivo with a stable non-radioactive heavy isotope containing amino acid for a short period of time. After diluting the pulsed cells into growth media without label, high resolution mass spectrometry-based proteomics is used to analyze the time-dependent decay and determine protein stability.
process;in vivo assay measuring T cell epitope specific survival after pathogen challenge;An in vivo assay measuring T cell epitope specific protection from pathogen challenge using survival.
process;cytometric bead array assay measuring epitope specific chemokine (C-C motif) ligand 20 production by T cells;A cytometric bead array assay that detects chemokine (C-C motif) ligand 20 production by T cells.
process;in vivo assay measuring T cell epitope specific survival after tumor challenge;An in vivo assay measuring T cell epitope specific protection from tumor challenge using survival.
site;interrogation point;Point within the fluidic subsystem at which the laser intersects the stream, illuminating the cells where they emit their fluorescence and scatter the light. The laser irradiates the cell at the interrogation point.
material entity;Amnis ImageStream;The ImageStream is a multispectral imaging flow cytometer manufactured by Amnis. Its has digital electronics, a single standard 488 nm solid state laser. In addition an optional 658 nm and your choice of either a 405 nm or 375 nm solid state laser can be added. Information is collected using cameras. The ImageStream system CCD camera produces six images of each cell, including darkfield, brightfield, and up to four fluorescent colors. Each image is used to calculate over 40 features, so a six-image assay results in ~250 morphometric and photometric features per cell. The ImageStream is a flow cytometer that takes pictures of the cells in flow. It has both components, an Image cytometer and a flow cytometer.
material entity;helium neon ion laser;A helium-neon laser (HeNe) is an ion laser that uses helium and neon gas-ions as lasing medium. HeNe lasers emit at 543 nm and 633 nm most commonly and can also be used at 543, 594, and 611 nm.
material entity;helium cadmium ion laser;A helium-cadmium laser is a metal vapor laser that emits wavelengths of 442, 325 and 354 nms. This laser is a metal vapor laser. A helium-cadmium laser can by used to irradiate cells in a flow cytometer.
material entity;Guava Personal Cell Analysis-96;The Guava Personal Cell Analysis-96 Systems is a flow cytometer analyser that includes a single 532 nm laser, and filters and PMTs to collect up to 2 fluorescent parameters. It includes a photodiode forward scatter collector. Guava cytometers use aspiration instead of fluid systems to transport cells within the machine. The PCA96 uses either tubes or 96 well plates to introduce specimen. The Guava PCA -96 cytometer is a small portable cytometer particularly useful for field measurement.
material entity;Influx Cell Sorter;A Influx Cell Sorter is a flow cytometer sorter manufactured by Cytopeia. It is a digital machine, with these laser options: Coherent 70, 90, 300 series water cooled lasers, solid state UV 355nm, Violet 408nm, Violet-Blue 479nm, Blue-488nm, Green-531nm, Red-635nm, Red-647nm. The sorting is multi-way, index, and proportional sorting. Filters and PMTs are used for all parameters (including forward light scatter), and up to 12 PMTs can be included. The Influx cell sorter can be used to measure, sort, and collect ndividual cells.
material entity;inFlux Analyzer;The inFlux Analyzer is a flow cytometer analyser manufactured by Cytopeia. It is a digital machine, with these laser options: Coherent 70, 90, 300 series water cooled lasers, solid state UV 355nm, Violet 408nm, Violet-Blue 479nm, Blue-488nm, Green-531nm, Red-635nm, Red-647nm. Filters and PMTs are used for all parameters (including forward light scatter), and up to 12 PMTs can be included. The Influx analyser can be used to measure the properties of individual cells.
process;antigen specific antibodies assay;An analyte assay that measures the presence or amount of antibodies to a specified antigen.
process;in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells;An in vivo assay measuring a B cell epitope specific protection from a tumor challenge after adoptive transfer of epitope specific antibodies or B cells.
process;HIV antibody assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to human immunodeficiency virus (HIV) antigens.
process;in vivo assay measuring B cell epitope specific pathogen protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival;An in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using survival.
process;HIV group O antibody assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to human immunodeficiency virus (HIV) group O antigens.
process;in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells;An in vivo assay measuring a B cell epitope specific protection from other challenge after adoptive transfer of epitope specific antibodies or B cells.
process;surface HBV antibody assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to hepatitis B virus (HBV) surface antigens.
process;in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival;An in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using survival.
process;core HBV antibody assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to hepatitis B virus (HBV) core antigens.
material entity;MACS Quant;A MACS Quant is a flow cytometer analyser manufactured by Miltenyi. It uses digital electronics, and has three lasers of wavelengths 405 nm, 488 nm, and 635 nm. It has filters and detectors to collect 7 fluorescent parameters and 2 scatter parameters. The MACS Quant is an analyser usually used in research applications.
material entity;Luminex 200;A Luminex 200 is a flow cytometer analyser manufactured by Luminex. The optical specifications are: Reporter laser: 532 nm, nominal output 10 - 15 mW, maximum 500 mW, frequency-doubled diode. mode of operation, continuous wave (CW). Classification laser: 635 nm, 9.1 6%, maximum output 25 mW, diode. mode of operation, continuous wave (CW) Reporter detector: Photomultiplier tube, detection bandwidth of 565 - 585 nm Classification detector and doublet discriminator: Avalanche photo diodes with temperature compensation
process;in vivo assay measuring T cell epitope specific pathogen protection from challenge resulting from the adoptive transfer of epitope specific T cells based on survival;An in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific T cells using survival.
process;temperature measurement assay;An assay to determine the temperature of an evaluant.
process;in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific T cells;An in vivo assay measuring a T cell epitope specific protection from a pathogen challenge after adoptive transfer of epitope specific antibodies or B cells.
process;volume measurement assay;An assay to determine the volume of an evaluant.
process;in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells based on survival;An in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells using survival.
process;Nanostring nCounter miRNA expression assay;A microRNA profiling assay using digital molecular barcoding technology to quantify target microRNA molecules without the need for amplification.
process;in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells;An in vivo assay measuring a T cell epitope specific protection from a tumor challenge after adoptive transfer of epitope specific T cells.
process;bromouride labeling and sequencing after UV exposure;An RNA-seq assay to identify transcription start sites and active enhancer elements through isolation of bromouridine (Bru) labelled RNAs after UV light exposure introduces transcription-blocking lesions.
process;in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells;An in vivo assay measuring a B cell epitope specific protection from a pathogen challenge after adoptive transfer of epitope specific antibodies or B cells.
process;extrachromosomal circular DNA sequencing assay;An assay which aims at identifying the endogenous population of extrachromosomal circular DNA originating from a subset of genomic loci and potentially having profound consequences on the regulatory and coding capabilities of these regions. The assay includes creation of a library out of the circular DNA molecules and subsequent sequencing using parallelized sequencing methods.
process;in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells;An in vivo assay measuring a T cell epitope specific protection from other challenge after adoptive transfer of epitope specific T cells.
material entity;light source;A light source is an optical subsystem that provides light for use in a distant area using a delivery system (e.g., fiber optics). Light sources may include one of a variety of lamps (e.g., xenon, halogen, mercury). Most light sources are operated from line power, but some may be powered from batteries. They are mostly used in endoscopic, microscopic, and other examination and/or in surgical procedures. The light source is part of the optical subsystem. In a flow cytometer the light source directs high intensity light at particles at the interrogation point. The light source in a flow cytometer is usually a laser.
material entity;laser;A laser (acronym for light amplification by the stimulated emission of radiation) is a light source that emits photons of the same characteristics in a coherent beam. A laser uses a solid, liquid or gaseous lasing medium, that contains molecules, of which some atoms have electrons that emit photons of the same frequency when falling back to their normal orbital after excitation (pumping) by external means A laser is the most common way to irradiate a cell in a flow cytometer.
material entity;LactoScope C4;A LactoScope C4 is a spectrophotometer with which the composition of milk and milk products is analysed via infrared technology. The LactoScope determines the amount of the constituents fat, protein, lactose and the total solids content with extreme accuracy.
material entity;krypton ion laser;A krypton-ion laser is an ion laser that uses krypton as the lasing medium. These lasers can emit at 468, 476, 482, 520, 531, 568, 647 (the most powerful line), and 676 nm all at once. They have much lower gain than argon lasers however.
material entity;Luminex 100;The Luminex 100 is a flow cytometer analyser manufactured by Luminex. It is a single laser system (575 nm) with avalanche photodiodes in red and infrared and a single PMT for fluorescence. The flow chamber is a square quartz cuvette.
material entity;LSR2;A LSR2 is a sorter manufactured by Becton Dickinson. It features digital electronics, a solid state 488 nm blue laser and optionally can also have any combination of solid state UV (355 nm) and violet (405 nm) lasers and the a HeNe (633 nm) ion laser. The LSR2 has the filters and PMTs to work with 13 fluorescent parameters. The LSR II is one of the most common sorters in use.
material entity;long pass filter;A long pass filter is an optical filter that passes high wavelengths of light but attenuates (or reduces) wavelengths lower than the cutoff frequency. A long pass filter with a cutoff of 500 nm would pass all wavelengths greater than 500 nm.
material entity;logarithmic voltage amplifier;A logarithmic voltage amplifier is an analog electronic circuit that puts out a voltage or current proportional to the voltage or current at its input, with logarithmic proportionality. In an analog system, the logarithmic voltage amplifier is used to present parameters with a high dynamic range on a more useful scale.
process;ionize process;a physical process of converting an atom or molecule into an ion by adding or removing charged particles such as electrons or other ions. This excludes chemical processes of dissociation.
material entity;Affymetrix Clariom S Assay, Mouse;A DNA microarray manufactured by Affymetrix, to obtain a gene-level view of the mouse transcriptome. The assay design covers >20,000 well-annotated genes, providing researchers with the ability to perform gene-level expression profiling studies, to identify expression biomarkers, and to quickly assess changes in key genes and pathways.
function;material separation function;A material separation function is a function that increases the resolution between two or more material entities. The to distinction between the entities is usually based on some associated physical quality.
function;heat function;A heat function is a function that increases the internal kinetic energy of a material
material entity;Illumina MouseRef-8 v2.0 beadchip;An Illumina BeadChip which employs direct-hybridization assay, for whole-genome expression profiling in the mouse.This Beadchip contains 8 microarrays, featuring more than 25,000 probes per array, derived from the NCBI RefSeq database and supplemented with MEEBO and RIKEN FANTOM2 content.
function;contain function;A contain function is a function to constrain a material entities location in space
material entity;Illumina HumanHT-12 V4.0 expression beadchip;An Illumina BeadChip which employs direct-hybridization assay, for whole-genome expression profiling and expression-based quantitative trait loci (eQTL) studies. This BeadChip contains 12 arrays, each featuring more than 48,000 probes, targeting more than 31,000 annotated genes, providing genome-wide coverage of well-characterized genes, gene candidates, and splice variants.
material entity;Affymetrix Human Exon Junction Array;A DNA microarray manufactured by Affymetrix, used to identify exon-exon junctions associated with alternate splice variants in the human transcriptome.
material entity;Affymetrix Mouse Exon Junction Array;A DNA microarray manufactured by Affymetrix, used to identify exon-exon junctions associated with alternate splice variants in the mouse transcriptome.
function;mechanical function;A mechanical function is a function that is realised via mechanical work (through an certain amount of energy transferred by some force).
function;filter function;A filter function is a function to prevent the flow of certain entities based on a quality or qualities of the entity while allowing entities which have different qualities to pass through
function;perturb function;A perturb function is a function that disrupts the normal function of a system induced through either internal or external means. External means of perturbation include: (1) displacement fields in the physical sense - e.g., temperature change, osmotic shock, pressure change. (2) application of small molecules such as drugs or toxins to perturb the function of specific pathways or application of surfactants to perturb the normal function of plasma membrane. Internal means of perturbation include: (1) manipulation of gene function via gene knockout or transcript knockdown via RNAi. (2) directed genetic mutation leading to minimal aa alterations that interfere with peptide function.
function;synthesizing function;A synthesizing function is a function to assemble new output materials from distinct input materials. The output materials typically consist of chemically distinct monomeric objects or object aggregate polymers.
function;freeze function;A freeze function is a function to decrease the internal kinetic energy of a material below the freezing point of that type of material.
function;excitation function;A excitation function is a function to inject energy by bombarding a material with energetic particles (e.g., photons) thereby imbuing internal material components such as electrons with additional energy. These internal, 'excited' particles may lead to the rupturing of covalent chemical bonds or may quickly relax back to there unexcited state with an exponential time course thereby locally emitting energy in the form of photons.
function;electricity supply function;An electricity supply function is an energy supply function to transfer electricity from one source to another, typically a consumer of the electricity or as a stimulus during a neuroscience experiment.
function;transfer function;A transfer function is a function to displace a material from one location to another.
process;administering substance in vivo to cause disease;An administration of substance in vivo with the intention to induce disease in the organism.
function;liquid filter function;A liquid filter function is a filter function which prevents the flow of solid objects, defined by specific qualities, in a liquid-solid mixture
function;gas filter function;A gas filter function is a filter function which prevents the flow of solid objects, defined by specific qualities, in a gas-solid mixture
material entity;peripheral blood mononuclear cell specimen;A processed specimen that is extracted from whole blood using gradient centrifugation that separates the blood into a layer of peripheral blood mononuclear cells under the top layer of plasma. It contains lymphocytes, monocytes or macrophages that are critical components in the immune system.
process;administering substance in vivo to reduce or prevent disease;An administration of substance in vivo with the intention to reduce the symptoms of or prevent development of a disease in the organism.
generically dependent continuant;antigen specific antibodies assay datum;A data item that is the specified output of an antigen specific antibodies assay.
generically dependent continuant;mid-upper arm circumference datum;A length measurement datum that is the specified output of an assay measuring the length around an upper arm, taken midway along the upper arm.
material entity;isoelectric focusing device;An isoelectric focusing device is a device in which isoelectric focusing can be performed. An isoelectric focussing device had the function to contain and control the contained environment and transfer electrical energy from a power supply to a separation medium and the charged material to be separated.
function;connection function;A connection function is a function to couple two or more flow channels so that material or signals can be transported from one set of channels to another.
function;cool function;A cool function is a function to decrease the internal kinetic energy of a material below the initial kinetic energy of that type of material.
function;ionization function;An ionization function is a function to physically convert an atom or molecule into an ion by adding or removing charged particles such as electrons or other ions.
process;antigen specific antibodies in milk assay;An antigen specific antibodies assay that has a milk specimen as evaluant.
process;antigen specific antibodies in blood assay;An antigen specific antibodies assay that has a blood specimen as evaluant.
function;signal amplification function;A signal amplification function is a signal conversion function to inject energy into an input signal so as to produce an output signal with increased differential magnitude while also seeking to minimize increases in the signal to noise ratio. For example, to produce a 0.1 KW output signal from a 1 mW RMS input signal.
process;enzymatic activity level assay;An assay in which the level of catalytic activity of an enzyme is determined.
material entity;blot module;A blot module is a device which has the function to conatin and facilitate the material transfer process blotting to be realised
generically dependent continuant;antigen specific antibodies in milk assay datum;An antigen specific antibodies assay datum that is the specified output of an antigen specific antibodies in milk assay.
function;signal conversion function;A signal conversion function is an information processor function which transforms a signal into another type of signal. For example an analog-to-digital converter, Ac/Ac converter, a synapse converts electrical action potentials into an intermediate chemical signal. The post synapse converts it back into an electric one passed on to the axon.
process;alanine aminotransferase activity level assay;An enzymatic activity level assay that measures the activity of alanine aminotransferase in a sample.
function;information processor function;An information processor function is a function that converts information from one form to another, by a lossless process or an extraction process.
process;5'-nucleotidase activity level assay;An enzymatic activity level assay that measures the activity of 5'-nucleotidase in a sample.
function;energy supply function;An energy supply function is a function to supply or transfer energy from an energy source to a consumer of the energy
process;amylase activity level assay;An enzymatic activity level assay that measures the activity of amylase in a sample.
material entity;thermostatic circulator;A thermostatic circulator is a device which cools or heats a circulating liquid. It has the function to contain control the contained environment and transfer energy from or to the circulating liquid
process;alkaline phosphatase activity level assay;An enzymatic activity level assay that measures the activity of alkaline phosphatase in a sample.
process;cholinesterase activity level assay;An enzymatic activity level assay that measures the activity of cholinesterase in a sample.
process;aspartate aminotransferase activity level assay;An enzymatic activity level assay that measures the activity of aspartate aminotransferase in a sample.
function;solid support function;A solid support function is a function of a device on which an entity is kept in a defined position and prevented in its movement
material entity;image creation device;An image creation device is a device which captures a digitized image of an object
function;image acquisition function;An image acquisition function is a function to acquire an image of a material
generically dependent continuant;antigen specific antibodies in blood assay datum;An antigen specific antibodies assay datum that is the specified output of an antigen specific antibodies in blood assay.
material entity;SomaScope;The SomaScope is an instrument to quantify somatic cells in milk.
process;creatine kinase activity level assay;An enzymatic activity level assay that measures the activity of creatine kinase in a sample.
material entity;Somacount;A Somacount is a flow cytometer analyser manufactured by Bently Instruments. It is a specialized tool for counting somatic cells in milk by specifically staining them with Ethidium Bromide and counting the cells that fluoresce. It has one laser, and the filters and a PMT for the single parameter. There are three sizes available, the 150, 300, and 500 with the number indicating the maximum number of cells that can be analysed per hour. The Somacount is an example of a very specific use cytometer. it exclusively counts somatic cells in milk.
material entity;solid state laser;A solid-state laser is a laser that uses a lasing medium that is a solid, rather than a liquid such as dye lasers or a gas such as gas lasers. Semiconductor-based diode lasers are also in the solid state, but are generally considered separately from solid-state lasers. The first laser developed was an optical pumped ruby crystal solid state laser.
material entity;short pass filter;A short pass filter is an optical filter that passes low wavelengths of light but attenuates (or reduces) wavelengths higher than the cutoff frequency. A short pass filter with a cutoff of 500 nm would pass all wavelengths less than 500 nm.
material entity;flow cytometer sorter;A flow cytometer sorter is a flow cytometer that analyzes and separates or sorts particles passing through (based on properties measured during analysis) to collect cells of interest.
process;small-angle scattering assay determining the 3D structure of a B cell epitope:antibody complex;A small-angle scattering 3D molecular structure determination assay that characterizes the 3-dimensional molecular structure of a B cell epitope:antibody complex
process;lactate dehydrogenase activity level assay;An enzymatic activity level assay that measures the activity of lactate dehydrogenase in a sample.
process;bio-layer interferometry assay measuring the on rate [kon] of a B cell epitope:antibody complex;A bio-layer interferometry assay that measures the on rate of an antigen with an antibody.
process;isocitrate dehydrogenase activity level assay;An enzymatic activity level assay that measures the activity of isocitrate dehydrogenase in a sample.
process;bio-layer interferometry assay measuring the off rate [koff] of a B cell epitope:antibody complex;A bio-layer interferometry assay that measures the off rate of an antigen with an antibody.
process;acyl-CoA oxidase activity level assay;An enzymatic activity level assay that measures the activity of Acyl-CoA oxidase in a sample.
process;bio-layer interferometry assay measuring binding of a B cell epitope:antibody complex;A bio-layer interferometry assay that detects the binding of an antigen with an antibody.
process;sorbitol dehydrogenase activity level assay;An enzymatic activity level assay that measures the activity of sorbitol dehydrogenase in a sample.
process;bio-layer interferometry assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A bio-layer interferometry assay that measures the dissociation constant [KD] of an antigen with an antibody.
process;ribonuclease activity level assay;An enzymatic activity level assay that measures the activity of ribonuclease in a sample.
process;carboxyfluorescein succinimidyl ester staining assay;An assay using carboxyfluorescein succinimidyl ester staining.
process;N-acetyl-beta-glucosaminidase activity level assay;An enzymatic activity level assay that measures the activity of N-acetyl-beta-glucosaminidase in a sample.
process;bio-layer interferometry assay;A binding assay that detects a shift in the interference pattern reflected from a layer of immobilized material on the biosensor tip to measure binding to- or dissociating from the material on the biosensor.
process;small-angle scattering 3D molecular structure determination assay;A 3D molecular structure determination assay in which the scattering pattern of a neutron or x-ray beam targeted at a material entity is recorded at small angles relative to the incident beam to determine the size, shape and structure of the material entity examined.
process;galactosidase activity level assay;An enzymatic activity level assay that measures the activity of galactosidase in a sample.
process;glutamate dehydrogenase activity level assay;An enzymatic activity level assay that measures the activity of glutamate dehydrogenase in a sample.
process;assay measuring the association constant [KA] of a T cell epitope:MHC:TCR complex;A T cell epitope binding constant determination assay that measures the association constant KA.
process;gamma-glutamyltransferase activity level assay;An enzymatic activity level assay that measures the activity of gamma-glutamyltransferase in a sample.
process;chromium release assay;An in vitro cell killing assay in which radioactive chromium is absorbed by cells and released into supernatant when the cells die. The amount of radioactivity measured in the supernatant is a proxy for the number of cells that have died.
material entity;Human 6x630K CGH Whole Genome Tiling Array;A tiling array which is manufactured by the Nimblegen corporation to analyze DNA sequence copy number by comparative genomic hybridization for human DNA against 6x630,000 features.
process;chromatography assay measuring binding of a B cell epitope:antibody complex;An analytical chromatography assay that detects the binding of an antigen with an antibody.
generically dependent continuant;prevalence of pathogen in specimens;A data item that is the frequency of detection of a specified pathogenic organism in collected specimens.
process;NMR assay measuring binding of a B cell epitope:antibody complex;A B cell epitope qualitative binding to antibody assay that uses a nuclear magnetic resonance assay.
generically dependent continuant;prevalence of blood meal specimens from a host organism;A data item that is the frequency of blood whose source is from a specified host organism in collected blood meal specimens.
process;ELISA measuring epitope specific granulysin release by T cells;An enzyme-linked immunosorbent assay that detects epitope specific granulysin release by T cells.
generically dependent continuant;presence of blood from host organism in blood meal specimen;A data item that indicates whether blood in a blood meal specimen came from a specified host organism.
process;intracellular material detection assay measuring epitope specific granulysin release by T cells;A flow cytometry assay that detects epitope specific granulysin release by T cells.
material entity;blood meal source organism;An organism that is the source of a blood meal.
process;fluorescence detection assay measuring binding off rate [koff] to determine direct binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures binding off rate [koff] to detect direct binding of a cell-bound-MHC molecule with a ligand.
role;blood meal source role;A role borne by an organism that is gained during a process in which another organism ingests blood as food from the organism.
process;fluorescence detection assay measuring binding on rate [kon] to determine direct binding of a cell-bound-MHC:ligand complex;A fluorescence detection assay that measures binding on rate (kon) to detect direct binding of a cell-bound-MHC molecule with a ligand.
role;arthropod attractor role;A role of a material entity realized in drawing an arthropod in the direction of the material.
process;fluorescence detection assay measuring equilibrium dissociation constant [KD] to determine competitive binding of a purified-MHC:ligand complex approximated by IC50;A fluorescence detection assay that measures equilibrium dissociation constant (KD) to detect the loss of binding of a known reference ligand to purified-MHC due to competition by the ligand under investigation and provides IC50 values determined under assay conditions where the IC50 approximates a KD value.
process;arthropod collection process with automated identification;An arthropod specimen collection process that involves a device that produces data specifying the types of arthropod collected.
process;split-ubiquitin assay;A binding assay that screens membrane soluble proteins by fusion of two integral membrane proteins (bait and prey) to two different ubiquitin moieties. One moiety is also fused to a transcription factor (TF) that can be cleaved off by ubiquitin specific proteases. Upon bait and prey interaction, Nub and Cub-moieties assemble, reconstituting the split-ubiquitin. The reconstituted split-ubiquitin molecule is recognized by ubiquitin specific proteases, which cleave off the reporter protein, allowing it to induce the transcription of reporter genes.
process;gravid female arthropod specimen collection process;An arthropod specimen collection process that has the objective of collecting gravid female arthropods.
process;T cell receptor repertoire sequencing assay;A sequencing assay that determines the sequences of DNA or RNA molecules that encode the repertoire of T cell receptors within an input sample.
process;intracellular material detection assay measuring epitope specific granzyme A release by T cells;A flow cytometry assay that detects epitope specific granzyme A release by T cells.
process;B cell receptor repertoire sequencing assay;A sequencing assay that determines the sequence of a DNA or RNA molecules that encode the repertoire of B cell receptors within an input sample.
process;planning;a process of creating or modifying a plan specification
process;drawing a conclusion based on data;A planned process in which data gathered in an investigation is evaluated in the context of existing knowledge with the objective to generate more general conclusions or to conclude that the data does not allow one to draw general conclusion
process;far-western blot assay;An assay that measures protein-protein interactions by separating target proteins on an SDS-PAGE gel, transfering them to a solid substrate, hybridizing with a protein probe and visualizing bound proteins using a probe-directed antibody. This is a adaptation on the western blot assay.
process;gene knock-down assay;An assay which transiently disrupts gene transcripts by expressing antisense RNA constructs or delivering RNA interfering molecules in cells.
process;nano-cap analysis of gene expression assay;A transcription profiling assay that is performed using a very low amount (nanogram scale) of mRNA samples using Cap analysis gene expression (CAGE).
process;cap analysis of gene expression assay;A transcription profiling assay which measures RNA transcript abundances in biological samples by extracting 5' ends of capped transcripts, RTPCR and sequence those. Copy numbers of CAGE tags provide a way of quantification and provide a measure of expression of the transcriptome
process;ELISA measuring epitope specific interleukin-17A production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-17A production by T cells.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-7 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-7 production by T cells.
process;epitope specific granulysin production by T cells;A process of granulysin production by T cells resulting from the recognition of a T cell epitope.
process;epitope specific granzyme A production by T cells;A process of granzyme A production by T cells resulting from the recognition of a T cell epitope.
process;yeast 2-hybrid assay;An assay that detects protein protein interactions and protein DNA interactions by testing for physical interactions (such as binding) between two proteins or a single protein and a DNA molecule, respectively. The premise behind the test is the activation of downstream reporter gene(s) by the binding of a transcription factor onto an upstream activating sequence (UAS). For two-hybrid screening, the transcription factor is split into two separate fragments, called the binding domain (BD) and activating domain (AD). The BD is the domain responsible for binding to the UAS and the AD is the domain responsible for the activation of transcription. The Y2H is thus a protein-fragment complementation assay.
material entity;mass analyzer;A Mass analyzer is a device that separates ions according to their mass-to-charge ratio. All mass spectrometers are based on dynamics of charged particles in electric and magnetic fields in vacuum where the two laws of Lorentz force law and Newton's second law of motion apply.
process;inductive reasoning;a interpreting data that is used to ascribe properties or relations to types based on an observation instance (i.e., on a number of observations or experiences). or to formulate laws based on limited observations of recurring phenomenal patterns.
process;RNA protection assay;An assay that determines the presence and estimates abundance of transcript species by first creating an homo or heteroduplex by adding a specific, complementary sequence to the sequence of interest and then exposing the mixture of ribonuclease, which will degrade only single stranded molecules. A detection step will reveal if the sample contained a sequence of interest.
process;histological sample preparation;histological sample preparation is the preparation of an input tissue via slicing and labeling to make tissue microstructure of interest visible in a future histology assay
process;electrophoretic mobility shift assay;An assay that measures information about Protein-DNA or Protein-RNA interactions using gel electrophoresis and relying on the fact the molecular interactions will cause the heterodimer to be retarded on the gel when compared to controls corresponding to protein extract alone and protein extract + neutral nucleic acid.
process;chromosome organization assay by fluorescence in-situ hybridization;An in-situ hybridization assay that uses fluorescence to detect chromosomal integrity
process;methylation-specific polymerase chain reaction assay;An assay that uses initial modification of DNA by sodium bisulfite, converting all unmethylated, but not methylated, cytosines to uracil, and subsequent amplification with primers specific for methylated versus unmethylated DNA.
process;amplification of intermethylated sites assay;An assay that estimates genome-wide DNA methylation and measures methylation of DNA sequences. AIMS is based on the differential enzymatic digestion of genomic DNA with methylation-sensitive and methylation-insensitive isoschizomers followed by restrained PCR amplification of methylated sequences.
process;in-situ hybridization assay;An assay that localizes a specific DNA or RNA sequence within a portion or section of tissue using artificially induced nucleic hybridization.
role;contact representative role;A role inhering in a person who represents an institution, organization, or service provider and realized when communication is directed at them about the entity they represent.
process;cytochalasin-induced inhibition of actin polymerization assay;An assay which uses compound cytochalasin (CHEBI: 23528) to block actin polymerization-dependent cell motility (GO:0070358) and actin filament polymerization (GO:0030041).
process;hypothesis generating investigation;is an investigation in which data is generated and analyzed with the purpose of generating new hypothesis
process;hypothesis driven investigation;is an investigation with the goal to test one or more hypothesis
process;Sos-recruitment assay;A binding assay that detects interacting proteins for a targeted domain where mammalian guanyl nucleotide exchange factor (GEF) Sos is recruited to the Saccharomyces cerevisiae plasma membrane harboring a temperature-sensitive Ras GEF, Cdc25-2, allowing growth at the nonpermissive temperature using the Sos recruitment system, a kind of yeast 2 hybrid system.
process;yeast one-hybrid assay;An assay that determines protein DNA interactions using a single fusion protein in which the activating domain is linked directly to the binding domain.
process;bacterial one-hybrid assay;An assay that identifies the sequence-specific target site of a DNA-binding domain. In this system, a given transcription factor (TF) is expressed as a fusion to a subunit of RNA polymerase. In parallel, a library of randomized oligonucleotides representing potential TF target sequences, is cloned into a separate vector containing the selectable genes HIS3 and URA3. If the DNA-binding domain (bait) binds a potential DNA target site (prey) in vivo, it will recruit RNA polymerase to the promoter and activate transcription of the reporter genes in that clone. The two reporter genes, HIS3 and URA3, allow for positive and negative selections, respectively. At the end of the process, positive clones are sequenced and examined with motif-finding tools in order to resolve the favoured DNA target sequence
process;in vivo assay measuring B cell epitope specific induction of hypersensitivity;An efficacy of B cell epitope intervention experiment that detects a hypersensitivity response by monitoring skin reactions.
material entity;ion source;An ion source is a device that is part of a mass spectrometer that ionizes the material under analysis. The ions are then transported by magnetic or electric fields to the mass analyzer. Techniques for ionization have been key to determining what types of samples can be analyzed by mass spectrometry. Electron ionization and chemical ionization are used for gases and vapors. In chemical ionization sources, the material is ionized by chemical ion-molecule reactions during collisions in the source. Two techniques often used with liquid and solid biological samples include electrospray ionization (due to John Fenn PMID 2675315.) and matrix-assisted laser desorption/ionization (MALDI, due to M. Karas and F. Hillenkamp (Measuring Mass: From Positive Rays to Proteins by Michael A. Grayson (Editor) (ISBN 0-941901-31-9))).
process;assay measuring epitope specific immune complex formation;A B cell epitope specific activation of additional immune response assay that detects agglutination in vitro.
process;in vivo assay measuring B cell epitope specific protection based on survival;An in vivo assay measuring B cell epitope specific protection from other challenge using survival.
process;in vivo assay measuring B cell epitope specific treatment of disease;An efficacy of B cell epitope intervention experiment that detects a decrease in disease.
process;assay measuring B cell epitope specific in vivo activity;A B cell epitope dependent biological activity determination assay that uses an in vivo intervention experiment.
process;antibody cross-blocking assay;A competitive inhibition of binding assay in which two antibodies that are known to bind the same antigen are tested for the ability of one antibody to inhibit binding of the other antibody to the antigen, thereby determining if they have overlapping binding sites.
function;magnify function;A magnify function is a function to increase the size of a transmitted object image through the precise arrangement of energy diffraction elements along an imaging path.
function;record function;A record function is a function that registers or collects information in a particular format on a particular recording medium. For example on paper or a digital representation
function;light emission function;A light emission function is an excitation function to excite a material to a specific excitation state that it emits light.
process;metabolite profiling assay;An assay that detects and identifies chemical entities resulting from biochemical and cellular metabolism
generically dependent continuant;molecular function identification objective;is an objective specification which aims to discover molecular function realized by a molecular entity
generically dependent continuant;cellular structure feature identification objective;is an objective specification which aims to discover cellular structure properties
material entity;ion detector;An ion detector is a device that measures and records the charge induced or current produced when an ion passes by or hits a surface. Example: In a scanning instrument the signal produced in the detector during the course of the scan versus where the instrument is in the scan (at what m/Q) will produce a mass spectrum, a record of ions as a function of m/Q.
process;in vivo assay measuring B cell epitope specific protection from fertility;An efficacy of B cell epitope intervention experiment that uses a epitope protection experiment based on reduction of fertility.
process;in vivo assay measuring B cell epitope specific tolerance induction;An efficacy of B cell epitope intervention experiment that uses a tolerance induction intervention experiment.
process;fluorescence imaging-based drug synergy assay;A type of cytometry assay in which fluorescent dyes are used to label and detect proteins or structures to determine if drugs applied to cells in combination have a greater effect together than the sum of their separate effects.
generically dependent continuant;latitude coordinate measurement datum;A measurement datum that is the measure of the latitude coordinate of a site.
process;fluorescence imaging-based cell morphology assay;A type of cytometry assay in which fluorescent dyes are used to label and detect proteins or structures in order to determine cell morphology.
generically dependent continuant;longitude coordinate measurement datum;A measurement datum that is the measure of the longitude coordinate of a site.
process;fluorescence imaging multiplex cytological profiling;A type of cytometry assay in which fluorescent dyes are used to stain seven major cellular components followed by automatic image capture and analysis which extracts shape, texture, and intensity parameters.
generically dependent continuant;investigation title;A textual entity that denotes an investigation.
process;protein state assay;A type of assay that measures the quantity and/or identity of proteins in their modficied and unmodified states where modifications include phosphorylation, methylation, acetylation, etc.
generically dependent continuant;organism species detection objective;A biological feature identification objective to identify the organism species in a specimen.
process;fluorescence imaging-based protein phosphorylation state assay;A type of protein state assay that employs high-throughput microscopy to measure levels of proteins in different phosphorylation states.
process;organism species detection assay;An organism detection assay that identifies the organism species in a specimen.
process;mass spectrometry-based protein state assay;A type of protein state assay that employs mass spectrometry to measure levels of proteins in different phosphorylation states.
generically dependent continuant;sequence annotation algorithm;An algorithm used to identify sequence features (e.g. protein coding regions) in the assembled contig sequence. This may also include a description of any manual curation that may have generated or validated the annotation.
process;targeted, drug-modulated, mass spectrometry-based protein phoshporylation-state assay;A type of mass spectrometry protein state assay that measures levels of a targeted set of proteins in different phosphorylation states in response to drug perturbations.
material entity;Bioinformatics Resource Center;An organization that is one of the Internet-based research centers established and funded by NIAID (the National Institute of Allergy and Infectious Diseases). The Bioinformatics Resource Centers (BRCs) were formed in response to the threats posed by emerging and re-emerging pathogens, particularly CDC Category A, B, and C pathogens, and their potential use in bioterrorism. The intention of NIAID in funding these bioinformatics centers is to assist researchers involved in the experimental characterization of such pathogens and the formation of drugs, vaccines, or diagnostic tools to combat them.
process;reverse phase protein array profiling assay;A type of protein state assay where tissue or cell samples are lysed and then spotted onto a slide which is probed with antibodies specific to proteins with and without post-translational modifications.
generically dependent continuant;country name;A textual entity that denotes a geographic location that is a site or part of a site that is identified as a country in the political geography.
process;SWATH-MS protein profiling assay;A type of mass spectrometry assay using a data-independent acquisition method to identify target peptides.
generically dependent continuant;investigation identifier;A CRID symbol used to identify an investigation.
process;tandem mass tag mass spectrometry assay;A type of tandem mass spectrometry where isotopomer labels are employed for accurate quantification and identification of specific proteins.
generically dependent continuant;grant identifier;A CRID symbol used to identify a grant.
process;fluorescence imaging-based reporter gene assay;A type of reporter gene assay that employs fluorescence imaging to detect a reporter gene's expression.
process;analytical chromatography;An analyte assay that uses a biomaterial's preferential affinity for either the mobile phase or the stationary phase to separate it from other materials and thereby detect its presence in an input material.
process;global chromatin profiling by mass spectrometry assay;A type of epigenetic modification assay that employs targeted quantitative mass spectrometry to profile modifications of the core histones of chromatin.
process;electron microscopy imaging assay;An imaging assay in which an electrons are used to probe the density, shape and composition of an input material which are detected in an electron microscope and utilized to produce an image of the material.
process;kinase inhibitor assay;A type of assay that identifies compounds that inhibit the activity of kinases.
process;immuno staining assay;A assay detecting a molecular label assay in which the label is attached to an antibody so that substances are marked based on the antibody's binding specificity.
process;KINOMEscan assay;A type of proprietary kinase inhibitor assay that and employs a panel of kinases against which one can test compounds for their selectivity and potency in interactions with kinases, without the need to add ATP to the reactions.
material entity;purified material;A material entity that is generated by a purification process in which an input material is separated to obtain a fraction with a higher concentration of a desired component
process;KiNativ assay;A type of proprietary in situ kinase inhibitor assay that employs biotinylated acyl phosphates of ATP and ADP.
process;calorimetric binding assay;A binding assay in which the heat generated or absorbed during a binding event is measured, which allows determination of binding constants, reaction stoichiometry, enthalpy and entropy.
process;landmark transcript profiling assay;A type of transcription profiling assay in which a set of landmark transcripts that have been determined to provide a comprehensive profile of cell activity, plus numerous steady-state controls, are assayed via ligation-mediated amplification followed by capture on fluorescently labeled microspheres followed by detection of fluorescence.
process;antibody binding detection by fluorescence quenching;A binding assay in which affinity is measured by detecting a change in fluorescence (usually quenching) that occurs upon binding of the antibody to the ligand. The fluorescent signal that is affected by binding is either from an exogenous fluorophore attached to the ligand, or is the intrisic fluorescence of aromatic (tryptophan) residues on the binding site of the antibody (no conjugated fluorophore necessary) or, less commonly, on the ligand binding region (epitope).
process;microenvironment microarray assay;A type of cytometry assay where cells are incubated for three days with a standardized set of extracellular matrix proteins in combination with various ligands creating varying microenvironment perterbations for the cells. Immunofluorescent imaging of cells is used to measure features such as morphology, metabolism, cell cycle, and nuclear activity.
generically dependent continuant;grant;A plan specification of organization A to give money to organization B so that B conducts investigations. Organization A has funder role and Organization B has research organization role.
process;microwestern meso-scale quantitative western blot assay;A western blot assay that provides a high-throughput, sensitive, and quantitative measurement of proteins from numerous samples via an array of small western blots on a single sheet of nitrocellulose.
process;positive/negative ion switching metabolite profiling assay;A type of metabolic profiling assay which employs a hybrid dual quadrupole linear ion trap mass spectrometer for steady-state profiling of endogenous polar metabolites from organic extractions from biological samples.
process;antigen inhibition assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex approximated by IC50;A B cell epitope equilibrium dissociation constant (KD) assay that provides IC50 values determined under assay conditions where the IC50 approximates a KD value using a B cell epitope antigen inhibition of binding assay.
process;cyclic immunofluoroescence assay;A type of microscopy assay resulting in highly multiplexed immunofluorescence imaging through sequential rounds of imaging followed by fluorophore inactivation.
process;assay measuring epitope specific Ig-mediated histamine release;A B cell epitope specific activation of additional immune response assay that detects histamine release in vitro.
process;multiplex bead-based protein state immunoassay;A type of protein state assay in which antibodies attached to different colored beads and fluorescent reporter dye labels are used in a multiplexed mixture to assay for proteins in specific states.
process;assay measuring epitope specific immunoglobulin-mediated antigen activation;A B cell epitope dependent biological activity determination assay that detects antigen activation.
material entity;endotracheal tube specimen;A specimen that derives from a biofilm that forms on the inner surface of an endotracheal tube while the tube is in the trachea. The specimen is collected upon removal of the tube from the trachea.
process;assay measuring epitope specific complement-dependent cytotoxicity;A B cell epitope specific activation of additional immune response assay that detects complement-dependent cytotoxicity in vitro .
material entity;endotracheal aspirate specimen;A specimen that derives from a biofilm that forms on the inner surface of an endotracheal tube while the tube is in the trachea. The specimen is collected by suction without removing the tube.
process;assay measuring epitope specific antibody-dependent cellular cytotoxicity;A B cell epitope specific activation of additional immune response assay that detects antibody-dependent cellular cytotoxicity in vitro.
process;assay measuring epitope specific immunoglobulin-mediated neutralization;A B cell epitope dependent biological activity determination assay that detects neutralization of the antigen.
process;assay measuring epitope specific opsonization;A B cell epitope specific activation of additional immune response assay that detects opsonization in vitro .
generically dependent continuant;input protein sequence start site;The position of the first amino acid in a protein sequence being analyzed (input protein sequence).
process;calorimetry assay measuring binding of a B cell epitope:antibody complex;A calorimetric binding assay that detects the binding of an antigen with an antibody.
generically dependent continuant;input protein sequence stop site;The position of the last amino acid in a protein sequence being analyzed (input protein sequence).
process;electron microscopy assay determining the 3D structure of a B cell epitope:antibody complex;An electron-microscopy 3D molecular structure determination assay that characterizes the 3-dimensional molecular structrue of a B cell epitope:antibody complex
generically dependent continuant;input gene sequence start site;The position of the first nucleotide in a gene sequence being analyzed (input gene sequence).
generically dependent continuant;adverse event trigger;revisit?
role;material to be added role;A role of a material entity that is realized in an "adding a material entity into a target" process where the bearer of the role is added into another material entity (the target).
material entity;eluate;a eluate is a material entity which results from an elution, e.g. from a chromatography column. it has as part a material entity with role mobile phase
process;NMR assay determining the 3D structure of a B cell epitope:antibody complex;A nuclear magnetic resonance 3D molecular structure determination assay that characterizes the 3-dimensional structure of a B cell epitope:antibody complex.
generically dependent continuant;input gene sequence stop site;The position of the last nucelotide in a gene sequence being analyzed (input gene sequence).
process;cross blocking assay measuring binding of a B cell epitope:antibody complex;A cross-blocking assay that detects the binding of an antigen with an antibody.
generically dependent continuant;reference protein sequence start site;The position of the first amino acid in a reference protein sequence (sequence being used for comparison).
process;RIA measuring binding of a B cell epitope:antibody complex;A radio immuno assay that detects the binding of an antigen with an antibody.
process;immunoblot assay measuring binding of a B cell epitope:antibody complex;An immunoblot assay that detects the binding of an antigen with an antibody.
generically dependent continuant;reference gene sequence start site;The position of the first nucleotide in a reference gene sequence (sequence being used for comparison).
process;plasmon resonance assay measuring binding of a B cell epitope:antibody complex;A surface plasmon resonance binding assay that detects the binding of an antigen with an antibody.
generically dependent continuant;reference gene sequence stop site;The position of the last nucelotide in a reference sequence (sequence being used for comparison).
process;immuno staining assay measuring binding of a B cell epitope:antibody complex;An immuno staining assay that detects the binding of an antigen with an antibody.
generically dependent continuant;altitude measurement datum;A length measurement datum between a point at sea or ground level and some point above it.
process;immunoprecipitation assay measuring binding of a B cell epitope:antibody complex;An immunoprecipitation assay that detects the binding of an antigen with an antibody.
process;capture Hi-C assay;A Hi-C assay in which a selection step is performed on ligated fragments in order to enrich for ligation products containing specific regions of interest.
process;mass spectrometry assay measuring binding of a B cell epitope:antibody complex;A mass spectrometry assay that detects the binding of an antigen with an antibody.
process;magnetic resonance imaging assay;An imaging assay in which nuclear magnetic resonance is used to produce information about the interior structure and composition of an input material entity.
process;phage display assay measuring binding of a B cell epitope:antibody complex;A phage display binding assay that detects the binding of an antigen with an antibody.
process;computed tomography imaging assay;An imaging assay that uses a series of X-ray images to produce information about the interior structure and composition of an input material entity.
process;electron microscopy assay measuring binding of a B cell epitope:antibody complex;An electron microscopy imaging assay that detects the binding of an antigen with an antibody.
process;positron emission tomography imaging assay;An imaging assay in which positron-emitting radionuclides are used to visualize functional processes of an input material entity.
process;ELISA measuring binding of a B cell epitope:antibody complex;An enzyme-linked immunosorbent assay that detects the binding of an antigen with an antibody.
generically dependent continuant;specimen collection duration;A time measurement datum that is the count of collection cycles over which a specimen collection process occurs.
generically dependent continuant;reference protein sequence stop site;The position of the last amino acid in a reference protein sequence (sequence being used for comparison).
process;ELISPOT assay measuring binding of a B cell epitope:antibody complex;An enzyme-linked immunospot assay that detects the binding of an antigen with an antibody.
material entity;material supplier;A person or organization that provides material supplies to other people or organizations.
process;flow cytometry assay measuring binding of a B cell epitope:antibody complex;A flow cytometry assay that detects the binding of an antigen with an antibody.
process;immunoprecipitation assay;An analyte assay in which an input material is mixed with antibodies and bound antigen:antibody complexes are separated out using immunoprecipitation. Either the antibody has known specificy, and the antigen mixture is tested for the presence of a specific antigen, or the antigen solution is well defined and the antibody solution is tested for the presence of antigen specific antibodies.
process;antigen inhibition assay measuring binding of a B cell epitope:antibody complex;A B cell epitope qualitative binding to antibody assay that measures the ability of an antigen to inhibit antibody binding to a known ligand.
process;immunoglobulin binding to epitope;a process of an immunoglobulin complex binding to a material entity at the immunoglobulin complementarity determining region (CDR).
process;assay measuring qualitative binding of a B cell epitope:antibody complex;An assay that detects the binding of an antigen with an antibody, and produces a qualitative measurement of the binding as an output.
process;assay measuring epitope specific activation of additional immune response in vitro;A B cell epitope dependent biological activity determination assay that detects secondary in vitro activity.
process;assay measuring epitope specific antigen inhibition of antibody activity;A B cell epitope dependent biological activity determination assay that detects inhibition of the antibody's activity by the antigen.
process;assay measuring biological activity resulting from B cell epitope:antibody binding;A B cell epitope assay that measures the immune response process resulting from the binding of an antibody receptor to epitope or recognition of the epitope.
process;immunoglobulin mediated histamine release;The release of histamine by cells stimulated through their Fc receptors which are loaded with immunoglobulins.
process;assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A B cell epitope binding constant determination assay that measures the dissociation constant KD.
process;assay measuring a binding constant of a B cell epitope:antibody complex;A B cell epitope recognition assay that quantitavely characterizes the binding of an antibody / BCR with a ligand by determining a binding constant.
process;in vivo assay measuring B cell epitope specific protection from challenge;An efficacy of B cell epitope intervention experiment that uses a epitope protection experiment.
process;in vivo assay measuring B cell epitope specific disease exacerbation;An efficacy of B cell epitope intervention experiment that uses a disease exacerbation in vivo intervention experiment.
process;B cell epitope specific opsonization;opsonization resulting from antibody binding to epitope
process;B cell epitope specific immunoglobulin-mediated neutralization;immunoglobulin-mediated neutralization resulting from antibody binding to epitope
process;B cell epitope specific complement-dependent cytotoxicity;complement-dependent cytotoxicity resulting from antibody binding to epitope
process;B cell epitope specific antibody-dependent cellular cytotoxicity;antibody-dependent cellular cytotoxicity resulting from antibody binding to epitope
process;assay measuring the on rate [kon] of a B cell epitope:antibody complex;A B cell epitope binding constant determination assay that measures the on rate.
process;assay measuring the association constant [KA] of a B cell epitope:antibody complex;A B cell epitope binding constant determination assay that measures the association constant KA.
process;B cell epitope specific immune complex formation;immune complex formation resulting from antibody binding to epitope
process;3D molecular structure determination assay of an antigen:antibody complex;A 3D structure determination of bound molecular complex assay that characterizes the 3-dimensional structure of an antigen:antobody complex.
process;B cell epitope specific hypersensitivity;hypersensitivity resulting from antibody binding to epitope
process;assay measuring the off rate [koff] of a B cell epitope:antibody complex;A B cell epitope binding constant determination assay that measures the off rate.
process;viral hemagglutination inhibition assay measuring binding of a B cell epitope:antibody complex;A viral hemagglutination inhibition assay that detects the binding of an antigen with an antibody.
process;B cell epitope specific histamine secretion mediated by immunoglobulin;histamine secretion mediated by immunoglobulin resulting from antibody binding to epitope
process;quenching assay measuring binding of a B cell epitope:antibody complex;A fluorescence quenching assay that detects the binding of an antigen with an antibody.
process;RIA measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A radio immuno assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
process;ELISA measuring the dissociation constant [KD] of a B cell epitope:antibody complex;An enzyme-linked immunosorbent assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
process;quenching assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A fluorescence quenching assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
process;surface plasmon resonance assay measuring the association constant [KA] of a B cell epitope:antibody complex;A surface plasmon resonance binding assay that measures the association constant [KA] of an antigen binding with an antibody.
process;surface plasmon resonance assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A surface plasmon resonance binding assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
process;quenching assay measuring the association constant [KA] of a B cell epitope:antibody complex;A fluorescence quenching assay that measures the association constant [KA] of an antigen binding with an antibody.
process;calorimetry assay measuring the association constant [KA] of a B cell epitope:antibody complex;A calorimetric binding assay that measures the association constant [KA] of an antigen binding with an antibody.
process;calorimetry assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex;A calorimetric binding assay that measures the dissociation constant [KD] of an antigen binding with an antibody.
function;sort function;A sort function is a function to distinguish material components based on some associated physical quality or entity and to partition the separate components into distinct fractions according to a defined order.
function;environment control function;An environmental control function is a function that regulates a contained environment within specified parameter ranges. For example the control of light exposure, humidity and temperature.
function;display function;A display function is a function to present information by translating that information through some lookup process into visual form.
role;nucleic acid template role;a reference substance role which inheres in nucleic acid material entity and is realized in the process of using the nucleic acid bearing the template role as a reference during synthesis of a reverse copy.
process;viral RNA extraction;The extraction of RNA from an input material that specifically isolates viral RNA
material entity;PCR product;is double stranded DNA that is the specified output of a polymerase chain reaction
role;primer role;a complementary nucleotide probe role which inheres in nucleic acid molecular entity and is realized by the use of the entity bearing the role to initiate chain elongation.
material entity;gel dryer;A gel dryer is a device which has the function to contain and to control the contained environment to facilitate the drying of gels
process;ELISA measuring the association constant [KA] of a B cell epitope:antibody complex;An enzyme-linked immunosorbent assay that measures the association constant [KA] of an antigen binding with an antibody.
process;RIA measuring the association constant [KA] of a B cell epitope:antibody complex;A radio immuno assay that measures the association constant [KA] of an antigen binding with an antibody.
process;X-ray crystallography assay determining the 3D structure of a B cell epitope:antibody complex;A X-ray crystallography 3D molecular structure determination assay that characterizes the 3-dimensional molecular structrue of a B cell epitope:antibody complex.
process;surface plasmon resonance assay measuring the off rate [koff] of a B cell epitope:antibody complex;A surface plasmon resonance binding assay that measures the off rate [koff] of an antigen binding with an antibody.
material entity;Leica Peloris rapid tissue processor;An automatic tissue processor that is a dual retort tissue processor manufactured by the Leica company to provide fast, high quality tissue processing for histology laboratories.
material entity;Microm Ergostar HM200;A microtome that is manufactured by Microm and uses a vertical cutting stroke common to all rotary microtomes engaged by a horizontal sliding movement. An operating arm replaces the handwheel and is attached to both sides of the instrument for greater convenience to permit control of sectioning from the left or right.
material entity;microtome blade;A device that is the part of a microtome used to slice specimens to a desired thickness.
material entity;Sakura Low profile Accu-Edge microtome blade;A microtome blade that is manufactured by Feather and is disposable. The ultra-sharp blades section specimens without striations, distortion or chattering.
generically dependent continuant;tissue section thickness;A length measurement datum that is the result of an assay measuring the thickness of a tissue section.
material entity;molecular analysis facility organization;An organization that provides molecular analysis service.
generically dependent continuant;reason for lack of data item;An information content entity that provides an explanation why a data item is not provided.
material entity;vacuum dryer;An instrument which removes liquid by the application of negative pressure, i.e. vacuum.
material entity;thermal cycler;An instrument that is capable of repeatedly altering and maintaining specific temperatures for defined periods of time.
material entity;spectrophotometer;A spectrophotometer is an instrument that measures the intensity of light as a function of the color, or more specifically, the wavelength of light, transmitted by a substance.
material entity;sonicator;A device that converts a variable electrical current to mechanical vibration of a metallic probe. The device is used for the lysis of cells, the mixing of compounds or solutions, to framgent molecules of DNA, or to create emulsions.
material entity;microarray wash station;A device that is used to wash Affymetrix-type arrays.
material entity;vortexer;A vortexer is an instrument that mixes small vials of liquid by creating a rotation of the liquid around its own center. It consists of an electric motor with the drive shaft oriented vertically and attached to a cupped rubber piece mounted slightly off-center. As the motor runs the rubber piece oscillates rapidly in a circular motion. When a test tube or other appropriate container is pressed into the rubber cup (or touched to its edge) the motion is transmitted to the liquid inside and a vortex is created.
material entity;oligonucleotide synthesizer;An instrument used to chemically synthesize oligonucleotides.
material entity;liquid handler;A device that is used for automated liquid transfer and handling.
material entity;hybridization station;A device which is used to maintain the temperature of one or more hybridization chamber(s) at a defined, constant temperature.
material entity;hybridization chamber;A device which is used to maintain constant contact of a liquid on an array. This can be either a glass vial or slide.
material entity;temperature control bath;A temperature control bath is a device that has the function to regulate the temperature of a material, the function to contain fluid and the function to vary and maintain the temperature of the contained fluid. Heat exchange (energy transfer) between the material and the heating element is facilitated via the contained fluid. A temperature control bath is composed of a container, a heating element and/or a cooling element and a means to adjust the needed temperature. In most cases also a timer and a means to stir the fluid is provided as well.
material entity;molecular crosslinker;A device that is able to chemically join two or more molecules.
function;injection function;The function of a device realized when administering a substance in vivo, applied particularly to the forcible insertion of a liquid or gas by means of a syringe, pump, etc.
material entity;centrifuge;A device with a rapidly rotating container that applies centrifugal force to its contents
material entity;arrayer;A device which deposits biological material onto a substrate in a defined pattern.
material entity;array scanner;An processed material which acquires images of fluorescence (induced with lasers) from labeled molecules on the surface of the microarray chip
material entity;DNA sequencer;A DNA sequencer is an instrument that determines the order of deoxynucleotides in deoxyribonucleic acid sequences.
material entity;homogenizer;A homogenizer is an instrument for the homogenization of various types of material, such as tissue, plant, food, soil, and many others.
material entity;heating block;A heating block is an instrument or part of an instrument which raises or maintains the temperature of a sample to a defined constant temperature during certain parts of an assay
material entity;computer;A computer is an instrument which manipulates (stores, retrieves, and processes) data according to a list of instructions.
material entity;waste tank;Part of the fluidics systems. In analyzers the sheath and sample fluid, once analyzed is dumped into a waste tank. The waste tank is where the fluids passing through the cytometer end up after the analysis is finished.
material entity;voltage amplifier;A voltage amplifier is a device that amplifies the voltage signal.
material entity;syringe pump;Part of the fluidics system. A syringe pump can be used to inject the sample fluid and cells into the sheath fluid in the flow chamber. Syringe pumps are useful for creating stable flow rates.
process;rapid plasma reagin test;An analyte assay that is meant to detect with the aid of carbon or charcoal particles general antibodies that react with substances that are produced by cellular damage caused by Treponema pallidum indicating a syphilis infection. RPR tests can be done without a microscope.
process;cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells;A reporter cell line analyte detection bioassay that detects tumor necrosis factor superfamily cytokine production by T cells.
process;HBV surface antigen assay;An analyte assay that is meant to detect hepatitis B virus (HBV) surface antigens.
process;ELISA measuring epitope specific interleukin-25 production by T cells;An enzyme-linked immunosorbent assay that detects interleukin-25 production by T cells.
process;HIV-1 nucleic acid testing;An analyte assay that is meant to detect human immunodeficiency virus (HIV-1) nucleic acids.
process;HCV nucleic acid testing;An analyte assay that is meant to detect hepatitis C virus (HCV) nucleic acids.
material entity;Scrub Typhus Detect IgM ELISA kit;An assay kit that is manufactured by InBios International to use ELISA to test for IgM antibodies for Orientia tsutsugamushi strains Karp, Kato, Gilliam, and TA 716, with a protein microarray that has a 96-well plate and the 56-kDa type-specific antigen.
process;Gram stain assay;An organism detection assay that identifies bacteria based on the differential retention of a crystal violet-iodine complex within the cell wall.
process;core HBV IgM antibody assay;An antigen specific antibodies assay that is meant to detectimmunoglobulin M (IgM) antibodies that bind to hepatitis B virus (HBV) core antigens.
material entity;lymph specimen;A specimen that is derived from a portion of lymph collected from an organism.
process;HCV antibody assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to Hepacivirus C (HCV) antigens.
material entity;cow-baited arthropod trap;A resting arthropod trap that consists of a tent inside which an adult cow is tethered to the ground, in order to attract arthropods and collect those that rest on the interior walls of the tent.
process;EBV IgG antibody assay;An antigen specific antibodies assay that is meant to detect immunoglobulin G (IgG) antibodies that bind to Epstein-Barr virus (EBV) antigens.
process;assay measuring epitope specific interleukin-25 production by T cells;A T cell epitope specific cytokine production assay that detects interleukin-25 production by T cells.
process;EBV IgM antibody assay;An antigen specific antibodies assay that is meant to detect immunoglobulin M (IgM) antibodies that bind to Epstein-Barr virus (EBV) antigens.
material entity;digestive tract specimen;A specimen that is derived from part of a digestive tract.
process;CMV antibody assay;An antigen specific antibodies assay that is meant to detect antibodies that bind to cytomegalovirus (CMV) antigens.
process;intracellular cytokine staining assay measuring epitope specific interleukin-25 production by T cells;A flow cytometry assay that detects interleukin-25 production by T cells.
process;venereal disease research laboratory test;An analyte assay that is meant to detect general antibodies that react with substances that are produced by cellular damage caused by Treponema pallidum indicating a syphilis infection. VDRL tests require a microscope and can be done on cerebrospinal fluid as well as blood.
process;detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-25 production by T cells;A detection of specific nucleic acid polymers with complementary probes that detects interleukin-25 production by T cells.
material entity;digital-to-analog converter;A digital-to-analog converter is an instrument that converts a finite resolution digital signal into an infinite resolution analog signal.
material entity;droplet sorter;A droplet sorter is part of a flow cytometer sorter that converts the carrier fluid stream into individual droplets, and these droplets are directed into separate locations for recovery (enriching the original sample for particles of interest based on qualities determined by gating) or disposal.
material entity;oil bath;An oil bath is a temperature control bath in which oil acts as contact medium for the temperature transfer (from heating or cooling elements to the sample).
material entity;water bath;A water bath is a temperature control bath in which a water acts as contact medium enabling temperature transfer from the heating element or cooling element to the sample. The temperature can be controlled in the 0 to 100 degree centigrade range (under normal pressure).
process;subcellular protein localization assay;A protein localization assay that determines the specific subcellular location of a protein. The location is visualized through electron microscopy.
process;subcellular protein immunohistochemistry assay;An immunohistochemistry assay that uses antibodies to display the specific subcellular location of proteins.
process;organism detection assay;An assay that detects a type of organism and/or the quantity of individuals of a type of organism.
process;ChIP-qPCR assay;A ChIP assay that uses quantitative PCR to determine levels of specific DNA in immunoprecipitated samples.
material entity;animal cage;A processed material which has the function to define a bounded habitat which is amenable to keeping animals.
material entity;microscope slide;A microscope slide is a device usually made of glass which is used as a solid matrix for (biological) material deposited on its surface and which is compatible for use with a microscope instrument
material entity;Panbio Dengue Early ELISA kit;An assay kit that is manufactured by Abbott to detect the NS1 Dengue viral protein with a protein microarray and an anti-NS1 monoclonal antibody.
process;multiplexed indexed T7 ChIP-seq assay;A ChIP-seq assay which leverages T7 promoter amplification to allow low sample input and chromatin barcoding and pool-and-split multiplexing for high-throughput, quantitative profiling of chromatin states.
material entity;Panbio Dengue IgM capture ELISA kit;An assay kit that is manufactured by Abbott to test for IgM antibodies for Dengue with a two-plate protein microarray. One plate contains stabilized Dengue viruses 1 through 4, and the other plate contains anti-human IgM antibody.
process;systematic evolution of ligands by exponential enrichment assay;A binding assay that identifies protein-binding sites on nucleic acids by selecting high-affinity target ligands from a randomized pool. The process is repeated in rounds, then the bound nucleic acids are separated from the unbound nucleic acids and amplified by PCR.
material entity;SD Bioline Chikungunya IgM capture ELISA kit;An assay kit that is manufactured by Abbott to detect human IgM antibodies for Chikungunya with a protein microarray and ELISA.
process;footprinting assay;An assay that measures ligand binding and conformational changes by the solvent accessibility of the backbone, bases, or side-chain structures of macromolecules through their sensitivity to chemical or enzymatic cleavage or modification reactions.
material entity;SD Bioline Chikungunya IgM RDT kit;A device manufactured by Abbott for rapid detection of human IgM antibodies for Chikungunya virus in blood, using analytical chromatography.
process;DNAse footprinting assay;An enzymatic footprinting assay that determines protein-binding sites on DNA by identifying bound fragments that are protected from DNAse I-catalyzed hydrolysis
process;mammalian 2-hybrid assay;A binding assay that increases the expression of a reporter gene in mammalian cells by proteins of interest attached to two portions of the transcriptional activator, bringing those portions closer together.
material entity;Advantage Chikungunya IgM Card kit;An assay kit that is manufactured by J. Mitra to detect human IgM antibodies for Chikungunya virus with a protein microarray and double-antigen sandwich ELISA.
process;protein localization assay;An assay that determines the specific location of a protein. Subcellular localization is distinguished from tissue-based localization based on the type of microscopy applied.
process;tissue-based protein localization assay;A protein localization assay that determines the specific location of a protein in a living tissue sample.
material entity;microscope;A microscope is an instrument which magnifies the view on objects (too small to be viewed by the naked eye) under increased resolution. A microscope can be an optical instrument but also and electronic instrument. There are various kind of optical microscopes, e.g confocal microscope, epifluoresence microscope)
material entity;microtome;A microtome is a mechanical instrument used to cut biological specimens into very thin segments for further treatment (e.g. ISH) and ultimately microscopic or histologic examination. Most microtomes provide cooling facilities (cryo-microtome) and use a steel blade to cut a slice of defined thickness. Some are automatic, and some are driven by hand.
generically dependent continuant;direct submission to IEDB;A report about experiments in an investigation that characterize immune epitopes, and was submitted directly by the authors to the Immune Epitope Database (IEDB)
process;whole-cell patch clamp assay;A patch-clamp assay where the electrode is left in place on the cell, as in cell-attached recordings, but the membrane patch has been perforated, providing access from the interior of the pipette to the intracellular space of the cell. Measurements made with this technique involve recording currents through multiple channels simultaneously, over the membrane of the entire cell.
process;cell-attached patch clamp assay;A patch-clamp assay where the electrode is left in place on the cell, and the membrane patch has been left intact been perforated. This maintains the separation of the interior of the pipette to the intracellular space of the cell. Measurements made with this technique involve recording currents through multiple channels simultaneously, over the membrane of the entire cell.
process;genomic SELEX;A systematic evolution of ligands by exponential enrichment assay that starts with a library derived from genomic DNA instead of synthetically derived random DNA molecules.
process;dot blot assay;An analyte assay that detects molecules in a mixture dotted on a membrane using DNA probes or antibodies.
process;Northwestern blot assay;A direct binding assay that detects interactions of labeled RNA with immobilized protein on a membrane.
process;Southwestern blot assay;A direct binding assay that detects interactions of labeled DNA with immobilized protein on a membrane.
process;immunocytochemistry;An immuno staining assay in which samples of intact cells are examined that have had most, if not all, of their surrounding extracellular matrix removed
process;ATP bioluminescence assay;An analyte assay that detects ATP concentration through light intensity when luciferase catalyzes the oxidation of luciferin in the presence of ATP, magnesium ions, and molecular oxygen.
process;electrophysiology assay;An assay that measures the electrical properties of biological cells or tissues. Typically, this assay will generate measurements of voltage changes or electric current (or other associated variables such as impedence or capacitance).
process;patch clamp assay;An intracellular electrophysiology assay where a glass micropipette is sealed to the surface of the cell membrane as a recording electrode to study ion channel activity. The key distinction of this technique is the electrical resistance of the seal between the cell membrane and the pipette is of the order 10-100 gigaohms, permitting high-resolution current measurements over the cell membrane in several different standard configurations.
material entity;cytometer;A cytometer is an instrument for counting and/or measuring characteristics of cells.
process;inside-out patch clamp assay;A patch-clamp assay where a patch of the membrane is attached to the patch pipette, detached from the rest of the cell, and the cytosolic surface of the membrane is exposed to the external media, or bath. This provides the experimenter has access to the intracellular surface of the membrane via the bath and can manipulate the environment at the intracellular surface of single ion channels. For example, channels that are activated by intracellular ligands can then be studied through a range of ligand concentrations.
material entity;image cytometer;An image cytometer is an instrument for image-based study or measurement of cells.
process;local field potential recording;An extracellular electrophysiology assay where a microelectrode is placed in the extracellular space of brain tissue to measure action potential and compared to an electrode either outside or inside that tissue.
process;outside-out patch clamp assay;A patch-clamp assay where a patch of the membrane is attached to the patch pipette. In this configuration, the external surface of the cell membrane is exposed as the outside of the membrane patch relative to the patch electrode. An outside-out patch starts with a gigaohm seal in a whole-cell recording configuration. The electrode is slowly withdrawn from the cell, until a fragment of membrane bulges away from the cell, which detaches and reforms as a convex membrane on the end of the electrode, with the original external surface of the membrane facing outward from the electrode. This provides the experimenter with access to the extracellular surface of the membrane via the bath and can manipulate the environment at the extracellular surface of single ion channels.
process;voltage clamp assay;An cellular electrophysiology assay where the membrane potential of a cell is controlled by the experimentalist. This is accomplished through a feedback mechanism where any change in membrane potential is countered by permitting electrical current to flow into or out of the cell.
process;two electrode voltage clamp assay;The two electrode voltage clamp (TEVC) method utilizes two low-resistance pipettes, one sensing voltage and the other injecting current. The microelectrodes are filled with conductive solution and inserted into the cell to artificially control membrane potential. The membrane acts as a dielectric as well as a resistor, while the fluids on either side of the membrane function as capacitors.[9] The microelectrodes compare the membrane potential against a command voltage, giving an accurate reproduction of the currents flowing across the membrane. Current readings can be used to analyze the electrical response of the cell to different applications. This technique is mainly used in the Oocyte preparation.
process;cut open oocyte voltage clamp assay;The cut-open oocyte Vaseline gap (COVG) voltage-clamp technique is designed to solve weaknesses in the two elextrode voltage clamp by maximizing the benefits of the Xenopus oocyte expression system by improving on clamp speed, signal-to-noise ratio, and ability to effectively perfuse the oocyte. In this way, it was possible to combine the most popular transient expression system, and the associated benefits of molecular cloning and site-directed mutagenesis, with the superior voltage-clamp properties of cut-open cell techniques.
process;current clamp assay;The current clamp technique records the membrane potential by injecting current into a cell through the recording electrode. Unlike in the voltage clamp mode, where the membrane potential is held at a level determined by the experimenter, in "current clamp" mode the membrane potential is free to vary, and the amplifier records whatever voltage the cell generates on its own or as a result of stimulation. This technique is used to study how a cell responds when electric current enters a cell. this is important for instance for understanding how neurons respond to neurotransmitters that act by opening membrane ion channels.
process;electroencephalography;An extracellular electrophysiology assay where electrodes are mounted outside the brain (either on the surface of the scalp on onto the brain surface itself during surgery) to measure the electrical field over the external surface.
process;single-unit recording;An extracellular electrophysiology assay where a single microelectrode is placed in close proximity to a single neuron to measure voltage and current changes over time. This is the technicque used by Hubel and Wiesel to measure firing properties of primary visual cortex neurons in the 1950s in their original Nobel-prize winning study. A classic, old technique.
process;multi-unit recording;An extracellular electrophysiology assay where a collection of microelectrodes (often in an 'array' configuration) is placed into neural tissue to measure the distribution of voltage and current changes for a population of cells over time.
material entity;protein microarray;A protein-microarray is a microarray, ususlly a piece of glass, on which different molecules of protein have been affixed at separate locations in an ordered manner. These are used to identify protein-protein or protein-small molecule interactions.
material entity;DNA microarray;A DNA-microarray is a microarray that is used as a physical 2D immobilisation matrix for DNA sequences. DNA microarray-bound DNA fragments are used as targets for a hybridising probed sample.
material entity;microarray;A processed material that is made to be used in an analyte assay. It consists of a physical immobilisation matrix in which substances that bind the analyte are placed in regular spatial position.
material entity;courier organization;An organization that delivers messages, packages, and mail.
generically dependent continuant;courier tracking number;A centrally registered identifier symbol assigned by a courier organization in order to track the delivery of an item.
material entity;power supply;A power supply is an device or part of a device that permits the required application of a defined electrical charge to an instrument. The power supply may permit the defined application of a given amount of current for a defined length of time.
material entity;gel tank;A device which holds a gel and running buffers to allow electrophoresis to be performed. A gel tank has the function to contain and to control the contained environment and transfer energy from an energy supply through the running buffers to the gel matrix and the material with charged molecules in an electric field across a porous matrix or medium with the objective to separate the charged molecules.
material entity;multispectral imaging flow cytometer;A multispectral imaging flow cytometer is an instrument which combines quantitative image analysis and flow cytometry in a single platform. It measures the amount, location and movement of molecules on, in, or between cells, and the location and co-localization of multiple markers on or in cells. It can also quantitate morphologically distinct cell subpopulations.
material entity;fluorometer;A fluorometer is an instrument for the detection and measurement of parameters of fluoresence, which in turn are used to identify the presence and amount of specific molecules in the sample.
